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Abstract.
Abnormalities on membrane function are widespread in many diseased states. It has been 
for some time postulated that these abnormalities are not due to the membrane proteins 
themselves but the matrix surrounding them; the phospholipid bilayer. The composition of 
the membrane affects its fluidity, which in turn affects its function. This composition is 
complex and although methods have been published which examine some aspects, few have 
succeed in providing a comprehensive analysis. This was the principle aim of the current 
study
A method has been developed to separate the lipid groups in the membrane and to analyse 
their fatty acid content individually. Cell membrane lipids were extracted then separated 
using a combination of silica Sep-pak and thin layer chromatography. Fatty acid methyl 
esters were then produced by acid catalysed transesterification and analysed by gas 
chromatography-mass spectrometry (GC-MS). This allows both for efficient separation and 
for positive identification of the esters. From these analyses, it was possible to determine 
indices of fatty acid desaturation and the saturated/unsaturated fatty acid ratio. The 
concentration of phospholipids present in the membrane could also be determined. Cell 
membrane cholesterol was also analysed by GC-MS and membrane microviscosity was 
assessed by fluorescence anisotropy using the fluorescent probe trimethylammonium 
diphenylhexatriene (TMA-DPH). In order to evaluate the individual contribution of the 
various lipid groups to the physical properties of the membrane, membrane lipid from 
erythrocytes and from hepatocytes from three experimental situations were analysed.
When hypertension was induced in Wistar-kyoto (WKY) rats, using the nitric oxide 
synthase inhibitor N° -nitro-L-arginine-methyl ester (L-NAME), erythrocyte membrane 
microviscosity was reduced. This coincided with changes in membrane composition which 
may explain this change in fluidity. There was an increase in the amount of fatty acid 
present in the L-NAME-treated membrane and an increase in desaturase activity as 
measured by fatty acid ratios. Also, the levels of membrane sphingomyelin were reduced 
and the levels of phosphatidylcholine increased. These changes should have increased 
membrane fluidity. In opposition to this, the level of membrane cholesterol was increased in 
the L-NAME-treated group, which would be expected to cause a reduction in membrane 
fluidity. This suggests that the changes in phospholipid composition more than compensate 
for the increased cholesterol. The liver cell membrane was also studied. The fatty acid 
composition was altered by L-NAME treatment although the magnitude of the changes was
not as great as for erythrocytes. Moreover, the changes in composition were confined to 
the smaller membrane constituents, suggesting a possible membrane homeostatic mechanism 
in the liver, possible since this tissue has a high capacity to vary its own lipid metabolism.
Stroke-prone spontaneously hypertensive rats (SHRSP) have increased erythrocyte
membrane microviscosity. Two strains were studied, the SHRSP(GiasgoW) and 
SHRSP(Hiedieberg)? both were compared to their WKY control. The saturated fatty acid 
content of some of the major lipids increased as was amount of sphingomyelin present in the 
membrane. Both of these would make the membrane more rigid. Interestingly, there was 
also an increase in the amount of polyunsaturated fatty acid present in the membrane. In 
particular, arachidonic acid was increased in the total lipid, free fatty acid and 
phosphatidylinositol fraction. Arachidonic acid is a key substrate for the production of a 
number of active substances such as prostaglandins and thromboxanes. Thus, in addition to 
throwing light on the membrane physical nature, comprehensive analysis may also reveal 
changes of functional importance.
The SHRSP(Hiedieberg) cross was used to assess whether the gene(s) which control membrane 
composition cosegregates with the gene(s) which control with blood pressure. Although 
differences were observed between the parental strains, none was found to correlate with 
blood pressure. Therefore, this study provided no evidence that inherited membrane 
abnormalities are causally related to the increase in blood pressure.
In the final study, erythrocyte membranes from diabetic patients were analysed. Although 
the literature suggests that the membrane microviscosity may be altered by diabetes, no 
alterations were observed here. However, changes were observed in the membrane 
composition, with the most marked of these occurring in the insulin-dependant diabetic 
patients. This study highlighted the usefulness of this method at detecting differences in the 
smaller lipid fractions which may be physiologically relevant but undetectable in the total 
lipid analysis.
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Chanter 1 Introduction and Literature Review
1.1 Historical Overview of Membrane Structure.
Initial reports that the cell membrane has a bilayer structure came from Gorter and Grendel 
in 1925. In their experiments, the lipids from erythrocyte membranes were extracted and 
floated as a mono-layer on water. From the surface area which these lipids covered, they 
concluded that there was sufficient to cover the cell surface twice. It is now apparent that 
the surface area of the cell was underestimated and all the lipid was not extracted. 
However, these inaccuracies cancelled each other out and the theory of the phospholipid 
bilayer was bom. In the same year, Fricke measured the electrical capacitance of 
erythrocytes in suspension and hypothesised that the cells were surrounded by a 
hydrocarbon layersnmi thick (Fricke 1925). Danielle and Davson(1935) then suggested 
that the membrane has a lipid core with polar groups facing outwards. The surface of the 
membrane, they surmised, would be covered by a protein mono-layer. However, this 
would sequester water away from the hydrophilic polar head groups, making it an unlikely 
model.
With the invention of the electron microscope cell membranes could be visualised as 
‘railway tracks4 around the outside of the cell. Robertson (1959) proposed that the cell 
membrane is a three layered structure 5rim wide, as had been proposed 30 years earlier by 
Fricke. Low angle x-ray defraction analysis of the myelin sheath around nerve cells 
confirmed the presence of a bilayer structure and showed that the membrane contained 
dense areas, the polar lipid head groups, and less dense areas, the fatty acyl core (Lodish et 
al 1995).
Although all the evidence points toward the cell membranes having a bilayer structure, 
they were thought to be solid structures until the emergence of magnetic resonance data 
and experiments using fused heterakaryon0:ells. These showed that membrane proteins 
have lateral motion, suggesting that the membrane exists in a dynamic fluid state (Frye & 
Edidin 1970). Then in 1972, Singer and Nicolson published the fluid mosaic model of the 
cell membrane, which is now widely accepted.
1.2 Basic Structure and General Composition of Membranes.
The fluid mosaic model of the cell membrane is shown in fig 1.1a. Lipids are its major 
structural component. The membrane proteins either span the bilayer or are attached to 
the outside of it. Most of the lipid is amphipathic phospholipid and it is this property
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which results in the formation o f the bilayer. They have a polar head group and non-polar 
the fatty acyl chains and form a sheet-like structure spontaneously with the polar head 
groups facing the aqueous solutions on either side o f the bilayer. The internal core o f the 
membrane contains the fatty acyl chains which are repelled by the aqueous phase and form 
a continuous hydrophobic layer, stabilised by van der W aal’s forces between the fatty acyl 
chains. Ionic and hydrogen bonds between the polar head groups stabilise the outer 
regions o f the membrane. M ost lipids in the membrane are phosphoglycerides, although 
sphingolipids and sterols are also present along with small amounts o f triglycerides, free 
fatty acids and cholesterol esters (Lodish et a l 1995).
Extracellular Space
-  Carbohydrate
Hydrophilic
Hydrophobic
i jpgs:
Hydrophilic
Fatty Acyl Chain
Cholesterol ^
Transmembrane Protein
Cytoplasm
Fig 1.2 Diagram of a phospholipid bilayer showing the position o f phospholipids, 
cholesterol, cell membrane proteins and glycolipids. Modified from Gurr and Harwood
(1991).
Membrane proteins are responsible for the specialised functions o f each cell type. The 
membrane-associated proteins o f the cytoskeleton give the cell its shape and rigidity and 
are responsible for fusing membranes together at tight junctions and desmosomes to 
facilitate communication between cells. Other membrane proteins include receptors and 
ion channels which are involved in cell signalling. The ratio o f protein to lipid in the cell 
membrane varies from cell to cell (table 1.2a).
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Membrane % of Protein % of Lipid % of Carbohydrate
Myelin 18 79 3
Plasma Membrane
Human Erythrocyte 49 43 8
Mouse Liver 44 52 4
Rat Liver 58 42 5-10
Retinal rods (bovine) 51 49 4
Table 1.2a Relative proportions of lipid, protein and carbohydrate in cell membranes from 
a variety of cells.
There are two categories of membrane proteins, intrinsic and extrinsic. Intrinsic proteins 
insert into the lipid bilayer and span it at least once but often many times; seven 
transmembrane-spanning proteins are common and include the adrenoceptors, muscarinic 
and angiotensin II (All) receptors. The amino acids in the membrane-spanning region are 
hydrophobic while those which lie outwith the membrane are hydrophilic. In glycophorin, 
an intrinsic erythrocyte membrane protein, 34 amino acids are involved in membrane 
binding, 23 of which are hydrophobic (Petty 1993). The bilayer-spanning region of most 
integral proteins has an alpha helical structure. Thehydrophobicamino acids orientate their 
side chains into theoutsideDf the helix where they form hydrogen bonds with each other to 
stabilise the helix. The hydrophobic amino acids orientate their side chains away from the 
helix to interact with the fatty acids in the membrane core. Some membrane proteins 
which only pass through one of the membrane leaflets are covalently linked to fatty acids 
which anchor them in the membrane.
Extrinsic proteins bind to the surface of the membrane through direct interactions with the 
phospholipid head groups or by indirect binding to intrinsic membrane proteins. Spectrin
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and ankyrin are extrinsic erythrocyte cytosketeton membrane proteins. Such proteins can 
usually be extracted with high ionic strength buffers which disrupt the ionic interactions 
between the membrane and the protein. In contrast, intrinsic proteins require detergents 
to extract them (Petty 1993). Extrinsic proteins can be attached to the membrane via a 
hydrocarbon chain. Glycosylphosphatidylinositol-anchored proteins (e.g. Thy 1 and 
alkaline phosphatase) attach to the outside of the membrane. Alternatively, proteins can 
attach to the inside of the membrane through myristate, a fourteen carbon fatty acid which 
forms an amide bond with a glycine residue at the N-terminus of the protein. Lastly, 
famesyl or geranylgeranyl molecules form thiolester bonds with the C-terminus of proteins
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for insertion into the membrane. Examples of these are the p60 protein and Ras, both of
which are involved in controlling cell growth and division (Lodish et al 1995).
Also present in the membrane are glycoproteins and glycolipids. In glycoproteins, the 
sugar moieties, a-D-N-acetylglucosamine, a-D-N-acetylgalactosamine, N-
acetylneuraminic acid or a-L-fructose, can be N-linked or O-linked to protein. In N-
/
linkage, the sugar is attached to the amide: group of an asparagine residue. O-linked
i
sugars are attached to the oxygen of serine or threonine residues. Glycoproteins are 
primarily present in the outer leaflet of the membrane. The carbohydrate residues are 
important for the correct folding of the extracellular protein as the hydroxyl groups 
present form hydrogen bonds with the extracellular fluid. Glycolipids are formed from 
sphingosine. The most simple is cerebroside which contains one glucose or galactose 
residue while gangliosides can contain up to 7 sugar residues (Stryer 1988). The
carbohydrate on the outside of the membrane is important for cell recognition.
1.3 Memhrane Lipid Composition
A variety of different lipids are present in the cell membrane but fatty acids are common to 
them all. The membrane contains fatty acids of between 14 and 26 carbon atoms although 
those with 18 and 20 carbon atoms are most abundant. Their degree of unsaturation 
varies from 0 to 6 double bonds. Cis bonds are more common than trans and are 
responsible for a kink in the fatty acid chain (fig 1.3a & b). Table 1.3a shows the short 
hand notation, trivial and systematic names for some common fatty acids. This gives an 
indication of the number of carbon atoms, the number of double bonds and where the first 
double bond occurs, i.e. 16:0 is palmitic acid with 16 carbons and no double bonds, 18:1 
n-9 is oleic acid with 18 carbons and one double bond at the 9 position (Petty 1993).
H H H
\  /  \c = c  c = c
H
Cis double bond Trans double bond
Fig 1.3a Carbon to carbon double bonds in the cis and trans positions.
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Fig 1.3b Representative 18 carbon saturated and unsaturated fatty acids.
Notation Trivial Name Systematic Name
14:0 Myristic acid n - tetradecanoic
16:0 Palmitic acid w-hexadecanoic
16:l(n-9) Palmitoleic acid cis - 9 hexadecenoic
18:0 Stearic acid n - octadecanoic
18:l(n-9) Oleic acid cis -9  - octadecenoic
18:2(n-6) Linoleic acid cic - cis - 9, 12 - octadecadienoic
18:3(n-6) Linolenic acid all - cis - 6, 9, 12 - octadecatrienoic
20:0 Arachidic acid n - eicosanoic
20:4(n-6) Arachidonic acid all - cis -5,8,11,14 - eicosatetraenoic
22:0 Behenic acid n - docosanoic
24:0 Lignoceric acid n - tetracosanoic
Table 1.3a Trivial and systematic names for some common fatty acids.
Phospholipids are the most abundant membrane lipid. Most are phosphoglycerides (fig
1.3 c). The glycerol back-bone has three possible sites for hydrolysis known as sn- 1-3. 
The sn-3 position is esterified to a phosphoric acid residue. This in turn is attached to a 
base moiety. In phosphatidylethanolamine (PE) and phosphatidylserine (PS), this is an 
amino alcohol. For phosphatidylcholine (PC) and lysophosphatidylcholine (LPC), the base 
is choline. The glycerol sn-1 and -2 positions have fatty acids esterified to them, usually 
one of which is saturated and the other unsaturated. At neutral pH, most lipids have no 
net charge but cardiolipin and PS are negatively charged. The sphingolipids are also 
choline-containing lipids (fig 1.3 d).
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Fig 1.3c Chemical structures of common membrane phospholipids.
PS
PtdCho
PtdSer
PG PtdGro
Ptdlns
H H
CH3-(CH2)12-C =  c - c -  OH
H I
NHfCHI
CHrOH
Sphingosine
H H
ch3 -  (CH2)12- c = c - c -  o h
H I y
CH3-(CH2)14-C -N -C -O HII u  1 '
o  n  c h 2- o
\ ' n
\  VV
-H Ceramide
CH,
+ 1
■ P~ 0 “ CH2 — CH2 — N“  CH3 Sphingomyelin 
CH,
PP-galactosyl
I p -D-glucosyl
Fig 1.3d Chemical structures of common sphingosine lipids.
Galactosylceramides 
Glucosy ceramide
6
Cholesterol does not form a bilayer but its 3P-hydroxyl group interacts with the polar head 
groups of other lipids and the sterol ring structure is incorporated into the bilayer beside 
the hydrophobic fatty acid chains. Fatty acids can be esterified to the hydroxyl group to 
yield cholesterol esters (fig 1.3e) (Petty 1993).
HO
Cholesterol
Fig 1.3e. Chemical structure of cholesterol.
The composition of the membrane varies from cell to cell (table 1.3b). Most is known 
about the erythrocyte membrane because it is simple to prepare free from contamination. 
Much is also known about hepatocyte membranes. The membranes of different organelles 
also have different compositions and therefore different properties.
Source C PC SPG PE PI PS PG DPG PA GL
Rat Liver 
Plasma membrane 30 18 14 11 4 9 1
ER (rough) 6 55 3 16 8 3 - - - -
ER (smooth) 10 55 12 21 6.7 - - 1.9 - -
Mitichondria (inner) 3 45 2.5 24 6 1 2 18 0.7 -
Mitichondria (outer) 5 50 5 23 13 2 2.5 3.5 1.3 -
Nuclear membrane 10 55 3 20 7 3 - - 1 -
Golgi 7.5 40 10 15 6 3.5 - - - -
Lysososmes 14 25 24 13 7 - - 5 - -
Myelin 22 11 6 14 - 7 - - 0 12
Rat erythrocyte 24 31 8.5 15 2.2 7 - - 0.1 3
Table 1.3b Lipid composition of major cell organelles and erythrocytes. Abbreviations - 
C, cholesterol, DPG, diphosphatidyl glycerol (cardiolipin), PA, phospahtidic acid, SPG 
sphingomyelin GL, glycolipids ER endoplasmic reticulum (adapted from Jain & Wagner 
1980).
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1.4 Membrane Asvmmetrv.
The lipids in the membrane are asymmetrically distributed (fig 1.2a). This was first 
reported by Bretscher (1972) who used a non-cell-penetrating probe to label 
aminophospholipids (PS & PE). Whole erythrocytes were slow to be labelled whereas 
leaky cell ghosts were labelled rapidly. This suggested that the majority o f the PE and PS 
is present in the inner-leaflet o f the membrane and, by inference, most o f the PC and 
sphingomyelin (SPG) must be in the outer-leafiet. The presence o f most choline- 
containing lipids in the outer-leaflet was confirmed using phospholipases specific to certain 
lipids, combined with freeze-etch electron microscopy (Verkleij et a l 1973). The 
phospholipases could not enter the cell and therefore could only digest lipids in the outer 
leaflet. Asymmetry has since been confirmed in erythrocytes and other cells (Zwall et al 
1975, Tilley et al 1986, Gordesky & Marinette 1973, Fontaine et a l 1980, Schick et al 
1981).
Total Phospholipid Extracellular Fluid
"2;a
"oJC,
Cl<Z)OJCcu
”3
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20  -
20  -
40 -
60 J
Sphingomyelin
Phosphatidylcholine
Plasma
Membrane
Phosphatidylserine 
Phosphatidylethanolamine
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Fig 1.4a Asymmetric distribution o f membrane phospholipids.
N ot only are the lipids asymmetrically distributed in the membrane but there is also some 
molecular species asymmetry within some lipid groups. In erythrocytes, mono­
unsaturated PE is located preferentially in the outer-leaflet and polyunsaturated PE, in 
particular arachidonic acid-containing PE, in the inner leaflet (Hullin et a l 1991). 
Interestingly, no molecular species asymmetry for PE has been observed in platelets
A27A
(Schick et al 1981). Asymmetry has also been observed for SPG which contains relatively 
more long chain fatty acids in the outer- than inner-leaflet (Boegheim et al 1983). The 
same is not true for PC. Labelled fatty acids are mainly incorporated into inner leaflet PC 
but the distribution of the fatty acids across the two leaflets is similar although there is a 
greater proportion of PC in the outer leaflet (Renooij et al 1974). Experiments have 
shown that without the polar head group, lipids will diffuse through the membrane quickly 
(Ganong & Bell 1984). Therefore, the polar head groups may be partially responsible for 
maintaining this differential distribution about the membrane. This may explain why 
choline- and amino-containing lipids have different membrane distributions and why the 
maintenance of asymmetry is different for the two groups.
The maintenance of membrane asymmetry requires ATP. Cells incubated with labelled PS 
incorporated it into the inner membrane; none was present in the outer-leaflet 
(Middelkoop et al 1988). Similarly, spin-labelled PC remained in the outer leaflet while 
PE and PS were transported into the inner leaflet (Seigneuret & Devaux 1984). ATP may 
also be required for maintenance of molecular species asymmetry (Hullin et al 1991). Cell 
morphology studies have shown that the transport of PS and PE across the membrane 
requires ATP and Mg2+ (Daleke & Huestis 1985). The stoichiometry of lipid transfer and 
ATP utilisation is 1.13 for PS and 1.11 for PE (Beleznay et al 1993). The necessity for 
ATP and the knowledge that when asymmetry changes, cell shape also changes, may 
explain why erythrocytes require ATP to maintain their shape (Seigneuret & Devaux
1984). Although ATP is generally thought to be important for the maintenance of 
asymmetry, some believe that when ATP is absent, asymmetry is not lost immediately but 
further transport of new PE and PS is inhibited (Tilley et al 1986). Most movement of 
phospholipids occurs in an ATP-dependant manner but in the endoplasmic reticulum (ER), 
it is independent of ATP (Devaux & Zachowski 1994).
The need for ATP in the maintenance of asymmetry suggests the involvement of a protein 
in the process. Translocation of aminophospholipids into the inner leaflet is mediated by a 
specific enzyme; PE and PS compete for the active site for which PS has a higher affinity, 
making its transport faster. A 31 kDa protein, identified using iodinated thiolation 
reagents, is responsible for the translocation of PS across the bilayer. These thiolation 
reagents are based on pyridyldithioethylamine, a compound which is known to inhibit the 
transfer of lipids across the bilayer. The enzyme is the same size as integral membrane 
protein band 7 (Connor & Schroit 1988) and is inhibited by cytosolic concentrations of
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Ca2+ greater than lpm (Zachowski et al 1986), possibly because ATP is being consumed 
by increased Ca2+ pump activity (Bitbol et al 1987). The aminophospholipid translocase, 
as the protein has become known, has some stereospecificity for the polar head group. It 
will translocate L-a-phosphatidyl-D-serine but not D-a-phosphatidylserine (Hall & 
Huestis 1994, Smeets et al 1994).
The aminophospholipid translocase, a P-type ATPase (see later), has pronounced substrate 
specificity. In erythrocytes, PE methylation, a step in its conversion to PC, reduced 
activity while replacing the glycerol backbone with a ceramide abolishes it completely. 
The sn-2 position must be esterified but the acyl chain length is not important (Morrot et 
al 1989). It can also translocate PE plasmalogens (Fellmann et al 1993). The translocase 
has been identified in a wide variety of cells (Pomorski et al 1996a, 1996b, Cribier et al 
1993) and tends to be most active in neonatal cell (Pomorski et al 1996b, Cribier et al 
1993). Its importance has been shown by incorporating it into PC bi-layer where it is 
capable of PS translocation itself (Auland et al 1994). The bovine aminophospholipid 
translocase has been identified as a member of the P-type ATPase family (Tang et al 
1996). A PC translocase, isolated from murine cell, has been identified as a p-glycoprotein 
which is coded for by the mdr2 gene (Ruetz & Cross 1994). It is ATP- and Mg2+- 
dependant (Bitol & Devaux 1988, Ruetz & Crossl994). PC asymmetry is retained in 
isolated membranes but PC to equilibration is much slower (Kramer & Branton 1979).
Other cellular constituents and proteins are important in the maintenance of asymmetry 
(Haest & Deuticke 1976). In particular, spectrin, a cytoskeletal protein, is thought to 
prevent the movement of aminophospholipids into the outer leaflet of the membrane. 
Incubation of cells with SH-oxidising agents, which disrupt the cytoskeleton by forming 
disulphide bridges, increases the amount of PE and PS present in the outer leaflet (Haest 
et al 1978). Studies using merocyamine, a fluorescent dye which only binds to fluid state 
membranes, have shown that disruption of spectrin causes a loss of the gel-like state of the 
outer leaflet. Vesicles shed from aged erythrocytes and erythrocytes from mice with 
spherocytic anaemia were used for these experiments. In both these cases, the amount of 
membrane-bound spectrin was less than normal (Williamson et al 1982). Spectrin binds to 
mono-layers of anionic but not neutral lipids, suggesting that it may interact directly with 
aminophospholipids (Mombers et al 1980). In erythrocyte ghosts from patients with 
hereditary spherocytosis, a disease where erythrocytes have defective cytoskeltons, 
asymmetry is disrupted and the activity of Mg2+-ATPase is increased (Vereulen et al
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1995). This may be the aminophospholipid translocase attempting to maintain asymmetry. 
Others have shown that in cells where the membrane is disturbed chemically and 
asymmetry is lost, the activity of this enzyme is greater than control (Bartosz et al 1994). 
Studies of PS asymmetry in erythrocytes suggest that its maintenance requires more than 
the presence of aminophospholipid translocase and spectrin (De Jong et al 1996) as 
transport can be inhibited without inhibiting the aminophospholipid translocase (Connor & 
Schroit 1990). The authors suggest that the second protein may be endofacial, perhaps 
part of the cytoskeleton. Both proteins must be active for translocation to occur.
Other possible candidates for this role are the Rh blood group polypeptides. When these 
proteins are precipitated with specific antibodies, aminophospholipids coprecipitate 
(Schroit et al 1990). Rh polypeptides also co-localise with the aminophospholipid 
translocase in erythrocyte vesicles, suggesting a multicomponent complex for 
aminophospholipid translocation (Bruckheimer et al 1995). These findings have been 
disputed on the grounds that asymmetry is ubiquitous to all cells but the Rh blood group 
system is not.
Divalent cations have also been implicated in the control of asymmetry. The presence of 
excess Ca2+ will disrupt asymmetry (Connor et al 1990). High concentrations of Ca2+, Sr2+ 
and the calcium ionophore A23187 cause increased movement of LPC into the inner 
leaflet of the membrane. Possibly these ions activate a proteinase which cleaves ankarin 
and disrupts the cytoskeleton (Henseleit et al 1990). Increasing cytoplasmic calcium levels 
activates transbilayer bi-directional lipid redistribution in human erythrocytes. The rates of 
movement of PC, PE and PS are all the same and continue as long as the concentration of 
Ca2+ is high. This redistribution was not caused by the aminophospholipid translocase 
which would not transport PC (Williamson et al 1992). However, the concentration of 
Ca2+ in these experiments was very high, in the non-physiological range. If the 
aminophospholipid transferase is involved in Ca2+-induced lipid redistribution, it looses its 
stereochemical preference. Ca2+-induced movement of lipids is bi-directional and applies 
to all lipid groups, with SPG being slightly slower to disperse (Smeets et al 1994). The 
redistribution observed here is probably not dependent on the aminophospholipid 
translocase.
Others have suggested that aminophospholipid translocase is involved in the Ca2+-induced 
breakdown of membrane asymmetry. Redistribution of PE begins to change as soon as
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aminophospholipid translocase activity is altered; PS is slower to change, possibly because 
it has a higher affinity for the enzyme. Other cations are also important. Sub- 
physiological concentrations of Mg2+ inhibit lipid transport, probably through inhibition of 
the Mg2+-ATPase. Replacement of Mg2+ with Mn2+ does not affect transport but Co2+ 
inhibits it. High extracellular Ni2+ and V 02+ (vanadyl) caused inhibition of 
aminophosphlipid translocase at an extracellular site. Vanadate (VO4 3 ) is also an inhibitor 
but it appears to act at an intracellular site (Bitol et al 1987); an intracellular site of action 
has also been established for vanadate inhibition of (Na+-K+)-ATPase (Cantley et al 1978). 
The presence of Mg2+ in the lysis buffer for preparing erythrocyte ghosts is necessary for 
the maintenance of asymmetry (Connor et al 1990).
Asymmetry is lost from erythrocyte and platelet membranes during calcium influx-induced 
vesicle formation and shedding. The cell sheds vesicles which have a random lipid 
composition and, as more vesicles are lost, the asymmetry of the remaining cell membrane 
is lost too. Removing Ca2+ from the cells reactivates the ATP-dependant 
aminophospholipid translocase but asymmetry is not restored to the vesicles (Comfiirius et 
al 1990). This may be because the vesicles do not contain adequate aminophospholipid 
translocase proteins or because the removal of Ca2+ from them is not sufficient to prevent 
this continued redistribution.
The aminophospholipid translocase in bovine aortic cells may be modulated by basic 
fibroblast growth factor in culture (Julien et al 1995).
It is interesting to note that the metabolism of lipids in the membrane is also asymmetric. 
Turnover of PE on the outer surface is four times faster than the inner surface. This effect 
is greatest for palmitic acid (Marinetti & Cattieu 1982).
A breakdown in asymmetry, in particular PS asymmetry, has a variety of physiological 
consequences. The movement of PS from the inner to the outer leaflet occurs as a prelude 
to apoptosis, irrespective of the stimulus for cell death (Martin et al 1995). Movement 
also occurs during platelet activation and has a procoagulant effect which is not related to 
breakdown of the cytoskeleton or inhibition of the aminophospholipid translocase (Gaffet 
et al 1995a). There is no concomitant movement of PC into the inner leaflet during PS 
movement, suggesting that the movement of PS into the outer leaflet is not due purely to 
lipid scrambling but may be due to a reverse aminophospholipid translocase (Gaffet et al
12
1995b). The presence of PS in the outer leaflet during platelet activation has been 
confirmed using annexin V, a protein which specifically binds to PS (Stuart et al 1995).
1.5 Locus of Membrane Lipid Synthesis
Synthesis of phospholipids occurs in the ER via the pathways outlined in figs 1.5a and 
1.5b. The composition of the phospholipids can be changed by de novo synthesis or by 
replacement of the fatty acids moieties by reacylation of lysophospholipids by 
acyltransferases and deacylation by esterases.
Synthesis of phospholipids begins with the esterification of glycerol by two fatty acids. 
Two different acyl-CoA:glycerol phosphate-O-acyl transferase enzymes are required 
which are specific for the sn-1 or sn-2 positions. The first step is the formation of 
phosphatidic acid (PA) from glycerol-3 phosphate, via 1-acylglycerol 3-phosphate 
synthesis. PA can also be formed from dihydroxyacetone phosphate and by turnover of 
pre-existing lipids. Most PA is hydrolysed by PA phosphatase to diacylglycerol (DAG) 
which is used for PC, PE, PS and triglyceride synthesis. PA phosphatase activity is found 
in both the cytosolic and microsomal fractions of the cell and is stimulated by 
glucocorticoids, growth hormone and cAMP but inhibited by insulin (Pittner et al 1986). 
Activity is regulated by varying the proportion of the enzyme bound to the membrane. 
Increasing fatty acid and fatty acyl CoA levels increase binding and thus increase activity, 
allowing the enzyme to respond to fatty acid loads (Bishop & Bell 1988).
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Enymes of phospholipid biosynthesis,
1, sn -glycerol-3 -phosphate acyltransferase, 2, dihydroxyacetonephosphate acyltransferase, 3, acyl (alkyl) 
dihyrodroxyacetonephosate acyltransferase, 4, lysophosphatidic acid acyltransferase, 5, phosphatidic acid 
phosphatase, 6, diacylglycerol kinase, 7, diacylglycerol acyltranferase, 8, choline kinase, 9, choline phosphat- 
cytidylyltransferase, 10, diacylglycerol:choline phosphotransferase, 11, ethanolamine kinase, 12, ethanol­
amine phosphate cytidylytransferase, 13, diacylglycerol:ethanolamine phosphotransferase, 14, phosphatidyl- 
ethanolamine N-metyltransferase, 15, PE:serine O-phosphatidyltransferase, 16, phosphtidylserine 
decarboxylase 17, PC:serine O-phosphatidyltransferase.
Fig 1.5a Pathway for the synthesis of the major membrane phospholipids, PS, PC and PE 
from glycerol.
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Fig 1.5b Pathway of PI and phosphatidylgycerol biosynthesis.
PC biosynthesis occurs primarily through the Kennedy pathway which involves the 
production of CDP-choline, which requires CTP, and is catalysed by the enzyme CDP- 
phosphocholine cytidyltransferase. This is the rate limiting step. The cytidyltransferase, 
like PA phosphatase, exists in both a membrane-bound and cytosolic form and again, the 
activity of the enzyme increases as more becomes membrane bound. PC biosynthesis 
increases with intracellular fatty acid levels (Pelech & Vance 1984) and when protein 
kinase C (PKC) is activated by phorbol esters (Pelech et al 1984). As cell growth is 
activated by PKC, this will produce more PC for new cell membranes. Protein kinase A 
(PKA)-mediated phosphorylation reduces the activity of the enzyme. This may be 
involved in the p adrenoreceptor response to stress as PKA is then activated, causing less 
cellular energy to be consumed in PC production (Petty 1993). Choline kinase may also 
contribute to the regulation of PC biosynthesis as growth factors increase its activity 
(Warden & Friedkin 1985). The final step in PC biosynthesis is catalysed by choline 
phosphotransferase which releases CMP. PC can also be produced by Ca2+-dependant 
base exchange with PE or PS or by acylation of monoacyl PC. This process is thought to 
be particularly important in the formation of arachidonic acid-rich lipid. PC can result
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from transacylation of monoacyl PC, important in the production of disaturated PC for 
lung surfactant (Gurr & Harwood 1991). Alternatively, PC can be synthesised by 
methylation of PE. Two methyl transferases exist in the erythrocyte membrane of 
Sprague-Dawley rats. The first is present on the inside of the membrane and produces 
phosphatidyl-N-monomethanolamine from PE using S-adenosyl-L-methionine as the 
methyl donor. The second enzyme is situated in the outer leaflet and converts the 
phosphatidyl-N-monomethanolamine into PC. The PC is therefore effectively being 
translocated across the cell membrane as it is produced (Hirata & Axelrod 1978).
PE is formed by a similar pathway to PC with phosphatidylethanolamine cytidyltransferase 
being a cytosolic enzyme and rate-limiting. This pathway is used for the formation of PE 
when ethanolamine is present in the cells. When ethanolamine concentration is limiting, 
the cell produces PE by the decarboxylation of PS. Like PC, PE can also be formed by 
Ca2+ -dependant base exchange and by acylation of monoacyl PE (Bishop & Bell 1988). 
PS cannot be synthesised independently of PC or PE. It is synthesised from these two 
lipids.
Production of anionic phospholipids, PI, PG and cardiolipin, occurs via CDP- 
diacylglycerol, the formation of which is catalysed by PA: CTP cytidyltransferase, thought 
to be present in both the ER and the mitochondria (Bishop & Bell 1988).
Sphingosine is formed from palmitoyl-CoA and serine in the presence of pyridoxal 
phosphate (fig 1.5c). The 3-ketodihydrosphingosine produced is then reduced to 
sphingosine using a flavoprotein enzyme (Gurr & Harwood 1991). Unlike the other lipids, 
SPG synthesis is predominately in the Golgi apparatus with only a small amount in the 
plasma membrane and the rough ER (Futerman et al 1990). Transport of SPG to the 
membrane is not dependant upon protein. Inhibition of cellular energy production with 
potassium cyanide slowed down the production of SPG but did not alter the percentage 
being transported to the cell surface. Brefeldin A, which inhibits protein transport through 
the Golgi apparatus, did not prevent the movement of SPG to the cell membrane. Both 
these facts point to SPG transport being vesicle- and not protein-mediated (Shiao & Vance
1993).
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CoAFatty acyl-CoA
Sphingosine Ceramide
Fatty acidCDP-Choline PhosphatidylcholineCDP-Choline
CMP DiacylglyerolCMP
Sphingosylphosphorylcholine ■>- Sphingomyelin
Fatty acyl-Co A CoA
*  —= main route
Fig 1.5c Proposed pathway for sphingomyelin biosynthesis. Adapted from Gurr and 
Harwood (1991).
1.6 Cell Memhrane Functions
The plasma membrane is the only structure ubiquitous to all cells. However, it is highly 
specialised and performs a wide variety of functions. Maintaining the composition and 
fluidity of the cell membrane is therefore important as membrane proteins will only 
function optimally in a precisely controlled physical environment.
The plasma membrane defines the boundaries of the cell and thus separates the cell 
contents from the extracellular milieu. Intracellular membranes compartmentalise cellular 
functions, allowing organelles to have internal conditions ideal for specialised groups of 
reactions. For example, lysosomes have an acidic pH to facilitate the breakdown of 
proteins. The cell membrane acts as a permeability barrier, preventing free movement of 
solutes and other molecules into and out of the cell. Flux of compounds across the 
membrane occurs by a variety of transport systems, the simplest being diffusion (Bangham 
et al 1965). Molecules with a molecular weight of less than 200 will diffuse across the 
membrane down the concentration gradient. Net flux stops when equilibrium is reached. 
This form of transport is non-saturable and does not require energy. Protein-mediated 
membrane transport is faster, can be saturated and has a degree of chemical specificity.
\)°
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Facilitated transport is energy-independent but cannot move molecules against the 
concentration gradient. Its mechanism is unclear. It appears that the proteins involved 
span the membrane, perhaps forming a shield to protect the transported substance from the 
hydrophobic core of the membrane. Glucose transport into the erythrocyte occurs in this 
way. The concentration gradient is maintained by the immediate phosphorylation of 
glucose as it enters the cell (Petty 1993).
Primary and secondary active transport are energy requiring and allow the transfer of 
solutes against the concentration gradient. The transport protein must be phosphorylated 
by ATP. For example, Na+K+ATPase transports 3 Na+ molecules out of the cell and 2 K+ 
molecules into the cell for every high energy phosphate group consumed. This is a P-type 
ATPase, so called because of the formation of a phosphorylated intermediate. It is 
important for the regulation of cell volume and creates an electrochemical potential across 
the membrane which is used by secondary active transport processes to facilitate 
movement of substances against the concentration gradient. Secondary active transport 
often involves the movement of Na+ down the concentration gradient, releasing energy 
which is harnessed to the movement of a second compound such as amino acids against its 
concentration gradient (Berne & Levy 1993). Apart from the P-type ATPases, two other 
types of ion transporting ATPase exist. The F-type ATPase which uses the H+ gradient 
across the inner mitochondrial membrane to produce ATP and the V-type ATPase which 
generates an FT electrochemical gradient across the membranes of lysosomes and 
endosomes, making the inside of the organelle acidic (Berne & Levy 1993). Membrane 
ion exchange proteins are important for many cell functions. The Na+/H+ exchanger 
maintains intracellular pH balance. The Na+-K+-Cf transporter simultaneously moves 1 
Na+, 1 K+ and 2 Cl" into the cell. It is stimulated by cell shrinkage to increase the ion 
concentration inside the cell, leading to the movement of water into the cell by osmosis.
Endocytosis and exocytosis are quite different transport procedures. Endocytosis occurs 
in two ways, phagocytosis, the uptake of particulate material and pinocytosis, the uptake 
of soluble material. These are sometime referred to as cell ‘eating’ and ‘drinking’. In both 
processes, the cell engulfs the extracellular material by extending pseudopodia around it. 
Some forms of pinocytosis require the deposition of clathrin under the cell membrane, 
forming structures known as clathrin-coated pits. Macromolecules bind to the outside of 
the membrane above these pits before internalisation. For example, low density 
lipoprotein (LDL) is taken up into the cell by this mechanism; LDL receptors are
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contained within clathrin-coated pits in the membrane (Petty 1993). Phagocytosis is the 
internalisation of large particles. Macrophage-mediated, antibody-dependant phagocytosis 
is a component of the immune response. Exocytosis is important for the export of 
substances. Compounds may stored in secretory granules near the cell membrane surface 
and fuse with the membrane prior to release. Examples of exocytosis are mast cells 
releasing histamine or neural cell release of neurotransmitters (Petty 1993).
Most regulatory substances act by binding to a specific receptor in the cell membrane. 
These receptors may be ligand-gated ion channels which cause the cell membrane to 
depolarise when a ligand is bound or linked to a signal transduction pathway. Many 
processes involve the activation of G-protein-linked signal transduction pathways. G- 
proteins are heteromeric proteins attached to the inside of the cell membrane. For signal 
transduction to occur the a, p and y subunits of the G-protein complex must link together. 
Efficiency of G-protein-linked receptors may therefore regulated by the fluidity of the 
membrane. G-proteins also affect the activities of K+ channels, phospholipase C (PLC) 
and phospholipase A2 (PLA2)
Other effects of agonists binding to a receptor include the activation of protein kinases and 
phosphatases. Some second messenger-mediated pathways involve alterations to the 
membrane itself. PLC, activated by a G-protein-linked receptor, cleaves 
phosphatidylinositol-bis-phosphate to produce inositol-1,4,5-triphosphate (IP3) and DAG. 
IP3 binds to ion channels in the ER and increases intracellular free Ca+ concentration. 
DAG activates PKC. PLA2 is also activated by a G-protein-linked receptor and cleaves 
the fatty acid at the sn-2 position of the cell membrane phospholipids, leading to the 
release of arachidonic acid for prostaglandin and leukotriene synthesis.
The carbohydrates on the surface of the cell are responsible for immunogeneity and cell 
adhesion. Glycoproteins which terminate with a sialic acid residue have a negative charge 
which allows cells to adhere to positively charged surfaces. Cell surface antigens are 
glycoproteins and glycolipids which carry the blood group antigens or major 
histocompatability complex antigens.
Some cells, in particular fibroblasts and tumour cells, are mobile. They form lamellipoda 
which allow them to crawl along a surface. This is possible because of the rapid 
depolymerisation and repolymerisation of the cytoskeleton and the fluid nature of the
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membrane. Membranes of other cells can deform and return to their original shape. For 
example the erythrocyte is 7.7pm in diameter and 1.9pm thick, but it must pass though 
capillaries much smaller than these dimensions.
1.7 Functions of individual fattv acids and lipids.
Cell membrane fluidity, the inverse of microviscosity, is affected by fatty acid content. In 
the most simple terms, unsaturated and short chain fatty acids make the membrane more 
fluid and saturated and long chain fatty acids make it more rigid. An unsaturated fatty acid 
has a kink in the acyl chain which reduces the interactions between it and its neighbours. 
This reduces the melting point of the membrane and the ordering of its fatty acyl chains, 
making it more fluid. Short chain fatty acids which have less surface area to interact with 
other fatty acids have the same effect (Lodish et al 1995). However, this is a gross 
oversimplification. Insertion of one double bond into a fatty acyl chain decreases the order 
of the membrane. The insertion of a second double bond will decrease it more but not 
twice as much. Insertion of four double bonds into the acyl chain has little more effect on 
the order than two double bonds (Stubbs et al 1981). Also, double bonds inserted into the 
middle of the acyl chain have more effect on fluidity than those inserted into the end of the 
chain (Stubbs & Smith 1984). Moreover, these effects are complicated by the presence of 
protein, by specialised regions of the membrane and by cholesterol. Although the 
membrane is referred to as a liquid-crystalline structure, most is in a highly ordered state 
with only a small region at the centre in a fluid state (Yeagle 1989).
An increase in the PC/SPG ratio in the membrane increases fluidity (Borochov et al 1977). 
SPG is a rigidifying lipid because it contains a large proportion of long chain fatty acids 
and the hydrophobic region contains a trans double bond and an amide bond, both of 
which decrease fluidity (Shinitzky & Barenholz 1974). Cholesterol is one of the best 
known membrane rigidifiers; it inserts into the phospholipid bi-layer preventing the free 
movement of the fatty acyl chains (Shinitzky 1984). Similarly, proteins are relativity 
incompressible and reduce membrane fluidity (Shinitzky & Inbar 1976, Schinitzky & 
Rivnay 1977).
Some lipids, in particular poly unsaturated fatty acids (PUFA), have specific effects on the 
cell. These occur at two levels, on gene transcription and on membrane function.
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1.7.1 Nuclear Effects.
The list of proposed modulatory actions of PUFA is endless. Although the precise 
mechanism is unclear, evidence suggests that they regulate transcription of a variety o f 
genes via a PUFA response element in the nucleus. This appears to be different form the 
fatty acid-activated nuclear factor with is also activated by saturated and monounsaturated 
fatty acids neither of which are know to affect gene transcription (Clarke & Jump 1994, &
1996). By preventing endogenous fatty acid biosynthesis, PUFA ensure that they will be 
required and inserted into the membrane (Clarke & Jump 1994). PUFA in particular 
arachidonic acid, inhibit the transcription of the stearoyl Co-A desaturase (Tebbey and 
Buttke 1993, Landschulz et al 1994). An additional metabolic effect of PUFA’s, again 
demonstrated for arachidonic acid, is to inhibit transcription of the GLUT-4 glucose 
transported gene and increase the rate of its mRNA turnover in adipocytes but it increases 
the GLUT-1 gene transcription (Tebbey et al 1994). PUFAs affect cell growth. In 
addition to activating PKC (McPhail et al 1984), arachidonic acid induces c-fos 
transcription (Tebbey and Buttke 1993) but y-linolenic acid (but not linoleic acid) inhibits 
the growth of human heptoma cells in culture (Booyens et al 1984). They also potentiate 
the TGF-p inhibitory action of carcinoma cells (Newman 1990). These last two actions 
may be of therapeutic value. Similarly, fatty acids may be antiviral, antibacterial, 
antimutagenic and modulate T and B cell response (Das 1991).
1.7.2 Effects on Protein Function.
Most effects of lipid on protein function appear to be mediated by free fatty acids. For 
example, extracellular docosahexaenoic acid (DHA) blocks the delayed rectifier K+ current 
in cells from the pineal gland. Other fatty acids containing at least four double bonds have 
the same effect (Polling et al 1995). The effect varies from tissue to tissue. Thus 
arachidonic acid inhibits the delayed rectifier K+ channel function in cardiac cells (Barhanim 
et al 1994) but activates it in rat neurocortical neurones (Palma et al 1993). Toad 
stomach smooth muscle cell K+ channels were activated by fatty acids and negatively 
charged monoacyl lipids. Neutral lipids had no effect and positively charged lipids 
inhibited the channels. The site of action is cytosolic and there may be a fatty acid binding 
site on the protein itself or on an associated protein (Petrou et al 1995). Arachidonic acid 
and DHA potentiate the NMD A receptor response (Miller et al 1992, Nishikawa et a l
1994) and a putative fatty acid binding site, homologous to known fatty acid binding, 
proteins, has been identified on the receptor (Petrou et al 1993). Arachidonic acid inhibits 
the uptake of glutamate in vitro in brain liposome systems containing reconstituted
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glutamate transporters. The fatty acid must be in the unesterified form for inhibition to 
occur (Trotti e ta l 1995).
Studies have been carried out on synthetic membrane systems to investigate the effects of 
phospholipids on reconstituted Ca+-activated K+ channels. Changing the membrane lipid 
from mono-methylated PE to PC increases the size of the phospholipid head group by 10A 
and increases the channel opening time Changes in the ordering of the fatty acid chains by 
changing the fatty acids esterified to the phospholipids had no effect on the channels 
(Chang et al 1995a).
Diets rich in n-3 fatty acids reduced the plasma triglyceride levels and increased in vivo 
insulin sensitivity in non-insulin dependant diabetic (NIDDM) patients without affecting 
the microviscosity of either platelets or erythrocytes (Rabini et al 1993), suggesting a 
direct action of the fatty acids on the insulin receptor. The membrane environment of the 
insulin receptor affects its binding and kinase activity. When purified insulin receptors are 
inserted into vesicles containing PE and PC, they lose their receptor kinase sensitivity and 
the affinity for insulin is increased. It is only when PS is included in the vesicles that the 
insulin sensitivity to the receptor kinase is restored (Lewis & Czech 1987). Phospholipid 
mixtures containing phosphatidyl inositol (PI) affect the autophosphorylation of the p- 
receptor subunit of the insulin receptor. This is biphasic, PI stimulates when present at 
low concentrations and inhibits at higher concentrations (Sweet et al 1987). Changes in 
membrane fluidity in cultured heptomas cells accomplished by incubation of cells with 
linoleic acid or 25-hydroxycholesterol caused insulin resistance. Basal amino acid uptake 
fell in the 25-hydroxycholesterol-treated cells but increased in the linoleic acid-treated 
cells. However, insulin-stimulated amino-acid uptake and glycogen synthesis were 
reduced in both cell types compared to nonsupplemented cells (Bruneau et al 1987). 
Previously, it has been suggested that diet might affect insulin sensitivity in subjects 
genetically predisposed to NIDDM. An increase in the prevalence of obesity, NIDDM and 
hypertension occurs in those who consume a high saturated fat diet (Simopoulos 1994). 
In light of the effects of fatty acids on insulin sensitivity, this may be a mechanism for this 
response.
Fatty acids, particularly C16-C20 PUFAs, inhibit the binding of All to its receptor in 
cultured bovine adrenal cells. Fatty acids also non-specifically inhibit aldosterone 
production (Goodfriend & Ball 1986). When fatty acids are removed from the surface of
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adrenal glomerulosa cells, the aldosterone response to All is increased (Goodfriend et al 
1991a). Salt loading increases plasma fatty acid levels in inverse correlation to the 
suppression of plasma aldosterone levels (Goodfriend et al 1991b). PUFAs also inhibit the 
binding of glucocorticoids to their receptors in liver cells. The fatty acids bind to the 
receptor at a site different from the hormone binding site. The inhibition appears to be of 
the mixed non-competitive-type and is a function of fatty acid chain length, degree of 
unsaturation and concentration (Vallette et al 1991). In studies where the protein was 
partially digested with trypsin, the fatty acid and hormone binding sites were located on 
the same area of the protein. DHA acid could not inhibit the binding of the glucocorticoid 
antagonist, RU486, as effectively as it inhibited the binding of dexamethasone, a synthetic 
glucocorticoid. This suggests that the antagonist induces conformational changes in the 
protein, preventing fatty acid binding (Sumida et al 1993). Fatty acids have also been 
implicated in the binding of estradiol to rat uterine receptors (Vallette et al 1988). At low 
estradiol concentrations, fatty acids inhibit binding but at high concentrations, the opposite 
is true.
Nuclear binding of triiodothyronine (T3) is competitively inhibited by fatty acids such as 
oleic acid in rat liver (Van der Klis et al 1989). Using purified proteins from a bacterial 
expression system, fatty acids were shown to interact directly with the T3 receptor, 
although the exact mechanism of action remains unclear (Van der Klis et al 1991).
1.7.3 Effects nn Memhrane Function.
Fatty acids interfere with platelet aggregation. In human subjects cis- but not trans- 
unsaturated fatty acids have this affect (MacIntyre et al 1984). The authors of this report 
claim that inhibition is due to free fatty acids. However, unsaturated fatty acids increase 
membrane fluidity and the potency of inhibition is inversely related to the fatty acid melting 
points (MacIntyre et al 1984). Thus inhibition of aggregation may be due solely to 
elevated membrane fluidity. Diets high in n-3 PUFAs inhibit platelet aggregation and 
thromboxane A2 production and reduce plasma triglyceride levels. Post-treatment platelet 
aggregation remained impaired for 14 weeks; the membrane concentration of n-3 fatty 
acids remained elevated for the same time, suggesting that composition determines 
aggregation (Tremoli et al 1995). Conversely, platelets from rats fed a high saturated 
fatty acid diet were less responsive to aggregatory stimuli than those fed diets high in n-3 
and n-6 fatty acids. The high saturated fat diet caused an increase in the amount of 
arachidonic acid in the membrane and reduced the cholesterol/phospholipid (C/PL) ratio
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compared to the other groups. In vitro modification of the C/PL ratio showed that platelet 
reactivity increases with increasing ratio (Heemskerk et al 1995).
Membrane fluidity can modulate the binding of opioids to their receptors in the brain. 
Incorporation of C l8:1 (n-6, 9 and 11) into synaptosomes decreases membrane 
microviscosity and inhibits the binding of mu, delta and kappa opioids. (Lazar & 
Medzihradsky 1992). Also in the brain, lipid peroxidation, which will alter the PUFA 
content of the membrane, alters the kinetics of muscarinic receptor binding by decreasing 
Bmax and increasing Kd for the receptor. Under these conditions, the cell membrane 
micro viscosity was increased (Ghosh et al 1993). The effects of membrane phospholipid 
on adrenergic receptor function have been reviewed by Williams et al (1995). Both a  and 
p adrenoceptors are regulated by the fluidity of their membrane environment. All of the 
reported alterations in a  receptor binding related to variations in the receptor Kd whereas 
for the p receptor, both Kd and Vmax were affected.
High concentrations of PS and PE cause cells to crenate and then to revert to discoid 
shape and finally to become stomatocytic. The extent of these shape changes is dose- 
dependant and increases with increasing hydrophobicity of the lipid. ATP and Mg2+ are 
also required (Daleke & Huestis 1985). The membranes of human erythrocytes will only 
tolerate small changes in the fatty acid composition of their phospholipids. Using a PC- 
specific transfer protein, the erythrocyte membrane PC can be replaced with disaturated 
PC. Replacing 40% of the cellular PC in this way causes the cells to lyse. Replacing 30% 
of the PC with di-unsaturated PC causes the cells to become leaky to potassium and to 
lyse. The cell functions best when the PC contains palmitic acid and either linoleic or 
linolenic acid. In general, the stability of the cell is lost when the degree is unsaturation is 
increased; permeability of the membrane increases with increasing unsaturated fatty acid 
(Kuypers et al 1984).
The activity of the erythrocyte Na+ pump is reduced by incorporation of short chain fatty 
acid PC (Dwight & Hendry 1995). The authors believe this to be related to the reduction 
in the width of the bilayer but the residual long chain fatty acids should maintain the bilayer 
width. They also show that increasing the amount of C l0:0 PC reduces the amount of 
arachidonic acid present in the membrane, possibly due to increased phospholipase activity 
caused by cell membrane deformation (Dwight & Hendry 1995).
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1.7.4 Effects Of Increased Membrane Cholesterol
Cholesterol makes the membrane more rigid by preventing the fatty acids from moving 
freely. Increased cholesterol in vascular smooth muscle cell (VSMC) membranes increases 
intracellular Ca2+ concentration by increasing unidirectional Ca2+ uptake. Removal of the 
cholesterol restores intracellular Ca2+ concentration to normal (Bialecki et al 1991). 
Rabbit VSMC enriched with cholesterol have an increased C/PL ratio and increased 
unstimulated Ca2+ influx and efflux and cystolic Ca2+ concentration. A reduction in 
membrane fluidity was observed in microsomes prepared from these cells. The authors of 
this report suggest that increased cholesterol content opens a new or normally silent L- 
type Ca2+ -channel (Gleason et al 1991).
Increasing erythrocyte membrane cholesterol increases microviscosity and affects many ion 
transport systems. The ouabain-sensitive Na+ influx is inhibited and the activity of the 
Na+-K+-ATPase, Ca2+-ATPase and Mg2+-ATPase are reduced, as are the activities of the 
Na+-K+-cotransporters and Na+-Li+-countertransporters and basal leakage of Na+-K+ 
(Lijnen & Petrov 1995). In rabbits fed a high cholesterol diet, erythrocytes have increased 
Na+-K+-pump activity compared to those fed a normal diet. A positive correlation 
between plasma cholesterol levels and pump activity was observed. Cell Na+ content 
correlated with both pump activity and with membrane cholesterol levels. Unexpectedly, 
the authors report that the membrane composition was not altered and they suggest that 
changes in fluidity were not responsible although this was not measured (Makarov & 
Kuznetsov 1995). Other studies using rabbits fed high cholesterol diets showed that the 
increase in plasma cholesterol caused an increase in membrane cholesterol and an 
inhibition of the Na+-K+ pump activity (Uysal 1986).
Incubation of human lymphocytes with cholesterol-rich serum reduces p adrenergic 
receptor density but does not affect membrane microviscosity. Incubating the cells with 
PE and PC to remove the cholesterol restored the receptor density to normal. The 
receptor density is not therefore related to the cell membrane microviscosity although it is 
related to membrane cholesterol content (Pieri et al 1992). Incubation of human neural 
cells with cholesterol hemisuccinate increases membrane microviscosity and the binding of 
opioid p-selective agonists to the high affinity state of the receptor. This binding can 
normally be inhibited by pertusis toxin but, in the rigidified membrane, it has no effect 
(Emmerson & Medzihradsky 1994). Increasing the cholesterol content in lipid bilayers 
from rat brain reduced the Ca2+-activated K+ channel open time and its probability of
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opening. The channel conductance was also reduced. Increasing the cholesterol in the 
membrane encourages this channel to move from the open to the closed state (Chang et al 
1995b).
1.18 Determinants of Membrane Lipid Composition
Membrane lipid composition is controlled by a variety of factors, including desaturase 
enzymes and diet. Desaturase enzymes control the insertion of carbon-carbon double 
bonds into fatty acids. They are in turn affected by diet, age and hormones. Diet also 
affects membrane composition directly as cells can incorporate lipids and fatty acids from 
the circulation into their membranes (see earlier).
1.8.1 Dfisatnrasfi
The activity of desaturases is a crucial determinant of the physical properties of the cell 
membranes. Their nature and the factors controlling their action must therefore be 
examined in detail.
The desaturase enzymes are ER-bound. Only the stearoyl-CoA desaturase (A9 desaturase) 
has been completely purified (Strittmatter et al 1974) and the gene identified (Thiede et al 
1986). Two other desaturase enzymes are known to exist, the A5 and A6 desaturases. A 
fourth, a A4 desaturase, has been postulated and will be discussed further later. The 
nomenclature of the enzymes indicates where the double bond is inserted in the fatty acid 
chain. For example, the A5 desaturase inserts a double bond between carbon five and six. 
The A5 and A6 desaturase enzymes act on both n-3 and n-6 fatty acids, although the 
enzyme affinity is greater for n-3 fatty acids (Geiger et al 1993, Hrelia et al 1995). The 
activity of the A5 desaturase increases with increasing chain length of the fatty acids from 
C16-C20. The activity of the A6 desaturase is not similarly affected (Pollard et al 1980). 
The pathway of desaturation was first demonstrated in yeast where it was observed that 
double bonds can be inserted into stearic acid provided that oxygen and a reduced cofactor 
were present. Fatty acids must be activated prior to desaturation by conversion to acid 
CoA:thiolesters. The availability of fatty acids for desaturation appears to be controlled by 
fatty acid binding proteins (Gurr & Harwood 1991).
The A9 desaturase, which is sometimes referred to as cyanide-sensitive factor, is a 53kDa 
mixed function oxygenase. Two other proteins are required for desaturation, the 
flavoprotein, NADH-cytochrome b5 reductase, and the haem-containing protein,
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cytochrome bs. These electron transport proteins are membrane-bound, although most of 
their structure is in the cytoplasm (Gurr & Harwood 1991). The desaturase is more firmly 
attached to the membrane. Hydropathy analysis measures the hydrophobic or hydrophilic 
nature of the constituent amino acids of the protein, making it possible to elucidate which 
sections of the protein, if any, span the bi-layer. This has shown that the enzyme contains 
3 hydrophobic areas in all, long enough to pass through the membrane twice (Shanklin et 
al 1994).
A cytoplasmic fraction maybe necessary for A6 desaturation to occur. This fraction has 
lipoprotein characteristics and contains PC and free fatty acids. Its function may be to 
remove the y-linolenic acid produced by the A6 desaturase, preventing product inhibition 
(Leikin & Brenner 1986). It is not clear whether similar fractions exist for the other 
desaturases or if this fraction can remove other desaturation products.
The A9 desaturase has been inserted into PC vesicles to study its substrate specificity. 
Providing that NADH and O2 are available, the enzyme will bind the acyl-CoA derivatives 
of 9 to 20 carbon fatty acids but will only desaturate 12 to 19 carbon fatty acid derivatives 
(Enoch et al 1976). The length of the fatty acid chain which can be desaturated is limited 
possibly due to the size of the fatty acid binding site (Brett et al 1971). The methylene 
chain of the stearoyl-CoA is in the eclipsed (gauche) conformation at carbons 9-10 in the 
enzyme substrate complex, suggesting that the hydrogen atoms can only be removed in the 
cis conformation leading to the formation of cis double bonds. Dehydrogenation is the rate 
limiting step in desaturation (Enoch et al 1976).
The A9 desaturase is a single polypeptide which contains one non-haem iron moiety 
(Strittmatter et al 1974). The actual mechanism of desaturation remains unclear. It is 
possible that the electron transport proteins transfer electrons from NADH to the non- 
haem iron which may then bind oxygen to facilitate desaturation. During desaturation, 
both hydrogen atoms are removed from the fatty acid together, suggesting that 
desaturation does not occur through a hydroxylated intermediate followed by dehydration 
(Gurr & Harwood 1991). The amino acid sequence of desaturases from various sources 
has been compared and an area of amino acid homology containing eight histidine residues 
has been detected. This conserved area may act as a binding site for the non-haem iron on 
the cytoplasmic face of the ER membrane (Shanklin et al 1994). It now appears possible 
that there are different homologues of A9 desaturase in different tissues; in particular
27
oligodendrocyte and myelin-specific genes have been identified from a cDNA library 
(Schaeren-Wiemers et al 1995).
Fig 1.8 shows the pathway for desaturation of essential fatty acids. It has long been 
accepted that long chain PUFA are formed by sequential desaturation by the A6, A5 and 
A4 desaturases with elongation occurring between each desaturation. However, the 
existence of a A4 desaturase has been difficult to prove. Rat liver microsomes will not 
desaturate 22:5 (n-3) to 22:6. However, when the substrates for chain elongation, 
malonyl-CoA and NADPH, are included in the suspension, 22:6 is produced. This 
suggests that 22:5 fatty acid is elongated to 24:5 which is then desaturated by a A6 
desaturase. The 24:6 produced could then undergo p oxidation to produce the 22:6 n-3 
fatty acid (Voss et al 1991). The same is true for production of n-6 fatty acids in rat liver 
microsomes (Selma Mohammed et al 1995). This pathway requires shuttling of the fatty 
acid around the cell as it must move from the ER to peroxisomes for oxidation and then 
return to the ER for incorporation into phospholipids (Sprecher 1996, Sprecher et al
1995). The same pathway has now been identified for n-3 fatty acid production in human 
retinoblastoma cell lines. This work suggests the presence of two chain length-specific A6 
desaturases, one capable of conversion of 18:3 n-3 to 18:4 n-3 and the other to convert 
24:5 n-3 to 24:6n-3 (Marzo et al 1996). However, work in liver microsomes does not 
suggest the presence of two enzymes (Geiger et al 1993). Fatty acids esterified to PC can 
be desaturated by a phospholipid-specific desaturase while esterified to glycerol (Pugh & 
Kates 1977). This avoids the need for fatty acid conversion to thiolesters. It also raises 
questions about the active site of the desaturase enzymes and why there is no steric 
hindrance to desaturation. The authors suggest that this system may only become 
effective when essential fatty acids are deficient. As yet no evidence has been presented to 
suggest that the same is true for other lipids.
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Fig 1.8 Pathway for essential fatty acid desaturation by the A6, A5 and putative A4 
desaturase enzymes in the liver.
Although most structural information is available for the A9 desaturase, many studies of 
the physiological control of desaturation have centred around the A5 and A6 desaturases 
because they are required for the production of prostaglandins and leukotrienes from 
essential fatty acids. Although the A6 desaturase has not been cloned, the complex has 
been isolated from liver microsomes and the membrane surrounding it analysed. It 
contained mostly PC and cholesterol in a 4:1 ratio. This area of the membrane is in a gel- 
phase state at physiological temperature (Leikin & Schinitzky 1995). Increasing enzyme 
activity will increase the amount of PUFA in the membrane and therefore increase the 
fluidity of the membrane. This movement away from the gel-state environment in which 
the enzyme resides may control enzyme function in that the enzyme may become inhibited 
when the membrane becomes too fluid. When extracting the desaturase from the liver
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microsomes, NADH-cytochrome bs reductase and cytochrome bs are co-extracted (Leikin 
& Shinitzky 1994).
Desaturases are not ubiquitous. Rat and human placenta (Ravel et al 1985, Chambaz et al
1985) and rat and human epidermis (Chapkin & Ziboh 1984, Chapkin et al 1986) have no 
activity while human platelets have very little (de Bravo et al 1985). Human foetal liver 
has active A5 and A6 desaturase enzymes (Chambaz et al 1985) but only the A6 desaturase 
is active in human endothelial cells from umbilical vein (Rosenthal & Whitehurst 1983). 
Liver microsomes from human neonates have active A5 and A6 desaturase enzymes 
although the activity of these enzymes is lower than in adults (Poisson et al 1993a). Cells 
from the rat small intestine, in particular jejunum and ileum cells, possess A9 and A6 
desaturase activity (Garg et al 1988a). Cultured rat cardiac myocytes and human 
enterocyte cell lines can also desaturate essential fatty acid (Hrelia et al 1995, Dias & 
Parsons 1995). Desaturases were thought to be limited to the ER but rat liver nuclei have 
now been reported to have A5 desaturase activity (Ves Losada & Brenner 1995). This 
may be important for the regulatory effects of arachidonic acid on gene transcription (see 
earlier).
Before a discussion of the factors which affect desaturases, it should be noted that their 
activities in rats are strain-dependant. Studies of A5 and A6 desaturases in normotensive 
rats strains have shown that Sprague-Dawley rats have lower activities than Wistar rats. 
There are even differences between rats of the same strain from a different source. Wistar 
rats from Charles River have a lower activities that those from Bio-breeding (de Antueno 
et al 1994). Some of these changes may be due to diet or housing conditions.
The activities of these enzymes are generally measured using two techniques. The first is a 
direct enzyme assay; whole cells or microsomes are incubated with radioactive substrates 
for desaturation. The rate of conversion of substrate to product can then be measured. 
The second way is to study the fatty acid composition of the membrane and calculate 
indices of desaturation. These are the ratios of product to substrate. This method is 
useful when the sample size is small as measurements for all the desaturases can be made 
from one sample.
30
1.8.2 Dietary Induced Changes In Desaturation.
Trace elements affect desaturation in Sprague-Dawley rat liver. Iron, copper and 
manganese deficiency reduce the activity of the A9 desaturase. This is an iron-containing 
enzyme and iron deficiency therefore reduces its activity. The mechanism of action of the 
other elements is less clear, although the authors suggest that copper is a component of 
the desaturase. A5 and A6 desaturase activities are also reduced by iron and copper 
deficiency. Zinc deficiency does not directly affect the enzyme activity but alters the fatty 
acid composition of the liver cells because zinc deficient rats have a reduced food intake 
(Eder et al 1996). The lack of effect of zinc deficiency has been reported previously in 
Long-Evans rats (Kramer et al 1984), although others have reported A9 desaturase 
activity to be decreased and A6 desaturase activity to be increased under the same 
conditions (Fogerty et al 1985). Neither of these studies directly measured enzyme 
activity; the fatty acid composition of the membrane lipids was analysed. The later study 
attributes most of these changes to neutral lipids. Since Kramer et al (1984) only studied 
phospholipids, these alterations may have been overlooked. Direct enzyme activity studies 
have shown A9 desaturase activity to be reduced in rats fed a zinc deficient diet with a high 
fat content, preventing the possible effects of essential fatty acid deficiency (Eder & 
Kirchgessner 1995). As the control rats were also fed a high fat diet and all rats were 
force fed, these changes cannot be attributed to diet. The effects of Mg2+ deficiency has 
been studied in LLC-PK cells derived from porcine kidney. Mg2+ deficiency impairs 
PUFA biosynthesis, possibly by reducing A5 and/or A6 desaturase activity which would 
reduce the amount of PUFA incorporated into cell membrane phospholipids (Mahfouz et 
al 1989). Others have observed a reduction in the arachidonic and stearic acid content and 
a reduction in oleic and linoleic acid content in erythrocyte membranes from Mg2+ deficient 
rats (Rayssiguier 1986).
Vitamin A-deficiency increases rat A9 desaturase activity which is reversed when vitamin 
A is restored to the diet (Alam & Alam 1985). Vitamin E is important for membrane 
homeostasis because it is a potent antioxidant, preventing the breakdown of PUFAs 
(Burton & Traber 1990, Buttriss & Diplock 1988). However, vitamin E may also affect 
desaturase activity. Increased levels of vitamin E intake have opposite effects; the activity 
of the A6 desaturase increases in brain tissue and decreases in liver tissue (Despret et al 
1992). The fact that the action is different in the two tissues suggests that this is not a 
general effect on the cell membrane. However, vitamin E decreases membrane fluidity in 
rat erythrocytes (Kameda et al 1985) and there is a negative correlation between A6
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desaturase activity and membrane microviscosity (Brenner 1984). This explains the results 
in the brain but not the liver. If there are two forms of the A6 desaturase as there may be 
for A9 desaturase this may explain the two different effects.
N-3 fatty acids and cholesterol inhibit A6 desaturase in rat liver microsomes although their 
effects are not additive (Garg et al 1988b). The ability of rats to recover from this 
inhibition has been studied. Diets high in n-3 fatty acids were fed to young and old rats to 
inhibit the enzymes. After 3 days of feeding an n-3 deficient diet, the activity of the 
enzymes had returned to normal in the young rats; the activity in the older rats never 
completely recovered (Dinh et al 1995). Although n-3 fatty acids reduce desaturase 
activities, this inhibition is only effective as long as large quantities of n-6 fatty acids are 
not present. High concentrations of n-6 fatty acids overcome the inhibition (Garg et al 
1990). Some fatty acids inhibit desaturases. In particular, C20:5 n-3 reduces A5 
desaturase activity in erythrocyte, plasma, liver and kidney but not heart tissue (Nassar et 
al 1986). In the liver of Zucker rats, A9 desaturase activity is inversely related to the 
proportion of linoleic acid in the liver lipid (Weekes et al 1986). Linoleic acid also 
regulates the expression of A9 desaturase mRNA in neonatal mice. The brain isoform of 
the gene has increased expression and the liver isoform decreased expression in rats nursed 
by mothers fed a high linoleic acid diet (De Willie & Farmer 1993). Unsaturated fatty 
acids in general reduce A9 desaturase activity in mice. After returning the mice to a 
normal diet, the activity increased but did not reach control levels within the time course 
of the study (De Antueno et al 1992). Highly purified 20:5 (n-3) and 22:6 (n-3) fatty acid 
supplemention reduced liver A5 and A6 desaturase activity. Very high doses of the fatty 
acids caused this inhibitory effect to disappear. None of the doses of fatty acids affected 
the putative A4 desaturase and all doses increased the p oxidation of fatty acids (Gronn et 
al 1992). The activity of the A6 desaturase in rat liver microsomes is also increased by 
diets high in 18:3 (n-3) and 18:2 (n-6). The same was found to be true for the A5 
desaturase while the A9 desaturase was inhibited by the above diets and a diet high in 20:5 
(n-3) and 22:6 (n-3) (Christiansen et al 1991).
PE or ethanolamine supplementation in rats reduces the activity of the A6 desaturase. 
Ethanolamine also inhibited the desaturation of linoleic acid by hepatocytes in culture 
(Imaizumi et al 1989), suggesting that this may be an action of the base group and not the 
fatty acid. Feeding rats a choline-free diet reduces the amount of PC in the membrane and 
increases the amount of PS. It also causes a reduction in the activity of the A5 desaturase
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in rat liver microsomes (Leikin & Brenner 1992). The reduction in PC increases the C/PL 
ratio making the membrane more rigid. The reduction in A5 desaturase activity will 
further exacerbate this decrease in membrane fluidity. PC (18:2) incorporation reduced A6 
desaturase activity and increased the fluidity of the membrane (Koba et al 1995).
Trans fatty acids can regulate desaturation. The n-9 trans fatty acid, elaidate, is a potent 
inhibitor of A5 desaturase in human skin fibroblasts (Rosenthal & Doloresco 1984). 
Geometrical isomers of 18:3 (n-3) fatty acid do not inhibit A6 desaturase in rat liver 
microsomes but they do increase the activity of A5 desaturase (Blond et al 1990). These 
two results suggest that the position of the trans double bond determines the effect of the 
fatty acid.
Low fat diets in human subjects increase A6 desaturase activity in lymphocytes while A5 
desaturase activity is unaffected (Hagve et al 1986). Desaturation in rat liver also 
increases during a fat-free diet (Voss et al 1991). This dietary control of desaturation may 
stabilise membrane lipid composition, keeping the concentration of arachidonic acid 
constant by increasing the conversion of linoleic acid. The increased activity may be due 
to lack of inhibition by the low fatty acid level in the diet. N-3 fatty acid deficiency 
prevented the age-related reduction in A6 desaturase activity in Wistar rat liver
microsomes (Dinh et al 1993). p
'
/ '
Increasing the cholesterol content of liver microsomal membranes makes them less fluid 
and increases their activity of A5, A6 and A9 desaturases. Increased dietary cholesterol 
induced similar changes in rat adrenal microsomes (Igal & Dumm 1994). Increased A9 
desaturase activity in spontaneously hypertensive rats (SHR) fed a high cholesterol diet 
(Ueno et al 1985) may be a device to increase fluidity to override the effects of increased 
cholesterol (Garda & Brenner 1985). Others, however, have observed that cholesterol 
feeding reduces the A6 desaturase activity (Garg et al 1986).
As desaturases are membrane-bound, they are ideally situated to maintain membrane 
composition and therefore cellular homeostasis. When fatty acids in the diet are plentiful, 
their activity is reduced but when this is limiting, activities increase to maintain the 
membrane levels of PUFA. Activity may be modulated by product or substrate inhibition. 
The enzymes also respond to membrane fluidity which is a complex result of cholesterol 
and phospholipid content.
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A5 and A6 desaturases are also affected by dietary protein content. Low protein diets in 
rats initially reduced activity but this reduction was not consistent and fluctuated with 
time. Returning to a normal diet for 2 days, increased the activity of the enzyme which 
was maximal by 13 days (Narce et al 1988). The authors postulate that these changes may 
relate to changes in insulin, thromboxane, thyroid hormones or corticosterone. Decreased 
A9 desaturase activity has been shown in growing rats fed a low protein diet; subsequent 
feeding with a normal diet returned activity to a level greater than it was before the low 
protein diet began (Narce et al 1992a). Casein increases serum and liver cholesterol levels 
as well as increasing the desaturation of linoleic acid to arachidonic acid more than 
soybean protein. Here, casein protein increased A6 desaturase activity to a greater extent 
than soybean protein. Dietary protein appears to affect desaturation by changing the 
membrane fluidity which was correlated with A6 desaturase activity (Koba et al 1993). In 
vitro, an increase in membrane fluidity reduces activity and a decrease in fluidity has the 
opposite effect (Garda & Brenner 1984, 1985). Casein diets increase the desaturation of 
linoleic acid although at least 35% of the dietary protein must be casein for this effect to 
occur. This protein-rich diet increases Vmax but does not alter Km (Peluffo & Brenner 
1974).
The effect of ethanol, which decreases liver and brain A6, A9 and A5 desaturase activity, 
also may be excerted by changing membrane fluidity (Wang & Reitz 1983).
1.8.3 H o rm o n a l C o n tro l n f D e sa tn ra tin n
Thyroid hormone excess increases lipogenesis, microsomal A9 desaturase activity (Towle 
& Mariash 1986) and the activity of PLA2 (Szymanska et al 1991). Direct assay of A5 and 
A6 desaturases showed an acute suppression of activity but this was not reflected in 
changes in membrane composition (Ves-Losada & Peluffo 1993). In these experiments, 
the expected (Slljk membrane fatty acid composition did not occur, possibly because the 
PLA2 is also less active. Conversely, on evidence of fatty acid composition, A6 desaturase 
activity is subnormal in hypothyroid patients (Van Doormal et al 1986), again possibly 
secondary to higher PLA2 activity.
In vivo and in vitro ACTH administration inhibits PUFA biosynthesis in rat liver and 
adrenocortical cells by inhibiting A5 desaturase. Isolated liver and adrenocortical cells 
from ACTH-treated animals have a reduced incorporation and rate of metabolism of
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dihomo-y-linolenic acid (Mandon et al 1987). ACTH has a similar effect on Sertoli and 
Leydig cells (De Catalfo et al 1992), suggesting that this is not solely due to 
corticosterone. ACTH acts through cAMP. In rat adrenocortical cells, dibutyryl cAMP 
mimics the effect of ACTH (Mandon & De Gomez Dumm 1989). Other lipid- 
metabolising enzymes are inhibited by ACTH, in particular the acyl-CoA synthase in 
adipose tissue and the adrenal gland (Hall & Saggerson 1985, Mandon et al 1988). In 
vitro corticosteroid administration also inhibited arachidonic acid production by these cells 
(De Catalfo et al 1992). Since glucocorticoid receptors are widespread, this may be an 
important effect. Dexamethasone, a glucocorticoid analogue, also reduces the activity of 
the A5 desaturase (Marra et al 1986, Mandon et al 1987).
Rat liver microsome A5 desaturase activity is also inhibited by the mineralocorticoids, 11- 
deoxycorticosterone and aldosterone. Both reduced the conversion of dihomo-y-linolenic 
acid to arachidonic acid. The inhibition caused by 11-deoxycorticosterone requires the 
presence of a soluble cytoplasmic 25 kDa protein fraction but aldosterone-induced 
inhibition does not, possibly suggesting a direct action of aldosterone on the membrane 
(De Alaniz & Marra 1992, Marra & De Alaniz 1991). Because the administration of these 
steroids does not change the C/PL ratio, the reduction in A6 desaturase activity caused by 
mineralocorticoids appears to be solely responsible for their effects on membrane fluidity 
in liver microsomes (Marra & De Alaniz 1990). 11-Deoxycorticosterone can also activate 
A9 desaturase in cultured hepatoma cells (Marra et al 1988).
In normal male rats, A9 desaturase activity decreases with age; oestrogen administration to 
castrated males prevents this. As the reduction is slower in female rats than males, 
oestrogens may have a role in maintenance of enzyme activity (Thorling & Hansen 1995). 
However, others have not confirmed that oestrogen affects desaturation in human subjects 
(Medeiros et al 1995). In this study, activity was compared with endogenous oestrogen 
levels. Other studies have shown the activities of A5 and A6 desaturases to be higher in 
postmenopausal than premenopausal women, suggesting that oestrogen may reduce the 
desaturase activity (Liu & Medeiros 1995). However, the age difference between these 
two groups would also account for differences in desaturation. It is difficult to compare 
these experiments as the first was carried out on male rats and the other two on female 
patients. A better experiment would have been to treat post-menopausal rats with 
oestrogen and to compare them with postmenopausal untreated rats. The activity of A9
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desaturase is increased by testoserone whereas the activities of A5 and A6 desaturase is 
reduced. These effects are greater in females than males (Marra & De Alaniz 1989).
Transgenic mice have been used to study the effect of growth hormone on A6 desaturase 
activity. Animals which expressed the growth hormone transgene had a significantly 
greater A6 desaturase activity leading to an increased arachidonic acid and DHA content in 
the liver phospholipids but not those of adipose tissue (Nakamura et al 1996). Others 
have previously reported that growth hormone administration to hypophysectomized rats 
caused the ratio of arachidonic to linoleic acid to increase rapidly (Maddaiah & Clejan 
1986), suggesting an increase in enzyme activity.
Adrenaline reduced the conversion of linoleic acid to y-linolenic acid, i.e. A6 desaturation. 
This effect could be blocked by propanolol, the p receptor antagonist (de Gomez Dumm & 
Brenner 1978). The authors therefore state that the reduction in desaturation by 
catecholamines is mediated through the p receptor by an increase in cAMP. Thus this may 
be a general response to cAMP (see above).
1.8.4 Hypertension and Fattv Acid Desaturation.
Higher A5 and A6 desaturase activity have been reported in SHR compared to Wistar- 
kyoto (WKY) rats at one month and 6 months (A6 only) of age. However, compositional 
analysis of the membranes showed an unexpected reduction in arachidonic acid content; 
increasing enzyme activity should have increased the arachidonic acid in the membrane. 
The authors postulated that this might be due to inefficient esterification of arachidonic 
acid into phospholipids or increased utilisation of arachidonic acid in eicosanoid 
production (Narce et al 1994). A year later, the same group published results showing 
reduced A5 and A6 desaturase activity in SHR microsomes. Enzyme activity was inversely 
related to blood pressure. Analysis of membrane lipids showed an increase in linoleic acid 
and a reduction in arachidonic acid content as expected (Narce & Poisson 1995). The 
authors suggest that these alterations may be due to increased insulin sensitivity in SHR or 
increased prostaglandin production. It is difficult to reconcile the conflicting results of 
these two similar experiments. No attempt was made in the 1995 paper to explain these 
anomalies.
The two previous studies (Narce et al 1994, Narce & Poisson 1995) only investigated the 
rate of desaturation of n-6 fatty acids; investigations of the desaturation of n-3 fatty acids
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further adds to the confusion. Hepatocyte A6 desaturase activity for n-3 fatty acids was 
higher in the young SHR rat than in the normotensive controls, but there was no difference 
when 12 month old rats were compared. Fatty acid analysis of the hepatocytes showed 
that the enzyme activity and n-3 fatty acid content of the membrane were not related. The 
authors postulate that the change in n-3 fatty acid desaturation is important in the 
pathogenesis of hypertension as it alters the eicosanoid balance (Narce et al 1995). There 
is, as yet, no evidence to indicate whether there are two different desaturase enzymes 
specific for n-3 and n-6 fatty acids. Therefore, it is difficult to explain why the activity of 
the enzyme can be increased for one fatty acid type but not the other. When the enzyme 
assay was carried out in whole hepatocytes, the enzyme activity was increased compared 
to control but when the assay was carried out using microsomes, a reduction activity was 
observed. A methodological artefact cannot therefore be excluded.
Stress, induced by housing animals one to a cage, reduced A5 and A6 desaturase activity 
in WKY rats. In SHR rats, only A5 desaturase activity was affected but this inhibition was 
greater than in WKY rats. Adrenaline administration reduced essential fatty acid 
desaturation in Sprague-Dawley rats (Mills et al 1994). This suggests that the effects of 
stress-induced hypertension may be due to release of adrenaline, which is known to be 
increased in this situation (Mills & Ward 1989). Blood pressure was increased in the 
stressed rats (Mills & Ward 1986a) but the levels of ACTH and corticosterone were not 
measured.
Both hypertension and salt loading reduced A5 and A6 desaturase activity while salt 
loading also reduced the incorporation of fatty acids into phospholipids. Again this effect 
was more marked in SHR than WKY rats (Poisson et al 1993b). Earlier studies had 
however suggested that A5 and A6 desaturase activities were increased in liver microsomes 
by salt loading (Narce et al 1992b). The concentration of salt in the drinking water used 
by Poisson et al (1993b) was 10% for four weeks whereas Narce et al (1992b) used 3% 
for 60 days. The difference in duration and magnitude of salt loading makes it difficult to 
compare these studies. Salt loading will suppress the renin-angiotensin-aldosterone system 
and increase the blood pressure which may also have had independent effects on 
desaturation. In patients, salt-loading caused the levels of unesterified plasma fatty acids 
to increase and plasma aldosterone levels to fall (Goodffiend et al 1991b). This is also a 
complex situation and it is unlikely that the aldosterone level is an important determinant 
of the lipid status here.
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1.8.5 Diabetes Mellitus and Fattv Acid Pesaturation.
Three different animal models have been used to study the effects of diabetes on the 
desaturase enzymes; streptozotocin (STZ)-induced diabetic rat, alloxan diabetic rats and 
spontaneously diabetic bio-breeding (BB) rats. STZ induces extrapancreatic toxicity 
which causes diabetes by an unknown action, possibly related to free radical formation. 
A5 desaturase activity is impaired in heart, liver, kidney, aorta, serum (Holman et al 1983), 
the renal cortex (Ramsammy et al 1993), testes (Wilder & Coniglio 1984) and in cells 
from the mesenteric vasculature (Fujii et al 1987). Interestingly, the levels of fatty acids 
from the n-3 series were less effected than those from the n-6 series (Holman et al 1983). 
Further studies of the renal cortex and isolated glomeruli showed that there is a reduced 
activity of the A5 and A6 desaturase, increased activity of the long-chain acyl-CoA 
synthetase and 1 -acyl-s«-glycero-3-phosphocholine acyltransferase. Elongase activity was 
not altered by STZ-induced diabetes. Lipid peroxidation was also lower in diabetic rats, 
as measured by monoalondialdehyde, the end product of lipid peroxidation. The authors 
claim that the changes were not due to increased p oxidation (Ramsammy et al 1993). The 
adrenal glands of STZ-diabetic rats make less arachidonic acid, due to impaired A5 and A6 
desaturase activity and this is partially reversed by insulin treatment. Insulin also increased 
arachidonic acid production in cultured diabetic rat adrenocortical cells (Igal et al 1991). 
Others have shown that insulin increases the activity of the A6 desaturase in diabetic rats 
(Shin et al 1995). Vitamin E, possibly acting as an antioxidant, improved desaturase 
activity and reversed several other STZ-induced changes (Douillet & Ciavatti 1995). 
However, unlike normal rats, STZ-diabetic rats fed either a diet high in either n-6 or n-3 
fatty acids did not have altered desaturase activity by direct enzyme assay although the 
membrane contained more PUFA (Igal & de Gomez Dumm 1995).
Alloxan-diabetic rats have raised A6 desaturase activity in the kidney compared to controls 
but A9 desaturase activity is unchanged. In liver cells, A6 desaturase activity was 
unchanged but A9 desaturase was depressed (showing different tissue effects). The 
authors suggest that the rate limiting step in A6 desaturation is the formation of the fatty 
acid thiolester as the activity of the acyl-CoA synthetase is increased in the renal cortex 
(Clarke & Queener 1985). Neither A5 desaturase nor membrane fatty acids were analysed.
In spontaneously diabetic (BB) rats, the activities of the putative A4 desaturase, A9, A5 
and A6 desaturases are all lower than control and normalised at least partially by insulin
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(Mimouni et al 1992, Mimouni & Poisson 1990, 1992). However, the authors did not find 
any changes the cell membrane composition consistent with reduced activity but the 
experimental groups were small (n=3) (Mimouni et al 1994). Reported insignificant 
changes in arachidonic/linoleic acid ratio and membrane palmitoleic acid content consistent 
with enzyme changes might be significant in a larger experiment.
Although platelets have little desaturase activity, they have been used to study enzyme 
activity in human insulin-dependant (EDDM) and NIDDM patients by the direct enzyme 
assay. A5 and A6 desaturase activities were impaired (Jones et al 1986). Short term 
ketoacidosis, a feature of poorly controlled patients, reduced the arachidonic acid content 
of the plasma. There was an inverse correlation between the plasma glucose levels and 
arachidonic acid content. These results suggest that metabolism of essential fatty acids by 
the A5 and A6 desaturases is impaired. It can be corrected by insulin (Bassi et al 1996).
1.8.6 Effects of Age
In rat liver microsomes, A6 desaturase activity decreases with age while that of the A9 
desaturase increases (Peluffo & Brenner 1974). This reduction in A6 desaturase can be 
prevented by the administration of y-linolenic acid (Hrelia et al 1989) which increases the 
desaturation of both n-6 and n-3 fatty acids (Biagi et al 1991). Previous studies, however, 
have suggested that diets high in unsaturated fatty acids actually reduce desaturation 
(Nassar 1986, Weekes 1986, Gronn 1992). For A6 desaturase Km for linoleic acid 
increases with age but Vmax is not changed. For n-3 fatty acids, Km was unaffected by 
age (Hrelia et al 1990) possibly because the enzyme has a higher affinity for n-3 fatty 
acids. Others have reported that desaturation fluctuates with time. For example, 
desaturation rate of a-linolenic acid increases in WKY rats from 1.5-3 months and then 
decreases until 24 months when it returns to the same levels as at 1.5 months. Linoleic 
acid desaturation rate increases until 6 months and remains constant thereafter. The 
activity of the A5 desaturase decreases from 1.5 to 3 months and then increases again to 
reach the 1.5 month level at 24 months (Maniongui et al 1993). The decrease in 
membrane fluidity which occurs with age and which may be related to desaturase action, 
can be reduced by restricting the food intake of animals. Feeding rats on an ‘every other 
day’ regime reduces microviscosity of splenic lymphocytes compared to control fed rats 
(Pieri 1991).
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1.8.7. Exogenous Inhibitors and Activators of Desaturation.
A number of inhibitors of microsomal desaturase have been identified but their use in the 
study of membrane lipid composition has been limited. Various inhibitors of microsomal 
desaturase enzymes have been identified. Curcumin (l,7-bis(4-hydroxy-3methoxyphenyl)- 
l,6-heptadiene-3,5-dione) inhibits A5 and A6 desaturases; its 4-hydroxyl group is essential 
for this effect (Kawashima et al 1996a). The same enzymes are inhibited by the 
structurally related gallic acid esters (Kawashima et al 1996b) and by benzyl viologen 
which induces free radical formation (Muriana et al 1991). Finally, sesamin, an aromatic 
constituent of sesame seeds, specifically inhibitor A5 desaturase (Shimizu et al 1991). 
Fibrates are used in the treatment of hyperlipidaemia syndromes. Their effects on lipid 
metabolism are complex and changes in A5, A6 and A9 desaturase activities inconsistent 
(Vazquez et al 1995, Alegret et al 1995, Sanchez et al 1993). It seems likely that these 
changes are secondary to altered lipid metabolism or possibly to peroxisomal proliferation 
(Alegret et al 1995). The activity of the A6 desaturase is inhibited by foetal bovine serum 
in enterocytes in vitro (Dias & Parsons 1995), possibly because it binds fatty acids, 
reducing their availability for desaturation.
1.9 Activities Of Enzvmes Other Than The Desaturases.
From the foregoing discussion, it is clear that the desaturases play a major role in 
determining membrane composition. However, it is not an exclusive role; several other 
enzymes are involved.
The concentration of arachidonic acid in the membranes of cultured cardiac myocytes from 
young SHR (3 days old) is lower than in WKY but there is more of this acid in their 
growth medium. Thus, more arachidonic acid is lost from SHR membranes. This is due 
to relatively higher deacylation rate in SHR cell membranes by a more active Ca2+- PLA2. 
The Ca2+-independent PLA2 was not different between the two strains. Membrane 
lysophospholipid content was also not different so that increased reacylation must 
compensate for increased PLA2 (Millanvoye-Van Bussel & Devynck 1995). The increase 
in PLA2 activity could be due to raised intracellular [Ca2+] which occurs in SHR or to a 
higher enzyme concentration. PKC, which regulates PLA2, activity (Exton 1994) is 
increased in SHR aortic cells (Murakawa et al 1988). Lipid peroxidation is also more 
marked in their myocardial cells (Janero & Burchardt 1989) and PLA2has a higher affinity 
for peroxilipids than their unoxidised precursors (McLean et al 1993). The increase in
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PLA2 activity may therefore be a device to remove these peroxilipids. Neonatal SHR are j 
nomotensive Millanvoye-Van Bussel & Devynck (1996) therefore suggests that these 
changes have a genetic basis. However, these rats had hypertensive mothers and 
consequent changes in the uterine environment may at least have been partly responsible. 
Moreover, neonatal SHR rats have cardiac hypertrophy (Clubb et al 1987).
Renal PLA2 activity is increased in|stroke-prone SHR (SHRSP) rats (Kawaguchi et al 
1986, Okamoto et al 1989). Their levels of PE and PC decrease with age, as does the 
arachidonic acid content of the cell membrane. In contrast, the levels of these lipids 
remain constant in WKY rats over time. Antihypertensive drugs, Nicardipine, Hydralazine 
and Enalapril, prevent "the decrease in SHRSP and increased membrane arachidonic acid. 
The PLA2 activity was also corrected by antihypertensive treatment (Okamoto et al 1989). 
Thus the increase in PLA2 activity in SHRSP is probably due to increased blood pressure. 
PLA2 acts preferentially on PC and PE (Kawaguchi et al 1986) which may explain why 
only these were affected in renal membranes. Interestingly, in the Okamoto et al (1989), 
study the levels of PE and PC in the membrane begin to fall before a detectable increase in 
PLA2 activity, suggesting that something else is controlling their levels. PLA2 activity is 
also increased in SHR aortic rings compared to WKY. Esterification of arachidonic acid 
into phospholipids is increased in SHR rats but esterification into neutral lipids was not 
different between groups. The increase in the amount of arachidonic acid in phospholipids 
does not appear to be due to reacylation of lysophospholipids but to de novo synthesis of 
lipids (Limas et al 1981).
PLC activities are increased in the renal membranes of SHRSP compared to WKY 
(Kawaguchi et al 1987). In SHR platelets, the activity of PLC is also enhanced. This 
leads to increased platelet reactivity as PLC breakdown of phosphatidylinosoitol 4,5- 
bisphosphate is an early step in the activation by thrombin (Koutouzov et al 1987).
It was suggested that turnover of PC is increased in SHR, SHRSP and Dahl salt-sensitive 
rats platelets compared to their control strains (Remmal et al 1988, Marche et al 1990) 
but not in those from deoxycorticosterone acetate (DOCA) -salt hypertensive rats (Marche 
et al 1990). However, when these studies were repeated with VSMC, conflicting results 
were obtained. When incubated with 32P, the total lipid-associated radioactivity was 
greater in the WKY cells. The labelling of PE was also greater in the WKY but there was 
a small reduction in the amount of labelled PS compared to SHRSP. The actual
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composition of the lipids was not different between the hypertensive and control rats 
(Dominiczak et al 1991a). Membrane fluidity is dependant on its lipid composition at any 
given time. That an increased turnover rate does not necessary mean that composition 
changes is emphasised by these observations of Dominiczak et al (1991a).
Diabetic subjects synthesise less lipid and there is an increased breakdown of the body's fat 
stores. In STZ-diabetic rat liver, lysophosphatidylcholine acyl-CoA transferase (LAT) 
activity is increased and PLA2 activity is decreased (Dang et al 1984). This contradicts 
previous reports that reacylation of PC in diabetic rat erythrocytes is less efficient than in 
control rats (Le Petit-Thevenin et al 1988). Others have observed that, in STZ-diabetic 
rats, membranes incorporate less palmitic, oleic and linoleic acid into erythrocyte 
membranes than controls (Arduini et al 1995), again suggesting that reacylation and the 
activity of LAT may be impaired in STZ-diabetics. Propionyl-L-camitine treatment 
reduces the vascular damage observed in diabetes rats (Corsico et al 1993), promoting 
investigation of its effect on erythrocyte membrane composition. This treatment corrects 
the deficit in reacylation of PC with linoleic acid; reacylation with the other fatty acids was 
partially restored (Arduini et al 1995). As Le Petit-Thevenin et al (1988) and Arduini et 
al (1995) both studied reacylation in erythrocytes, this impairment may be restricted to 
these cells. The incorporation of radioactive fatty acids into erythrocyte membrane 
phospholipids is reduced in diabetic rats and cannot be corrected by insulin treatment 
(Dang et al 1991). This is strong evidence that reacylation is impaired.
The arachidonic acid concentration in platelet membranes from STZ-diabetic rats is normal 
3 weeks post-induction of diabetes but is increased compared to controls 6 weeks post­
induction. Arachidonyl-CoA synthetase, acyl-CoA:lysophophatidylcholine acyltransferase 
and PLA2 activities in platelets were not different at 3 and 6 weeks post induction of 
diabetes (Dang et al 1992), strongly suggesting that the alterations observed in platelet 
membranes are not caused by impaired activity of the deacylaction-reacylation cycle.
Diabetes is associated with an increase in enterocyte microsomal membrane total 
phospholipids, including PE and SPG. The phospholipid composition of the cells did not 
correspond with the activities of choline phosphotransferase (CTP), PE methyltransferase 
(PEMT) and l,2-diacylglycerol:CDPcholine esterase which were similar for both diabetic and
control cells. As there was no change in the activity of the enzymes responsible for 
converting PE to PC, the observed difference in membrane composition may be due to
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alterations in de novo PE biosynthesis (Keelan et al 1994). Insulin increases 
sphingomyelinase activity (Petkova et al 1990) and, as insulin levels were low in these 
animals, activity should be lower than normal. This may have increased the amount of 
SPG in the cell observed by Kellan et al (1994) which would lead to a reduction in 
membrane fluidity.
It is worth noting that the liver microsomal acyltransferase system (1-acylglycerol 3- 
phosphocholine (1-acyl-GPC) acyltransferase) does not appear to differentiate between n- 
3 and n-6 fatty acids when esterifying PC. The system does, however, have a preference 
for unsaturated fatty acids and a degree of chain length specificity (Lands et al 1982).
1.10 Uptake of Fatty Acids and Lipids into the Cell Memhrane.
Most information about lipid uptake into the membrane has been derived from studies of 
erythrocytes. These unique cells are incapable of lipid production and therefore any 
alteration in composition must be due to uptake. The composition of erythrocyte 
membranes changes throughout their life span and often reflects changes in the lipid 
composition of the plasma.
Rabbits fed diets containing large quantities of linoleic acid show an increase in the 
proportion of this fatty acid in the membrane. Linoleic acid is preferentially incorporated 
into the sn-2 position in PC and PE at the expense of oleic acid. Uptake is dependant on 
the presence of an acyltransferase which may be sn-2 specific (Mulder et al 1963). The in 
vitro uptake of fatty acids into phosphoglycerides is ATP- and coenzyme A-dependant. 
With these present, rabbit erythrocytes take up more linoleic, oleic and palmitic acid than 
stearic, myristic or lauric acid. The amount of fatty acid incorporated into the membrane 
parallels its plasma concentration (Mulder & Van Deenen 1965a). Fatty acids have been 
shown to be incorporated into erythrocyte ghosts in the presence of ATP, MgCl and 
coenzyme A, although C l6:0 was incorporated from C16:0-CoA without cofactors. 
Incorporation of linoleic acid was the highest. Again, most of this was incorporated into 
the sn 2 position of PC (Oliveira & Vaughan 1964).
Human erythrocytes will take up fatty acids in vitro. Each fatty acid is taken up into the 
cell at a different rate and the rates of membrane association and esterification of the fatty 
acid into lipids are different. Palmitic and stearic acid become membrane-associated to a 
greater extent than oleic and linoleic acid but the actual incorporation rate into membrane
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lipids is greater for oleic and linoleic (Donabedian & Karmen 1967). The presence of 
different pools of fatty acids in the membrane has been suggested. Palmitic acid is taken 
up rapidly, independent of cell metabolism, into a pool from where it can be removed 
using defatted albumin. This suggests that the fatty acid is loosely associated with the 
outside of the membrane. From this pool, fatty acids pass into a deeper pool from which 
they cannot be removed. This may not actually be physically deeper in the membrane but 
the fatty acids may be more tightly associated. Incorporation into this pool is energy- 
dependent, as is the subsequent incorporation of fatty acids into phospholipids (Schohet et 
al 1968). Fatty acids are preferentially incorporated into the lipids in the inner leaflet; this 
may be the deeper fatty acid pool suggested by Schohet (Renooij et ah 1974).
Phospholipids exchange between plasma and the erythrocyte membrane in both man and 
the dog. Approximately 60% and 30% of the total PC and SPG respectively is 
exchangeable with a turnover time of 5 days. PE and PS are thought to be stable, in that 
they do not exchange with plasma lipids (Reed et al 1968). This may be due to their 
absence from plasma or because they are inner-membrane lipids. LPC, PC and SPG also 
exchange. The rate is greater for LPC than PC with SPG exchange being slowest 
(Sakagami et al 1965). Little exogenous free 32P is taken up by the cell (Reed et al 1968) 
but what is taken up is incorporated into phosphatidic acid (Sakagami et al 1965). 
Intravenous infusion of PUFA-PC for 3 days decreased the cholesterol content and 
increased the PUFA content of the membranes. The increase in PUFA was not confined 
to PC; the arachidonic acid content in PS and PE also increased (Catafora et al 1992). 
Cholesterol can also be transfered between plasma and the erythrocyte membrane (Lange 
et al 1977). Increasing dietary cholesterol also increases its erythrocyte membrane 
content. Incubating cells with cholesterol will increase membrane cholesterol by as much 
as 47% (Lijnen & Petrov 1995).
Lysed rabbit erythrocytes can convert LPC to PC. This transacylation requires ATP and a 
fatty acid-CoA derivative. When no ATP is present, the cell will convert LPC to PC and 
glycerophosphorylcholine (Mulder et al 1965). The same authors suggest that 
erythrocytes accept lysophospholipids from the plasma as they cannot deacylate lipids. 
The erythrocyte could then reacylate the lysopospholipids and insert them into the 
membrane. Because there is more LPC than lysophosphatidylethanolamine (LPE) in the 
plasma, the composition of PC changes faster than that of PE (Mulder & Van Deeden 
1965b).
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Changes in membrane composition with diet are not restricted to erythrocytes. Diets high 
in n-3 and n-6 fatty acids changed the composition of mouse liver hepatocytes within 7 
days. These changes were reversed by a normal diet with the correction of 20:5 n-3 taking 
longest. The unsaturation index was not altered, suggesting a concomitant increase in 
saturated fatty acid. The C/PL ratio was also unchanged by these manipulations and so 
the changes in fatty acid composition observed were not due to increased incorporation of 
phospholipids (De Antueno et al 1992).
While lipids can be taken up by the erythrocyte, they can also be released. If the lipid is 
taken into the cell as a total lipid molecule, it is also released that form. The uptake and 
release rates are similar. However, if the lipid was taken into the cell as free fatty acid and 
then esterified to a lipid, then it is released from the cell as free fatty acid. Fatty acid is 
often transferred from PC to PE and neutral lipids before being released in its free form 
(Schohet 1970).
The knowledge that erythrocyte lipid composition changes with diet has been used to 
check compliance in studies involving feeding of lipids. Treatment with y-linolenic acid 
increased the erythrocyte concentration of n-6 fatty acids, in particular dihomo-y-linolenic 
acid (Biagi et al 1994). Increased n-3 fatty acids in the diet for 4 months (3g/day) leads to 
increased n-3 fatty acids in erythrocyte membranes (Russo et al 1995).
The concentrations of oleic acid and arachidonic acid in rat liver microsomal membranes 
were increased by diets high in olive oil (high in oleic acid) or evening primrose oil (high in 
linoleic acid) respectively. Addition of cholesterol to the diet increased membrane 
cholesterol, membrane PC, C/PL and PC/PE ratio. There was a increase in the mono­
unsaturated fatty acid (MUFA) and a slight reduction of saturated fatty acid (SFA). 
Arachidonic acid content was reduced and that of linoleic acid was increased; the ratio of 
these fatty acids was reduced by high cholesterol diet. This suggests that cholesterol 
increases the activity of the A9 desaturase and decreases the activity of the A5 and A6 
desaturases. Cell membrane microviscosity measured by fluorescence anisotropy (see 
later) was increased and membrane fluidity correlated with the unsaturation index (Murina 
eta l 1992).
45
Although erythrocytes cannot synthesise fatty acids, they can produce acyl: Co A esters and 
have one a c y ^ o A  synthetase enzyme. Its role in the cell is uncertain but it may 
participate in the transport of unsaturated fatty acids from the circulation (Davidson & 
Cantrill 1985). Others have shown that n-3 fatty acids are specifically incorporated into 
plasmalogens and phospholipids in the inter leaflet (Knapp et al 1994).
1.11 Physiological Conditions Affecting the Cell Membrane
1.11.1 M e ta h n lic  d isease
During combined hyperlipidemia, the levels of plasma triglycerides and cholesterol are 
increased. Therefore, erythrocyte membranes should be altered. However, the expected 
correlation between plasma and membrane cholesterol does not exist. The membrane 
levels were normal but the membranes from the combined hyperlipidemic group were 
more fluid than those of the control group and basal Ca2+ pump activity are decreased 
(Muzulu et al 1995). These results suggest that the membrane possesses an a adaptive 
process to prevent excessive amounts of cholesterol entering the membrane. Platelet 
membranes from hyperlipidemic patients have an increased C/PL ratio; the opposite is true 
for membranes from hypercholesterolemic patients and the PC/SPG ratio is also decreased 
in these patients (Levy et al 1994). SPG is a membrane rigidifier while PC is a membrane 
fluidiser. A fall in the ratio should increase membrane fluidity (Borochov et al 1977). 
Others have observed that hypercholesterolemia increases platelet cholesterol content and 
does not alter the trimethylammonium diphenylhexatriene (TMA-DPH) or 
diphenylhexatriene (DPH) anisotropy, hypertriglycerideaemia decreases the C/PL ratio and 
decreases the DPH anisotropy (Le Quan Sang et al 1993a).
1.11.2 Hormones
Oestrogens have antioxidant actions. For example, they inhibit metal ion-dependant lipid 
peroxidation in liposomal and microsomal membrane preparations (Wiseman & Halliwell
1993). Synthetic oestrogens reduce membrane fluidity in phospholipid microsomes 
produced from ox brain and this correlates with the antioxidant action. It is not clear 
whether the mechanism of the antioxidant action is the reduced fluidity (Wiseman & Quinn
1994). Tamoxifen, another oestrogen-like compound, inhibits lipid peroxidation in this 
way (Wiseman et al 1993). Combined oestrogen and progesterone therapy decreases 
membrane PUFA and increases SFA and MUFA. The concentration of arachidonic acid is 
also decreased (Ranganath et al 1996). This decrease in PUFA may explain reduced 
membrane fluidity. It is difficult to reconcile the reported cardio-protective effects of
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oestrogen with a decrease in membrane fluidity especially when the evidence of the 
adverse effect of reduced membrane fluidity in hypertension is considered.
1.11.3 Diabetes
1.11.3a Animal Models of Diabetes.
Changes in cell membrane structure and function have been reported in animal models of 
diabetes. Some of these have been discussed previously (see sections 1.8.5) with reference 
to lipid metabolising enzymes. Many reports of changes in the physical properties and 
composition of the membrane are conflicting (see also chapter 6).
In STZ-diabetic rats ileal enterocyte (Brasitus & Dudeja 1985) polymorphonuclear 
lycocytes (PML) (Masuda et al 1990) and renal cell membrane fluidity (Ramsammy et al 
1993) has been reported to be reduced but that of synaptosomal membranes to be 
increased (Medow et al 1994). Others have found membrane fluidity to be unchanged in 
cerebral microvessels (Mooradian & Smith 1992) and intestinal brush border cells 
(Gourley et al 1983)
Microviscosity can be affected by a variety of factors, some of which change in diabetes. 
For instance, erythrocyte membrane C/PL ratio is elevated in diabetic rats suggesting 
reduced membrane fluidity. This can be corrected by Brazilin, a compound used to reduce 
blood glucose and blood viscosity (Moon et al 1993). A similar increase in the C/PL ratio 
and membrane cholesterol, prevented by insulin, has been observed in ileal enterocytes 
from STZ-diabetic rats (Brasitus & Dudeja 1985). Again these changes should increase 
membrane microviscosity. Synaptosomal and microvessel membrane cholesterol and C/PL 
ratio were not altered by STZ (Medow et al 1994 Mooradian & Smith 1992). Ramsammy 
et al (1993) suggest that cholesterol is not responsible for the changes in membrane 
fluidity in diabetes. Removing proteins and cholesterol from renal cells increased 
membrane fluidity but those from diabetic rats were still more rigid than control. This 
suggests that fatty acid composition may be important in determining fluidity. There is 
much evidence for this.
STZ reduces membrane palmitic, palmitoleic, arachidonic, docosatetraenoic (DTA) and 
docosapentaenoic acids (DPA) but increases linoleic, stearic acid and DHA (Dang et al 
1991, Shin et al 1995, Moon et al 1993, Lin et al 1985). Many of these changes may be
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caused by alterations in desaturase activity or to impaired reacylation of the membrane 
lipids in some cell types (see earlier). There is considerable variation in the effect of 
experimental diabetes between tissues (Lin et al 1985, Ramsammy et al 1993, Black et al 
1993, Medow et al 1994, Mooridan & Smith 1992) which may be real or due to 
differences in analytical technique.
Because membrane fluidity may be reduced in diabetics, diets rich in n-3 fatty acids may be 
therapeutic as they should increase membrane fluidity. In cardiac cell membranes from 
diabetic animals fed diets high in n-3 fatty acids, membrane EPA and DHA increased and 
DTA in PE fell compared to non-diabetic controls. The fatty acid composition of PC was 
unaltered. The authors postulate that the beneficial effects of n-3 fatty acids are through 
mechanisms other than changes in the membrane phospholipid composition even though 
the diet led to increases in the amount of unsaturated fatty acid in the membrane (Black et 
al 1993). However, the size of the experimental groups for some fatty acids (n=2) 
reduced the usefulness of these results. Increased fatty acid peroxidation, by decreasing 
membrane unsaturation, should reduce membrane fluidity in STZ rats (Mooradian & 
Smith 1992)
Insulin treatment, particularly from the onset of diabetes, prevents membrane abnormalities 
occurring (Lin et al 1985, Medow et al 1994, Dang et al 1991, Shin et al 1995). 
However, the efficiency of metabolic control is important. PML membrane fluidity 
correlated negatively with serum glucose levels measured the previous week. In animals 
with a low serum glucose level (below lOmM), the membrane fluidity returned to normal 
over time. Interestingly, when glycosylated protein from diabetic rat serum was incubated 
with normal cells, cell membrane fluidity was also reduced (Masuda et al 1990), 
suggesting that protein glycation may affect membrane fluidity.
1.11.3b Human Diabetics.
Changes in erythrocyte structure and function are involved in the pathogenesis of diabetic 
vascular disease. (Isogia et al 1981 Schmid-Schonbein & Volger 1976). However the 
state of the literature on membrane biochemistry is confused and reflects the difficulty in 
carrying out rigidly controlled studies.
The erythrocyte membrane fluidity has been variously reported to be less than (Caimi et al 
1992, Mazzanti et al 1989, Bryszewska et al 1986, Paolisso et al 1993, Kamada & Otsuji
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1983, Dowd et al 1994) greater than (Bryszewska & Leyko 1983, Testa et al 1988, 
Mazzanti et al 1992) or the same as normal (Freyburger et al 1988, Hill & Court 1983, 
Candiloros et al 1995). If the literature on PML is reviewed (Caimi et al 1995, Kantar et 
al 1991), the outcome is similar. Similarity, there is little agreement on the effect of 
human diabetes on membrane composition. While, most studies indicate reduced fluidity 
(Watala 1993) affecting cell function, the reported fall in NIDDM membrane cholesterol 
and phospholipids and C/PL ratio should have the opposite effect (Baldini et al 1989). 
Both erythrocyte membrane C/PL ratio and plasma cholesterol correlate with fluidity in 
diabetic subjects (Bryszewska et al 1986). Others have failed to show a difference in 
erythrocyte or platelet membrane phospholipid or cholesterol content or the ratio of 
cholesterol/phospholipid (Hill & Court 1983, Urano et al 1991, Caimi et al 1995).
Erythrocytes and platelets from diabetic patients have an increased SPG content and/or a 
reduced PE concentration compared to control (Kamada & Otsuji 1983, Caimi et al 1995) 
tending to reduce fluidity because SPG contains most long chain saturated fatty acids and 
PE contain primarily unsaturated fatty acids (Rouser et al 1968). Membrane fluidity 
correlated negatively with membrane PS and PC concentrations in controls and negatively 
with the C/PL ratio and the membrane SPG content in the diabetics (Caimi et al 1995). 
The PC content was greater in young IDDM than controls (Baldini et al 1989).
Membrane fatty acid composition is altered in a complex fashion in diabetes and this is 
determined to a large extent by the altered desaturase activities (see earlier). In NIDDM 
erythrocyte membranes, the unsaturation index is higher than normal according to 
Pelikanova et al (1991) with higher levels of n-3,n-6 arachidonic acid and DHA (Urano et 
al 1991, Pelikanova e ta l 1991). In complete contradiction, others found reduced levels of 
PUFA, DHA and arachidonic acid while saturated fatty acid levels were increased 
(Parthiban et al 1995, Ruiz Gutierrez et al 1993). Platelet membrane analysis showed 
higher stearic acid and dihomo-y-linolenic acid levels in NIDDM patients but arachidonic 
acid, an important factor in platelet aggregation, was normal (Rodier 1995). In a more 
detailed study, Baldini et al1 (1989) analysed the fatty acid content of erythrocyte 
membrane PS, SPG and PC and found relatively more saturated fatty acid in those from 
NIDDM patients. Similar results for PS and PC have been reported by Perssom et al 
(1996) who also found more C22:5 (n-3) in these fractions. It has been suggested that 
insulin resistance is associated with reduced skeletal muscle membrane PUFA (Borkman et 
al 1993).
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Treatment of erythrocytes and erythrocyte membranes with in vitro physiological 
concentrations of insulin increases membrane fluidity (Dutta-Roy et al 1985, Bryszewska 
& Leyko 1983, Juhan Vague et al 1986). At supraphysiological insulin doses, this effect is 
reversed. These effects are independent of plasma glucose (Dutta-Roy et al 1985).
As with the rat models, the degree of metabolic control affects membrane fluidity in 
diabetics. Erythrocytes membrane from IDDM patients with poor metabolic control were 
less fluid; this was most marked in ketoacidosis, suggesting that hyperglycaemia and 
ketone bodies are key factors (Candiloros et al 1995). Anisotropy values correlate 
positively with the amount of membrane protein glycation, lipid peroxidation and 
membrane cholesterol content (Watala & Winocour 1992, Winocour et al 1990 1992a 
1992b). Incubation of platelets with glucose increases protein glycation and reduces 
membrane fluidity. Acetylation of proteins with aspirin or acetyl chloride has a similar 
effect. Therefore, it is not the glucose moieties which change the membrane fluidity but 
the attachment of a molecule to a glycation site (Winocour et al 1992c). Incubation of 
erythrocyte with glucose reduced membrane fluidity according to Bryzewska & Szosland 
(1988) but Birlouez-Aragon et al (1990) found normal values even though glycation was 
increased in the diabetics patients.
Membrane fluidity also affects insulin binding and receptor number. Supplementation of 
Y79 retinoblastoma cells with DHA increases membrane fluidity, insulin binding and 
insulin receptor number (Yorel et al 1989). The opposite is also true; increasing 
membrane SFA of 3T3-L1 adipose cells caused a reduction in insulin binding by 
decreasing both receptor number and binding affinity (Grunfeld et al 198). Diets high in n- 
3 fatty acids fed to NIDDM patients improved in vivo insulin sensitivity (Popp Snijders et 
al 1987).
1.11.4 Blood pressure
1.11.4a Animal Models Of Hypertension
A variety of rat stains have been used to study the effects of hypertension on cell 
membrane structure and function. These include the genetically hypertensive rats, the 
SHR strain and its stroke-prone sub-strain, the SHRSP rat. Other stains which have been 
used are the Dahl and Sabra hypertensive (SBH) rats, both of which develop salt-
50
dependant hypertension, and the Lyon hypertensive strain. The results have varied 
between investigator, model and tissue.
Using the fluorescent probe DPH, Montenay-Garestier et al (1981) was the first to 
observe that the erythrocyte membranes of young SHR were less fluid than those of 
control WKY rats. These results have since been confirmed for erythrocytes (Orlov et al 
1982) hepatocytes, synaptosomes and cardiomyocytes (Devynck et al 1982). Others have 
only been able to show erythrocyte and platelet membrane fluidity to be reduced in male 
SHR rats compared to WKY. Salt loading increased membrane microviscosity in platelets 
but had no effect on erythrocytes. No difference was observed between the 
microviscosities of vesicles produced from lipids extracted from erythrocyte ghosts from 
SHR and WKY rats (Aragon-Birlouez et al 1984, 1982).
Electron spin resonance techniques using 5’-nitroxide stearate as a probe have been used 
to investigate the membrane microviscosity of erythrocytes and cultured VSMC from SHR 
compared to WKY rats. Fluidity was reduced in both cell types from SHR. This 
reduction was enhanced when the Ca2+ ionophore A23187 was used to load the cell with 
calcium (Tsuda et al 1992a). Similar alterations in membrane microviscosity have been 
observed in VSMC anderythrocytes from SHRSP rats compared to WKY (Dominiczak et 
al 1991, McLaren et al 1993). However, when VSMC cells were incubated with calcium, 
the cell membranes from the SHRSP rats became more fluid, becoming more like the 
control cells (Dominiczak et al 1991). McLaren et al (1993) showed that membrane 
microviscosity did not correlate with blood pressure either in the F2 population of an 
SHRSP * WKY cross or in two subgroups with either a WKY or an SHRSP male 
progenitor. The same was found to be true for membrane microviscosity of an F2 
population of SHR * WKY (Norman & Achall 1993).
Conversely, others have observed membrane fluidity to be increased in small intestine and 
jejunal brush border cells (Lau et al 1986 Vazquez et al 1996), microsomes from VSMC 
and endothelial cells (Jaiswal et al 1 1983) and erythrocytes and synaptosomes (Yamori et 
al 1982). It is difficult to explain these disagreements except perhaps on technical 
grounds. Jaiswal et al (1983) used lpM DPH with a microsomal suspension containing 
lOOpg protein/ml which may itself have affected microviscosity. Dominiczak et al (1991) 
reported that a probe to phospholipid ratio of 1:200 did not perturb the membrane 
microviscosity but higher probe concentrations did. This ratio was achieved by incubating
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5nmol/l of probe with membrane at a protein concentration of 1 mg/ml. The same may 
also be true for the report by Yamori et al (1982), where DPH was used as a probe at a 
concentration of 20pmol/l.
Platelet and erythrocyte membrane microviscosity was increased in SBH rats compared to 
their specific control. Salt loading increased platelet microviscosity but not erythrocyte 
membrane microviscosity, suggesting that the composition of these two membranes may 
be controlled by different mechanisms (Aragon-Birlouez et al 1984 1982). In contradiction 
to this, Kunes et al (1994) showed SBH rats to have lower membrane microviscosity than 
control but only after salt loading when hypertension was present. Erythrocyte 
membranes from Dahl salt-sensitive rats are more fluid than control prior to salt loading 
(Kunes et al 1994). The reduction in membrane microviscosity in SBH rats may be in 
response to increased blood pressure whereas, in Dahl rats, the membrane abnormality 
appears to be blood pressure-independent. In all the rat strains studied here, membrane 
microviscosity was negatively correlated with blood pressure (Kunes et al 1994). Others 
have observed that the membrane microviscosity is reduced when platelets from SBH rats 
are suspended in Na+ free medium, a difference independent of dietary salt intake. The 
authors postulate that this may be an inherited effect which may contribute to the 
susceptibility of these animals to hypertension caused by salt loading (Le Quan Sang et al 
1994a). An earlier study failed to show any difference in the membrane microviscosity 
between the platelets and erythrocytes from SBH and Sabra hypertension resistant SBR 
rats (Le Quan Sang et al 1991).
Lyon hypertensive rats have lower core membrane microviscosity than their control strain 
which correlated negatively with blood pressure and cystolic free Ca2+. The microviscosity 
measurements obtained with TMA-DPH, a measure of fluidity at the outer regions of the 
membrane, was correlated positively with cytosolic free Ca2+ (Le Quan et al 1994b), 
suggesting that the core and outer regions of the membrane are affected in opposite ways 
by Ca2+ concentrations.
Differences in membrane microviscosity appear to be limited to genetically hypertensive 
rat strains. Membrane microviscosity is unaffected by DOCA-salt-induced hypertension or 
two-kidney, one clip Gold-Blatt renal hypertension (Orlov et al 1982). Cardiac 
sarcolemmal plasma membrane cholesterol and phospholipid composition were not altered 
in portal hypertension compared to control (Ma et al 1995).
52
A variety of alterations have been observed in the membrane composition of hypertensive 
and control animals. Studies in SHR and WKY rats have shown that linoleic acid is 
reduced in the total lipid extract from SHR mesenteric arterial beds. The SHR 
phospholipid fraction contained more palmitic, oleic and linoleic acid (Mtabaji et al 1988). 
The ratio of arachidonic acid to other fatty acids in VSMC membranes was higher in 
SHRSP than WKY. The membranes of the SHRSP cells were significantly less fluid 
(Dominiczak et al 1993). WKY renal membrane lipid has increased levels of PE 
compared to SHRSP . The levels of PC are also lower and the PC/SPG ratio is decreased 
in SHRSP compared to WKY. There was a decrease in the amount of arachidonic acid in 
the renal medulla of older SHRSP (Okamoto et al 1989). When SHRSP were compared 
with their stroke-resistant controls, SHRSR, VSMC cholesterol levels and cholesterol 
biosynthesis were lower in SHRSP and SHRSR compared to WKY. Membrane 
phospholipid content and phospholipid biosynthesis were increased in SHRSP compared 
to WKY but the cholesterol/phospholipid ratio was reduced in SHRSP. The levels of 
arachidonic, linoleic EPA were decreased in SHRSP compared to WKY. Incorporation of 
linoleic acid into the membrane was reduced in both SHRSP and stroke-resistant (SHR) 
SHRSR compared to WKY (Nara et al 1986).
In young SHR (4 weeks), the amount of DAG produced by stimulated aorta was 
significantly greater than in the WKY rats. By twenty weeks of age there was no longer a 
difference. The fatty acid composition of the DAG was similar for both groups as was the 
PE, PC and triglycerides (TRIG) composition of the membranes. This may be important 
in regulation of blood flow. The cholesterol content of SHR aortas was higher than 
controls (Okumura et al 1990).
The activity of many ion transport systems is altered in hypertension. Many of these 
investigations have been carried out in VSMC as changes in ion-transport are thought to 
be involved in the vascular hypertrophy and hyperplasia seen in hypertension. Early 
reports showed the VSMC from SHR to be more permeable to Na+ and K+ than cells from 
WKY rats (Jones 1973, Friedman & Friedman 1976, Friedman 1979). Friedman (1979) 
only found the active transport of ions to be increased in SHR rats over sixteen weeks of 
age, suggesting that this may be an effect of blood pressure in this strain. A generalised 
effect of blood pressure was excluded by inducing hypertension in WKY rats by renal 
artery constriction. No changes in ion transport were observed. Similar changes in ion
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transport have been observed in erythrocytes from SHR compared to WKY (Van de Ven 
& Bohr 1983). The novel sodium-sensitive fluorescent dye, sodium-binding benzofluran- 
isophthalate, has been used to study intracellular cytosolic sodium ([Na+]i). Resting 
intracellular sodium was lower in SHR VSMC than those from WKY rats (Tepel et al
1995). As Na+ influx is greater in SHR, [Na+]i should be increased. This is not the case 
suggesting that Na+ efflux must also be increased. This has also been found to be true in 
DOCA-salt induced hypertension where permeability of cells to Na+ and Na+ extrusion rate 
are both increased in both tail artery and aortic VSMC. Neither of there cell types showed 
an increase in the [Na+]i (Friedman et al 1975, Jones & Hart 1975). Changes in the Na+ 
transport in rat tail arteries have been observed ten days after the administration of 
DOCA-salt prior to the blood pressure rise (Friedman et al 1986), suggesting a possible 
genetic effect.
The Na+-H+ exchanger in SHR VSMC is more active under tissue culture conditions than 
in control cells. This suggests that this is a primary change and is not due to increased 
blood pressure, hypertrophy or hyperplasia. The increase in exchanger activity is 
concurrent with the increased growth rate in the VSMC from SHR compared to WKY. In 
later passages, when the two growth rates become similar, the activity of the exchanger 
also becomes similar. Intracellular pH is also greater and the recovery from acidification 
faster in SHR- than WKY-derived cells (Berk et al 1989). The exchanger is involved in the 
growth of vascular smooth muscle cells. It controls intracellular pH, which is elevated by 
growth factor stimulation. It is active in the early stages of the mitotic cell cycle and is 
required for the cells to enter the S phase of the cycle (Bobik et al 1991). Also as the 
exchanger is responsible for maintaining cell volume, its activity is increased when cells are 
actively dividing and during hyperplasia; in both these situations, the cell size is increased. 
This goes some way to explaining why the exchanger activity is increased in VSMC. It is 
more difficult to explain why the activity of the exchanger is also increased in skeletal 
muscle (Syme et al 1990), neutrophils (Feig et al 1986), lymphocytes (Feig et al 1987) 
and erythrocytes (Orlov et al 1989). There is probably a genetic basis to this abnormality 
but whether this is in the exchanger gene or in a factor which controls the exchangers 
activity, such as the cell membrane, is not clear. The increase in activity is not due to 
increased gene transcription as the messenger RNA levels in the cells are similar to control 
(La Pointe et al 1995). It is possible that the increased activity is caused by the lipid 
environment surrounding the cell.
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The blood lymphocyte count was lower and the intralymphocyte Na+ content was 
increased in SHRSP, DOCA-salt induced hypertensive rats and in the two kidney one clip 
hypertensive rat compared to their controls but in none was the K+ content altered. Net 
sodium and potassium fluxes were increased in the SHRSP rats but only net sodium flux 
was increased in the DOCA-salt induced hypertensive rats (Furspan & Bohr 1985). As 
these studies were carried out a 4°C, these were passive ion fluxes and not active transport 
and the increased fluxes may be caused by an alteration in the cell membrane. However, 
as the membrane structure changes with temperature, it is difficult to estimate what would 
occur at physiological temperature. Later studies showed that the abnormality in K+ flux 
correlated positively with blood pressure in an F2 cross of SHR and WKY rats (Furspan et 
al 1987).
VSMC intracellular Mg2+ concentration is reduced in cells from SHR compared to WKY 
rats (Kisters et al 1996). This may be due to a disturbance in the membrane magnesium 
ion transport. Erythrocyte Mg2+ levels were significantly lower in hypertensive subjects, 
the membrane microviscosity was also increased in these patients (Paolisso et al 1987).
Intracellular Ca2+ content is a controlling factor in the VSMC contractile process. An 
increase leads to vasoconstriction. Total calcium concentration is higher in SHR VSMC 
compared to control and also in DOCA-salt induced hypertension. Using patch clamp 
technology, it has been observed that the long-lasting Ca2+ current is greater in cells from 
SHR (Rush & Hermsmeyer 1988). The authors suggest that this is an abnormality of the 
Ca2+ channel but it could just as easily be caused by abnormalities in the cell membrane. In 
erythrocytes, increasing intracellular Ca2+ concentration leads to a reduction in membrane 
fluidity (Weed et al 1969). The work of Tsuda et al (1992b) confirms this. This theory is 
further advanced by the knowledge that hepatocytes membranes have an increased 
microviscosity during endotoxic shock, but that this effect is prevented by calcium channel 
blockers (Salgia et al 1993). Thus cellular calcium homeostasis is important in the 
maintenance of membrane fluidity and membrane transport functions.
The activity of the erythrocyte Ca2+-Mg2+-ATPase has been investigated in an F2 cross of 
SHR and WKY rats. Blood pressure was found not to correlate with either enzyme 
activity or cell membrane microviscosity, suggesting that neither are causally related to 
blood pressure. The authors assume that similar results would have been observed in
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VSMC and therefore that cell membrane abnormalities do not play a role in hypertension 
(Norman & Achall 1993).
During salt-induced hypertension, there is an increase in intracellular free calcium but no 
change in calcium influx rates and a reduction in intracellular sodium concentration 
compared to the salt resistant rats. High salt intake decreases membrane microviscosity in 
SBH rats and this is inversely correlated with blood pressure. Intracellular free calcium 
concentration correlated positively with diastolic blood pressure and negatively with 
intracellular sodium concentrations (Pemollet et al 1994). When there is no external 
sodium present, rat and human platelet membranes become less fluid; this as not the case 
in erythrocyte ghost membranes (Le Quan Sang et al 1991).
Salt-loaded hypertensive rats suffer from renal failure leading to proteinururia. 
Administration of PUFA prevented renal damage while reducing the increase in blood 
pressure. Other oils containing shorter chain fatty acids did not have a similar effect, 
suggesting that this is a selective effect of the long chain unsaturated fatty acids found in 
fish oil (Hobbs et al 1996). The authors suggest that this is an effect of incorporation of 
long chain fatty acid into renal cell membranes. However, no attempt was made to 
quantify this.
Borderline hypertensive rats, (cross of WKY * SHR) stressed by isolation did not develop 
prolonged hypertension when fed y-linolenic acid while those not fed the fatty acid 
developed non-neurogenic hypertension. The response to noradenaline in the y-linolenic 
acid-fed rats was not affected whereas the pressor response to angiotensin II was more 
prolonged but less severe. During stress, A6 desaturase activity was reduced by the 
presence of increased adrenaline and corticosterone. Thus y-linolenic acid may reduce the 
peripheral or the sympathetic response to stress (Mills et al 1985). It would have been 
interesting to see the effect of removing the y-linolenic acid diet. Would the stress 
response still be as great? A low dose of y-linolenic acid also reduced the increment in 
blood pressure sustained during stress isolation of Sprague Dawley rats but did not 
prevent it. However, a higher dose did prevent the increase in blood pressure (Mills & 
Ward 1984). There were no changes in heart rate, suggesting that the fatty acid did not 
act through the central nervous system. In WKY rats, Mills and Ward (1986a) showed 
that y-linolenic acid administration reduced blood pressure in the unstressed state. The 
administration of arachidonic acid attenuated the increase in blood pressure only in the
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first two weeks of stress-induced hypertension. Blood pressure was not affected by the 
administration of linoleic acid or a-linolenic acid, the n-3 fatty acid. The pressor response 
to noradrenaline was unaffected. Olive oil affected the response to All stimulation in a 
similar way to y-linolenic acid. Therefore, the blood pressure lowering and AH effects of 
Y-linolenic acid are probably by different mechanisms (Mills & Ward 1986a). A6 
Desaturase is known to be inhibited by stress hormones. In these animals, therefore, the 
administration of the y-linolenic acid may compensate for this. Mills and Ward (1986b) 
continued their study of stress-induced hypertension in WKY rats by testing the 
effectiveness of EPA which is also desaturated and should compensate for desaturase 
deficiency. However, EPA attenuated but did not inhibit the increase in blood pressure 
induced by stress. Since the amount of EPA used here was equimolar to the amount of y- 
linolenic acid able to inhibit the increase in blood pressure completely, n-3 fatty acids do 
not have the same therapeutic potential as n-6. EPA also appears to have some 
tachicardic action, increasing the heart rate both during and before stress induction; the 
response to noradrenaline was increased in the EPA-treated rats (Mills & Ward 1986b).
The attenuation of experimental hypertension by linoleic acid administration appears to be 
strain-dependant. Dahl salt sensitive rats and 2 kidney 1 clip rats on high salt diets are 
both renin-independent forms of hypertension while the 2 kidney, 1 clip, low salt diet rat 
shows a renin-dependant form of hypertension. Linoleic acid administered from 4 weeks 
of age is only effective in attenuating hypertension in renin-dependant hypertension (Reddy 
& Kotchen 1996). This may be due to linoleic acid inhibiting renin and the acute in vivo 
pressor response to renin (Kotchen et al 1975). High linoleic acid diet is thought to inhibit 
the secretion of renin (Codde et al 1984). Inhibition of cyclooxygenase reduced the 
antihypertensive effect of linoleic acid (Ten Hoor & Vandengraft 1978). Thus, 
prostaglandin may be involved in the hypotensive effect of this fatty tacid.
1.11.4b Human
Platelet membranes are less fluid in patients with untreated essential hypertension than in 
normotensive subjects. The cholesterol content of their platelet membranes is similar to 
controls but they contain less linoleic acid (Naftilan et al 1986). Others have suggested 
that platelets from hypertensive patients have a more fluid outer region than those from 
control patients. The anisotropy values for TMA-DPH correlated negatively with cystolic 
free Ca2+ and blood pressure. DPH anisotropy did not correlated with blood pressure (Le 
Quan Sang 1991).
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Electron spin resonance studies have shown erythrocytes from essential hypertensive 
patients to have a reduced membrane fluidity and this reduction was more marked when 
the calcium ionophore A23187 was used to load the cell with calcium (Tsuda et al 1992a). 
In the same study, patients with secondary hypertension, (primary hyperaldosteronism, 
pheochromocytoma and renovascular hypertension) showed no abnormality in cell 
membrane fluidity or composition. The platelet membranes of patients with primary 
(essential) hypertension have an increased C/PL ratio which would make the membrane 
more rigid. This was not the case in the erythrocyte membranes (Benjamin et al 1990).
Platelet intracellular pH is thought to be increased in essential hypertension. This and 
membrane microviscosity were measured in human subjects with essential hypertension. 
Cytosolic pH was inversely related to the membrane microviscosity as measured using the 
fluorescent probe TMA-DPH. Here the cytosolic pH was not affected by specific 
inhibitors of Na+-H+-exchangers (Astarie et al 1992). This would suggest that membrane 
fluidity is increased in hypertension. The sialic acid content of glycolipids is higher in 
essential hypertensive patients than renal hypertensive patients or normotensive controls. 
This could affect Ca2+ binding which is also increased in hypertension (Reznikova et al 
1984).
Although Carr et al (1995) could not confirm abnormalities in erythrocyte in patients with 
essential hypertension using either TMA-DPH or DPH, they claim to have identified a 
subgroup with a family history for hypertension where TMA-DPH anisotropy was 
increased. Na+-Li+-countertransport activity was increased and its Km for sodium was 
lower in patients with a family history of hypertension than those without. The authors 
suggest that the increase membrane microviscosity in these patients may affect Na+-Li+- 
countertransport (Carr et al 1995). Although the studies show variable effects of 
hypertension on membrane microviscosity the consensus of opinion from rat and human 
studies would suggest that membrane fluidity is reduced and microviscosity increased in 
genetic hypertension. A variety of serum fatty acid concentrations correlate with blood 
pressure. Cholesterol ester (CE) -bound palmitoleic acid increases with increasing systolic 
blood pressure while stearic acid increases with decreasing diastolic blood pressure. CE- 
bound dihomo-y-linolenic acid increases with increased diastolic blood pressure as does 
phospholipid-bound eicosatrienoic acid (Simon et al 1996). The inverse association of 
stearic acid concentration with blood pressure may explain why increased stearic acid is
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not thought to be an increased cardiovascular risk factor. Studies of fatty acid 
composition of erythrocyte membranes in control and untreated hypertensive patients 
revealed that the linoleic acid content was lower in the hypertensive patients and the 
arachidonic acid and oleic acid content was higher (Ollerenshaw et al 1987). Platelet 
membrane PC was higher in hypertensive patients compared to control although 
membrane fluidity was not different between the two groups (Caimi et al 1996).
There is considerable evidence that cell membrane function is altered in essential 
hypertension. Platelet Ca2+ concentration increases with increasing blood pressure and 
increasing plasma triglycerides (Le Quan et al 1995) but only in patients with a family 
history of hypertension. This report suggested a link between intracellular calcium 
concentration and blood pressure but the activity of the platelet Ca2+ pump was not 
investigated. Sodium transport is affected by hypertension. Platelet Na+-H+-exchange is 
increased in hypertensive patients compared to controls (Livne et al 1987). Whether this 
is due to an increase in the number to exchangers or to alterations in the kinetics of 
exchange is not clear. Erythrocyte Na+-K+-countertransport activity and Na+K+- 
cotransport activity is negatively related to membrane cholesterol, phospholipid and free 
fatty acid content in normal subjects (Lijnen et al 1994). Na+-K+-ATPase activity is also 
inversely related to membrane cholesterol and phospholipid content. Thus elevated 
erythrocyte membrane lipids in normal men are associated with lower cation transport rate 
(Lijnen et al 1994). Digitalis-like factor, an endogenous Na-K-ATPase inhibitor, is 
increased in essential hypertension and its plasma concentration also correlates with 
reduced membrane fluidity in these patients (Tsuda et al 1992a). Na+-H+-countertransport 
activity is greater in erythrocytes from essential hypertensive patients than from 
normotensive controls (Canessa et al 1980). Na+-Li+-exchange activity has also been 
studied in a group of white hypertensive patients using atomic absorption 
spectrophotometry. It is higher in the patients than in controls. There was also more PS 
and less PE in the hypertensive patient’s membranes than the control. The authors 
hypothesise that the changes in lipid to protein interaction in the membrane are responsible 
for weaker Na+ binding and faster rates of ion exchange in the membrane (Chi et al 1996).
Studies to evaluate how erythrocytes respond to the increased shear flow observed in 
hypertension have shown that the fluidity of the outer region of the membrane is 
negatively correlated with shear rate, shear flow and blood velocity. The inner regions of 
the membrane were not affected by this. This suggests that either shear flow affects
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membrane fluidity or that the membrane changes to cope with the increased flow (Le Quan 
Sang et al 1993a & b).
N-3 fatty acids reduce cardiovascular risk factors and atheroschlerotic plaque formation. 
Diets high in n-3 fatty acids reduced blood pressure (5 mmHg SBP, 4 mmHg DBP) which 
was further improved by dietary salt restriction. This is thought to be due to a change 
from the production of vasoconstricting to vasodilating eicosanoids produced from n-3 
fatty acids (Semplicini& Valle 1994). In contradiction to this, a 4 month diet high in EPA 
and DHA (n-3 fatty acids) had no effect on the blood pressure or heart rate in mild 
essential hypertension (DBP 105 mmHg) although the amount of erythrocyte membrane n- 
3 fatty acids was increased (Russo et al 1995).
Diets high in essential fatty acids decrease plasma/TRIGs, increase high density lipoprotein 
(HDL) cholesterol, decrease blood pressure, increase vasodilation, decrease fibrinogen, 
decrease platelet aggregation and decrease cardiac arrhythmias (Horrobin 1995). On the 
other hand, high membrane C20 and C22 fatty acid levels may predispose to coronary and 
peripheral vascular disease; their levels are increased in patients with diabetes and 
hypertension (Horrobin 1995). There is also an opinion that an alteration in the 
composition of arterial cell membranes precedes the onset of atherosclerosis. At the 
branch points in human and swine arteries, there is an increase in the membrane content of 
SPG and a decrease in the other phospholipids compared to the non-branching areas of 
the arteries. The branch points are the areas most prone to the formation of atherscherotic 
plaque formation (Kummerow et al 1994). As SPG has a higher transition temperature, it 
is thought that this will effect an increase the rigidity of cell membranes. It is also thought 
that these alterations will change the surface charge on the cell which may lead to calcium 
binding to the cell.
It is clear that, while there is much evidence that changes in the physical properties and 
chemical composition of the membranes of many cell types is altered in a variety of 
diseases, the precise changes and their direct causes remain obscure. While much of the 
confusion has been due to the difficulty in comparing very different experimental models 
and designs or tissues, much has been contributed by the differences in analytical 
techniques which are continuously improving.
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1.12 Techniques of Lipid Analysis.
Most lipid analysis techniques follow the same protocol; the lipids are extracted, purified 
or separated and then derivatised for analysis. Before discussion of these techniques, it is 
necessary to consider one of the major problems of lipid analysis, that of lipid oxidation.
1.13 Prevention of Oxidation
Lipids, in particular unsaturated fatty acids, are prone to oxidation. The oxidation reaction 
has a low activation energy and is therefore difficult to prevent. It can be minimised by 
keeping all samples in a dark, metal-free environment at -20°C and by degassing all 
reagents and flushing all sample containers with nitrogen (Christie 1989).
Initiation of oxidation occurs when lipids are attacked by any species which is reactive 
enough to remove a hydrogen atom (equation 1). The carbon radical, formed by the 
removal of hydrogen, is stabilised to form a conjugated diene, which reacts with oxygen to 
form a hydroperoxide radical (equation 2). Hydroperoxide radicals can remove hydrogen 
from other lipid molecules leading to a chain reaction (equation 3). Reduced iron 
complexes react with hydroperoxides to produce alkoxy radicals (equations 4a & b) 
(Halliwell & Gutteridge 1984).
Lipid-H +OH —» Lipid* + H20  (1)
Lipid* + 0 2 —» Lipid-02* (2)
Lipid-02* + Lipid-H —> Lipid-02H + Lipid* (3)
Lipids- 0 2H + Fe2+complex —» Lipid-O* + Fe3+complex +OH (4a) 
__________ Lipids- Q2H + Fe3+complex —> Lipid-Q2* + Fe2+complex + H (4b)__________
Although it is necessary to keep lipid samples in a metal free environment (Christie 1989), 
transition metals do not appear to initiate oxidation but they do cause the breakdown of 
hydroperoxides which are present in most samples. How the hydroperoxides are formed is 
not clear but the mechanism is thought to involve oxygen in the activated singlet state 
(Halliwell & Gutteridge 1984). As transition metals catalyse oxidation, so do compounds 
which contain transition metals such as haem or haem products, haematin and photophorin 
(Tappel 1961, Dodge & Phillips 1966). These compounds are non-specific catalysts of 
peroxide decomposition. The catalytic activities of myoglobin, haemoglobin, haemin and 
cytochromes are all equal (Tappel 1955). Also, haemoglobin is capable of oxidising lipids 
(Yoshida et al 1994).
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Chain breaking antioxidants prevent initiation and propagation of oxidation. They are 
aromatic and phenol amino compounds which form loose molecular complexes with free 
radicals. Butylated hydroxytoluene (BHT) acts as an antioxidant because the phenol group 
is able to donate a proton to neutralise free radicals (Pryor 1994). In this form, the 
radicals are too unreactive to initiate or maintain a chain reaction. BHT is the most 
commonly used chain breaking antioxidant but its use is not without its difficulties. At 
high temperatures, BHT reacts with oxygen, leading to the formation of free radicals 
(Frenkel 1980). It thus becomes a pro-oxidant (Christie 1989). Although BHT is volatile 
and can be removed from samples during evaporation of solvents under nitrogen (Christie 
1989), some analysts have observed contaminating peaks arising from BHT during gas 
chromatography (Moffat et al 1991, Eder et al 1992b, Zang et al 1996). Others report 
that BHT is itself esterified during methylation reactions with boron trifluoride methanol 
(BF3MeOH) (Heckers et al 1987) and methanolic (zw-trifluoromethylphenyl) trimethyl 
ammonium hydroxide (Zang et al 1996), leading to contamination of gas chromatographs. 
The esterification of BHT also causes it to loses its antioxidant ability as methylation of 
the hydroxyl group in BHT prevents the removal of a proton (Pryor 1994). The 
compounds into which BHT is converted during BF3MeOH methylation have been 
identified by mass spectrometry as 2,6-di-fer/-butyl-4-methoxyphenol, 2,6-di-terf-butyl 
methylphenol and 2,6-di-tert-butyl-4-methoxy-5-hydroxyphenol (Moffat et al 1991).
As transition metals, in particular iron, have been implicated in the generation of free 
radicals (Halliwell & Gutteridge 1984, Schaich 1992), the use of chelating agents such as 
citric, phosphoric and ascorbic acids in lipid analysis solutions has been recommended. It is 
also possible to use synthetic chelating agents such as diethylenetriamine-pentaacetic acid 
(Zang et al 1996). Chelating agents are preventative antioxidants and a synergistic effect 
of adding these together with chain breaking antioxidants to samples has been claimed 
(Frenkel 1980).
1.14 Extraction of Lipids
Extraction of lipids from tissues is the first stage in lipid analysis and some basic 
considerations apply. The tissue must be removed immediately post mortem and either 
processed or frozen in liquid nitrogen. This prevents enzymes such as lipases, which 
remain active after death, from altering the composition of the membrane. They catalyse 
the conversion of diacylphospholipids to lysophospholipids and free fatty acids and the 
conversion of diacylglycerols to phosphatidic acid. Therefore, the presence of large
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quantities of lysophospholipids and phosphatidic acid are indicative of membrane 
degradation by these enzymes (Hamilton et al 1992). The use of hot acetic acid may 
prevent enzymatic degradation of lipids (Phillips & Privett 1979). This method was 
developed for plant tissue but was reported as being useful for mammalian systems too. 
However, its use is rarely reported, probably due to the hazards of working with hot acid 
and the risk of lipid hydrolysis.
For lipid extraction, organic solvents are used to disrupt the interactions between 
membrane lipids and proteins. In particular, methanol is required to break the hydrogen 
bonds between protein and lipid. There are three commonly used lipid extraction 
techniques, the methods developed by Folch et al (1957) and Bligh and Dyer (1959) and 
that developed by Ways and Hanahan (1964) which is a modification of the Folch et al 
(1957) method. Folch et al (1951) extracted lipids by homogenising the tissues in 
chloroform/methanol (2:1 v/v) followed by a water wash. This led to a loss of 1% of the 
lipid. In a modified procedure, salts were added (CaCk, MgCE, NaCl or KC1) to the wash 
and its volume reduced. Some of these salts are extracted from the tissue along with the 
lipid. The authors state that acidic lipids are extracted as salts of Na, K, Ca or Mg, and 
are present in the organic phase in their undissociated form and in the aqueous phase in the 
dissociated form. The addition of extra salt to the system will cause more of the lipid to 
move into the organic phase, thus increasing lipid recovery. The losses incurred using this 
technique were small (0.3% and 0.6% for brain white and grey matter) (Folch et al 1957).
In Bligh and Dyer’s (1959) modification of this method, the composition and volume of 
the chloroform and methanol mixture were adjusted according to the water content of the 
tissues. For efficient extraction, the solvents and the sample water must form a 
monophasic solution after homogenisation. Extra chloroform was then added to produce 
a biphasic solution allowing for removal of non-lipids. This method led to a loss of 1% of 
the total lipid, which according to the authors, compares favourably with the Floch et al 
(1957) method (Bligh & Dyer 1959).
The third commonly used lipid extraction procedure was developed by Ways and Hanahan 
(1964) specifically for use with erythrocytes. Membrane lipids were extracted with 
methanol by mixing the cells with 5 times their volume of methanol at room temperature. 
An equal volume of chloroform was then added to the mixture and the mixture filtered. 
Multiple extractions of the residue increased recovery. Potassium chloride was then added
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to the combined extract which was allowed separate into an organic and aqueous phase in 
a separating funnel (Ways & Hanahan 1964). Although others report this method as being 
useful, it is cumbersome. Moreover, many of the steps in the procedure require the 
samples to stand at room temperature for prolonged periods which will lead to oxidative 
loss of lipids.
Most lipid analysts choose one of the above techniques, probably because the solvents can 
be purchased relatively inexpensively in pure form, but frequently modify them. For 
example, when using the Floch et al (1957) extraction procedure, the recovery of lipid 
may be improved if chloroform/methanol/water (3:48:47 v/v/v) is used to wash the extract 
(Hamilton et al 1992). Similarly, keeping the pH of the solvents in the Bligh and Dyer 
procedure low (pH < 2.5) makes it possible to extract the intermediates of glycerol 
synthesis, acyl and alkyl dihydroxyacetone phosphate (Hajra 1974). In another 
modification to improve recovery of glycosphingolipids, the membrane lipids were 
extracted and the residue peracetylated with formamide, pyridine and acetic anhydride. 
The acylated products were then extracted with chloroform (Millar-Podraza et al 1993). 
The complete extraction of polyphosphoinositides has necessitated many modifications 
including the addition of calcium chloride (Hausser & Eichberg 1973) and extraction with 
chloroform and methanol followed by chloroform/methanol/hydrochloric acid (Wells & 
Dittmer 1965).
Although chloroform and methanol are most frequently used, there are alternative solvents 
such as isopropanol. Rose and Oklander (1965) observed that, on extraction of lipids 
from whole erythrocytes with chloroform and methanol, the cholesterol content was lower 
than expected and that extracts were heavily contaminated with haem. The amount of 
cholesterol extracted was inversely proportional to the concentration of chloroform in the 
solvent and the haem contamination increased with increasing polarity of the alcohol used. 
The authors report effective extraction of all lipids with little haem contamination using 
chloroform/isopropanol (7:11 v/v) (Rose & Oklander 1965). However, the technique 
requires the extract to stand for long periods of time at room temperature so that extra 
care should be taken to prevent lipid oxidation. Others have used isopropanol in 
conjunction with hexane for lipid extraction but this should not be used when quantitative 
extraction of gangliosides is required (Hara & Radin 1978). Isopropanol has been 
employed by other groups for the extraction of lipids from very small samples (Wang et al 
1994). Samples were sonicated in isopropanol/hexane/water (3:1:3 v/v/v); the water
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present is that derived from the sample. After sonication, 0.9% NaCl in hexane was added 
to make the ratio of solvents isopropanol/hexane/water (3:3:6 v/v/v) (Wang et al 1994). 
The use of isopropanol alone for lipid extraction has also been recommended for whole 
erythrocytes and was as effective as the other systems mentioned above (Peuchant et al 
1989). This latter method will be discussed further later with reference to esterification of 
lipids. The risk of oxidation caused by the long standing times at room temperature 
required by this technique can be overcome by the addition of BHT (Eder et al 1992b). 
Butanol can extract most lipids at neutral pH (Hajra 1974). Lipids from brain white 
matter can also be extracted with tetrahydrofluran. The resulting extract contains only 
trace amounts of protein (Diaz et al 1992).
Most lipid extracts produced using these methods do not require further purification but 
some, in particular extracts of bone and brain, do. Cellulose columns have been used for 
the removal of non-lipid contaminants but losses of PI are high (Garcia et al 1956). 
Sephadex resin has also been used (Wells & Dittmer 1963) but reproducibility is poor as a 
very slow flow rate through the column is required for the complete removal of non-lipids. 
Sephadex beads (G-25) may be used instead of the resin. The amount of water in the 
stationary phase can be increased to allow the flow rate to be increased (Wurthier 1966). 
More complex clean up procedures have used C l 8  reverse phase columns to remove non­
lipid contaminants from PC, cerebrosides, sulphatides and gangliosides. This system was 
developed to study the synthesis of lipids and its use for purifying membrane lipid extracts 
is probably limited (Figlewicz et al 1985).
1.15 Separation of Lipids Groups
Before discussion of the methods used for the separation of lipid groups, it is first 
necessary to explain the principles behind the chromatographic procedures used. There 
are three main types of liquid chromatography commonly used, adsorption, partition and 
ion exchange chromatography.
1,15.1 A b so rp tio n  C h rn m atn p rfln h v
Adsorption chromatography utilises an adsorbent which has an affinity for the lipids. 
Lipids with polar functional groups bind to the adsorbent by dipole-dipole interactions and 
are retained on the adsorbent. Non-polar lipids do not bind and will be eluted. Silica is 
the most commonly used adsorbent for lipid separation. Various factors affect its ability 
to do so. Silanol groups (Si-OH) on the surface have a strong affinity for water. Thus,
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the water content of solvents must be carefully controlled. The pore size, volume and the 
surface area of the silica column or plate affect separation. Metal ions also affect the 
chromatography as do basic solvents which dissolve silica (Hamilton et al 1992). In 
general, the polarity of the mobile phase should be opposite to that of the adsorbent.
1.15.2 Partition Chromatogranhv.
There are two forms of partition chromatography, normal phase and reverse phase. In 
normal phase chromatography systems, the stationary phase is more polar than the mobile 
phase. The opposite is true for reverse phase chromatography which is often used to 
separate the components of a single lipid class as a function of their fatty acid chain length. 
Octadecylsilyl silica (C l8 ), which is synthesised by reaction of the silanol groups with 
organochlorosilane, is most commonly used.
(Surface Si) - O - Si - C l 8  
This is often referred to as bonded phase chromatography because the stationary phase has 
been chemically bonded to the surface of the support material, in this case silica. Partition 
chromatography relies on the relative solubility of the solute in the mobile or stationary 
phase; a compound which is more soluble in the mobile phase will be eluted more rapidly. 
Paper chromatography is also partition chromatography.
1.15.3 Ion-Exchange Chromatography
Commonly used ion-exchange packings are diethylaminoethyl (DEAE)- and 
triethylaminoethyl (TEAE)- cellulose. Ion change chromatography involves the 
competitive substitution of ions on sites of opposite charge on the stationary phase. Thus 
only ionic forms of molecules can be separated. The retention times of lipids can be 
controlled by altering the solvent pH or by addition of counter ions.
1.15.4 Other Types of Chromatography
In argenation chromatography, silica gel is impregnated with silver nitrate. Polar 
complexes are formed between the double bonds in the lipids and the silver ions. Cis 
double bonds interact more strongly than tram  and lipids can be separated as a function of 
the acyl chain length and number of double bonds.
In ion-pair chromatography, the stationary phase is non-polar and the mobile phase 
contains a large counter-ion such as tetrabutyl ammonium. This forms an ion- pair with 
ionic lipids, which will undergo normal chromatography. Exclusion chromatography uses
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the pore structure of the stationary phase to control the elution of compounds. Small 
molecules can permeate the solid phase and are retained in the column while large 
molecules elute. A difference of 10% in molecular weight between the compounds is 
required for compound separation, making its use for lipid analysis limited (Sewell 1992).
A variety of chromatography methods is used to study lipids and fatty acids. These 
include thin layer chromatography (TLC), solid phase chromatography, high performance 
liquid chromatography (HPLC) and gas chromatography (GC). Some methods utilise a 
combination of these.
1.16 Thin Laver Chromatography.
TLC is adsorption chromatography. The adsorbent, usually silica or alumina, is coated on 
a thin layer on a support, usually glass, polyester or aluminium. Lipid samples are applied 
to a plate and the plate developed in ascending mode using the solvent of choice. Lipids 
have characteristic mobilities on the plates which are quantified as their Rf values.
There are many solvents systems for separating different lipid groups by TLC (see also 
chapter 3). In general, using one dimensional chromatography, it is only possible to 
separate the constituents of neutral or polar lipids. To separate both completely, it is 
normally necessary to use 2 dimensional TLC. For instance, phospholipids, free fatty 
acids, mono-, di- and triglycerides, cholesterol and cholesterol esters were separated using 
long silica plates and a double development system (Freeman & West 1966). Silica gel H 
has been used to separate PE, PC, PI, PS, sphingomyelin and neutral lipids (Vitiello & 
Zanetta 1978). Two dimensional TLC has been used to separate non-polar lipids, 
cerebrosides and sulphatides and PC, PI, PS, PE, LPC. PA, PGS and sphingomyelin 
(Rouser et al 1970). Most separations use silica plates but silicic acid TLC has also been 
used (Mangold & Malins 1960). Separate TLC systems have been developed for specific 
uses. For example, in argenation TLC, lipids are separated as a function of the number of 
double bonds present; lipids with 1 to 6  double bonds can be separated using this 
technique (Kennerly 1986). In high performance TLC (HPTLC), silica particle sizes are 
smaller (4.5-5 pm) and the layer is thinner than standard TLC. Less solvent and sample is 
required, resolution is better and nanogram quantities of neutral lipids can be separated. 
However, three different solvent systems are necessary, drying the plate between each 
development with hot air introducing a clear oxidative risk (Conte & Bishop 1988). One 
recent report showed that 8  major phospholipids can be separated on one dimensional
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TLC without any pre-treatment of the plates. The fatty acid composition of the separated 
lipids was then analysed by HPLC (Miwa et al 1996).
Lipids can be identified on the plates in a variety of ways. Once identified, the lipids can 
either be quantitated on the plate or removed from the plate prior to quantitation. Lipid 
spots can be identified by charring the plates but this is destructive. Iodine vapours can be 
used but are toxic. Moreover, losses of polyunsaturated fatty acids may be caused by 
iodination of the double bonds (Nichaman et al 1963). The most commonly used 
detection systems are fluorescent dyes such as Rhodamine B or 6 G which bind to the lipid 
groups. It is also possible to convert lipids into fluorophores, which allows their 
quantification on TLC or HPTLC plates using a spectrofluorimeter (Segura & Gotto 
1974, Segura & Navarro 1980, Harrington et al 1980). Densitometery can also be useful 
(Bitman et al 1983, Macala et al 1983). Finally, they can be removed from the plate and 
quantitated by their fatty acid composition (Bitman et al 1984) but a major problem is to 
remove of the lipid spots quantitatively. This can be overcome by using polyester-backed 
plates which can be cut easily.
One of the major advances has been the development of TLC with flame ionisation 
detection (FID). Known as Iatroscan TLC/FID, it uses re-usable silica or silicic acid- 
coated quartz columns called chromarods. The rods are developed like a TLC plate and 
then passed through a stationary flame in an FID system. However, the results may be 
variable, depending on the sample size and the speed at which the rod is passed through 
the flame (Crane et al 1983). Reproducibility for neutral lipid separation was poor, due to 
variability between the rods, although this could be improved using an internal standard 
(Farnworth et al 1982). TLC/FID compares favourably with phosphorus assay as a means 
of analysing phospholipids but the results obtained by Kramer et al (1985) were higher 
than those from GC. Others found it compares well with GC (Rao et al 1985). Like 
TLC, the rods can be chemically treated. For example, silver nitrate impregnated rods 
have been used to study the degree of unsaturation of TRIG; this is argentation 
chromatography (Sebdio et al 1985). Copper (II) sulphate (Kaimal & Shantha 1984) and 
oxalic acid impregnation improved both resolution and reproducibility. Oxalic acid is a 
strong organic acid which alters the chromatographic properties of the silica (Baneijee et 
al 1985). Okumura et al (1988, 1990) used TLC/FID to study diacylgycerols and 
Peuchant et al (1989) to separate phospholipids. Lipids cannot be recovered from
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TLC/FID. It is therefore possible to quantitate the individual lipids but not to determine 
their specific fatty acid composition.
1.17 Solid Phase Separation
Solid phase separation procedures use small, often disposable, columns. The most 
common is silica in the form of Sep-pak columns. These have been used to separate the 
neutral lipids from polar lipids (Bitman et al 1983, Juaneda & Rocquelin 1985). Neutral 
lipids are eluted with either hexane or chloroform and the polar lipids with methanol. 
Judicious manipulation of the composition of the eluting solvents allows for more 
demanding separations. Hamilton & Comia (1984) could separate neutral lipids and then 
separate PE and PC and their later report claimed separation of CE, TRIG, free fatty acids 
(FFA), partial glycerides (PGS) and cholesterol. PI + PE are eluted together followed by 
PC + LPC + sphingomyelin (Hamilton & Comia 1988). This latter study has, however, 
been difficult to reproduce (Christie 1992) (see chapter 3). Another modification allows 
the separation of cholesterol from polar lipids (Wang et al 1994). The separation of free 
fatty acids, PE and PC is also possible. Here this technique was used to study the 
oxidation products of FFA by converting them to ammonium salts which gave them a 
much longer retention time (Ansari & Shoeman 1988). Janero & Burghardt (1990) used 
silica Sep-pak cartridges to remove neutral and non-choline-containing lipids from choline- 
containing lipids and platelet activating factor.
Better resolution can be obtained using larger columns. Silica gel column chromatography 
has been used to extract FFA and TRIGs from human plasma. The individual fatty acids 
present in these groups were then analysed by GC-MS (Ingalls et al 1995). The same 
group earlier reported a method of separation of FFA, CE, TRIGs cholesterol, di- and 
monoglycerides, ethanolamine-containing phospholipids and choline-containing 
phospholipids, also using silica column chromatography. The lipids were separated in 
seven elution steps with only cholesterol and diglycerides being eluted together. The 
recovery of added heptadecanoic acid after the extraction and separation steps was 81% 
and the recovery of synthetic lipid analogues was between 80 and 91% (Ingalls et al 
1993).
Using aminopropyl-bonded phase columns, it was possible to recover CE, TRIG, di- and 
mono-glycerides, cholesterol, FFA and phospholipids separately and quantitatively 
(Kaluzny et al 1985). The author refers to this as ‘chromatographic mode sequencing’.
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The compounds were eluted by changing either the solvent, the solid phase or both. This 
method is complicated, involving the use of many disposable columns linked together in 
sequence. Kim & Salem (1990) failed to reproduce it precisely but this modification 
separated cholesterol, FFA and TRIG followed by the elution of PC + PE + SPG together 
and PI + PS + PA together. The final solvent, which eluted PI, PS and PA, contained 
formic acid and 5% phosphoric acid, which introduces the risk of lipid breakdown and 
selective loss of PUFA. However, the authors state that these losses are no greater then 
those incurred during TLC. Aminopropyl silica columns have been used to purify fatty 
acid ethyl esters. Fatty acid ethyl ester and cholesterol esters can be eluted with hexane. 
Cholesterol esters can then be removed from the sample using C l 8  columns (Bemhart et 
al 1996).
The antibiotic neomycin is an aminoglycoside with an affinity for phosphoinositides. 
Neomycin was first used, coated on to glass beads, to remove polyphosphoinositides from 
phospholipids (Schacht 1978). It has since been used to separate non-acidic lipids from 
phospholipids which elute sequentially: PS, PA, PI, phosphatidyl glycerol and the 
polyphosphoinositides (Palmer 1981). The use of this technique has been limited by its 
relatively inadequate separation of the lipids groups and the difficulty of producing 
reproducible batches of neomycin-coated beads in the laboratory.
Silicic acid column chromatography is ion exchange chromatography. It has been widely 
used for lipids. A variety of factors affect separation, such as the water content of the 
silicic acid, the amount of silicate present, the particle size of the silicic acid and the 
amount of lipid loaded. PC binds to the column more tightly than PE and LPC binds the 
tightest because of its ability to form hydrogen bonds. This technique was used to prepare 
phospholipids from erythrocytes, but it is a complex procedure requiring large volumes of 
blood (Williams et al 1966). DEAE cellulose has also been used. Here the zwitterionic 
lipids, PC and sphingomyelin have longer retention times that the non-acidic lipids. 
(Rouser et al 1961). Neutral lipids, glycolipids and polar lipids can be separated using a 
series of solvents (Wing et al 1986). Others have used DEAE cellulose to separate neutral 
lipids from choline-containing lipids and PE (Christie et al 1987). DEAE and TEAE 
cellulose chromatography are expensive, require large amounts of solvents and TEAE in 
particular, shrinks in the column, leading to packing irregularities. To overcome some of 
these difficulties, quaternary ammonium glycophase, covalently bound to controlled pore 
size glass, will bind ionic and polar lipids which allows sequential elution of neutral lipids,
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PC + sphingomyelin followed by PE and PS and finally PI + sulphatides (Bandi et al 
1982).
1.18 High-Performance Liquid Chromatography.
HPLC is a form of solid phase separation, carried out on a large column which is reused. 
It can be both preparative and quantitative. The stationary phase can be a liquid, an ion- 
exchange resin or a porous polymer in a metal column through which the mobile phase 
passes at high pressure. The sample is injected into the mobile phase and the components 
are detected as they are eluted. In this way, a much higher degree of resolution and 
reproducibility can be obtained. The mobile phases used in HPLC, like other 
chromatography systems, usually contain organic solvents. Both isochratic and gradient 
elution programmes have been used. The type of detection used often determines which 
solvents are used (see below).
No detection device is ideal. Ultraviolet (UV) spectrophotometric detectors are the most 
commonly used but the compounds must absorb UV light or be derivatised to do so. 
Moreover, many solvents absorb in the same range (200-210 nm) as the lipids as well as 
impurities which increase background readings. These detectors are most sensitive to 
compounds with conjugated double bonds or aromatic rings. Other lipids need to be 
derivatised. Fatty acids are converted to aromatic esters, glycolipids are benzolated and 
phospholipids are converted to diacylglycerols before esterification with aromatic acid 
derivatives. Fluorescence detectors are more sensitive than UV detectors provided that 
the conditions of use are well-controlled. Fatty acids must be converted to fluorescent 
derivatives. Refractive index detectors respond to molecules which have a different 
refractive index from the mobile phase. This detector is less sensitive than the UV 
detector and is sensitive to changes in the ambient temperature. It cannot be used with 
gradient elution systems. Infra-red spectrophotomeric detectors are as sensitive as 
refractive index detectors but, since all organic compounds absorb infra red light, including 
the solvents, high background levels are a problem. Mass detectors or light scattering 
detectors rely on the solvent being rapidly evaporated as it elutes from the column. The 
solute is not evaporated but nebulised and the small droplets pass through a light beam and 
are refracted or reflected. The amount of scattered light is proportional to the amount of 
compound present. This system will cope well with gradient elution systems but all 
solvents must be volatile and a supply of dry filtered compressed air is required (Robinson 
& Macrae 1984). For use with preparative HPLC, a stream-splitting system is inserted
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before the detection system. Flame ionisation detectors are perhaps the most widely used 
detection and quantitation system but only volatile solvents can be used. The use of mass 
spectrometry with HPLC is now becoming more common (Sewell 1992).
Visible and UV light detection systems for HPLC have been compared. Visible light 
systems could detect 400 finol-1 pmol and UV systems between 100 and 200 fmol. 
Recoveries were quantitative and the inter- and intra-assay variability low (Miwia & 
Yamamoto 1987). Possibly the best identification results are obtained combining both UV 
and mass detector together (Sothiros et al 1985). Mass spectrometry will be discussed 
further later in connection with gas chromatography.
As with TLC, many HPLC systems have been described in the literature; a few examples 
will be discussed here. Molecular species of diacylglycerols have been studied using 
HPLC to separate them from other lipids and reverse-phase HPLC (RFHPLC) to separate 
the individual molecular species after benzolation. This led to a 99% recovery of the lipids 
(Lee & Hajra 1991). Hamilton & Comia (1984) report the separation of CE, FFA and 
TRIG by HPLC with the additional separation of some of the major molecular species 
within these groups. Preparative separation of lipids by HPLC followed by GC of their 
fatty acids has been used to quantitate lipids as well as to study their fatty acid 
composition (Eder et al 1992b). A similar combination has been reported by Seewald & 
Eichinger (1989) although the authors report a difficulty with drifting GC baseline. Patton 
et al (1982) also reported a similar type of separation using RPHPLC using a Cl 8  column. 
A similar column was used by Dominiczak et al (1993) to separate chromophore esters of 
fatty acids and by Sotirhos et al (1985) to separate individual molecular species in 
phospholipids. Separation of plasma CE by fatty acid chain length has been achieved 
(Smith et al 1980). Neutral lipids separate on a silicic acid HPLC column but the 
recoveries of TRIG and CE were unreliable (Greenspan & Schroeder 1982). Others have 
reported the separation of major phospholipids by HPLC using a silica gel column and a 
diol column (Soudant et al 1995).
1.19 Gas Chromatography
Gas chromatography is partition chromatography; the mobile phase is a gas and the 
stationary phase is liquid. It is possible to separate the molecular species of simple lipids 
by GC but separation of more complex lipids requires them to be broken down into their 
component parts by either enzymatic or chemical hydrolysis. The original stainless steel
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columns used in gas chromatography techniques caused the selective loss of PUFA but 
this problem has been overcome by the use of silica or glass columns. The most 
commonly used columns are capillary, wall-coated open tubular columns where the liquid 
phase is attached to silica capillary columns with an internal diameter of 0 .1-0.3 mm. Gas 
chromatography columns are situated in a temperature-controlled oven to allow for high 
column temperatures. The more volatile lipids will elute at lower temperatures; higher 
temperatures are needed to elute the less volatile compounds. The stationary phases in 
GC are often poysiloxanes bonded to the column by cross linking between polymer chains. 
These bonded phase columns are more thermally stable than columns with non-bonded 
stationary phases. Polarity of the stationary phase can be changed. For instance, it can be 
increased by adding phenyl groups. It is also possible to separate lipids in thermally stable, 
polarisable stationary phases such as phenyl methyl polysiloxane polymer which becomes 
more polar with increasing temperature
Samples are introduced into a heated injection port above the capillary column in a small 
volume of solvent. The solvent and the sample are then volatilized into the carrier gas 
which permanently flows though the column. During ‘split’ injection, there is a high flow 
of carrier gas through the injection zone and the sample is volatilized into the carrier gas. 
Much of the sample is lost because of the high flow rate of gas through the injection zone. 
This prevents column overloading. It is not suitable for thermally labile compounds but is 
adequate for fatty acid methyl esters. For ‘splitless’ injection, the carrier gas flow rate is 
low. The initial column temperature is also low, allowing for the samples to condense at 
the top of the column. After a time, a flow of gas is introduced to the injector area to 
clear any remaining sample. This technique cannot easily differentiate between high and 
low molecular weight compounds.
Eluting lipids can be detected and identified by flame ionisation or mass spectrometry. It 
is possible to identify lipids by their retention time compared to standard mixtures, 
although ideally these should be checked on more than one column. There is a wealth of 
information in the literature on the GC properties of lipids using different columns, 
temperature programs and lipids derivatives. TRIGs can be separated by carbon number 
and to some extent by the number of double bonds (Evershed 1992). It is also possible to 
perform total lipid profiling by GC. Phospholipase is used to convert the phospholipids 
into diacyl glycerols which are then analysed as trimethyl silyl ethers. Glass columns are 
suitable for long, repetitive use (Lanza 1980). Fatty acid methyl esters (FAME) have been
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separated using a capillary column with a free fatty acid solid phase, the poly (ethylene 
glycol) ester of nitroterphthalic acid (Beamelle & Vial 1986). GC analysis has shown that 
there are odd numbered FAME in the membrane along with methylated isomers, double 
bond position isomers dimethyl acetals and branched chain fatty acids in erythrocyte ghost 
lipids (Alexander et al 1985).
Multiple dimensional GC has been employed to analyse fiiran fatty acids. For this, two 
columns are connected in series, a precolumn and an analytical column. The precolumn 
partially fractionates the samples and the fraction of interest can be diverted to the 
analytical column for compete analysis (Wahl et al 1995). This twin column technique 
may be useful for samples containing isomers of fatty acids.
1.20 Mass Spectrometry
Mass spectrometry (MS) is the most sensitive detection and identification technique 
available for lipids analysis. It can be used in conjunction with GC or with HPLC. MS 
relies on the fragmentation of the compound and quantitation of the ions formed by 
chemical or electrical ionisation. The mass spectrum (i.e. the pattern of ions formed) is 
characteristic of the structure of the compound. For example, fragmentation sites 
frequently occur at double bonds. The mass spectrometer consists of a sample inlet, an 
ion source, a mass analyser and ion detector. The ion source, mass analyser and ion 
detector are all maintained in a vacuum by a turbomolecular pump. For electron 
ionisation, electrons are produced from a hot filament as an electron beam which ionises 
compounds in its path. The molecular ion is a radical cation formed by the removal of an 
electron from the compound. If this species is stable, it will be seen as the highest mass 
ion in the spectrum. Usually, it is unstable and breaks down into smaller ions. The pattern 
is reproducible and the total ion current can be used for quantitation.
Although MS can be used to identify lipids, my interest was to use it in conjunction with a 
separation technique to analyse fatty acid mixtures released from lipids, that is, to use it as 
a quantitative method with positive identification of individual fatty acids. For GC-MS, 
the fatty acids eluting sequentially from the capillary column pass into the mass 
spectrometer.
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1.21 Esterification of Fattv Acids
Fatty acids must be volatile under GC conditions. Converting them to their methyl esters 
enhances volatility. When this process is carried out with fatty acid attached to lipids, it is 
called transesterification. Esterification of fatty acid residues in lipids and free fatty acids 
can be acid-catalysed. Free fatty acids will not undergo esterification by base catalysis 
although fatty acid attached to lipid will (reactions 1 & 2 ).
H + or -OCH3
R' -CO-OR'' + R-OH ^  R' -CO-OR +R' -OH [ 1 ]
H +
R' -CO-OH + R-OH ^  R-CO-OR + HOH [2]
Esterification is a reversible reaction which under certain conditions will reach equilibrium. 
To drive the reaction to the right, it is necessary either to remove the products or to have a 
large excess of alcohol present. For acid-catalysed esterification, reagents and samples 
must be completely dry to avoid ester hydrolysis (which is reversible). Ester hydrolysis 
which occurs during base-catalysed esterification is irreversible. The carboxylate anion 
formed does not react with alcohol and will react with sodium or potassium to form a soap 
(Lui 1994). An advantage of acid-catalysed transesterification is that it can take place in 
the presence of silica so that there is no need to extract lipids after TLC (Christie 1972). 
Here, the methods of acid-catalysed esterification will be discussed, followed by those of 
base-catalysed esterification.
Fatty acid methyl ester synthesis by heating lipids with BF3MeOH (produced by bubbling 
BF3 though cold methanol) has been reported as being useful (Liu 1994). Inclusion of 
benzene improved the esterification of fatty acids present in neutral lipids (Morrison & 
Smith 1964). As BF3MeOH has a greater ability to esterify free fatty acids than to 
transesterify lipids, it has been suggested that alkaline hydrolysis should be carried out 
prior to esterification with BF3MeOH (Metcalfe et al 1966). Although this technique was 
recommended by the American Oil Chemists Society in 1969, it is not without difficulties. 
In 1964, Lough reported that it led to the formation of methoxy-substituted fatty acid 
esters, probably by the addition of methanol to the double bond of oleic acid. They were 
therefore thought to be a mixture of the 9- and 10- methoxy derivatives of stearic acid 
methyl ester. The formation of artefacts increased with the time the sample was heated
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and age of the reagents (Lough 1964, Klopfenstien 1971). A 30% reduction in the 
recovery of oleic acid was observed (Fulk & Shorb 1970). As in the study by Lough 
(1964), this appears to have been caused by the addition of methanol to oleic acid. 
Klopfenstein (1971) confirmed that artefacts were formed at concentrations of boron 
trifluoride greater than 50%. BF3MeOH from different sources was also contaminated to 
a variable level which may have caused the artefacts. The authors of this study advocate 
the use of boron trichloride methanol. In a study of methylation of fish oils containing 
high quantities of PUFA, 7 and 14% BF3MeOH reduced the yield of oleic acid compared 
with sulphuric or hydrochloric acid in methanol, sodium methoxide in methanol and 
tetramethylguanidine in methanol and produced an artefact which eluted between the 20:5 
and 24:1 fatty acid methyl esters (Medina et al 1992). In this case, the BF3MeOH used 
was one month old and the reaction was only allowed to continue for 2-3 mins so that 
these problems are unlikely to have been due to old reagents or long reaction times (see 
above).
Esterification of lipids by heating with hydrochloric acid and methanol is popular. The 
reagent can be prepared either by bubbling anhydrous hydrogen chloride through 
methanol, by adding liquid acetyl chloride to methanol (Kishimoto & Randin 1959) or by 
adding hydrochloric acid to methanol (Jham et al 1982). Sulphuric acid in methanol is 
also easy to prepare and was adopted as their standard method by the Association of 
Official Analytical Chemists in 1965. It has been claimed that a reaction times as short as 
1 0  min at 60 °C quantitatively produced esters from mouse erythrocytes and synaptosomal 
membrane phospholipids (Wing et al 1986). However, because the fatty acid in 
sphingomyelin is attached via an amide bond, transesterification requires high 
concentrations of acid and longer reaction times which may cause fatty acid losses (Eder et 
al 1992a). As mentioned previously, Peuchant et al (1989) favoured the use of 
ispropanol as an extracting solvent for lipids. If 1% sulphuric acid was then added and 
heated, isopropyl esters were formed. These are less polar then methyl esters but 
recoveries of unsaturated fatty acid and the fatty acids present in sphingomyelin were 
quantitative. Only one test-tube was used and losses caused by transferring of samples 
between tubes were avoided.
Transesterification with a mixture of chloroform, methanol and acetylchloride is useful for 
smaller samples. Heating releases hydrogen chloride which is neutralised with silver 
carbonate. The sample is centrifuged and the supernatant analysed for fatty acid methyl
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esters without further treatment (Stransky & Jursik 1996). This method appears to be 
more suitable for esterification of short chain fatty acids, although caution should be 
exercised in heating mixtures containing chloroform.
Base-catalysed transesterification is not suitable for use with free fatty acids or 
sphingomyelin or for samples containing silica (Christie 1989). Treatment with methanolic 
sodium methoxide at ambient temperature is the only way to get quantitative formation of 
methyl esters (Eder et al 1992a). However, the experimental conditions used in this report 
were inconsistent and no fair comparison with other studies can be made. Bannon et al 
(1982) suggest that this is the best method for esterification of triglycerides but the 
mixture needs to be refluxed briefly.
Another base-catalysed procedure for transesterification uses methanolic tetramethyl 
ammonium hydroxide (TMAH). In this process, the fatty acids in lipids are converted into 
fatty acid methyl esters. The free fatty acids are converted into TMAH salts which can 
then be pyrolytically alkylated to produce fatty acid methyl esters (Metcalfe & Wang 
1981). Some artefacts are produced and trimethylsulphonium hydroxide (TMSH) has 
been suggested as a suitable alternative. It is less expensive and does not form artefacts 
(Butte 1983). TMSH compared favourably with the sodium methoxide-catalysed 
procedure. The method does cause loss of some polyunsaturated fatty acids when the 
TMSH is injected straight into the injection port of the GC-MS as has been recommended 
(Elhamdy & Christie 1993). Interestingly, this reaction can be accomplished in situ in the 
GC injection port. The process is referred to as thermally-assisted hydrolysis and 
methylation pyrolysis derivatisation. Free fatty acids and methanolic TMAH are injected 
together into the injector port of a GC. The TMAH salts which are formed then undergo 
thermal decomposition to produce fatty acid methyl esters. One problem is that the 
PUFAs undergo isomerisation but this can be prevented by reducing the concentration of 
TMAH or by using trimethyl(trifluoro-m-tolyl) ammonium hydroxide. Submicrogram 
quantities of lipid can be handled and no separation and reaction steps are required prior 
to injection (Challinor 1996).
Shantha et al (1993) compared four methods; 1). sodium methoxide in methanol, 2). 
methanolic sodium hydroxide and boron trifluoride in methanol, 3). tetramethylguanidine 
in methanol and 4). methanol- benzene- acetyl chloride to synthesise methyl esters of 
linoleic acid isomers. Methods 1 and 4 destroyed some fatty acid isomers and produced
77
an artefact which co-eluted with fatty acids esters. Methods 2 and 3 were deemed suitable 
for low concentrations of free fatty acids (Shantha et al 1993).
Enzymatic methods of esterification of fatty acids have been described. Haas & Scott 
(1996) reported a method combining normal transesterification and lipase-mediated 
esterification. Lipid extracts were treated with alcohol and potassium hydroxide, leading 
to the formation of esters from glycerides and phosphoglycerides. The reaction could be 
carried out at room temperature and was compete within 1 hour. The pH of the reaction 
mix was then reduced and the free fatty acid present was esterified by means of a lipase- 
dependant esterification reaction. The yield of fatty acid esters was low. The efficiency of 
the alkaline transesterification was not greater than 90% and only 63% of the free fatty 
acid present in the reaction mixture was esterified in the lipase-mediated reaction (Haas & 
Scott 1996). This method was only suitable for use with primary alcohols. It was 
ineffective with isopropanol.
Diazomethane can be used to catalyse the esterification reaction. The esterification of free 
fatty acids is rapid but it is not possible to transesterify phospholipids. It is toxic, 
potentially explosive and has a short self life (Liu 1994).
It is normally accepted that lipids must be extracted into organic solvents prior to 
derivatisation. This may not be the case. Abel et al (1963) found that it was possible to 
esterify the lipids in bacterial cells using BF3MeOH without prior extraction and Dugan et 
al (1966) reported that it was possible to transmethylate lipids directly in animal tissue 
with sulphuric acid and methanol. There have also been reports of in situ esterification by 
basic catalysts such as methanolic sodium methoxide and potassium hydroxide in methanol 
(Hougen & Bodo 1973, Long et al 1988). The fatty acid profiles obtained by direct and 
extraction methods were comparable in tissue containing high quantities of PUFA (Guillou 
et al 1996). However, this may not be suitable for tissues containing haemoglobin which 
will catalyse oxidation. In his review of methylation techniques, Liu (1994) reports that in 
situ methylation is simple, highly sensitive and is useful for analysis of total membrane fatty 
acids.
Methods of esterification described as on-line techniques have also been reported. Fatty 
acids in oils were methylated with acetyl chloride in methanol. The lipid was dissolved in 
n-hexane and pumped along a thin tube together with the derivatisation mixture. When
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the reaction tube was full, the flow was stopped and the tube was heated to 80°C. A 
stream of water was then introduced to the reaction tube distal to the heated area to 
remove residual acetyl chloride. The hexane solution of derivatives could then be injected 
directly into a gas chromatograph. This method is reported to compare well with 
methanolic sodium hydroxide and boron trifluoride methanol methods (Ballesteros et al 
1993).
From the preceding reviews, evidence suggests that cell membrane microviscosity varies 
physiologically in some diseases. What changes in their composition account for these 
changes? The literature on the subject is inconclusive. Moreover, changes in the fatty 
acid/lipid composition of the membrane may alter its function without significantly 
changing viscosity. By establishing and evaluating a method of comprehensive analysis of 
membrane lipids, it was intended to address these questions.
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Chapter 2 Materials and Methods
2.1 Materials
All reagents employed were of the highest quality available and were obtained from the 
following suppliers.
2.1.1 Gftnftral Reagents.
The following reagents were purchased from Sigma Chemical Company, Poole Dorset: 
ammonium acetate, bovine serum albumin, butylated hydroxytoluene, Folin & Ciocalteu’s 
phenol reagent, Krebs ringer bicarbonate buffer mix, sodium potassium tartate, Tris base, 
Rhodamine B spray reagent, pyridine, hexamethyldisilazane, jtrimethyl chlorsilane, N,N- 
dimethylformamide.
The following reagents were purchased from BDH Chemicals Ltd., Dorset, England. 
Hydrochloric acid, calcium chloride, dipotassium orthophosphate, potassium dihydrogen 
orthophosphate, sodium chloride, sodium carbonate, sodium hydroxide pellets, cupric 
sulphate, pH buffer tablets pH 4, 7 and 9, ethanol.
The following reagents were purchased from Rathbum Chemicals, Walkerbum, Scotland: 
hexane, methanol. Prolabo, Manchester supplied the chloroform and concentrated 
sulphuric acid. ,
2.1.2 Fattv Acid and Lipid Standards
All free fatty acids, fatty acid methyl and ethyl esters and all lipid and cholesterol standards 
were purchased from Sigma Chemical Company Ltd. Poole, Dorset, U.K.
2.1.3. Chromatography Apparatus
The following chromatography products were purchased from or donated by Whatman 
Ltd, Maidstone, Kent, England; polyester-backed PE SEL G thin layer chromatography 
plates, glass-backed 150A and 60A LK5DF fluorescent plates and 3mm chromatography 
paper and thin layer chromatography tanks.
Waters Corporation, 34 Mapel Street, Milford Massachusetts supplied the silica Sep-pak 
cartridges.
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2.1.4 GC-MS equipment.
Finnigan MAT Ltd (Paradise, Hemel Hempstead, Herts) supplied the Finnigan MAT 
ITS40 GC-MS, the auto-sampler, dedicated computer and the Magnum software. J&W 
Scientific (91 Blue Ravine Road, Folsom, California) supplied the 30m DB-5 capillary 
chromatography column.
Sigma Chemical Company (Poole Dorset) supplied the Supelco pre-treated septa. Burke 
Analytical (Glasgow, Strathclyde) supplied the injection port liners, Hamilton syringes, 
auto-sampler vials and lids and sample vials with Teflon lined screw caps. BOC 
(Guildford Surrey) supplied the CP grade helium.
2.1.5. Fluorescence Anisotropy Equipment
The fluorescent probe, trimethylammonium diphenylhexatriene (TMA-DPH) was obtained 
from Molecular Probes Inc. (Eugene, Oregon, USA). Perkin-Elmer LS-50 luminescence 
spectrophotometer was obtained from Perkin-Elmer Ltd (Beaconsfield, Buckinghamshire, 
UK).
2.2 Blood Samples.
Human blood samples were taken using Vacutainer needles and bottles containing lithium 
heparin (Becton Dickinson, Vacutainer Systems Europe, Meylan, Cedex-France). Rat 
blood samples were obtained by cardiac puncture into 1 0 ml syringe which were pre­
washed with lithium heparin. The blood was then transferred into Vacutainer bottles as 
above.
2.3 Animals
All experimental animals were obtained from the breeding colonies of SHRSP and WKY 
rats housed in the Department of Medicine and Therapeutics, Gardiner Institute, 
University of Glasgow. Rats were housed two to a cage with free access to food and 
water. The animals were maintained on a 12 hour light dark cycle. Blood pressure was 
measured by the tail cuff method; rats were prewarmed to 30°C. The blood pressure 
measurements for each rat were an average of 8  consecutive readings. Rats were 
anaesthetised with halothane prior to blood sampling.
81
2.4.1 Glassware
All test-tubes were treated in a sonicating water bath for 30 minutes in a solution of Decon 
75 (Decon Laboratories Ltd., Hove, United Kingdom), rinsed thoroughly with tap water 
and then distilled water (dH20 ) and dried in an oven at 37° C.
2.5 Membrane Preparation.
2.5.1 Preparation of Ervthrocvte Cell Membranes.
Erythrocyte membranes were prepared following the method of Saito et al (1986). Blood 
was drawn into lithium heparin Vacutainers, mixed and placed on ice. Erythrocytes were 
separated from the plasma by centrifugation at lOOOg (200 r.p.m.) for 10 minutes at 4°C. 
The plasma and bufly coat were removed and the erythrocytes resuspended in 5 volumes 
of cold erythrocyte wash buffer. The cells were pelleted again by centrifugation, the 
supernatant was removed and the cells resuspended in erythrocyte wash buffer. This 
washing procedure was repeated until the supernatant was clear after centrifugation. The 
erythrocytes were then lysed with 40 volumes of cold erythrocyte lysis buffer. The cell 
lysate was then centrifuged at 15,000g (20,000 r.p.m.) for 20 min at 4°C. The supernatant 
was removed and the pellet resuspended in erythrocyte lysis buffer and centrifuged again. 
This washing procedure was continued until there was no haemoglobin present in the 
membrane pellet and the supernatant was clear. The white membrane pellet was 
resuspended in 1 ml of buffer and frozen at -70°C under an atmosphere of nitrogen until 
use.
2.5.2 Preparation of Liver Cell Membranes.
Liver samples were obtained and kept on ice in Krebs ringer bicarbonate (Krebs) buffer 
until use. The tissue was minced into pieces not more then 2mm across using sterile 
scissors. The suspension of tissue was then washed in erythrocyte lysis buffer to eliminate 
erythrocytes from the preparation. The tissue suspension was centrifuged at lOOOg (200 
r.p.m.) for 10 minutes at 4°C. The supernatant was removed and the tissue transferred 
into a cold, hand-held homogeniser and homogenised for 0.5-1 min. The homogenate was 
then transferred to a centrifuge tube and washed with Krebs buffer. This was then 
centrifuged at 15,000g (20,000 r.p.m.) for 20 min at 4°C. The supernatant was removed 
and the pellet resuspended in Krebs buffer. The washing procedure was repeated until the 
supernatant was clear after washing. The liver cell membranes were then resuspended in 
Krebs buffer and stored at - 70°C under and atmosphere of nitrogen until use.
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2.6 Lowrv Protein Estimation.
Protein concentrations were measured by the method of Lowry et al (1951). A standard 
curve was constructed using concentrations of bovine serum albumin ranging from 0 .1 - 
1 mg/ml.
2.7 Measurement of Cell Membrane Microviscositv
Erythrocyte membranes were resuspended in 50mmol/l TRIS-HC1 (pH 7.4) at a protein 
concentration of 1 mg/ml. This was incubated with TMA-DPH (solution in N,N- 
dimethylformamide) at a final concentration of 5nmol/l at 37 °C for 30 min. Fluorescence 
anisotropy was measured in quadruplicate with a Perkin Elmer LS-50 luminescence 
spectrophotometer with computer-controlled excitation and emission polarizers.
Fluorescence intensity (I) was measured at excitation and emission wavelengths of 340 
and 450nm respectively. The slits were set at 20nm. Anisotropy (A) was calculated 
according to the following equations:
A = (IW- GU) / (Iw + 2GIvhi £
G Ihv /  Ihh
where the first element of the subscript pair is the excitation orientation and the second 
element is the emission orientation (v, vertical; h, horizontal). G, the correction factor for 
the optical system, was evaluated prior to each experiment. The auto-fluorescence of the 
erythrocyte membranes was checked before each reading and subtracted from the 
experimental readings (McLaren et al 1993).
2.8 Lipid Analysis Techniques
The following techniques are a summary of the methods developed in chapter 3 for the 
analysis of membrane lipids.
2.8.1 Extraction of Membrane Lipids
Cell membranes were thawed and sonicated in a cold sonicating bath for lOmins. The 
volume of membrane corresponding to 2 mg of protein was placed in a cold test tube on 
ice. The internal standards for CE, TRIG, FFA, PE, PC, and LPC were added to the test 
tube and mixed (see chapter 3). Methanol (2ml) was added to the test tube, mixed and 
then sonicated for 2 min. Chloroform (4ml) was added to the tube, mixed and sonicated 
as previously. Aqueous Na2C 0 3 (1.2 ml of a 0.73% solution) was then added to the tube
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and mixed before centrifugation at lOOOg (200 r.p.m) for 5 min. This led to the formation 
of a biphasic solution. The upper aqueous layer of this was removed with a Pasteur 
pipette and the interface between the two layers was also carefully removed. The 
remaining organic phase was evaporated under nitrogen at room temperature. The lipid 
residue was resuspended in hexane (1ml). The dead space in the test tube was flushed 
with nitrogen prior to storage at -20°C. All solvents contained BHT (10mg/100ml) and 
where possible, all procedures were carried out on ice.
2.8.2 Separation of Lipid Groups
The protocol for lipid separation is detailed in chapter 3. Briefly, hexane was removed 
from the lipid samples by evaporation under nitrogen and the residue was redissolved in 
methyl-tert-butyl-ether (MTBE) (2ml). This was applied to a washed Sep-pak cartridge 
and the neutral lipids eluted with MTBE (12ml) and MTBE/MeOH/ammonium acetate 
(25:4:l:v/v/v) (15ml). The solvent was removed from the neutral lipid fraction by 
evaporation under nitrogen and the lipid residue resuspended in hexane/MTBE (200:3 v/v) 
and stored under nitrogen at -20°C until further analysis. The polar lipids were eluted 
from the Sep-pak cartridge following the revised elution system outlined in chapter 3. The 
solvents were evaporated from the polar lipid fractions prior to the further separation of 
the polar lipids by TLC (see chapter 3). The lipid spots on the TLC plate were visualised 
using Rhodamine B spray diluted with ethanol (1:20 v/v). The neutral lipids were also 
applied to a washed Sep-pak and separated as described in chapter 3.
Fatty acid methyl esters were prepared and extracted from the various lipid fractions using 
the method outlined in chapter 3.
2.8.3 Analysis of Fattv Acid Methvl Esters
Fatty acid methyl ester solution dissolved in hexane (lpl) was applied to the GC-MS. The 
GC oven temperature programme was as follows:- 160°C for lmin, increase to 229°C at 
2°C per min, to 275°C at 2.5°C per min and finally to 290°C at 5°C per min. Fatty acid 
methyl esters were then quantitated using the Magnum soft-ware.
The indices of desaturation were calculated as follows:- A5 desaturase: arachidonic 
acid/dihomo-y-linolenic acid, A6  desaturase: linolenic acid/linoleic acid, total desaturase: 
arachidonic acid/linoleic acid, A9 desaturase: oleic acid/stearic acid. The
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saturated/unsaturated fatty acid ratio was calculated by summing the quantities of the two 
fatty acid groups and calculating a ratio of the two amounts.
The following formulae were used to convert the measurements of fatty acid methyl esters 
into the amount of phospholipid present in the membrane (Seewald & Eichinger 1989).
1. Calculation of the total fatty acid (FA) molecular weight of the phospholipid (ng):
X  n g  FAl +  X n g  FA2 + X n g F A 2 +  +  X  n g  Fai =  X  n g  ZFA
2. Calculation of the relative amount of a single fatty acid (%)
(ng fai / ng zfa> 100 = % FA l; (ng fa* J ng zfa> 100 = % FA%i
3. Calculation of average FA molecular weight(OMWFA) of the phospholipid
% FA1/100 . MWFA1 = .........
%FAi/100 . MWFAi = ........
£=100%  £  = OMWFA
4. Determination of the phospholipid molecular weight (MWPL)
(n • OMWFA) + M W PL core = MWPL 
Where n = number of fatty acid linked to the phospholipid, OMWFA = average fatty acid 
molecular weight, M W PL core = molecular weight of the phospholipid core which has no 
fatty acids bonded to it.
5. Calculation of the relative amount of fatty acids in the whole phospholipid 
molecule (% FAPL).
(n .  OMWFA. 100) / MWPL = %FAPL
6 . Determination of the absolute amount of phospholipid;
(ng sfa/ %FAPL) • 100 = absolute amount of PL in ng/ml total extract.
2.8.4 Estimation of Membrane Cholesterol
The protocol for measuring of membrane cholesterol concentration is detailed in Chapter 
3, part 2. Briefly, membrane lipids were extracted as described previously from a volume 
of sample which corresponds to 0.1 mg/ml of protein. The solvent was removed from the 
extract and trimethyl silyl ethers of cholesterol were synthesised. These were then 
analysed on the GC-MS using the same GC oven temperature program as for the analysis 
of fatty acid methyl esters.
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2.9 Buffers.
Erythrocyte lysis buffer contained 5 mM K2HPO4 dissolved in dH20 . The pH of the 
solution was adjusted to pH 8  by addition of KH2P 0 4. Erythrocyte wash buffer was 
produced from erythrocyte lysis buffer by adding 0.15M NaCl.
Krebs buffer contained sachet of Krebs ringer bicarbonate buffer mixture dissolved in the 
appropriate amount of dH20 . Calcium chloride (1.2mM) and sodium bicarbonate 
(25.8mM) were added and the pH adjusted to 7.4.
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Chapter 3 The Development of a Method of Analysis of Cell Membrane Lipids
3.1 Introduction
The following chapter describes the development of a method for the complete analysis of 
the fatty acids and lipids present in the cell membrane. In part 1 the development of the 
method for the fatty acid analysis will be presented. The methods studied here include the 
production and extraction of fatty acid alcohol esters and the separation of the lipid groups 
in the cell membrane, followed by the quantitative recovery of the fatty acids esterified to 
these. Although several different techniques will be discussed here, some basic principles 
are the same for all. These will be detailed here with a brief discussion of each aspect. 
The production of standard curves for analysis by GC-MS is explained and the inter and 
intra assay variability for the method will also be discussed. In the second part of this 
chapter, the development of an assay for membrane cholesterol is described.
Part 1
3.1.1. Samples and Reference Standards 
Neutral Lipids
For cholesterol esters, free fatty acids and triglycerides, two types of standards were used, 
one containing the internal standard, heptadecanoic acid, and one containing a fatty acid 
commonly found in the membrane. These naturally occurring lipids have been used as 
research standards to evaluate the method as they behave in a similar manner to membrane 
lipids. No internal standard-containing lipid was available for partial glycerides; in this 
case therefore, heptadecanoic acid was added directly to the test tube in which the neutral 
lipids were to be methanolysed. The composition and quantities of the lipids used to 
evaluate the methods are given in Table 3.1.1.a. The quantities of lipids have been 
calculated to yield fatty acids at the following concentrations; research standard fatty 
acids: 50 ng/pl and heptadecanoic acid: 20 ng/pl. In all cases, the concentrations stated 
assume one hundred percent esterification and recovery.
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Lipid Group Fatty Acid 
Composition Of Lipids 
Used
Concentration Of Fatty 
Acid In Final Sample
Volume Of 1 mg/ml 
Solution Used
CE Heptadecanoic Acid 2 0  ng/pl 24 pi
CE Oleic Acid 50 ng/pl 58 pi
TRIG Heptadecanoic Acid 2 0  ng/pl 1 0  pi
TRIG Linoleic Acid 50 ng/pl 27 pi
FFA Heptadecanoic Acid 2 0  ng/pl 1 0  pi
FFA Palmitic Acid 50 ng/pl 25 pi
FFA Stearic Acid 50 ng/pl 25 pi
PGS Stearic Acid 50 ng/pl 27.5 pi
Table 3.1.1a Concentration and fatty acid composition of neutral lipids used during 
method development.
Polar lipids
For PE, PC and LPC, two types of reference standards were used, one research standard 
lipid, as previously described, and one lipid containing the internal standard, heptadecanoic 
acid which was a 1,2-diheptadecanoyl derivative. For the research standards, the fatty 
acids at positions snl and sn l differed from each other, as they would in the membrane. 
Although the recoveries are given for both fatty acids, it is only possible to calculate for 
one fatty acid to be present 50 ng/pl, (see table 3.1.1 .b). No commercially available 
internal standards were available for the remaining lipid groups. In these cases, free 
heptadecanoic acid was used as internal standard as described for partial glycerides (see 
above). The composition and quantities of the lipids used are listed in table 3.1.1 .b. These 
concentrations again assume 1 0 0 % esterification and recovery.
Lipid Group Fatty Acid 
Composition Of 
Lipids
Concentration of 
Fatty Acid In Final 
Sample
Volume of 
1 mg/ml Solution 
Used
FFA Heptadecanoic Acid 2 0  ng/pl 1 0  pi
PC Palmitic Acid 50 ng/pl 74 pi
PE Stearic Acid 50 ng/pl 33 pi
PE Heptadecanoic Acid 2 0  ng/pl 13 pi
LPC Palmitic Acid 50 ng/pl 48 pi
LPC Heptadecanoic Acid 2 0  ng/pl 19 pi
PI Stearic Acid 50 ng/pl 8 8  pi
SPG Palmitic Acid 50 ng/pl 70 pi
Table 3.1.1b Concentration and fatty acid composition of the polar lipids used during 
method development.
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The fatty acid methyl esters formed from each fraction or esterification reaction were 
analysed by GC-MS (see chapter 1 ). The amount of fatty acid present is proportional to 
the total ion current (TIC) at the appropriate retention time. This value was used to assess 
the recovery of the lipids after chromatography. The TIC values produced by fatty acids 
esterified to lipids which underwent chromatography (referred to as sample) were 
compared to those from unchromatographed standards. Efficiency of methanolysis was 
assumed to be equal for both the unchromatographed standards and the samples.
Where heptadecanoic acid-containing lipid was available, a direct comparison was made. 
The TIC value for the unchromatographed standard was taken as maximum and the TIC 
value for the sample expressed as a percentage of that. The percentage recoveries of the 
internal standard and research standard were also compared to each other, as a measure of 
whether both groups behaved in a similar manner.
Where no internal standard-containing lipid was available, the analysis was carried out as 
above and the results were further analysed as follows:- A ratio of the TIC produced by 
the fatty acids from the lipids and the heptadecanoic acid was calculated. As there was 2.5 
times more of the research standard fatty acid present than there was internal standard, the 
expected ratio was greater than 1. The value obtained for ratio derived from 
unchromatographed standards was taken as maximum and the value obtained for the 
chromatographed sample was compared to this and expressed as a percentage. This 
method of evaluating the results was chosen because the quantitation computer software 
package for the GC-MS uses this ratio to calculate the amount of fatty acid present in the 
sample.
For the evaluation of the esterification method, the TIC values for fatty acid methyl esters 
produced by methanolysis were compared to those for commercially available standard 
fatty acid methyl esters at the same concentration.
Where the samples and internal standards were shown to be recovered in the same 
proportion, there was no need to correct further for losses during analysis. Results are 
expressed as mean percentage of maximum with standard deviations in brackets. Unless 
otherwise stated, n=6 . The results were analysed using Students t-test: the probability
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level required for significance was taken to be p<0.05. Where appropriate, 2 way analysis 
of variance was used.
3.2.1 Esterification Study
To allow their analysis by GC-MS, it is necessary to volatilise fatty acids. This is usually 
facilitated by their conversion to alcohol esters and can be achieved using a variety of 
methods (see chapter 1). The aim of this study was to evaluate the use of acid-catalysed 
transesterification for the production of esters and to evaluate their subsequent extraction 
using diethyl ether.
3.2.2 Method.
The basic method (Christie 1989) for acid catalysed transesterification and extraction is 
described below. Modifications will be explained later.
3.2.2a E s te r if ira tin n .
1. The lipids were extracted from the appropriate tissue using chloroform/methanol (2:1 
v/v) containing BHT (10mg/ 100ml) (During the development of the method, standard 
solutions of lipids in hexane were used).
2. The solvent was evaporated under nitrogen at room temperature and the lipid residue 
was resuspended in 1% concentrated sulphuric acid in methanol (2ml). The tubes were 
stoppered and the contents mixed well before incubating at 50°C overnight in a dry 
incubator. The dead space in the tube was flushed with nitrogen before incubation.
3.2.2h Extraction of Fattv Acid Esters.
1. After incubation, the tubes were removed from the incubator and allowed to cool to 
room temperature.
2. Diethyl ether (5ml) was added to each tube and the contents mixed. Distilled water 
(5ml) was then added and mixed. The tubes were placed in a freezing ethanol bath to 
freeze the lower aqueous layer. The diethyl ether layer was then transferred into a clean 
test tube and the frozen aqueous layer discarded.
3. The diethyl ether was washed with 0.05% NaHCC>3 in distilled water (5ml). The 
diethyl ether phase was again separated in a freezing bath and the washing procedure 
repeated with distilled water (5ml).
4. The diethyl ether was dried with anhydrous sodium sulphate and evaporated to dryness 
under a stream of nitrogen at room temperature. The fatty acid ester residue was
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resuspended in hexane (500pl) containing BHT (lOmg/lOOml), the dead space in the vial 
was flushed with nitrogen and the vial stored at -20°C until required for analysis.
3.2.3 Eipprimental 1.
3.2.3.a Alcohol Esters Study
Although methyl esters are most commonly used in the analysis of fatty acids, it seemed 
possible that the production of other alcohol esters might have some advantages, for 
example, by simplifying GC separation of the Cl 8  fatty acids which is notoriously difficult. 
The properties of both saturated and unsaturated fatty acid esters were studied. The fatty 
acids ranged from C16-C22 and these were esterified using methanol, ethanol, butanol and 
isopropanol using the protocol described in section 3.2.2a.
3.2.3.H Efficiency of Esterification
To allow for valid quantitation, it is necessary to ensure that all fatty acids, internal and 
research standards, are being esterified and recovered uniformly. A number of factors in 
the procedure described above could affect this. The following were tested using the 
esterification and extraction procedure detailed in section 3.2.2:-
1. The effect of the absence or presence of BHT on esterification and extraction was 
studied by carrying out two parallel experiments, one with BHT (lOmg/lOOml) present in 
all reagents and a second with no BHT present.
2. The effect of removing the water from the alcohols was tested by drying the alcohols 
with anhydrous sodium sulphate (300g/llitre w/v). The mixture was allowed to settle for 
at least 4 hours prior to use.
3. The effect of using different reaction tubes was tested by replacing glass stoppered test 
tubes with test tubes with Teflon-lined screw caps.
3.2.4 Results 1
3.2.4.A Alcohol Esters Study
The retention times of the fatty acid esters analysed by gas chromatography are 
summarised in table 3.2.4.al. Table 3.2.4.a2. details the retention times of saturated fatty 
acids and the difference in retention time between each saturated fatty acid ester and the 
one most closely adjacent to it. This gives an index of separation efficiency. Table
3.2.4.a3. summarises the same information for the unsaturated fatty acid esters.
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Fatty Acid Ester Type
Fatty Acid__________________ Methyl______Ethyl_______ Butyl_______Isopropyl
Palmitic C l6:0 23:54 24:45 25:35 27:10
Palmitoleic C l 6 : 1 22:28 24:15 27:35 26:22
Heptadecanoic C17:0 25:24 27:13 28:01 28:27
Stearic C l 8 : 0 27:48 29:26 30:06 30:34
Oleic C18:l 27:11 28:48 29:45 29:54
Linoleic C l8:2 26:59 28:43 29:23 29:31
Linolenic C l8:3 27:39 28:49 27:33 27:59
Arachidonic C20:4 30:14 32:13 33:02 34:30
Table 3.2.4.al. Retention times (min:sec) for a variety of fattv acid esters on the pas
chromatograph.
Fatty Acid Retention Time Adjacent fatty acid and
+ Ester Type difference in retention time
Methyl Esters
Palmitic 23:54
Heptadecanoic 25:24 17:0- 16:0= 1:30
Stearic 27:48 18:0-17:0 = 2:24
Ethyl Esters
Palmitic 24:45
Heptadecanoic 27:13 17:0-16:0 = 2:28
Stearic 29:26 18:0- 17:0 = 2:13
Butyl Esters
Palmitic 25:35
Heptadecanoic 28:01 17:0- 16:0 = 2:26
Stearic 30:06 18:0- 17:0 = 2:02
Isopropyl Esters
Palmitic 27:10
Heptadecanoic 28:27 17:0- 16:0= 1:17
Stearic 30:34 18:0- 17:0 = 2:07
Table 3.2.4.a2 Retention times (min:sec) of saturated fatty acids and the difference 
between retention times of closely adjacent saturated fatty acid esters.
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Fatty Acid Retention Time Adjacent fatty acid and
+ Ester Type difference in retention time
Methyl Esters
Palmitoleic 22:28
Oleic 27:11 18:1 - 18:2 = 0 : 1 2
Linoleic 26:59 18:2- 16:1 =4:31
Linolenic 27:39 18:3 - 18:1 =0.28
Arachidonic 30:14 20:4-18:3 = 0:12
Ethyl Esters
Palmitoleic 24:15
Oleic 28:48 18:1 - 18:2 = 0:05
Linoleic 28:43 18:2- 16:1 =4:31
Linolenic 28:49 18:3 - 18:1 =0.01
Arachidonic 32:13 20:4-18:3 = 3:24
Butyl Esters
Palmitoleic 27:35
Oleic 29:45 18:1 - 18:2 = 0 : 2 2
Linoleic 29:23 18:2-16:1 = 1:48
Linolenic 27:33 18:3 - 16:1=0:02
Arachidonic 30:02 20:4- 18:1 = 0:17
Isopropyl Esters
Palmitoleic 26:22
Oleic 29:54 18:1 - 18:2 = 0:23
Linoleic 29:31 18:2- 18:3 = 1:32
Linolenic 27:59 18:3 - 16:0= 1:34
Arachidonic 34:30 20:4- 18:1 =4:36
Table 3.2.4.a3 Retention times (min:sec) of unsaturated fatty acids and the difference in 
retention times between closely adjacent unsaturated fatty acid esters.
1. All fatty acid esters were adequately separated including the esters of the C18:0, 
C l8:1, C18:2 and C l8:3 fatty acids. The retention times for all the fatty acid esters were 
at least 5 seconds away from the nearest fatty acid ester, allowing for individual 
quantitation. For any given fatty acid, the retention time for each ester increased with 
increasing molecular weight of the alcohol used in the esterification.
2. The different fatty acid alcohol esters provided different degrees of separation of fatty 
acid esters. However, there was no constant pattern to these differences. The difference 
between C l8:0 and C l7:0 and between C l8:2 and C l8:3 appears to decrease with 
increasing molecular weight of the alcohol. The results for other fatty acids were more 
variable.
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3.2.4.h Efficiency of Esterification
The coefficients of variation for the following experiments are detailed in tables 3.2.5.bl- 
b2 .
Fatty Acid ME ME+BHT ME Dry ME Teflon
Palmitic 20.69 11.51 6.99 8.24
Palmitoleic 16.78 15.17 23.34 14.06
Heptadecanoic 8.33 6.94 20.19 7.48
Stearic 15.09 12.33 4.67 11.74
Oleic 9.94 17.46 23.92 13.58
Linoleic 6 . 1 2 7.14 7.98 6 . 8 6
Linolenic 13.31 11.39 9.03 14.74
Arachidic 14.75 26.51 22.59 9.51
Arachidonic 14.63 7.34 23.62 12.81
Behenic 15.17 13.59 6 . 2 0 11.67
DHA 9.06 26.70 23.44 13.95
Lignoceric 11.14 2 0 . 2 2 9.10 10.72
Nervonic 11.79 24.21 6.16 7.13
Hexacosanoic 28.86 27.17 36.01
Table 3.2.4.bl. Coefficients of variation for the experiments to produce fattv acid methvl
esters under a variety of conditions as described in section 3.2.3b.
Abbreviations. ME: methyl esters. ME+BHT: methvl esters with BHT present. ME Drv:
Methyl esters produced using dried methanol, ME Teflon: methyl ester produced in Teflon
lined screw capped vials.
Fatty Acid EE EE +BHT EE Dry EE Teflon
Palmitic 12.32 4.26 45.51 28.75
Palmitoleic 17.30 19.47 14.01 18.91
Heptadecanoic 8.74 7.76 10.56 7.85
Stearic 6.50 5.08 13.59 24.09
Oleic 14.51 26.32 11.76 20.13
Linoleic .56 8.53 6.44 17.22
Linolenic 16.85 16.42 6.62 12.78
Arachidic 8.17 10.75 8 . 2 0 16.40
Arachidonic 4.62 6.26
Behenic 13.16 7.25 5.63 16.99
DHA 6.73 10.62 13.41 18.55
Hexacosanoic 46.43 62.98
Table 3.2.4.b2 Coefficients of variation of the experiments to produce fatty acid ethyl 
esters as described in section 3.2.3b.
Abbreviations, EE: ethyl esters, EE+BHT: ethyl esters with BHT present, EE Dry: ethyl 
esters produced using dried ethanol, EE Teflon: ethyl ester produced in Teflon lined screw 
capped vials.
3.2.4.H1 Effects of the presence or absence of BHT.
The results for esterification in the absence and presence of BHT (tables 3.2.4.b3-b4) can 
be summarised as follows:-
1. With no BHT present, the recoveries varied from 19.91% (5.41) to 155.32% (19.16) 
for methyl esters and 62.93% (5.37) to 214.03% (13.39) for ethyl esters. The coefficients
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of variation ranged from 6.12-28.86% for methyl esters and 4.62-17.30% for ethyl esters. 
Analysis of variance showed there was no statistical difference between the TIC values of 
the laboratory-produced methyl esters and the standards (p=0.78). There was a significant 
difference between the ethyl ester standards and the laboratory produced esters (p=0 .0 2 ). 
The values which were statistically significantly different are indicated in table 3.2.4.b3.
2. With BHT present, the recoveries varied from 44.15% (4.92) to 168.56% (25.44) for 
methyl esters and 29.76% (5.15) to 101.18% (8.27) for ethyl esters. The coefficients of 
variation ranged from 6.96-27.17% for methyl esters and 4.26 to 26.32% for ethyl esters. 
Analysis of variance showed there was no statistical difference between the TIC values of 
the laboratory-produced methyl esters and the standards (p=0.55). There was a significant 
difference between the ethyl ester standards and the laboratory produced esters (p<0 .0 0 1 ). 
The values which were statistically significantly different are indicated in table 3.2.4.b4.
3. No definite trend was observed between saturated and unsaturated fatty acids in either 
group. The same fatty acids gave high recoveries for methyl esters both with and without 
BHT. These were C16:0, C18:0, C22:0 and C22:6. The coefficients of variation were in 
general lower for the ethyl esters than methyl esters. BHT had no effect on this. The 
variability of the results for each fatty acid was not consistent for all four treatments. For 
stearic acid, the coefficient of variability ranged from 5.08-15.09% over the four 
treatments. Comparison by analysis of variance of the values obtained in the presence and 
absence of BHT showed no statistical difference between the groups (p=0.51).
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Fatty Acid. ME ME
STD
% of 
Max.
EE EE
STD
% o f
Max.
Palmitic 28.60 24.34 117.49 21.74 27.01 80.49
C16:0 (5.92) (0.71) (24.31) (2 .6 8 ) (0.67) (9.92)
Palmitoleic 2 0 . 2 1 36.36 53.32 19.27 * 64.74 29.76
C16:l (3.87) (1.69) (8.95) (3.33) (3.21) (5.15)
Heptadecanoic 20.95 27.81 75.34 22.14 * 38.11 58.09
0 7 :0 (1.74) ( 1 .1 0 ) (6.28) (1.93) (5.08) (5.08)
Stearic 38.26 22.70 168.56 29.36 29.50 99.53
0 8 :0 (5.78) (0.74) (25.44) (1.91) (3.51) (6.47)
Oleic 31.23 50.65 61.66 32.90 * 49.72 66.16
0 8 :1 (3.20) (3.74) (6.13) (4.77) (3.74) (9.60)
Linoleic 20.96 30.50 68.74 20.84 * 40.40 51.59
0 8 :2 (1.28) (1.32) (4.21) (1.16) (5.44) (2.87)
Linolenic 14.58 22.83 63.86 20.13 * 27.67 72.74
0 8 :3 (1.94) (1.75) (8.50) (3.39) (1.99) (12.26)
Arachidic 16.71 12.30 135.42 21.38 21.13 101.18
C20:0 (2.46) (0.67) (19.98) (1.83) (1.27) (8.27)
Arachidonic 20.04 40.51 49.48 20.30 * 1 1 . 2 1 181.10
C20:4 (2.93) (1.64) (7.24) (0.94) (1.33) (8.36)
Behenic 27.49 26.47 103.85 20.58 * 27.93 75.52
C22:0 (4.17) (1.17) (15.75) (2 .6 6 ) (1.33) (9.94)
DHA 22.92 22.26 1 0 2 . 8 6 26.98 27.61 97.14
C22:6 (2.07) (1.18) (9.32) (1.82) (1.24) (6.54)
Lignoceric 8.18 18.52 44.15 5.28 NA NA
C24:0 (0.91) (1.14) (4.92) (0.71)
Nervonic 17.20 23.07 76.77 18.34 NA NA
C24:l (2.03) (2.45) (9.05) (1.46)
Hexacosanoic 5.33 15.57 34.23 2.37 NA NA
C26:0 (1.54) (1.60) (9.88) (0.65)
Table 3.2.4.b3 Total ion currents (106) and percentage of maximums produced by fatty 
acid esters synthesised in the absence of BHT, results are expressed as mean (SD), n=6 .. 
Abbreviations NA: not available all others as described in table 3.2.4bl & b2.
Statistics ANOVA for methyl esters p=0.78, for ethyl esters p=0.02 * = statistically 
different from maximum using unpaired Students t-test.
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Fatty Acid. ME 
+ BHT
ME
STD
% of 
Max.
EE 
+ BHT
EE
STD
% of 
Max.
Palmitic 28.37 24.34 116.57 25.21 27.01 93.33
C16:0 (3.27) (0.71) (13.45) (1.08) (0.67) (3.98)
Palmitoleic 26.73 36.36 73.51 26.92 * 64.74 41.55
C16:1 (4.05) (1.69) (11.15) (5.23) (3.21) (8.09)
Heptadecanoic 23.19 27.81 8 8 . 2 2 25.74 * 38.11 67.53
C17:0 (1.71) ( 1 .1 0 ) (6.13) (2 .0 0 ) (5.08) (5.24)
Stearic 35.26 22.70 155.32 29.64 29.50 100.47
C18:0 (4.35) (0.74) (19.16) (1.50) (3.51) (5.10)
Oleic 39.98 50.65 78.93 38.28 * 49.72 76.98
C18:l (6.98) (3.74) (13.78) (10.07) (3.74) (20.26)
Linoleic 22.65 30.50 74.26 25.42 * 40.40 62.93
C18:2 (1.61) (1.32) (5.30) (2.17) (5.44) (5.37)
Linolenic 17.55 22.83 74.91 2 1 .2 2 * 27.67 76.69
C18:3 (2.06) (1.75) (8.53) (3.48) (1.99) (12.59)
Arachidic 16.17 12.30 131.06 18.83 * 21.13 89.12
C20:0 (4.28) (0.67) (34.74) (2.03) (1.27) (9.58)
Arachidonic 21.84 40.51 53.92 23.99 * 1 1 . 2 1 214.03
C20:4 (1.60) (1.64) (3.96) (1.50) (1.33) (13.39)
Behenic 21.36 26.47 80.71 17.73 * 27.93 63.47
C22:0 (2.80) (1.17) (10.91) (1.28) (1.33) (4.60)
DHA 21.44 22.26 97.89 24.34 27.61 87.62
C22:6 (5.47) (1.18) (26.14) (2.59) (1.24) (9.31)
Lignoceric 4.80 18.52 25.92 4.05 NA NA
C24:0 (0.97) (1.14) (5.24) (0.53)
Nervonic 13.61 23.07 60.75 15.09 NA NA
C24:l (3.30) (2.45) (14.71) (2.32)
Hexacosanoic 3.10 15.57 19.91 1.14 NA NA
C26:0 (0.84) (1.60) (5.41) (0.42)
Table 3.2.4.b4 Total ion current (106) produced by fatty acid esters synthesised in the 
absence of BHT and the percentage of maximum, results are expressed as mean (SD) n=6 . 
Statistics ANOVA for methyl esters p=0.55, for ethyl esters p>0.001 * = statistically 
different from maximum using unpaired Students t-test.
3.2.4.h2 The Effect of Removing Water from the Alcohol.
The recoveries of the fatty acid ester produced with alcohol dried with Na2 S0 4 are shown 
in table 3.2.4.b5 and can be summarised as follows:-
1. The recoveries of methyl esters ranged from 34.95% (3.18) to 133.26% (31.24). The 
recoveries of ethyl esters ranged from 36.68% (5.14) to 290.86% (30.71). Coefficients of 
variance ranged from 4.67-36.01% for methyl esters and 5.63-45.51% for ethyl esters. 
Analysis of variance showed a statistical difference between the TIC values of the 
laboratory produced methyl esters and the standards (p<0.001). The same was true of 
ethyl esters (p<0.001). The values which were statistically difference by t-test are 
indicated in table 3.2.4.b5.
2. Under these conditions, there was no trend between the yields obtained for saturated 
and unsaturated fatty acids. The two fatty acid methyl esters which produced the highest
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recoveries were C l8:2 and C22:6 (these were not statistically different from maximum). 
For ethyl esters, the highest yields were for PUFA in particular C18:2 and C18:3. 
Comparing these recoveries with the recoveries obtained in the previous experiment (no 
BHT), this experiment gave fewer yields of greater than 100%. Analysis of variance 
showed the that two experiments gave different results (p<0 . 0 0 1  for both methyl and ethyl 
esters). For methyl esters, only the recovery of linoleic acid was increased using dried 
alcohol. All other fatty acids were either less well recovered or not affected. For ethyl 
esters, the recoveries of oleic, linolenic and arachidic acid were greater using dried 
alcohol.
Fatty Acid ME ME
STD
% o f
Max.
EE EE
STD
% of 
Max.
Palmitic 12.75 * 25.24 50.51 15.78 * 28.08 55.37
C16:0 (0.89) ( 1 .1 2 ) (3.53) (7.19) (1.13) (25.20)
Palmitoleic 15.77 * 30.86 51.11 24.31 * 66.28 36.68
C16:l (3.70) (1.77) (11.93) (3.40) (14.87) (5.14)
Heptadecanoic 15.70 * 27.48 57.13 36.45 * 12.53 290.86
C17:0 (0.78) (1.38) (2.83) (3.85) (0 .8 8 ) (30.71)
Stearic 18.70 * 27.82 67.18 22.79 * 34.17 66.65
C18:0 (0.87) (1.14) (3.14) (3.07) (1.51) (9.06)
Oleic 19.10 * 40.57 47.08 28.82 31.73 90.83
C18.T (4.57) (2.99) (11.26) (3.30) (3.26) ( 1 0 .6 8 )
Linoleic 25.32 24.18 104.73 30.23 * 1 1 . 2 0 269.67
C18:2 (2 .0 2 ) (1.34) (8.36) (1.95) (0.79) (17.36)
Linolenic 13.73 * 28.61 47.96 17.87 * 10.85 164.67
C18:3 (1.24) (1.46) (4.33) (1.18) (0.82) (10.91)
Arachidic 23.53 27.73 87.26 31.90* 27.67 115.29
C20:0 (5.35) (2.31) (19.71) (2.62) (1.85) (9.45)
Arachidonic 16.66 * 29.55 56.40 23.07 NA NA
C20:4 (3.88) (2.70) (13.12) (2.23)
Behenic 14.93 * 38.71 38.56 20.19 * 28.71 72.80
C22:0 (0.92) (3.99) (2.39) (1.18) (1.63) (4.10)
DHA 16.10 12.70 133.26 21.67 20.67 108.08
C22:6 (3.77) (1.08) (31.24) (2 .1 1 ) (1.34) (14.55)
Lignoceric 10.37 * 29.68 34.95 10.47 NA NA
C24:0 (0.94) (3.63) (3.18) (0.72)
Nervonic 36.09 * 40.01 90.20 43.10 NA NA
C24:l (2 .2 2 ) (1.27) (5.56) (2.76)
Hexacosanoic 40.05 43.45 92.06 19.39 10.82 179.20
C26:0 (14.37) (2.41) (33.15) (9.00) (0 .8 6 ) (83.20)
Table 3.2.4.b5 Total ion current (106) produced by fatty acid esters synthesised using 
dried alcohol, and the % of maximum obtained as in table 3.2.5.bl (n=6 )
Statistics ANOVA for methyl esters p > 0.001, for ethyl esters p > 0.001
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3.2.4.b3 The Effect of Different Reaction Vessels
The results for the experiments carried out in Teflon-lined screw capped test tubes (table 
3.2.4 b6 ) can be summarised as follows:-
1. The yields of methyl esters ranged from 28.52% (4.01) to 132.74% (14.23). The yields 
of ethyl esters ranged from 23.48% (4.44) to 201.61% (126.61). The coefficients of 
variation for methyl ester ranged from 6.86-27.36% and for ethyl esters from 7.85- 
62.98%. Analysis of variance showed a statistical difference between the TIC values of the 
laboratory produced methyl and ethyl esters and the standards (p<0 .0 0 1 ), the values which 
were statistically significantly different are indicated in table 3.2.4.b6.
2. Most of the fatty acids which gave high yields were saturated fatty acids, in particular 
C16:0, C18:0 and C24:0. The yields of ethyl esters, although different to those of the 
methyl esters, were not consistently higher or lower. The highest yield fatty acid ethyl 
esters were a mixture of saturated and unsaturated fatty acids (C l7:0, C22:0, C l8:2 and 
C l8:3). The variability of the recoveries here is in general lower for the methyl esters 
compared to the original method. The same is not true for ethyl esters. Comparing these 
results with those obtained using the original protocol, the results are statistically different 
for both methyl and ethyl esters (p<0.001 for both). The only methyl ester which gave a 
significantly higher recovery using the Teflon-lined screw capped vials was lignoceric acid 
methyl ester; all other esters gave yields either the same or lower than previously. For 
ethyl esters, palmitic, heptadecanoic, linoleic, linolenic and behenic acid ethyl esters gave 
higher recoveries than previously.
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Fatty Acid ME ME % o f EE EE % of
STD Max. STD Max.
Palmitic 33.20 * 25.24 116.06 19.32* 28.08 68.80
C16:0 (10.90) ( 1 .1 2 ) (9.56) (5.55) (1.13) (19.78)
Palmitoleic 8.80 * 30.86 28.52 15.56 * 66.28 23.48
C16:1 (1.24) (1.77) (4.01) (2.94) (14.87) (4.44)
Heptadecanoic 17.79 * 27.48 64.74 23.63 * 12.53 188.60
C17:0 (7.41) (1.38) (4.84) ( 1 .8 6 ) (0 .8 8 ) (14.81)
Stearic 34.02 * 27.82 125.61 31.24 34.17 91.43
C18:0 (6.05) (1.14) (14.75) (7.53) (1.51) (22.03)
Oleic 10.81 * 40.57 26.65 18.14 * 31.73 57.18
C18:l (1.47) (2.99) (3.62) (3.65) (3.26) (11.51)
Linoleic 15.48 * 24.18 64.28 19.79 * 1 1 . 2 0 176.55
C18:2 ( 1 .1 1 ) (1.34) (4.41) (3.38) (0.79) (30.14)
Linolenic 8.78 * 28.61 30.67 12.56 * 10.85 115.79
Cl 8:3 (1.31) (1.46) (4.52) (1.54) (0.82) (14.18)
Arachidic 8.51 * 27.73 30.70 13.11 * 27.67 47.37
C20:l (0.80) (2.31) (2.92)) (2.15) (1.85) (7.77)
Arachidonic 10.45 * 29.55 35.36 15.46 NA NA
C20:4 (1.34) (2.70) (4.53) (2.98)
Behenic 29.38 38.71 94.89 32.76 28.71 114.12
C22:0 (5.55) (3.99) (11.07) (5.57) (1.63) (19.39)
DHA 8.67 * 12.70 68.25 15.45 * 20.67 74.76
C22.6 ( 1 .2 1 ) (1.08) (9.52) (2.87) (1.34) (13.87)
Lignoceric 29.03 29.68 132.74 35.05 NA NA
C24:0 (6.03) (3.63) (14.23) (7.39)
Nervonic 23.19 * 40.01 57.95 15.64 NA NA
C24:l (1.65) (1.27) (4.13) ( 1 .2 2 )
Hexacosanoic 18.88 * 43.45 43.45 21.81 10.82 201.61
C26:0 (5.17) (2.41) (11.89) (13.74) (0 .8 6 ) (126.97
)
Table 3.2.4.b6 Total ion currents (106 ) for the esters produced using Teflon-lined screw 
capped tubes and % of maximum data (n=6 ). Abbreviations are as above.
Statistics ANOVA for methyl esters p > 0.001, for ethyl esters p > 0.01
Comment.
In the light of the results obtained from these experiments the extraction procedure which 
follows was evaluated and then used for all subsequent experiments.
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3.2.3 Experimental 2
3.2.3c Alteration to The Extraction Procedure
Methyl esters were produced as described previously using reagents containing no BHT. 
Dried alcohol and Teflon-lined screw capped tubes were used. The extraction procedure 
was as follows:-
1. The test-tubes were removed from the incubator and allowed to cool to room 
temperature. Diethyl ether (3ml) was added to each tube and mixed well. Water (5ml) 
was then added mixed and allowed to settle.
2. The diethyl ether phase was then transferred by means of a Pasteur pipette into a clean 
test tube. The pipette was washed with 1 ml of the salt solution (0.05% NaHCCh) by 
pipetting it down the inside of the pipette allowing the salt solution to run into the test 
tube containing the diethyl ether. The residual water was back-extracted with diethyl ether 
(3ml); this was added to the first extract with a further 4ml of salt solution which was also 
washed down the inside of the pipette.
3. The diethyl ether layer was separated from the salt solution into a clean test tube. The 
pipette was washed with distilled water (2.5ml) also into the clean test tube.
4. The residual salt solution was back-extracted with diethyl ether (1ml) which was added 
to the previous extract. The pipette was washed with distilled water (2.5ml) into the test 
tube. The diethyl ether phase was separated from the water by freezing (-20°C).
5. Finally, the diethyl ether layer was decanted into a clean test tube and evaporated to 
dryness under a stream of nitrogen at room temperature. The residue was resuspended in 
500ml of hexane containing BHT (lOmg/lOOml). The vial was flushed with nitrogen and 
stored at -20°C.
3.2.3.d Improving the Efficiency of Esterification
The following experiments were carried out using the new extraction procedure to 
improve the efficiency of esterification.
1. Effect of acid concentration on the efficiency of esterification was tested by using 1% 
and 2% H2 SO4 in methanol for the esterification reaction. Heat was applied using an 
aluminium heat block.
2 . The effect of incubation temperature was tested by increasing the temperature to 60°C 
and reducing the time of incubation to 2  hours.
3. Effects of these procedures on the stability of standard fatty acid methyl esters were 
tested. Standard esters were dissolved in 2 % H2 SO4 in methanol and immediately 
extracted using the method in 3.2.3.C to evaluate losses of fatty acid methyl esters during
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the extraction procedure. To evaluate the losses of fatty acid during the incubation, the 
standard esters were incubated at 60°C for two hours in the incubator or heat block and at 
50°C in the incubator overnight before extraction.
3.2.4 Results 2
3.2.4c Alteration To The Extraction Procedure
The results for the recovery of fatty acids extracted using the modified extraction 
procedure are shown in table 3.2.5.cl and can be summarised as follows>
1. The yield of fatty acid esters ranged from 39.65% (1.18) to 73.76% (3.45). The 
coefficients of variation ranged from 2.98-10.75%.
2 . None of the fatty acid esters produced a yield of greater than 100% and the variability 
of the results was reduced. Comparing this with the previous experiment, showed that the 
two methods provided different recoveries of fatty acid methyl esters (p<0 .0 0 1 ) (see table 
3.2.5.c2). The overall yield of the fatty acid esters was more uniform (i.e. low coefficients 
of variation) using the new procedure with most of the fatty acid methyl esters being 
recovered at between 50 and 70% of maximum.
Fatty Acid ME ME STD % of Max. CV
Palmitic 13.74(1.17) 25.24 ( 1 .1 2 ) 5 4 . 4 4  (4.65) 8.54
Palmitoleic 13.89(1.49) 30.86 (1.77) 45.01 (4.84) 10.75
Heptadecanoic 19.98(1.59) 27.48 (1.38) 72.71 (5.78) 7.95
Stearic 18.32 (1.35) 27.82 (1.14) 65.84 (4.84) 7.35
Arachidic 20.45 (0.95) 27.73 (2.31) 73.76 (3.45) 4.68
Behenic 15.35 (0.46) 38.71 (3.99) 39.65 (1.18) 2.98
Nervonic 20.01 (1.32) 40.04 (1.27) 50.02 (3.31) 6.62
Lignoceric 18.05 (0.82) 29.68 (3.63) 60.81 (2.77) 4.55
Table 3.2.4.cl Total ion currents (106) from the fatty acid methyl esters. The esters 
where produced using the original procedure (incubating at 50°C) and then extracted using 
the washing procedure described in section 3.e. The % of maximum for the synthesised 
esters compared to the standard esters is also shown as is the coefficient of variation (CV).
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Fatty Acid % o f 
Max. Original 
Protocol
CV Original 
Protocol
% of Max. 
New Protocol
CV New 
Protocol
Palmitic 117.49 (24.31)* 20.69 5 4 . 4 4  (4.65) 8.54
Palmitoleic 53.32 (8.95) 16.78 45.01 (4.84) 10.75
Heptadecanoic 75.34 (6.28) 8.33 72.71 (5.78) 7.95
Stearic 168.56 (25.44)* 15.09 65.84 (4.84) 7.35
Arachidic 135.42 (19.98)* 14.75 73.76 (3.45) 4.68
Behenic 103.85 (15.75)* 15.17 39.65 (1.18) 2.98
Nervonic 76.77 (9.05)* 11.79 50.02 (3.31) 6.62
Lignoceric 44.15(4.92) 11.14 60.81(2.77) 4.55
Table 3.2.4.c2. Comparison of the percentage of maximum TIC for the fatty acid methyl 
esters extracted using the original protocol and the modified protocol.
3.2.4d Optimisation of the Esterification Procedure.
3.2.4d1 Effect of acid concentration.
The results produced by increasing concentration of the acid present in the methanol are 
shown in table 3.2.4.c3 and can be summarised as follows:-
1. The recoveries of the fatty acid methyl esters produced with 1% acid present in 
methanol ranged from 46.27% (10.60) to 116.42% (21.82). The recoveries of the esters 
produced with 2% acid in methanol ranged from 52.39% (6.35) to 112.16% (7.27).
2. The recoveries of the fatty acid methyl esters produced using 2% acid were in general 
slightly greater, although not significantly, than those produced using 1 % acid, the only 
exception to this being arachidic acid. The variability in the yield of fatty acid methyl 
esters was reduced when esters were produced using 2 % acid (CV: 6.48-12.12%) 
compared to 1% (CV: 18.74-23.66%). Comparison of the recoveries obtained using 1 
and 2 % acid by analysis of variance showed no significant difference (p=0.38).
Fatty Acid ME STD 1% TIC 1 % 
% max.
1% CV 2% TIC 2 % 
% max.
2% CV
Palmitic 25.24 14.46 57.33 21.35 16.16 64.04 9.20
( 1 .1 2 ) (3.15) (12.24) (1.49) (5.89)
Palmitoleic 30.86 14.29 46.27 22.91 16.17 52.39 1 2 . 1 2
(1.77) (3.26) (10.60) (1.95) (6.35)
Heptadecanoic 27.48 16.85 61.33 20.43 18.60 67.69 7.77
(1.38) (3.44) (12.53) (1.45) (5.26)
Oleic 40.57 20.92 51.57 23.66 21.92 54.03 10.47
(2.99) (4.95) ( 1 2 .2 0 ) (2.30) (5.66)
Linoleic 24.18 14.48 59.87 24.07 14.97 61.91 10.55
(1.34) (3.49) (14.41) (1.58) (6.53)
Arachidic 27.73 32.29 116.42 18.74 31.10 112.16 6.48
(2.31) (6.05) (21.82)
✓ i  r \ 6 \  n
(2 .0 2 ) (7.27)
Table 3.2.4.c3 The total ion currents (106) for fatty acid methyl esters when passed 
through the gas chromatograph and fatty acid methyl esters produced in either 1 % or 2 % 
sulphuric acid in methanol and the % of maximum data and coefficients of variation.
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3.2.4.d2 Effect of Tncuhation Temperature.
The results produced when the incubation temperature was increased to 60°C (table
3.2.4.c4) can be summarised as follows (here the concentration of the acid was 2%).
1. The yield of fatty acid methyl esters produced ranged from 86.41% (7.83) to 103.13% 
(10.44) (CV: 4.69-10.47%).
2. The results were less variable than previously and none of the TIC values produced by 
the laboratory-esterified fatty acids were significantly different from those produced by the 
standard fatty acids.
Fatty Acid ME STD 2 % H2 SO4  in 
MeOH 2h 60° HB
% Of Maximum CV
Heptadecanoic 15.35 13.48 (0.98) *1 87.79 (6.43) 7.32
Stearic 16.87 (0.39) 15.78 (1.65) *2 93.52 (9.79) 10.47
Linolenic 10.61 (0.26) 10.94(1.11) *3 103.13 (10.44) 1 0 . 1 2
Arachidic 15.74 (0.42) 15.22 (0.71) *4 96.67 (4.53) 4.69
Arachidonic 20.98 (0.53) 18.13 (1.65) *5 86.41 (7.83) 9.06
Table 3.2.4.c4 Total ion currents (106) from the fatty acid methyl esters where the 
samples were incubated for 2hours at 60°C, the percentage of maximum is also shown. 
The abbreviations are as described previously. *1 P=0.136, *2 P=0.252, *3 P=0.997, *4 
P=0.607 *5 P=0.373.
3.2.4.d3 Effect of the extraction and incubation procedures on standard fattv acid 
methvl esters.
The results (table 3.2.4.c5-7) can be summarised as follows.
1. The yields of fatty acid esters produced by dissolving fatty acid methyl esters in the acid 
methanol mix and immediately re-extracting ranged from 92.95% (6.22) to 140.16% 
(7.03). The yield of fatty acid methyl esters produced after incubation for 2 hours at 60°C 
in the heat block ranged from 80.98% (5.43) to 120.43% (4.85), a similar incubation in the 
incubator produced yields ranging from 72.05% (2.87) to 105.16% (7.99). Incubation in 
the incubator overnight at 50°C produced yields ranging from 61.46% (5.36) to 194.59% 
(15.22)
2. The yields of fatty acid esters obtained after incubation in the heat block were greater 
than those obtained for either incubation in the dry incubator. The results obtained after 
incubating overnight in the incubator were the most variable. Linolenic acid methyl ester 
gave yields of consistently greater than 1 0 0 % irrespective of the treatment, suggesting the 
standard mixture may not be 1 0 0 % pure and may contain some unesterified fatty acid 
which has been esterified by these procedures.
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Fatty Acid STD RE EXT 2h 60° C HB 2h 60°C INC 24h 50°C INC
Heptadecanoic 16.69 15.51 13.98 12.52 10.69
(0.36) (1.04) (0.63) (0.36) (0.95)
Stearic 17.60 18.10 15.44 14.09 11.99
(0.35) (1.10) (0.95) (0 .6 6 ) ( 1 .0 1 )
Linolenic 8.27 11.59 9.96 8.70 16.09
(0.24) (0.58) (0.40) (0 .6 6 ) (1.26)
Arachidic 17.40 20.18 16.45 14.55 12.84
(0.38) (1.54) (1.23) (0.82) (1.44)
Arachidonic 20.51 19.51 16.61 14.78 12.60
(0.43) (0.75) (1.11) (0.59) ( 1 .1 0 )
Table 3.2.4.c5. TIC values of for the standard study described in section 3.2.3d.
Abbreviations RE EXT: immediate retraction. 2h 60° C HB: two hour incubation in heat
block, 2 h 60°C INC; two hour incubation in incubator, 24h 50°C INC; overnight
incubation in incubator.
Fatty Acid RE EXT 2h 60° C HB 2 h 60°C INC 24h 50°C INC
Heptadecanoic 92.95 83.79 75.01 64.06
(6 .2 2 ) (3.76) (2.18) (5.68)
Stearic 102.94 88.72 80.04 105.67
(6.33) (5.41) (3.94) (8.92)
Linolenic 140.16 120.43 105.16 194.59
(7.03) (4.85) (7.99) (15.22)
Arachidic 115.97 94.53 84.15 73.80
(8.83) (7.04) (4.87) (8.29)
Arachidonic 95.13 80.98 72.05 61.46
(3.68) (5.43) (2.87) (5.36)
Table 3.2.4.c6. Percentage of maximum recoveries for standard study described in section
3.2.3d.
Fatty Acid RE EXT 2h 60° C HB 2h 60°C INC 24h 50°C INC
Heptadecanoic 6.69 4.49 2.91 8.87
Stearic 6.15 6 . 1 0 4.92 8.44
Linolenic 5.01 4.03 7.60 7.82
Arachidic 7.61 7.45 5.79 11.23
Arachidonic 3.89 6.70 3.98 8.72
Table 3.2.4.c7 Coefficients of variation for the standard studv described in section 3.2.3d.
3.2.5. Discussion.
Because the molecular weights of the fatty acids studied here do not differ greatly, they 
can be difficult to separate by gas chromatography. In particular, the 4 fatty acids 
containing 18 carbon atoms only vary from each other by 2  atomic mass units each. 
However, the use of the graduated temperature program for the gas chromatograph (see 
section 2.8.3) allows adequate separation of the fatty acid esters. Although all the 
alcohols used produced esters which were adequately separated by gas chromatography
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and the different esters were separated by different amounts, only the study of methyl and 
ethyl ester production was continued for the following reasons. Methanol and ethanol are 
available at low cost and high purity. Pure methyl esters of all naturally occurring fatty 
acid are available commercially for use as standards; pure ethyl esters are available for 
most fatty acids. While butyl and propyl ester standards could have been synthesised, the 
separation of these was no more efficient than methyl or ethyl esters so that the 
expenditure of time and money was not justified. It became apparent after the initial 
experiments that there was no advantage in the production of ethyl esters and this too was 
abandoned. Some groups do routinely use other alcohol esters. For example isopropyl 
ester production was favoured by Peuchant et al (1989). This method allows for the lipids 
to be extracted with isopropanol.
Using the original extraction procedure, the experiments to test the esterification reaction 
efficiency provided results which were inadequate. In particular the recoveries were 
variable, ranging from less then 50% to greater than 150%. The low recoveries may have 
been due to incomplete esterification or extraction or losses incurred during the extraction 
procedure possibly, due to oxidation. These will be discussed further later. Greater than 
theoretical recoveries must have been due to differences in recovery between the standard 
and the synthesised esters. Identical recovery of the internal standard and sample esters is 
essential for valid quantitation using the computer quantitation package. It is not a 
necessity for esters to be recovered 1 0 0 % but all fatty acid esters must be recovered in 
similar proportions. This was not the case here.
As mentioned previously, the low recoveries observed may have been due to incomplete 
esterification of the fatty acids. The esterification reaction is impaired when water is 
present in the reaction mix (Christie 1989). Any residual traces of water were removed 
from the alcohol with anhydrous sodium sulphate. Although the water content of the 
alcohol was not tested, the drying procedure used is widely accepted as being adequate. 
Also, the addition of the sulphuric acid, itself a dehydrating agent, should have eliminated 
any residual water from the mixture. Other groups (Fixter, personal communication) 
report that for esterification to proceed, the methanol must bubble when the acid is added 
to it; this was routinely observed. Drying of alcohol did not increase the efficiency of 
esterification. In fact, in many cases the yields produced with dry alcohol were lower than 
before. Many of the previous results showed yields of greater than maximum; drying the 
alcohol prevented this. The reason is not clear. As it is not an expensive or time
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consuming, the drying procedure was adopted as an extra precaution. Other sources of 
error were investigated. It is interesting, however, that there are reports of esterification 
continuing in the presence of up to 10% water in the sample (Eder et al 1992a).
Fatty acid esters may have been lost during the extraction procedure or have not been 
completely extracted. One of the major problems with the extraction procedure was the 
loss of solvent from the test-tubes during mixing. Ground glass stoppers formed an 
inadequate seal and allowed the diethyl ether to escape, reducing recoveries. Other groups 
recommend the routine use of test tubes with Teflon-lined screw caps (Eder et al 1992a). 
Therefore, these were evaluated. Teflon liners are necessary since the solvents leaching 
plasticizers from the plastic which may interfere with the subsequent gas chromatography 
of the fatty acid esters. This is discussed further elsewhere (see section). Great care was 
taken to avoid residual water in the cap after washing (see above).
The screw cap allowed for better mixing of the solutions and prevented the escape of the 
diethyl ether during the extraction procedure. The tight seal also reduced the risk of 
evaporation of methanol during incubation. Although the use of these tubes did not 
improve the recoveries or the reproducibility of the results, they were more convenient and 
were therefore used throughout subsequent experiments. Again, using Teflon lined screw 
capped vials reduced the number of yields which were greater the maximum.
As mentioned previously, it was possible that oxidation was causing loss of fatty acid 
esters during the extraction. Contrary to previous reports that the presence of the 
antioxidant BHT is beneficial in all lipid extractions (Hamilton et al 1992) and 
esterification reactions (Eder et al 1992a), no benefit was observed here. Moreover, the 
presence of large quantities of BHT produced GC-MS peaks which interfered with the gas 
chromatography of the esters, particularly those of the C l 8  fatty acids. BHT is also 
reported to form free radicals at high temperatures (Frenkel 1980) and at high 
concentration is a pro-oxidant (Christie 1989), leading to the oxidation of fatty acids (see 
chapter 1). With BHT present in all the extracting solvents, its final concentration was 
difficult to control as the repeated evaporation of solvents leads to a build up of high 
concentrations. With BHT present in only the storage solvents, the final concentration is 
much lower and does not affect gas chromatography. BHT was therefore omitted from 
the esterification and extraction procedure but included in the hexane used to redissolve 
the samples for storage. All samples were stored under an atmosphere of nitrogen at -
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20°C, which should minimise sample oxidation. The autosample facility on the GC-MS 
was routinely used throughout this work. BHT was included in the hexane used here to 
prevent oxidation while the samples awaited injection.
Oxidation could occur during the extraction procedure. For example, while in the freezing 
bath, the diethyl ether layer containing the fatty acids was not submerged in the ethanol, 
because the freezing bath was not deep enough, and was exposed to light, (both heat and 
light catalyse oxidation of fatty acids) (Frenkel 1980). The time the tubes spent in the 
freezing bath varied from sample to sample and day to day as did the temperature of the 
laboratory. To avoid these problems as far as possible, the time taken for extraction was 
reduced from up to six hours to 45 minutes and was carefully standardised. Phase 
separation by freezing was discontinued in favour of separation using a Pasteur pipette and 
the aqueous washings were back extracted.
A variety of steps were taken to optimise the esterification reaction. Heating during the 
esterification was changed from using a dry incubator to using an aluminium heat block 
which may improve the transfer of the heat as aluminium is a better conductor of heat than 
air. Recoveries of esters were also improved by increasing the concentration of the 
catalyst, H2 S 04, to 2 % from 1 %. This may have had two effects, improved efficiency of 
catalysis or possibly better dehydration of the alcohol.
The final modification made was to increase the temperature of incubation from 50°C to 
60°C. The maximum temperature is limited by the boiling point of methanol (64.7°C). At 
this higher temperature, the incubation time could be reduced, reducing the risk of 
oxidation. Although none of the small modifications made significantly improved the 
results, cumulatively they increased the recoveries of fatty acid methyl esters to 
quantitative and reduced the variability.
Using standard methyl esters, it was shown that the losses during the revised esterification 
and extraction procedure were negligible. In the second part of this study, where standard 
esters were incubated in the incubator, some losses were incurred possibly due to 
oxidation. The products of oxidative breakdown of fatty acids are aldehydes and ketones 
which are not detected on the gas chromatograph using the conditions employed here.
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There are several alternative methods of fatty acid ester synthesis and choice may depend 
on the aims of the experiment and the local conditions. Here it was desired that the 
esterification procedure should be suitable for the study of all the lipid groups. For 
example, free fatty acids and sphingomyelin cannot be esterified using base-catalysed 
esterification (Christie 1989) whereas acid-catalysed esterification is universally effective.
In 1968, the American Oils Chemists Society recommended the use of boron trifluoride 
methanol as an approved method for ester formation (Firstone 1969). A variety of authors 
had previously reported the successful use of this reagent (Morrison & Smith 1964). 
Boron trifluoride methanol is toxic and unstable and the use of old regent has been 
reported to cause the decomposition of PUFA and production of methoxy-substituted 
derivatives and other artefacts (Lough 1964, Fulk & Shorbl970, Shepard & Inverson 
1975). It is possible to use other trihalides. For example, boron trichloride methanol has 
been reported to produce fatty acid esters without destruction of PUFA (Klofenstein 
1971). The same group suggest that boron trifluoride in methanol only produces artefacts 
when the conditions employed are too harsh and that, when esterification is carried out in 
an inert environment, no artefacts occur (Klofenstein 1971). Because of the toxicity of 
boron trifluoride methanol and the risk of polyunsaturated fatty acid degradation, this 
reagent was not investigated here.
The use of acid-catalysed esterification is simple, rapid and, providing the conditions are 
carefully controlled, the results are highly reproducible. The use of methanolic 
hydrochloric acid has been preferred by some groups (Christie 1989) while others 
recommend the use of sulphuric acid (Hitchcock & Hammond 1980). The reagents are 
inexpensive and can be prepared fresh daily, avoiding the problems of degradation and 
concentration variation with time.
Eder et al (1992a) has evaluated the use of a variety of esterification procedures, paying 
particular attention to the esterification of small amounts of phospholipids. The methods 
tested were based on boron-trifluoride methanol, methanolic sodium methoxide and 
methanolic sulphuric acid. This paper suggests that the only suitable method for 
methylation of phospholipid-bound fatty acid is methanolic sodium methoxide. However, 
as this is a base-catalysed esterification, it was not suitable for use here. The use of 
methanolic sulphuric acid is not recommended by the author but the conditions they 
employed were harsh (6 % sulphuric acid and 90°C). The authors state that under these
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conditions, there was no loss of polyunsaturated fatty acids (Eder et al 1992a). However, 
in the same paper they also suggest that high concentrations of acid and high temperatures 
may be responsible for the loss of fatty acids esterified to sphingomyelin, which may 
explain why the authors observed poor recoveries of fatty acids from phospholipids. It is 
clear from this study and others that there is a great variation in the performance of 
methods.
Although some of the evidence would dissuade from the use of acid-catalysed 
esterification, many people report it as their method of choice because the reagents are 
stable, relatively safe and inexpensive. The results here show that the method can be both 
accurate and reproducible.
3.3.1 Senaration of Neutral Lipids Using Silica Sen-Pak Cartridges
Complete analysis of the cell membrane requires that the neutral lipid fraction is separated 
into its constituent groups. The method of Hamilton and Comia (1988) reports the 
complete and quantitative separation of cholesterol ester, triglycerides, partial glycerides 
and free fatty acids. It utilises radioactively labelled standards to estimate the recoveries. 
Here an attempt has been made to recover fatty acids from the individual lipid groups both 
quantitatively and without mutual contamination. This method evaluated here is based on 
the use of silica Sep-pak cartridges as recommended by Hamilton and Comia (1988).
3.3.2 Methods
The separation method (Hamilton & Comia 1988) is as follows:-
1. Silica Sep-pak cartridges were activated with hexane/MTBE (96:4 v/v) (4ml) followed 
by hexane (12ml). The eluate was discarded.
2. The lipid sample was dissolved in hexane/MTBE (200:3 v/v) (2ml) which was applied 
to the cartridge. The test tube was washed with a further 2ml of solvent which was also 
applied to the cartridge followed by a further 10ml of the solvent. The total eluate was 
saved as fraction 1  containing cholesterol esters.
3. Hexane/MTBE (96:4 v/v) (12ml) was then applied to the cartridge and the eluate saved 
as fraction 2  containing triglycerides.
4. Hexane/acetic acid (100:0.2 v/v) (12ml) was added to the cartridge and the eluate 
saved as fraction 3.
5. Hexane/MTBE/acetic acid (100:2:0.2 v/v/v) (12ml) was then applied to the cartridge 
and the eluate saved as fraction 4 containing free fatty acids.
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6 . MTBE/acetic acid (100:0.2 v/v) (12ml) was applied to the cartridge and the eluate 
saved as fraction 5 containing partial glycerides.
Fractions were collected in Pyrex tubes and evaporated to dryness under nitrogen at room 
temperature. Fatty acid methyl esters were produced and extracted as described 
previously (section 3.2.3c). The volume of eluting solvent was on occasion increased to 
improve the recovery of lipids; the volume used will be given in the results section. In 
general, where the recovery was not adequate, the volume of eluting solvent was increased 
to 15 ml.
3.3.3 Experimental procedures.
Each lipid group was studied in turn using standard lipids (section 3.1.1). The samples 
were added to a test tube and the solvents removed by evaporation under nitrogen. The 
samples were then applied to the Sep-pak cartridge and eluted following the protocol 
above.
3.3.4 Results
Early gas chromatograms contained contaminating peaks. These were avoided if the 
elution rate from the Sep-pak cartridge was maintained with a constant negative pressure 
from a water pump which shortens the elution time and if all solvents were stored in glass 
bottles with glass lids. The probable origin of these peaks will be discussed later. Initially, 
BHT was present in all the eluting solvents to prevent oxidation of the lipids during the 
elution procedure. However, BHT was later eliminated from all solvents except those 
used for sample storage for the reasons described above. Recoveries for the individual 
lipid groups were as follows:-
3.3.4.A Cholesterol Esters.
The results (graph 3.3.4.a) can be summarised as follows:-
Cholesterol esters were recovered quantitatively in fraction 1, which contained 95.15% 
(8.10) and 107.92% (4.95) of maximum heptadecanoic and oleic acid methyl esters from 
cholesterol esters respectively. This did not differ significantly from maximum (p=0.35 
and 0.16). There was no difference between the percentage recovery of research and 
internal standards (p=0.06).
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Graph 3.4.4a Elution pattern o f cholesterol esters from silica Sep-paks showing the 
percentage o f maximum recoveries o f the fatty acid methyl esters produced and standard 
deviation for each fraction and the p values for an unpaired T-test (n=6).
3.3.4.b Triglycerides
The results (table 3.3.4.b and graph 3.3.4b) can be summarised as follows:- 
Triglyceride recovery was not quantitative. Fraction 2 contained 68 89% (4.72) and 
72.16% (7.48) o f the maximum for linoleic acid and heptadecanoic acid respectively. The 
elution volume for fraction 2 was therefore increased to 15ml. The recoveries of 
trigylcerides were then quantitative. The percentage o f maximum recoveries of 
heptadecanoic and linoleic acid methyl ester liberated from triglycerides were 93.38% 
(13.29) and 95.35% (11.39) respectively (p=0.17 and 0.33). There was no difference 
between the percentage recovery o f research and internal standards (p=0.64).
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Fraction % o f Maximum o f % o f  Maximum of
Heptadecanoic Acid Methyl Ester Linoleic Acid Methyl Ester
1 6.81 (4.51) 1.74(1.12)
2 72.16(7.48) 68.89 (4.72)
3 0.74 (0.84) 2.14(1 .17)
4 0 (0 ) 2.91 (2.39)
5 0.37(0 .90) 3.48 (1.03)
Table 3.3.4.b Percentage o f maximum recoveries and standard deviations for each
fraction from the Sep-pak cartridges for fatty acid methyl esters liberated from
triglycerides (n=6).
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Graph 3.3.4b. Elution pattern o f triglycerides from silica Sep-pak cartridges showing the 
percentage o f maximum recoveries o f  the fatty acid methyl esters produced and the 
standard deviation and p values for an unpaired T-test (n=6)..
3.3.4.C Free Fattv Acids.
The results (table 3.3.4.c and graph 3.3.4c) can be summarised as follows:- 
Initially the recovery o f  free fatty acids was not quantitative. Fraction 4 contained 51.61% 
(3.62), 47.24% (2.85) and 50.92% (5.01) o f palmitic acid, heptadecanoic acid and stearic 
acid methyl esters respectively. The volume o f eluate for fraction 4 was increased to 
15ml. This made recovery o f free fatty acids quantitative; the percentage o f fatty acid 
recovered was 106.63% (23.21), 91.61% (20.51) and 108.65% (20.44) for palmitic, 
heptadecanoic and stearic acid respectively. These recoveries did not differ significantly 
from maximum (p=0.58, 0.12 and 0.41). There was no difference between the percentage 
recovery o f research and internal standards (p=0.09 and 0.1 for palmitic and stearic acid).
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Fraction % o f Maximum 
Palmitic Acid Methyl 
Ester
% o f Maximum 
Heptadecanoic Acid 
Methyl Ester
% o f Maximum 
Stearic Acid Methyl 
Ester
1 0.63 (0.33) 0.03 (0.08) 0.22 (0.12)
2 0.97 (0.30) 0.02 (0.06) 0.34 (0.10)
3 0.32 (0.27) 0 (0 ) 0 .14(0  10)
4 51.61 (3.62) 47.24 (2.85) 50.92 (5.01)
5 7.00 (6.44) 0.20 (0.34) 5.62 (3.16)
Table 3 .3 .4.C Percentage o f maximum recoveries for free fatty acids eluted from a Sep-pak 
cartridge. Volume o f fraction 2 equals 15 ml (n=6).
Stearic Acid 
Heptadecanoic Acid 
Palmitic Acid
5
p=0.41
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Graph 3 .3 .4c. Elution pattern o f free fatty acids from Sep-paks showing the percentage of 
maximum recoveries o f the fatty acid methyl esters produced and the standard deviation 
and p value for and unpaired T-test (n=6).
3.3.4.d Partial Glycerides
The results (graph 3.3.4.d) can be summarised as follows
As the volumes o f the previous fractions were increased to 15ml, the volume o f fraction 5 
was also increased. The recoveries o f partial glycerides were not quantitative. The 
percentages o f maximum stearic acid and heptadecanoic acid recovered from fraction 5 
were 77.94% (10.53) and 73.55 (5.79) respectively. The ratio o f C18:0/C17:0 eluted 
with fraction 5 was not significantly different from the maximum (p=0.26) and the research 
and internal standard behaved in the same way (p=0.22).
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Graph 3 .4.4d Elution pattern o f partial glycerides from silica Sep-pak cartridges showing 
the percentage o f maximum recoveries o f the fatty acid methyl esters produced and the 
standard deviations and p values for and unpaired T-test (n=6).
3.3.5. Discussion
In the initial experiments, contaminating peaks were observed on the GC-MS which 
interfered with the chromatography o f the Cl 8 and C20 fatty acids. These appear to have 
come from the plastic surfaces with which the solvents came into contact (the Sep-pak 
cartridge and the lids o f the solvent bottles) as the peaks disappeared when the solvents 
were stored in all-glass bottles and the flow rate o f the solvents through the Sep-pak 
cartridge was increased. In general, the greater the flow rate o f solvent through a 
chromatography column, the poorer the resolution o f the compounds to be separated 
However, here a balance had to be found between adequate resolution o f  the lipid groups, 
good recoveries and avoidance o f contaminating peaks. The occurrence o f contaminating 
peaks during gas chromatography after the use o f Sep-pak cartridges has been reported 
elsewhere. In his discussion o f solid phase extraction, Christie (1992) suggests that these 
are plasticisers or more precisely phthalates. He states that these should be removed from 
the cartridge during the washing procedure. It would be possible to overcome this by 
purchasing glass silica-columns or producing silica columns in the laboratory. The cost of 
the first option is prohibitive, the second option would lead to variability in the results as 
the packing density and water content of the silica could not be easily controlled. M ost of
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the contaminating peaks observed here were probably derived from the plastic lids of the 
storage bottles.
After the initial experiments BHT, was omitted from the eluting solvents. All the solvents 
used for chromatography were degassed with nitrogen or by sonication to prevent 
oxidation. The reasons for omitting BHT have been discussed previously.
In the initial experiments involving the separation of free fatty acid and triglyceride 
fractions, the recoveries were poor and variable. These were improved to approximately 
100% by increasing the elution volume. The use of larger volumes of solvent than 
necessary is, however, to be avoided, again due to the risk of oxidative losses during 
evaporation of eluates to dryness. This is discussed further in the next section. The fatty 
acid liberated from the partial glycerides could not recovered quantitatively. However, 
since both the internal standard and the research standard had similar recoveries, valid 
quantitation by gas chromatography was possible using the Magnum software package 
without further correction for losses. Fraction three contained no lipid and functions to 
acidify the column. Altering the elution volumes of the other fractions did not alter this 
situation. Increasing the volume of earlier fractions did not lead to premature elution of 
free fatty acids or partial glycerides in this fraction.
The modified method is fast and efficient and does not require large amounts of specialised 
equipment or large volumes of solvent. The recoveries of all the lipid groups either did 
not differ significantly from maximum or from the recovery of the internal standard. It has 
also been established that the recoveries of neutral lipids containing the internal standard 
heptadecanoic acid were identical to those containing naturally occurring fatty acids. 
Therefore these are valid recovery standards for lipids from biological samples.
The most commonly used techniques for the separation of neutral lipids are thin layer 
chromatography (TLC) and high performance liquid chromatography (HPLC). TLC is 
effective for the separation of neutral lipids, but many of the solvent systems reported to 
separate lipids contain acetic acid (Mangold & Malins 1960, Henderson & Tocher 1992) 
which introduces the risk of hydrolysis. As the recovery estimate for the lipids depended 
on subsequent assessment of fatty acid content, the use of acetic acid in solvent systems 
should be avoided. This will be discussed in more depth in the next section. Other TLC 
techniques involve a double development of the plate with drying between (Conte &
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Bishop 1988), which again introduces the additional risk of oxidation. Thin layer 
chromatography has a limited sample capacity and overloading causes poor resolution of 
the lipid groups. There are also difficulties in recovering samples quantitatively because 
they must be scraped off the plate which is inefficient and time consuming. It also exposes 
the lipids to oxidation because recovery from the plate cannot be performed in an inert 
atmosphere. A modified TLC method has been reported for the isolation of partial 
glycerides which involves TLC followed by flame ionisation detection (Okumura et al 
1988). This requires specialised equipment but it has been used successfully to separate 
cholesterol and phospholipids (Rosasromero et al 1996). A full discussion of this method 
is contained within the introduction (section 1.16).
HPLC, although efficient at separating lipid groups, also requires expensive equipment 
and, depending on the detection system used, identification of the lipid groups can be 
difficult. Retention times on HPLC vary with changes in atmospheric conditions, making 
identification by retention time alone unreliable. Also, because the lipids have a range of 
fatty acids esterified to them, the peaks they produce are diffuse. It would be possible to 
separate the lipids by preparative HPLC and then reapply the individual lipid groups under 
different conditions to separate the lipids with reflect their fatty acid composition.
Many groups use silica cartridges to separate the neutral lipids from polar lipids (Bitman et 
al 1983, Ansari & Shoeman 1988, Hamilton & Comia 1984, Janero & Burghardt 1990). 
Also, the use of aminopropyl-bonded phase disposable columns has been shown to be 
effective for the separation of the lipids studied here, providing quantitative recoveries of 
lipids (Kalunzy et al 1985). This method was not tested here because the recoveries of the 
polar lipids have proved unreliable and it was desirable to use the same method to separate 
the neutral and polar lipids. This will be discussed further later.
The use of disposable Sep-pak cartridges allows for a high capacity, fast, efficient and 
relatively inexpensive separation of lipid groups. The lipids are separated as a function of 
their own polarity and that of the solvent with the least polar lipids being eluted first. The 
principle of this and other solid phase extraction procedures are similar to those of HPLC 
involving adsorption and partition chromatography (see chapter 1 ).
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3.4.1 S e p a ra tio n  o f P o la r  LipiH G ro u p s  U sing  Silica S ep -P ak  C a rtr id g e s .
For the complete analysis of the cell membrane, it was necessary to isolate and separate 
the major phospholipid groups. The method chosen, as for the neutral lipids, was that of 
Hamilton and Comia (1988). In this method, polar lipids were separated into two groups, 
with PI and PE in one group and PC, LPC and sphingomyelin in the other. Recoveries 
were measured using standard phospholipids in which the base group was radioactively 
labelled. In the following modifications to this method, particular attention has been paid 
to obtaining quantitative recoveries of non-radioactive lipids. Here, this has been 
monitored by measuring the recovery of fatty acid methyl esters produced from recovered 
lipids as previously described.
3.4.2. Method
The use of a gradient solvent systems to elute neutral lipids from a silica Sep-pak cartridge 
was as described on section 3.3.1. The initial method for the separation of the polar lipids 
is a continuation of this method and was as follows.
1. Neutral lipids were eluted from the cartridge as described previously (see section 
3.3.1), ending with the elution of partial glycerides with MTBE/Acetic acid (100:0.2 v/v) 
(15ml) fraction 5.
2. MTBE/methanol/aqueous ammonium acetate (25:4:1 v/v/v) (pH 8 .6 ) (8 ml) was applied 
to the cartridge and the eluate saved as fraction 6 containing PI and PE.
3. MTBE/methanol/aqueous ammonium acetate (10:4:1 v/v/v) (pH 8 .6 ) (12ml) was 
applied to the cartridge and the eluate saved as fraction 7 also containing PI and PE. 
Fraction 6  and 7 are pooled at this stage.
4. MTBE/methanol/aqueous ammonium acetate (5:8:2 v/v/v) (pH 8 .6 ) (12ml) was applied 
to the cartridge and the eluate saved as fraction 8 containing LPC, PC and sphingomyelin.
5. MTBE/methanol/aqueous ammonium acetate (5:4:1 v/v/v) (pH 8 .6 ) (12ml) was applied 
to the cartridge and the eluate saved as fraction 9 also containing LPC, PC and 
sphingomyelin. This was repeated and the eluate saved as fraction 10 also containing 
LPC, PC and sphingomyelin. Fractions 8 , 9 and 10 are pooled at this stage.
The concentration of aqueous ammonium acetate used in the preparation of the solvents 
was 0.3mM dissolved in distilled water.
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To evaluate recovery and specificity, each lipid group was studied separately using 
standards (the fractions were not pooled but analysed separately). The preparation of fatty 
acid methyl esters and their subsequent analysis was as described in 3.1.1.
3.4.3 Experimental
As a preliminary evaluation of this method, the following questions were addressed:-
1. Was the elution pattern of the lipids as published? To test this, the method outlined in
3.4.2 was used to evaluate the recovery and fractional distribution of PI.
2. Was the acetic acid present in the solvents for the elution of neutral lipids affecting the 
elution and recovery polar lipids? This was investigated by replacing solvents 3-5 (neutral 
lipid separation) with solvents containing a range of acid concentrations. The volume of 
solvent 3 was also manipulated. Table 3.4.3.b shows the composition and volume of the 
solvents used. The solvents will be referred to by the numbers in the table. Here the 
results are expressed as % recovery of the total fatty acid.
Solvent Volume of Acid Volume of Fraction 3
(per 1 0 0 ml solvent) Applied to the Cartridge
Solvent 1 0 1 2  ml
Solvent 2a 0 . 1 2  ml
Solvent 2b 0 . 1 4 ml
Solvent 2 c 0 . 1 1 2  ml
Solvent 3 a 0 . 2 2  ml
Solvent 3b 0 . 2 4 ml
Solvent 3 c 0 . 2 1 2  ml
Solvent 4a 0.4 2  ml
Solvent 4b 0.4 4 ml
Solvent 4c 0.4 1 2  ml
Table 3.4.4.b3 Volume of acid present in all solvents and volume of fraction 3 applied to 
the cartridge in experiment 2 .
3. Is it possible to remove the neutral lipids from the Sep-pak cartridge with one solvent, 
allowing for subsequent separation of polar lipids? This was tested using the protocol 
described below. The final solvent in the elution system for the neutral lipids was 
MTBE/acetic acid (100:0.2 v/v), which should remove all the neutral lipids from the Sep- 
pak cartridge. As the omission of acid from the solvent system was necessary, the ability 
of MTBE alone to elute the neutral lipids was tested using the protocol described below.
A. Palmitic acid, heptadecanoic acid, trilinolein, cholesterol oleate and PI (containing 
mostly stearic and arachidonic acid) were dissolved in MTBE (2ml) and applied to a 
prewashed Sep-pak cartridge. A further 2ml of MTBE was added to the test tube and
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mixed before being added to the cartridge. MTBE (10ml) was then added to the 
cartridge. The combined eluate was collected in Pyrex culture tubes. This formed 
fraction 1.
B. The polar lipid separation procedure described in 3.4.2 was carried out beginning with 
the addition of MTBE/MeOH/aqueous ammonium acetate (25:4:1 v/v/v) (pH 8 .6 ) ( 1 2 ml) 
to the cartridge. This formed fraction 2.
C. MTBE/MeOH/aqueous ammonium acetate (10:4:1 v/v/v) (pH 8 .6 ) (12ml) was then 
added to the cartridge forming fraction 3.
D. MTBE/MeOH/aqueous ammonium acetate (5:4:1 v/v/v) (pH 8 .6 ) (12ml) was then 
added to the cartridge forming fraction 4.
E. MTBE/MeOH/aqueous ammonium acetate (5:8:2 v/v/v) (pH 8 .6 ) (12ml) was then 
added to the column forming fraction 5. This was repeated forming fraction 6.
The above procedure was repeated using distearin to assess whether partial glycerides 
were quantitatively removed by MTBE. The samples were analysed as described 
previously (see section 3.1.1 and 3.1.2.).
4. Was the recovery of the polar lipid groups improved using the above method? To test 
this, each of the polar lipid groups were studied in turn; the sample analysis was as 
described previously. Where the volume of the solvent used was altered to increase the 
recovery of the lipids, the volume used is given in the results. In general, where the 
recovery of the lipid was inadequate, the volume of eluting solvent was increased to 15ml.
5. Were the lipids being applied to the cartridge in a quantitative manner? To test this, 
the lipid was dissolved in MTBE as usual and then transferred to another test tube before 
the removal of the solvent and methylation. This simulated the addition of the sample to 
the Sep-Pak cartridges. Samples were also dissolved in MTBE (2ml) and sonicated in a 
water bath for 2 min prior to treatment as above. The effect of removal of solvents by 
evaporation under nitrogen on the recovery of the fatty acids was evaluated by adding the 
lipid to of appropriate solvent (15 ml) and to dry under nitrogen prior to methylation (PE 
and LPC were used for this study).
3.4.4 Results
N.B. Where ratio of research standard/internal standard was expressed as a percentage of 
maximum. The value of the ratio for the unchromatographed standards was taken as
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maximum and the value of ratio obtained for the chromatographed samples was compared 
to this and expressed as a percentage.
3.4.4a Elution of PI using the original method
The method of Hamilton and Comia (1988) did not separate the polar lipid groups 
adequately (table 3.4.4.a). Fraction 7 contained 84.53% (12.17) of the maximum fatty 
acid liberated from PI. However, fractions 4, 5 and 6  contained 20.44% (10.73), 25.78% 
(23.39) and 17.33% (10.73) of the fatty acids respectively. The variability of the results 
obtained were unacceptably high.
Fraction % of Maximum Fatty 
Acid
4 20.4 (10.73)
5 25.78 (23.39)
6 17.33 (11.36)
7 84.53 (12.17)
8 12.67 (3.29)
9 4.5 (0.61)
Table 3.4.4. a Elution pattern of PI showing the percentage of maximum fatty aids for the 
fatty acids liberated from PI following the original method of Hamilton and Comia (1988).
3.4.4h The effect of acetic acid on the elution pattern of the lipids.
The results (tables 3.4.4 bl-b4) can be summarised as follows:-
The elution pattern which most closely matched the published pattern was obtained with 
no acid present in the solvent. No lipid was found in fraction 4. With the other eluting 
solvents, the volume of fraction 3 was also varied. In general, the greater the volume of 
fraction 3, the greater the quantity of lipid observed in fractions previous to fraction 6  (i.e. 
the fractions where neutral lipids elute). Solvent 4, which contained 0.4% acetic acid 
caused the elution of lipid earliest in the protocol.
In a separate experiment, PI was added to a test tube containing 0.2% acetic acid in 
methanol, mixed and left to stand in the bench for 10 min. Subsequent extraction of 
showed a small amount of fatty acid methyl esters has been released from PI.
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Fraction % of Total fatty acid eluted with solvent 
1
3 0
4 0
5 14.17
6 7.18
7 63.26
8 13.02
9 2.36
Table 3.4.4.bl. Percentage of maximum recoveries of the fatty acid methyl esters 
produced from PI after elution from the Sep-pak cartridgesusing solvent 1, containing no 
acid.
Fraction_______________ % of total fatty acid eluted with each solvent
Solvent 2a Solvents 2b Solvent 2c
3 0 0 0
4 0 0 12.63
5 46.27 42.63 53.86
6 1 0 . 6 8 7.93 13.94
7 26.08 32.46 13.66
8 11.70 13.51 5.90
9 5.27 3.467 0
Table 3.4.4.b2 Percentage of maximum recoveries of the fatty acid methyl esters from PI
after elution from the Sep-pak cartridge using solvent 2 a, b and c 
acid
; containing 0 . 1  ml acetic
Fraction % of total fatty acid eluted with each solvent
Solvent 3 a Solvent 3b Solvent 3 c
3 0 0 0
4 0 10.47 18.8
5 6.24 37.80 19.6
6 7.45 7.24 5.8
7 20.92 25.90 39.29
8 7.63 13.49 13.68
9 2.75 5.09 2.72
Table 3.4.4.b3 Percentage of maximum recoveries for the fatty acids produced from PI 
after elution from the Sep-pak cartridges using solvent 3 a, b and c containing 0.2 ml 
acetic acid.
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Fraction % of total fatty acid eluted with each solvent
Solvent 4a Solvent 4b Solvent 4c
3 0 1.09 0.96
4 18.26 18.87 21.49
5 32.45 24.68 15.07
6 9.22 7.49 6.09
7 23.72 37.22 39.45
8 12.83 7.98 13.79
9 3.52 1.62 3.14
Table 3.4.4.b4 Percentage of maximum recoveries for the fatty acids produced from PI 
after elution from the Sep-pak cartridges using solvent 4 a, b and c containing 0.4 ml 
acetic acid.
3.4.4c Removal of Neutral Lipids from the Sep-pak cartridge using MTBE.
The results (table 3.4.4.c) can be summarised as follows:-
The neutral lipids were eluted with both fractions 1 and 2 of the solvent system described 
in 3 .4.3. The amount lipid of recovered did not vary significantly from maximum. Fraction 
1 contained 95.76% (10.27) of linoleic acid from trilinolein, 99.76% (15.30) of oleic acid 
from cholesterol oleate and 93.66% (16.72) of stearic acid from partial glycerides. 
Fraction 2 contained 97.33% (10.38) of the free fatty acid, palmitic acid (p=0.2645 for 
palmitic acid p=0.2899 for the linoleic acid, p=0.9729 for oleic acid, p=0.47 for stearic 
acid). The 62.10% (11.43) of PI was eluted from the column with fraction 3 none was 
eluted in fractions 1 and 2. Therefore, there was no residual neutral lipid to interfere with 
the polar lipid analysis.
Fraction Palmitic Linoleic Oleic Stearic Stearic From 
PGS
1 6.96 (4.44) 95.13(10.27)n 99.76(15.30>2 6.29(1.16) 93.66(16.74)m
2 97.33(10.38)*3 0 2.05 (0.53) 9.04 (2.53) 4.88 (1.96)
3 3.47 (3.84) 1.40 (2.18) 9.25 (1.98) 62.10(11.43) 2.59 (0.71)
4 7.41 (0.66) 0.22 (0.53) 3.08 (0.45) 10.15(2.30) 1.38(0.1)
5 2.36(1.19) 0 0.55 (0.47) 2.54 (0.50) 0
6 2.72 (0.29) 0 0.69 (0.36) 1 . 8 6  (0 .2 2 ) 0
Table 3.4.4.C. Percentage of maximum fatty acids for the lipids stripped from the Sep Pak 
cartridge to allow for the elution of polar lipids. Palmitic acid was present as a free fatty 
acid, linoleic acid was liberated from trilinolein and oleic acid was liberated from 
cholesterol oleate. Stearic acid was liberated from PI. (n=6 ). *1 p=0.290 *2 p=0.265
*3 p=0.973 *4 p=0.48.
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3.4.4d Efficiency of Separation and recovery of the Polar lipids after removal of the 
neutral lipids.
The results (table 3 .4 .4 .dl) can be summarised as follows:- 
3.4.4dl Phosphatidvlinositol
As has been shown previously, PI was present in fraction 3 o f the modified elution system. 
The volume o f the eluting solvent for fraction 3 was increased to 15 ml, which recovered 
then all the PI. The percentage o f C l8:0 liberated from PI present in fraction 3 was 
87.10% (4.90), which did not differ significantly from maximum (p=0.54). The value 
obtained for C 18:0/C 17:0 in fraction 3 was 87.43% (7.685) (p=0.014). There was no 
difference between the recovery o f research and internal standards (p=0.59).
Fraction
^  C18:0/C17:0 
□  C18
{p=0.014
p=0.54
—r~
20
~r~
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Graph 3.4.4dl Elution pattern o f PI from silica Sep-pak cartridges showing the 
percentage o f maximum recoveries o f the fatty acids from PI, the standard deviations and 
p values for an unpaired T-test (n=6).
3.4.4d2 Phosphatidylcholine
These results (table 3.4.4.d2 and graph 3.4.4.d2) can be summarised as follows:- 
Most o f the PC was eluted with fraction 4. The percentage C l 6:0/C l 7:0 in fraction 4 was 
79.68 (3.598) and for C18:2/C17:0, the percentage present in fraction 4 was 69.23 (7.72). 
The volume o f fraction 4 was increased to 15 ml, which completely recovered the PC. 
The percentage o f maximum recoveries for palmitic and linoleic acid liberated from PC in 
fraction 4 were then 99.41 (12.95) and 87.85 (12.69) respectively (p=0.96 and 0.14). The 
percentage o f 0 6 : 0 / 0 7 : 0  present in fraction 4 was 98.218 (10.06), which was not
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significantly different from maximum (p=0.72). The percentage o fC 1 8 :2 /C 1 7 :0  present 
in fraction 4 was 86.60 (8.50) (p=0.015). There was no difference between the recovery of 
research and internal standards (p=0.74 and 0.19 for palmitic and linoleic acid).
Fraction %  o f Maximum %  o f  Maximum %  o f  Maximum % o f Maximum
C16:0 C18:0 C16:0/C17:0 C18:2/C17:0
1 7.06 (1.45) 0.61 (0.79) 7 .22(1 .298) 0.742(0.976)
2 5.66 (0.36) 0.24 (0.59) 5.705 (0.808) 0.248(0.608)
3 18.38 (2.56) 11.71 (2.49) 16.13 (1.635) 10.752 (3.668)
4 91.43 (12.56) * 1 79.37(12.10) * 2 79.68 (3 .598) 69.23 (7.718)
5 17.98 (6.63) 15.01 (5.94) 16.485 (5.509) 13.728 (5.019)
6 2.07 (0.64) 0 2.048 (0.403) 0
Table 3.4.4.d2. Percentage o f maximum C 16:0/C 17:0 and C18:2/C17:0 for Phosphatidyl 
choline elution for Sep=pak cartridges standard deviations shown in parenthesis. Volume 
o f fraction 3 = 15 ml. (n=6) * 1 p= 0.37 * 2 p=0.018
Fraction
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Graph 4.3.3d2 Elution pattern o f PC from silica Sep-pak cartridges showing the 
percentage o f maximum recoveries and ratios for the fatty acids from PC, the standard 
deviations and p values for an unpaired T-test (n=6).
3.4.4d3 Phosphatidvlethanolamine
These results (tables 3.4.4.d3 3.4.4.d3) can be summarised as follows:- 
The majority o f PE was recovered in fraction 3, which contained 54.36% (23.38) o f C l 7:0 
and 56.93% (24.63) o f C l 8:0 liberated from PE (p=0.0029 and 0.0052). The volumes of 
fractions 3-6 were increased to 15ml and the samples were sonicated for 2 min before their
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application to the Sep-pak cartridge (see section xxxx). PE was adequately separated 
from the other lipid groups, but the recoveries were significantly less than 100%. Fraction 
3 contained 62.27% (8.38) o f C17:0 and 63.41% (7.76) o f C18:0 liberated from PE. 
There was, however, no difference between the recovery o f research and internal 
standards (p=0.81).
Fraction % of Maximum C17:0 % o f Maximum 0 8 : 0
1 0.29 (0.47) 1.24 (0.88)
2 0.76 (0.46) 3.79 (0.78)
3 54.36 (23.38) 56.93 (24.63)
4 3.50 (1.38) 4.52 (0.94)
5 0.51 (0.56) 1.71 (0.92)
6 0.61 (0.46) 1.68 (0.25)
Table 3 .4.4.d3 % o f maximum recoveries o f the fatty acids liberated from PE were both 
fraction 3 and 4 were 15 ml in volume.
-1 □  C18:0
 ' 1 ' 1 1 1 1 1
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Graph 3.4.4.d3. Elution pattern o f PE from silica Sep-pak cartridges showing the 
percentage o f maximum recoveries for the fatty acid from PE, the standard deviation and p 
values o f an unpaired T-test (n=6).
3.4.4d4 Lvsophosphatidvlcholine
These results (table 3.4.4.d4 & graph 3.4.4.d4) can be summarised as follows:- 
The recovery o f LPC was significantly less than maximum. The percentage o f C l6:0 and 
C17:0 recovered from the lipid was 14.67% (10.76) and 13.24% (12.27) in fraction 4 and 
14.67% (7.50) and 26.43 % (19.12) in fraction 5 respectively. Sonication o f the sample 
prior to its application to the Sep-pak cartridge increased the recoveries o f LPC. 40.94 %
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(15.25) o fC 16:0  from LPC was eluted with fraction 4 and 44.62% (8.84) with fraction 5. 
Fraction 4 contained 45.28% (11.19) o f C 17:0 liberated from LPC and fraction 5 
contained 45.79% (7.21). These were still significantly less than maximum. Adding to 
two fractions together gave a recovery o f 92.20% (13.18) for C l6:0 and 92.51% (12.62) 
for C l7:0 (p=0.25 for both lipids). LPC was quantitatively recovered in fractions 4 and 5 
combined. There was no difference between the recovery o f  research and internal 
standards (p=0.97).
Fraction %  o f Maximum C l 6:0 % o f Maximum C 17:0
1 4.17(1.55) 1.47 (1.59)
2 3.99 (0.75) 0.86 (0.67)
3 9.31 (1.97) 1.95 (1.60)
4 14 67 (10.75) 13.24(12.27)
5 14.67 (7.50) 26.43 (19.12)
6 3.81 (1.25) 2 .32(1.31)
Table 3.4.4.d4. Percentage o f maximums for fatty acids liberated from LPC fractions 3-6 
were 15 ml.
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Graph 3.4.4.d4 Elution pattern o f LPC from silica Sep-pak cartridges showing the 
percentage o f maximum recoveries for the fatty acids from LPC, the standard deviations 
and p values for an unpaired T-test (n=6).
3.4.4rt5 Sphingomyelin
As has been the case for all the lipids, fatty acid methyl esters were produced by acid 
catalysed transesterification. As there is no internal standard for sphingomyelin, recoveries 
were calculated using the ratio C16:0/C17:0. Using 2% sulphuric acid in methanol, the 
ratio obtained o f the unchromatographed standards was lower than expected {0.61
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(0.03)}. Using 5% acid in methanol for the esterification the ratio was still less then 
expected (0.68 (0.015)}. Overnight incubation at 50°C with hydrochloric acid : methanol 
(5:1 v/v) provided a ratio o f 1.33 (0,03). This was closer to the expected ratio. The 
amount o f  heptadecanoic acid esterified and recovered using this method and the method 
using 1% sulphuric acids were not significantly different (p=0.54). This esterification 
protocol was therefore used routinely for sphingomyelin analysis.
The results for the separation o f sphingomyelin using this esterification method (graph 
3.4.4.d5) can be summarised as follows:-
Sphingomyelin was recovered quantitatively with fraction 4; 101.91% (6.71) o f the 
palmitic acid liberated from sphingomyelin was recovered there. This was not significantly 
different from maximum (p=0.44). This fraction contained 77.42% (18.93) o f the ratio 
C16:0/C17:0 maximum fatty acid (p=0.04). There was no difference between the recovery 
o f research and internal standards (p=0.05).
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Graph 3.4.4.d5 Elution pattern o f SPG from silica Sep-pak cartridges showing the 
percentage o f maximum recoveries o f the fatty acids and the ratio o f sample/internal 
standard for the fatty acid from SPG, the standard deviation and p values for an unpaired 
T-test (n=6).
3.3.5e Are the lipids being applied to the Sep-pak cartridge quantitatively ?
128
The results of experiments to simulate the application of the lipid to the cartridge can be 
summarised as follows:-.
In the absence of sonication, the recovery of PE and LPC was not quantitative, the 
percentages of C17:0 and C18:0 liberated from PE recovered being 78.66% (6.65) and 
75.93% (8.19) respectively. For LPC, the percentages of C16:0 and C17:0 recovered 
were 3.94% (3.23) and 1.89% (3.34) respectively. Sonication of the sample led to 
recoveries of C17:0 and C18:0 from PE of 73.26% (31.04) and 75.34% (22.89) 
respectively which were not significantly different from maximum (p=0.15 and 0.08). For 
LPC recoveries for C l6:0 and C l7:0 were 96.39% (11.38) and 94.06 % respectively 
which were not significantly different from maximum (p=0.55 and 0.24 ).
The results of the experiment to test the effects of evaporation of solvent on the recoveries 
of PE can be summarised as follows :-
For PE, where the lipid was dissolved in the solvent, dried and esterified, the percentages 
of C17:0 and C18:0 recovered were 99.87% (3.97) and 99.38% (1.93) respectively which 
were not different from maximum (p=0.98 and 0.86).
3.4.1 Discussion
In the original report of this method, the polar lipids were eluted after the sequential 
elution of neutral lipids (Hamilton & Comia 1988). The polar lipids were not completely 
separated but were eluted in two distinct fractions, one containing PI and PE and one 
containing PC, LPC and sphingomyelin. Here this was not the case. Table 3.4.5 
compares the expected elution pattern with the one obtained. PI was identified in fractions 
both before and after it was expected to elute.
Fraction Reported Results Obtained Fraction Separation of Polar
Original Results Modified Lipids
1 CE CE
2 TRIG TRIG
3 FFA FFA + PI
4 PGS PGS + PI 1 PGS + TRIG+CE
5 PI PI 2 FFA
6 PI + PE PI 3 PI + PE
7 PC+LPC+SPHING PI 4 PC+SPHING+LPC
8 PC+LPC+SPHING PI 5 LPC
9 LPC PI 6
Table 3.4.5 Difference in the elution pattern from reported using the original method and 
the modified method.
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The method of estimating recovery may partly explain these differences. One method of 
estimating phospholipid recovery is to measure the phosphate content of samples (Bartlett 
1959). This technique cannot differentiate between different phospholipids and is now 
rarely used. Hamilton and Comia (1988) used phospholipids with radioactively labelled 
base groups to differentiate between different phospholipid groups. Neither of these 
methods gives a measure of whether the lipids are being recovered intact. The assessment 
of recovery used here was to measure the recovery of fatty acids after methanolysis. That 
this could be done quantitatively had been ascertained using standards. The quantity of 
phospholipid present can be calculated from concentrations of fatty acids (Seewald & 
Eichinger 1989, Wang et al 1994). The results using this technique, in contrast to other 
methods, will take account of the chain lengths and molecular weights of the fatty acids 
present. The results obtained for the fatty acids can also be used, as discussed previously, 
to calculate indices of enzyme activity and the proportion of saturated and unsaturated 
fatty acids present. As the separation properties of the lipid groups have been assessed 
individually, it is not possible that the fatty acids could have come from any source other 
than the lipid being studied. When studying polar lipids, contamination of the free fatty 
acid fraction may be indicative of lipid breakdown.
Several other factors could influence the elution pattern. Lipid breakdown, caused by 
either acid hydrolysis or lipid oxidation, would obviously allow for fatty acid elution and 
elution of other fragments in the wrong fraction. This cannot have been the sole reason 
for the differences observed because increasing the eluting solvent volume considerably 
improved recoveries in some cases. The lipids may adsorb to either the column or the test 
tube, delaying or preventing recovery. These possibilities will be discussed in turn.
Sulphuric or hydrochloric acid is used during the production of fatty acid esters to catalyse 
the hydrolysis of the fatty acid to glycerol ester bond. Most reports suggest that strong 
acids, high incubation temperatures and long incubation times are required for the 
complete esterification of fatty acids (Eder et al 1992a). The purpose of the acetic acid in 
the solvent system is to acidify the column during the neutral lipid separation for the 
subsequent elution of free fatty acids and partial glycerides. Acetic acid is weak but its 
presence in the chromatography solvents may cause some hydrolysis of the phospholipid, 
thereby liberating the fatty acids to be eluted as free fatty acids. This hypothesis was 
tested by manipulating the concentration of acid in the eluting solvents to range from 0 - 
0.4% (Hamilton and Comia used 0.2%). Whether acid catalysed hydrolysis of fatty acids
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could occur under these conditions was tested by adding PI to a test tube containing 
methanol and 0.2% acetic acid. After a short incubation at room temperature, fatty acid 
methyl esters were found to be present, confirming that acetic acid is capable of catalysing 
the hydrolysis of fatty acids from lipid. The amount of fatty acid hydrolysed from the lipid 
on the column appears to increase with both acid concentration and volume of solvent 
used. The amount hydrolysed is small in comparison to the total amount present. 
Therefore, this loss may not significantly effect the results obtained for the lipids present in 
the membrane at high concentrations. However, the liberated fatty acid appears to be 
contaminating the free fatty acid fraction. In biological samples, the concentration of free 
fatty acid is low and even a small contamination will grossly distort its concentration.
As mentioned previously, Hamilton and Comia (1988) used radioactively labelled standard 
lipids to measure recovery and the loss of fatty acids from the lipids would not have been 
evident. That is, their recoveries were probably spuriously good. The amount of 
phosphate or base recovered was not measured here. However, the finding that the 
phospholipids were quantitatively eluted in a fraction distant from the free fatty acid 
fraction and that the recoveries of each constituent fatty acid was equal is good evidence 
of the accuracy of this recovery index.
The omission of acid from the solvents was the most obvious way to solve the problem of 
phospholipid breakdown. However, for the separation of neutral lipids it was retained in 
the solvents since quantitative recoveries were obtained. Therefore, the possibility of 
analysing neutral and polar lipids separately was investigated. Because the size of the 
available sample is often small, both fractions must be derived from the same sample. A 
neutral lipid fraction which contained no phospholipid was first eluted from the Sep-pak 
cartridge. The polar lipids could then be sequentially eluted in the absence of acid. 
Results show that there was no significant overlap of the neutral and polar fractions, nor 
were there significant loses of neutral lipids using this modified separation. An interesting 
observation is that under these conditions, the free fatty acids elute after the partial 
glycerides. In the separation of neutral lipids described in section 3.1, free fatty acids elute 
before partial glycerides. It is difficult to explain why the elution of these two lipids was 
inverted here but one possibility is that the absence of the acid is affecting the pH of the 
solvents and therefore the ionisation state of the free fatty acids and their binding to the 
silica. The use of the final solvent from the neutral lipid separation protocol to elute lipids
131
from the Sep-pak cartridge has been employed by other groups to recover cholesterol and 
phospholipids (Wang eta l 1994).
Using a different procedure from that for the neutral lipids, the recoveries of most of the 
phospholipids were quantitative. However, PE and LPC presented some difficulties. 
Lipids, in particular unsaturated fatty acids, are prone to oxidation (Frenkel 1980). This 
may explain the loss of lipid. Oxidation can be overcome by the addition of antioxidants 
to all the reagents but for the reasons discussed previously, BHT was not included in the 
solvents used here. However, other steps were taken to minimise oxidation which have 
also been discussed previously. Most of the phospholipids studied here possess two fatty 
acid moieties. Usually one of these is unsaturated, making all lipids equally prone to 
oxidation. The risk of oxidation increases with the time spent on the cartridge which was 
longest for PC, LPC and sphingomyelin but these were recovered quantitatively. PE 
elutes before these lipids, suggesting that oxidation on the cartridge is not the cause of the 
low recoveries observed. Oxidation could also be occurring during the removal of the 
solvents by evaporation. However, direct testing suggests that this was not the case. Loss 
of PE has been observed in lipid extracts from erythrocyte membranes separated on Silica 
gel H; oxidised lipids may bind more tightly to this. However, in this study, the lipids were 
stored in a dry form prior to analysis with no BHT present. This is not normal practice 
and may allow some lipid breakdown. The authors could provide no reason why PE 
should be more prone to oxidation (Dodge & Phillips 1966).
The third possible reason for the low recoveries of some lipids is that the elution volume 
used was not sufficient. In most cases, increasing the volume of eluting solvent to 15 ml 
maximised recoveries. However, this was not effective for PE or LPC. The absence of 
either lipid in subsequent fractions suggests the low recoveries were not due to insufficient 
solvent; had the elution volume been too small, the lipids should have eluted with the next 
fraction. Increasing the volume above 15ml unnecessarily was avoided. Increasing the 
volume of solvent, which was wet, will increase the time required for evaporation and 
therefore increase the risk of oxidation. Increasing the temperature of evaporation was 
avoided for the same reason. It might have been possible to speed up this process by 
drying the extract before evaporation with anhydrous sodium sulphate or by freezing. This 
was not tested here. Had internal standards been available for all the lipid groups, the use 
of these methods may have been easier to apply since any losses of lipid caused by the
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drying technique would be corrected for by the presence of the appropriate internal 
standard.
It is possible that LPC was not adequately dissolved in the solvent used for application to 
the cartridge although recoveries were increased by sonicating the samples in a cold water 
bath prior to their application. Why LPC was more difficult to dissolve than other polar 
lipids is not clear. It differs from PC by the absence of one fatty acid moiety and, as fatty 
acids are non-polar, this may increase the polarity of the lipid, making it difficult to 
dissolve in organic solvent.
PE may be more prone to adsorption to the column or glass surfaces. It was the only lipid 
studied with a terminal nitrogen group. Sonication of the sample should have ensured 
complete solution but, although the recovery of PE after sonication was on average 
maximum, the results were variable. Three subsequent and more polar aliquots of solvent 
were applied to the cartridge after the fraction where PE elutes and very little PE was 
recovered from these fractions. The lipid may be adsorbed to the glass. A possible way of 
preventing this is to siliconise the test tubes. However, with GC-MS, it leads to the 
appearance of peaks which interfere with the gas chromatography. Oxidised lipids bind 
more tightly to silica gel H (Dodge & Phillips 1966) but it is not clear in the current study 
whether the lipids were oxidised and if so, whether they would bind more tightly to the 
silica used here. In the case of PE, internal standard and research standard were recovered 
in the same proportion to each other. This makes it possible to accept the low recoveries 
and still obtain valid quantitation. PE is eluted cleanly in one fraction which means any 
residual PE will not interfere with other lipids.
The expected value for the maximum ratio C16:0/C17:0 produced by sphingomyelin was 
estimated from the values obtained for other C16:0-containing lipids and was lower than 
anticipated, suggesting that the C l6 : 0  was not being completely hydrolysed from the 
sphingomyelin. The fatty acid is attached via an amide bond which is more stable than the 
hydroxyl (ester) bonds and therefore its hydrolysis requires methanol and hydrochloric 
acid (Eder et al 1992a). Quantitative sphingomyelin recoveries were obtained by 
incubating the lipid with 5% hydrochloric acid in methanol overnight at 50 °C.
The method of Hamilton and Comia (1988), as they reported it, provided perhaps the most 
efficient means of separating the various lipid groups available, although Christie (1992)
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observes that it has been difficult to reproduce in other laboratories. Other groups 
(Bitman et al 1983, Ansari & Shoeman 1988, Hamilton & Comia 1984, Janero & 
Burghardt 1990) used silica Sep-pak cartridges for the simple separation of neutral and 
polar lipids and for the separation of PE from PC (Hamilton & Comia 1984). Realistic 
alternatives to silica Sep-pak chromatography for the separation of lipids are few. 
Successful use of one dimensional TLC has been reported (Vitiello & Zanetta 1978, 
Rouser 1970). Also, using a chloroform/methanol/water solvent system, Lepage (1964) 
reported the separation of the lipids studied here. Our experience using this solvent 
system could not confirm this (see section 3.5). Two dimensional TLC is not economical 
and is logistically less convenient. Silver nitrate TLC has also been applied (Kennerly 
1986). Again, it is more expensive than Sep-pak cartridges and the plates must be handled 
in the dark (Henderson & Tocher 1992). The problems of recovering samples 
quantitatively from TLC plates is discussed elsewhere.
HPLC efficiently separates polar lipids although the detection of the lipid classes remains 
difficult. This has been discussed previously (see Chapter 1 part 2). Success has been 
reported using a UV detector (Yeo & Horrlock 1988, Hundrieser & Clarke 1988) and a 
mass detector (Stolyhwo et al 1987). Neither method gives information about the fatty 
acid composition of the polar lipids which was the key aim of this study. An alternative is 
to use reverse phase HPLC (Sothiros et al 1985) to study the fatty acid composition of 
lipid groups or to use HPLC as a preparative step, as with the Sep-pak chromatography, 
followed by the separate analysis of fatty acids (Seewald & Eichinger 1989).
Neomycin binds phospholipids and has proved valuable in the isolation of 
polyphosphoinositides (Schacht 1978). Neomycin-coated beads have since been employed 
in systems for the separation of phospholipids (Palmer 1981) but this technique did not 
separate as extensive a range of lipid groups as Sep-pak cartridges or HPLC. Moreover, 
preparation of the antibiotic-coated beads in the laboratory may be difficult to standardise 
between batches.
A method using disposable aminopropyl-bonded phase columns has been reported by 
Kaluzny et al (1985) to separate phospholipids from neutral lipids. Not only is this 
method complex with many columns being used and columns being ‘piggy backed’ 
together to provide separation but it has also been proved unreliable by other groups who
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observed that PI and phosphatidic acid were retained on the column (Christie 1992, 
Egberts & Buiskool 1988, Kim & Salem 1990).
It is apparent from the literature that there is no ideal method for the separation of all lipid 
groups. The altered method used here provides quantitative recovery of the lipids studied. 
Where the recovery differs from maximum, the use of an internal standard-containing lipid 
still allows for valid quantitation of the fatty acids present. The method yields two distinct 
groups of lipid which can then be separated easily using thin layer chromatography. This 
will be the topic of the next section.
3.5.1. Thin Laver Chromatographic Separation Of Lipids
Membrane lipids consist of a complex mixture of compounds with relatively similar 
physical properties (see chapter 1). For this project, it was necessary to separate each lipid 
type completely. As discussed previously, silica Sep-pak cartridges separate neutral lipids 
but the polar lipids are eluted in two groups, one containing PI and PE and a second 
containing LPC, PC and sphingomyelin. These individual lipids must then be separated 
and recovered quantitatively, or at least with high reproducibility. The lipids are present at 
low concentration and, to avoid non-specific contamination, the analytical system has to 
have a high level of cleanliness. With these requirements in mind, the ability of three types 
of chromatographic support-silica gel thin layer chromatography (TLC) on glass plates 
and TLC on polyester backed plates and paper chromatography using heavy duty 
(Whatman 3mm) paper, were tested. The solvent system composition was also 
manipulated. An initial decision was taken to use one dimensional chromatography. Two 
dimensional chromatography requires one plate or paper for each sample which is 
expensive for large scale studies; moreover, it is not possible to run reference standards 
alongside the biological samples.
3.5.2. Methods
The source and specification of the TLC plates and chromatography paper are given in 
Materials (Chapter 2). Samples of lipid standards corresponding to the groups obtained 
for the Sep-pak cartridge separation of the polar lipid groups (see table 3.1.1 .b) were 
evaporated to dryness under nitrogen and redissolved in chloroform/methanol (2 : 1  v/v) 
(20 pi). The resuspended lipids were applied quantitatively to the TLC supports as spots 
under a stream of nitrogen to minimise oxidation. The test tubes were washed with a 
further volume of solvent and that too was applied to the plate. The chromatograms were
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developed at 4°C using a variety of solvent systems (see section 3.5.3.a). All solvents, 
including those used for spotting, contained BHT (10mg/100 ml). For all
chromatography, the glass tanks were lined with 3 mm Whatman chromatography paper, 
sealed using a glycerol and starch sealant and equilibrated at 4°C for at least 4 hours. 
Where possible, the tanks were allowed to equilibrate overnight. Chromatography tanks 
were washed and fresh solvent added after every second chromatogram. The developed 
chromatograms were dried under nitrogen and stained with Rhodamine B spray r e a g e n t ^ /  
(Rhodamine B/ethanol l:20(v/fv). The appropriate spots were located under UV light and 
removed, either by scraping the silica gel off the support (TLC-glass plates) or by cutting 
out the appropriate areas (TLC-polyester plates; paper), followed by elution of the lipids 
using chloroform : methanol (2:1 v/v). These samples were transesterified, extracted and 
analysed by GC-MS as described previously. Recoveries were measured only when the 
separation of the lipid groups was complete as it is impossible to determine the lipid group 
from which the fatty acids have been liberated when separation is incomplete.
3.5.3. Results
3.5.3a Paper Chromatography
The solvents used for the separation of the lipids and the results obtained are listed in table 
3.5.3a. As can be seen, none of the solvents used were capable of separating the lipids 
completely.
Solvent_______________ Support_______________ Results
chloroform : acetone; methanol: acetic 
acid: water (6 :8 :2 :2 : 1  v/v/v/v/v)
paper PI and PE were not viable 
PC, LPC and sphingomyelin were not 
resolved (Rf = 0.94)
chloroform: methanol: 28% aqueous 
ammonia (65:35:5 v/v/v)
paper All the lipid groups migrated the same 
distance (Rf = 0.70)
Chloroform : methanol: 28% aqueous 
ammonia 
(65:25:5 v/v/v)
paper PI and PE were unresolved (Rf = 0.7). 
LPC and PC migrated with the solvent, 
sphingomyelin was not visible.
Chloroform : methanol: 28% aqueous 
ammonia (65:15:5 v/v/v)
paper LPC migrated with the origin, 
sphingomyelin (RF =0.81) PC (Rf = 0.78)
chloroform : methanol: 28% aqueous 
ammonia (75:15:5 v/v/v)
paper PC and LPC were not resolved ( R f= 
0.51)
Table 3.5.3.a. Solvent systems used and the results obtained for paper chromatography of
lipids.
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3.4.3b TLC-glass hacked plates.
The solvent systems used and the results obtained using them are listed in table 3.5.3.b. 
Where solvents A and B are listed, the plates were developed to half of their total distance 
with solvent B, dried and then developed fully with solvent A.
As can be seen from the table, the only solvent capable of separating all the lipid groups
was chloroform: methanol: water (65:25:4 v/v/v). The Rf values for the lipids in this 
solvent system are listed in table 3.5.3 b. The other solvents used were capable of moving
sphingomyelin and PC from the origin but could not resolve them.
Solvent Support Results
Solvent A : Hexane : diethyl ether: glacial 
acetic acid (80:20:2 v/v/v)
Solvent B : ethyl acetate : propan-2-ol: 
chloroform : methanol: 0.25 aqueous KC1 
(25:25:25:10:9 v/v/v/v/v)
Silica PC and Sphingomyelin were removed 
on glass from the origin together, LPC remained 
at the origin. PI and PE were not 
visible.
Solvent A: hexane : diethyl ether : glacial 
acetic acid (70:30:2 v/v/v) 
Solvent B was as above
Silica 
on glass
PC and sphingomyelin were removed 
from the origin but not resolved, LPC 
was not removed. PI was moved from 
the origin .
Solvent A: hexane : diethyl ether : glacial 
acetic acid (60:40:2 v/v/v) 
Solvent B was as above
Silica 
on glass
Sphingomyelin and PC were removed 
from the origin but not resolved, LPC 
was not removed from the origin. PI 
and PE were not visible.
Redevelopment of the above plate in 
solvent A
silica 
on glass
PC and LPC and sphingomyelin were 
removed form the origin but not 
removed. PI was removed from the 
origin.
Chloroform : methanol: acetic acid 
(65:25:4 v/v/v)
silica 
on glass
All the lipid groups were separated and 
removed form the origin. (RF values in 
table 3.5.3.b2)
Table 3.5.3.M. Solvent svstems used and the results obtained using glass backed TLC 
plates. Where two solvents are listed the plates were developed half way in solvent B and 
then fully in solvent A.
Lipid RF Value
Phosphatidylcholine
Lysophosphatidylcholine
Sphingomyelin
Phosphatidylethanolamine
Phosphatidylinositol
0.235
0.075
0.115
0.345
0.175
Table 3.5.3.b2. The RF values for the lipids separated on the Glass Backed TLC plates.
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3.5.3c Recoveries of Fattv Acid Methvl Esters Liberated From the Separated 
Lipids
The recoveries of the lipids were again assessed by recovery of the fatty acids esterified to 
the lipids. The recoveries are listed in table 3.5.3.C. The solvent system used was 
chloroform/methanol/water (65:25:4 v/v/v) (see above). The recoveries of both the 
research standard fatty acid (C l8:0) and the internal standard fatty acid liberated from PE 
did not differ significantly from maximum, (p=0.58 and 0.447 respectively). Comparison 
of the recovery of the research and internal standard showed no significant difference 
between the groups (p=0.34).
The recovery of LPC was not quantitative but the recovery of research standard fatty acid 
did not differ significantly from that of the internal standard fatty acid (p=0.812) showing 
that both lipid groups are behaving in a similar manner. Although the fatty acids from 
sphingomyelin were not recovered quantitatively, there was no significant difference 
between the ratio of C16:0/C17:0 for the chromatographed and unchromatographed 
samples (p=0.083). Comparison of the recovery of the research and internal standard 
showed no significant difference between the groups (p=0.44).
The recoveries of fatty acids liberated from PI and PC were significantly different from 
maximum.
Lipid % of Maximum % of Maximum Ratio Where
Naturally Occurring Internal Standard Applicable
____________________________Fatty Acid________________________________________
Lysophosphatidylcoline 42.65(25.13) 42.16(24.27)
Phosphatidylcholine 55.68 (30.88) 61.87 (36.28)
Phosphatidylethanolamine 104.14(16.57) 94.42(17.38)
Sphingomyelin 44.39(21.04) 53.56(17.40) 80.87(21.39)
Phosphatidylinositol_______ 63.15 (12.62)_______________________________________
Table 3.5.3.cl The recoveries of the fatty acid methyl esters liberated from the lipids 
separated on the glass backed TLC plates (n=6 ).
3.5.3d TLC-Polvester hacked plates
The recoveries of the fatty acids liberated from the lipids separated on polyester backed 
plates (table 3.5.3.d) can be summarised as follows:-
The recovery of LPC was not quantitative but comparison of the percentage recovery of 
research standard and internal standards showed both groups to be behaving in the same
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way (p=0.21). The same was true for PC (p=0.864) and therefore no further correction 
was required for valid quantitation.
The recoveries of PE was not significantly different from maximum (p=0.05 and 0.41 for 
the internal standard and research standard respectively). Comparing the maximum 
recoveries for the two lipid groups showed no significant difference (p=0.469). The 
recovery of sphingomyelin was assessed using the ratio of C16:0/C17:0, which did not 
differ significantly from maximum (p=0.23). Comparison of the recovery of the research 
and internal standards showed no significant difference between the two (p=0.14). PI was 
analysed in the same way by comparing the ratio of C18:0/C17:0. There was no 
significant difference between the unchromatographed and unchromatographed samples 
(p=0.14). Comparing the percentage of maximum recoveries for the internal standards 
and research standard showed no significant difference from maximum (p=0.34).
Lipid % of Maximum Naturally 
Occurring Fatty Acid
% of Maximum 
Internal Standard
Ratio Where 
Applicable
Lysophosphatidylcoline
Phosphatidylcoline
Phosphatidylehanolamine
Sphingomyelin
Phosphatidyliositol
87.30(9.15) 
87.49 (6.04) 
105.65 (12.75) 
87.90 (6.63) 
55.23 (15.57)
79.02 (12.02) 
88.01 (2.94) 
110.42 (9.05) 
95.34 (9.12) 
47.60 (9.58)
92.78 (12.02) 
115.85 (22.32)
Table 3.5.3.c2 The recoveries of the fatty acid methyl esters liberated from the lipids 
separated on the polyester backed TLC plates (n=6 )
3.5.4. D iscussion
The physical properties which determine the separation of mixtures of compounds by 
paper chromatography or TLC are solubility and adsorption. In paper chromatography, 
the paper fibres are coated with a liquid stationary phase, usually aqueous alcohol, during 
equilibration. During development of the paper, a less polar mobile phase which is 
saturated with stationary phase moves over the layer of stationary phase on the paper. 
The movement of the compounds depends on their partition coefficient between the two 
phases, hence the term partition chromatography. Good separation of compounds can be 
obtained with only very small difference in the partition coefficient and solvent systems are 
chosen to provide maximum differences. TLC is adsorption chromatography. The 
compounds have an affinity for the solid support, in this case silica, the molecules in the 
solvent compete with those in the solute for the adsorption sites. Non-polar molecules
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have only weak affinity for the silica and are easily displaced and therefore have large Rf 
values. Polar lipids form dipole-dipole interactions with the silica and are retained.
Paper chromatography is inexpensive and the recovery of the samples by elution is simple. 
It is also easy to prepare in a high state of purity. Unfortunately, paper chromatography 
was not able to separate the mixture of membrane lipids using the solvent systems 
evaluated here. The Rf values obtained were not reproducible. These inconsistencies in 
the Rf values may have been due to differences in the saturation of the atmosphere in the 
tank, causing alterations in the coating of the paper with stationary phase which in turn 
will lead to alterations in the movement of the mobile phase over the paper. However, 
these variations should have been minimised by the carefully standardised conditions of 
temperature and equilibration time. In retrospect, the use of a descending chromatography 
systems may have given better resolution because longer development is possible. 
However, longer development times in an air atmosphere might increase oxidative losses. 
Another serious problem was that a high background fluorescence was present when the 
lipids were visualised with Rhodamine B under UV light which made locating the lipid 
spots difficult. There was also evidence of significant losses due to irreversible lipid 
adsorption at the origin. Finally, the loading capacity of paper is less than that of TLC. 
On a practical note, sheets of 3mm paper were less easy to handle than plates. There are 
reports of the use of paper chromatography to separate phospholipids, but the 
experimental details are vague (Wuthier 1966). In his review of the subject, Rouser et al 
(1961) suggests that paper chromatography should only be used in method development 
and it is not appropriate for quantitative recovery of lipids.
The use of thin layer chromatography for the separation and recovery of lipids is 
commonplace and its use has been discussed in both the previous sections. As can be 
seen from the table 3.5.3.b, several solvent systems were evaluated for their ability to 
separate the membrane lipids but only chloroform/methanol/water (65:25:4 v/v/v) 
performed adequately. The differences in the Rf values were small but separation was 
reproducible and reliable using both glass and polyester backed plates. It is difficult to say 
why some of the solvents recommended elsewhere failed to separate the membrane lipids 
here. All the solvents investigated here were used at 4°C, which should not only 
standardises the vapour pressure and development time, but also help to minimise lipid 
oxidation. There will be small difference in the pore and particle size of the silica 
purchased from different manufacturers but this should make only small differences in the
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retention of lipids on the plates. The use of a fluorimeter to measure the florescence 
produced by the Rhodamine B may have enabled the detection of small differences in the 
retention times between the lipids. The use of radioactive lipids would also have allowed 
for mechanical detection of the lipid spots but it was felt preferable to avoid their use if 
possible.
The quantitative removal of lipid spots from the glass-backed plates was difficult, leading 
to poor recovery. The silica gel had to be scraped off the plate and transferred to a test 
tube for the transesterification reaction during which time there is risk of oxidation. 
Moreover, the silica plates had been sprayed with Rhodamine B and creation of aerosols 
of silica containing this toxic compound is difficult to avoid. These factors made the 
routine use of the medium unattractive. It is possible to stain the TLC plates with iodine 
but this causes loss of polyunsaturated fatty acids which are proportional to the number of 
double bonds in the fatty acids. These losses are due to iodination of double bonds 
(Nichaman et al 1963). Also, iodine vapour is toxic.
The use o f the polyester-backed plates from which the appropriate areas can be cut 
improved the recovery of all lipid groups both in terms of efficiency and reproducibility. 
Only PC and PI were not recovered quantitatively but the recovery of the internal standard 
closely mimicked the recovery of the research standard, allowing for correction for losses.
Other systems have been suggested for the separation of polar lipids by TLC. Wing et al 
1986) reports a technique using plates coated with a mixture of silica gel HF and silica gel 
G. As the plates have to be produced in the laboratory, their use was not assessed here. 
Other modifications include over-developing the plate (Bitman et al 1984). High 
performance TLC (HPTLC) has been reported to separate twenty lipids classes using four 
different solvent systems (Yoa & Rastetter 1985). The need for multiple drying of the 
plates and the difficulty in recovering lipids from HPTLC plates makes this system 
unacceptable.
3.6.1 Fattv Acid Methvl Ester Standard Curve Production and Main Ion 
Identification.
During the development of the method analysis, of fatty acid methyl ester recovery has 
been achieved using the total ion current produced on the GC-MS. It is possible, 
however, to use the Magnum Soft-ware (Version 2.40) on the GC-MS to identify and
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quantitate the fatty acid methyl esters. For this to be possible, standard curves must be 
applied to the GC-MS and stored in the memory of the soft-ware. This allows 
identification of the esters by comparison with the spectrum of standards and quantitation 
of the esters present. Quantitation requires the internal standard to be at a fixed 
concentration in all samples (20ng/pl). To produce the standard curve, the soft-ware 
calculates the ratio of the peak area of the sample/peak area of the internal standard. This 
ratio is plotted on the Y axis; the concentration of the sample fatty acid is plotted on the X 
axis. The amount of fatty acid present in the sample is calculated using the same ratio.
3.6.2 Methods.
3.6.2a Selection of Principle Ions for Compound Identification
Standard fatty acid methyl esters were applied to the GC-MS and a spectrum obtained. 
Three or four ions were then identified from the spectrum on the basis of both their 
concentration and uniqueness to each fatty acid. The retention time was also noted.
3.6.2h Standard Curve Production and Evaluation
Standard fatty acid methyl esters were dissolved in hexane at a final concentration of 1 
mg/ml. These stock solutions were then used to produce a standard curve with a final 
concentration ranging from 5ng/pl to 400ng/pl. The final concentration of heptadecanoic 
acid methyl ester was 20ng/(j,l. Each concentration was applied to the GC-MS in replicate 
(n=6 ). The total ion currents produced were assessed for variability. The linearity of the 
standard curves was also assessed. Results are expressed as mean ± (SEM).
3.6.3 Results.
3.6.3a Principle Ion Identification.
Table 3.6.3a shows the formula, retention time, molecular weight and the principle ions for 
all the fatty acid methyl esters to be studied. All have distinct spectra making their 
identification in a biological sample simple. vr ^,
A  c ^
3.6.3h Standard Curve Evaluation.
Table 3.6.3b shows the peak areas of a variety of fatty acid methyl esters. Table 3.6.3c 
shows the correlation coefficient for the standards curves and the linear equation.
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Common Name Of 
Methyl Ester
Formula Molecular 
Weight (AMU)
Retention 
Time (Secs)
Main Ions
Palmitic C17H34O2 270.5 793 143, 171, 227, 271
Palmitoleic C17H32O2 268.4 762 110, 123, 237, 269
Stearic C19H38O2 298.5 1 1 1 1 143, 255
Oleic C19H36O2 296.5 1071 110, 123,264, 297
Linoleic C10H34O2 294.5 1063 109, 121.263,294
Linolenic C19H33O2 292.6 1075 107, 121, 261, 292
Arachidic C21H42O2 326.4 1439 143, 227, 284
Arachidonic C21H34O2 318.5 1336 105, 119, 147, 319
Dihomo y linolenic C21H36O2 320.5 1375 107, 121, 135, 320
Behenic C23H46O2 354.6 1665 143,255,311,355
DHA C23H34O2 342.5 2093 105, 117,313,388
Lignoceric C25H50O2 382.7 2134 143, 241, 340, 382
Nervonic C25H48O2 380.7 2134 111, 135. 348, 381
Hexacosanoic C27H54O2 410.7 2500 143,255,368,411
Heptadecanoic C18H36O2 284.5 949 149, 185, 241, 285
Table 3.6.3a Formula and molecular weights of the methyl esters of the fatty acids to be 
studies and the retention time in seconds of the fatty acids on the gas chromatograph.
Fatty Acid Methyl Concentration of Fatty Acid Methyl Esters
Esters
400 300 200 100 50 25 10 5
Palmitic 12.41 10.48 8.01 3.46 2.24 1.27 0.66 0.26
(0.28) (0.18) (0.15) (0.03) (0.07) (0.02) (0.04) (0.02)
Palmitoleic 21.47 17.20 13.30 6.81 2.93 1.17 0.98 0.235
(0.39) (0.80) (0.36) (0.15) (0.07) (0.04) (0.01) (0.02)
Stearic 17.98 14.28 12.20 7.62 4.42 2.56 0.68 0.39
(0.75) (0.6) (5.95) (0.55) (0.31) (0.31) (0.13) (0.1)
Oleic 15.55 14.05 11.87 5.33 3.36 1.76 0.76 0.24
(0.27) (0.21) (0.18) (0.09) (0.14) (0.05) (0.04) (0.03)
Linoleic 37.50 33.81 28.48 17.05 7.68 3.01 2.10 0.38
(1.42) (0.19) (0.47) (0.3) (0.19) (0.07) (0.16) (0.03)
Arachidonic 25.52 22.35 19.52 10.88 4.17 1.00 0.55 0.14
(0.59) (1.24) (0.49) (0.59) (0.28) (0.05) (0.04) (.007)
Behenic 10.69 8.99 7.86 4.70 2.61 1.20 0.35 0.16
(0.49) (0.25) (0.15) (0.36) (0.18) (0.12) (0.08) (0.05)
Lignoceric 7.27 5.69 4.84 2.31 1.05 0.42 0.13 0.06
(0.41) (0.24) (0.18) (0.28) (0.09) (0.05) (0.03) (0.02)
Hexacosanoic 2.44 1.40 1.05 0.54 0.30 0.12 0.06 NA
(0.11) (0.1) (0.02) (.006) (.008) (.002) (.002)
Table 3.6.3b Peak areas produced by a selection of fatty acid methyl esters on the gas 
chromatograph for the concentrations used in the standard curve.
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Fatty Acid Methyl Esters Correlation Coefficient Linear Equation
Palmitic 0.991 y = 0.391 +0.04x
Palmitoleic 0.967 y = 0.128 +0.03 x
Stearic 0.989 y = 0.579+ 0.04x
Oleic 0.995 y = 0.283 + 0.05x
Linoleic 0.994 y = 0.479 + 0.06x
Arachidonic 0.986 y = 0.347 + 0.04x
Behenic 0.982 y = 0.476 + 0.02x
Lignoceric 0.984 y = 0.308 + 0.02x
Hexacosanoic 0.997 y = -0.08 + O.Olx
Table 3.6.3c Correlation coefficient and linear equations for the fatty acid methyl ester 
standard curves using the ratio peak area of sample / peak area of internal standard.
3.6.4 Discussion
The main ions obtained will allow the positive identification of specific fatty acids. This a 
major benefit of the GC-MS over other systems. The spectra for the saturated fatty acids 
have a characteristic 143 ion. The fragmentation pattern of palmitic acid methyl ester is 
shown below with the molecular weights which relate to each fragment (Alexander et al 
1985). The spectrum obtained here is in good agreement with this (see fig 3.6.4a).
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Fig 3.6.4a Mass spectrum and fatty acid structure of palmitic acid, showing break sites in 
the fatty acids chain and the atomic weight of the fractions produced.
The more highly unsaturated fatty acids also have characteristic ions. Linolenic and
dihomo-y-linolenic acid methyl esters both have three double bonds and a main ion of 107.
The spectra for all the unsaturated fatty acids follow similar step wise pattern; the most
abundant ion has the smallest molecular weight and the abundance decreases as the
molecular weight increases. Fragmentation occurs at double bonds (see fig 3.6.4b).
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Fig 3.6.4b Mass spectrum of arachidonic acid showing the typical step wise fragmentation 
pattern caused by multiple double bonds.
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The reproducibility of the spectrum and retention times were good and all the standard 
curve studied were linear. Quantitation using these standard curves should therefore be 
accurate.
3.7.1 Inter- and Intra-Assav Variability for the Lipid Separation.
A sufficiently large blood sample was obtained to allow for repeated analysis of 
erythrocyte membrane lipid fatty acid composition. The preparation was stored at a 
protein concentration of 2 mg/ml of protein. Samples were assayed in replicate (n=6) on 
six separate occasions. Coefficients of variation were used to assess intra and inter assay 
variability. To asses variation between batches (inter-assay variability), the scatter of the 
batch means was measured.
3.7.2 Results
The intra-assay variabilities are shown in table 3.7.2a, the inter-assay variabilities are 
shown in table 3.7.2b. The intra- and inter-assay variabilities for the indices of 
desaturation and the saturation/unsaturated fatty acid ratio and the phospholipid 
composition are shown in tables 3.7.2c, 3.7.2d and 3.7.2.e.
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Lipid A5 A6 total A9 sat/unsat
desaturase desaturase desaturase desaturase
CE 28.57 108.34 65.62 43.13 34.21
TRIG 103.63 50.03 69.17 21.21 25.62
FFA 46.87 48.10 95.72 18.05 28.89
PGS 62.50 30.98 46.67 30.08 38.56
PI 12.39 24.24 59.60 11.19 36.32
PE 32.50 48.54 34.17 26.30 22.30
PC 34.59 21.53 41.17 18.96 59.07
LPC 85.71 67.83 69.13 19.33 26.46
SPG 57.76 85.06 116.50 34.67 59.52
TOTAL 40.00 44.38 28.40 14.57 18.44
Table 3.7.2c. Inter assay variability (coefficient of variation) for the indices of
desaturation and the saturated/unsaturated fatty acid ratios derived from the results
obtained for the lipid separation technique.
Lipid A5 A6 total A9 sat/unsat
desaturase desaturase desaturase desaturase
CE 57.14 64.33 62.50 29.11 28.95
TRIG 50.53 31.91 58.26 40.16 26.54
FFA 62.50 58.57 99.80 11.89 38.92
PGS 50.00 55.29 60.55 20.70 26.23
PI 20.23 50.26 16.77 35.07 7.88
PE 26.85 43.43 30.34 18.03 21.30
PC 17.79 31.22 26.78 32.67 17.54
LPC 50.00 76.05 61.11 22.68 15.54
SPG 48.39 50.63 24.26 27.95 25.46
TOTAL 26.31 18.65 20.93 13.58 23.23
Table 3.7.2d Intra assay variability (coefficient of variation) for the indices of 
desaturation and the saturated/unsaturated fatty acid ratios derived from the results 
obtained for the lipid separation technique.
Lipid Inter assay variability Intra assay variability
PI 15.86 20.85
PE 20.16 56.57
PC 17.18 12.07
LPC 18.70 36.37
SPG 22.70 27.91
Table 3.7.2e Inter and intra assay variabilities for the derived phospholipid concentrations 
obtained from the results of the fatty acid analysis after separation of the lipid groups. .
3.7.3 D iscussion
The separation efficiency of the lipid groups was good (see section 3, 4 & 5) but the 
variability of some of the measurements made was high. Interpretation of the analyses on 
the three subsequent studies, particularly of measurements of those fatty acids present in 
low concentration, must take this into account.
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With any multistep analysis, large variabilities are inevitable as each step in the process
introduces more variability. Every effort was made to keep the variability of the method
extraction. All the samples were also processed in an identical manner. However, it is 
difficult to control laboratory conditions such as temperature and water pressure (used to 
operate Sep-pak chromatography). Both may have affected the results. High variability 
was not limited to a particular lipid group, suggesting it is not a function of the lipids 
themselves. Nor was the high variability limited to unsaturated fatty acids, suggesting that 
oxidation was not solely responsible.
Samples were injected into the GC-MS automatically. They were in the autosampler for 
up to 10 hours. During this time, the samples were contained in dark glass tubes 
containing BHT but it is still possible that a small amount of sample degradation occurred. 
Manual injection of the very large number of samples required too much time to be a 
realistic option.
Part 2.
3.8.1 M easurement of Cholesterol Bv GC-MS
The current in-house colorimetric technique for the measurement of cholesterol is a 
modification of the method of Gamble et al (1978). This method requires larger sample
sizes than were available here. Moreover, the precision i ■ variauip. m e
measurement of cholesterol esters is described in section 3.3. There are several well- 
characterised, sensitive methods for the measurement of cholesterol using GC-MS. The 
method evaluated here involves the conversion of extracted cholesterol to its trimethyl silyl 
ether (TMS) (Christie 1989).
3.8.2 Methods.
3.8.2a Production of cholesterol TMS ether.
Lipid was extracted from the sample as previously described. The solvent was evaporated 
under nitrogen and the residue resuspended in pyridine (500pl). Hexamethyldisilazane 
(150pl) was added to this and mixed. Trimethylchlorosilane (50pl) was then added and 
mixture was shaken for 30 seconds and left at room temperature for 5 min.
The solvents were removed by evaporation and the residue resuspended in hexane (2ml). 
The solution was washed with water (2ml) which was removed by freezing. The
to a minimum by the addition of internal standards to the sample at the time of lipid
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remaining hexane was transferred to a clean test tube and the solvent evaporated to 
dryness under nitrogen. The residue was resuspended in hexane containing BHT (500pl) 
in preparation for analysis by GC-MS.
3.8.2b Main Ton Identification
The mass spectrum was obtained for cholesterol TMS ethers and the internal standard, 50 
cholestan-3-a-ol. The spectra were compared and 3 unique ions identified for each 
compound.
3.8.2c Standard Curve Production.
Standard curves were produced by derivatising a range of cholesterol concentrations with 
the internal standard. The internal standard concentration was 20 ng/pl. Cholesterol 
concentration ranged from 10-400ng/pl.
3.8.2d Linearity of measurements with increasing sample size.
An extract of erythrocyte membranes was prepared as previously described. Aliquots with 
protein content ranging from 0.05-0.5 mg/ml were analysed for cholesterol.
3.8.2e Inter- and Tntra-Assav Variability.
A large sample of erythrocyte membrane was prepared at a protein concentration of 0.1 
mg/ml. Cholesterol was determined in replicate (n=6) on six different occasions. The 
inter and intra-assay variability was calculated as described in section 3.7.1.
3.8.3 Results.
3.8.3a Main Ton Identification.
The ions selected for identification of cholesterol TMS ether were 368, 329 and 129 
atomic mass units. For 50-cholestan-3a-ol ether they were 370, 355, and 215 atomic 
mass units.
3.8.3b Standard Curve Production
The standard curve was linear (y = 0.046x - 0.08) with a correlation coefficient of 0.995.
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3.8.3c Linearity of the Cholesterol Concentration in Biological Samples
Table 2.13.1 shows the concentration of cholesterol obtained at the various protein 
concentrations used. The results are expressed as mean ± (SEM) (n=3). The correlation 
coefficient R = 0.897. Linearity was tested using linear regression analysis (p = 0.011).
Protein Concentration (mg/ml) Concentration of cholesterol 
present (ng/jj.1)
0.05 34.704 (0.55)
0.1 59.167 (2.89)
0.2 95.452 (2.23)
0.3 186.000 (3.68)
0.4 446.917(42.87)
0.5 872.271 (74.79)
Table 3.8.3 Concentration of cholesterol present in samples with a range of protein 
concentrations.
3.8.3d Tnter and In tra  Assay Variability.
In tra Mean 50.569 Inter Mean
SD 2.745 SD
CV 5.43% CV
3.8.4 Discussion.
The advantages of this method over the colorimetric methods are two fold. It requires 
very little sample and it is very precise. The method is rapid, effective and the intra- and 
inter-assay variabilities are low. The GC-MS analysis can be automated, reducing further 
the time spent in the analysis.
The concentration of the cholesterol over the various protein concentrations shows a 
linear trend but the correlation coefficient was less than 1. Additional errors are 
contributed by the extraction and the estimation of protein concentration. The method had 
adequate precision for the sample sizes available in subsequent studies.
3.9 Summary.
A method of extracting, separating and measuring the concentrations of individual lipid 
groups from cell membranes has been devised and assessed. In order to test its 
performance further, it was used to study membrane composition in hypertension and 
diabetes mellitus.
50.569
2.906
5.74%
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Chanter 4 L-NAME Induced Hypertension.
4.1 Introduction.
The lipid and fatty acid composition of the cell membrane determines its physical 
properties. To date, changes in membrane fluidity or microviscosity have only been 
observed in patients with essential hypertension and in rat models of genetic hypertension. 
Studies of secondary hypertension in the DOCA-salt induced hypertension and two- 
kidney, one-clip Goldblatt hypertension rat models have failed to show any alteration in 
membrane microviscosity (Orlov et al 1982). The same is true for human renal 
hypertension (Orlov & Prostnov 1982). However, alterations in membrane function, such 
as an increase in net sodium fluxes across the lymphocyte membrane (Furspan & Bohr 
1985) and increased intracellular calcium (Pemoller et al 1994), have been observed in 
secondary hypertension, suggesting that some abnormality of the membrane may be 
present.
In recent years, interest in the potent vasodilator, nitric oxide (NO), has been increasing 
exponentially. NO is produced during the conversion of L-arginine to L-citrulline by NO 
synthase (NOS). NO, produced in the endothelial cells, activates guanylate cyclase in 
VSMC. Guanylate cylcase then catalyses the conversion of GTP to cGMP which activates 
a cGMP-dependant protein kinase and this in turn causes vasorelaxation. Inhibition of 
NOS induces hypertension in Brattleboro, Long-Evans and Wistar rats (Gardiner et al 
1990a, Gardiner et al 1990b, Morton et al 1993). This increase in blood pressure is 
accompanied by an increase in plasma renin (Morton et al 1993, Johnson & Freeman 
1992, Ribeiro et al 1992, Baylis et al 1992, Gardiner et al 1992), suggesting that it is a 
renin-dependant form of hypertension. Several analogues of L-arginine have been shown 
to act as competitive inhibitors of NOS. Two of the most commonly used are N°-nitro-L- 
arginine methyl ester (L-NAME) and N°-monomethyl-L-arginine (L-NMMA). Three 
types of NOS have been identified, type I (brain NOS), type II (inducable NOS) and type 
III (endothelial NOS).
Therefore, L-NAME appears to cause malignant hypertension by a mechanism which 
resembles that in the two-kidney, one-clip Goldblat hypertension rat model. A small 
increase in blood pressure activates renin secretion which further increases blood pressure, 
leading to a vicious circle of increasing blood pressure and increased plasma renin. 
Morton et al (1993) showed that L-NAME-induced hypertension could be inhibited by 
administration of Captopril, an inhibitor of angiotensin converting enzyme, suggesting a
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role for the renin-angiotensin system. This might be a logical conclusion if antagonism of 
NOS has a purely vasoconstrictor effect. However, Morton et al (1993) also noted 
considerable vascular and cardiac hypertrophy which itself may have exerted a positive 
feedback effect on blood pressure.
Here the effects of L-NAME-induced hypertension on membrane lipid composition and 
membrane microviscosity in the rat have been studied.
4.2 Materials and Methods.
32 WKY rats (male/female 50:50) were split equally into treated and control groups. 
Treatment began at 8 weeks of age and continued until 11 weeks. The treated group 
received L-NAME (lOmg/kg/day) in their drinking water while the controls received I 
water only. Both groups were maintained in a twelve hour light-dark cycle and food and 
water were available ad libitum. At the end of the treatment period, blood and liver 
samples were obtained and analysed as previously described. Lipid analysis was carried 
out in 8 animals from each group and the microviscosity was measured in all 16 animals 
from each group.
Data were analysed by ANOVA. Only when p was less then 0.05 were unpaired Students 
t-tests carried out to compare the concentrations of the individual fatty acids. Only 
statistically significant results (i.e. p<0.05) are shown p<0.01 is indicated by an *. All 
graphs show the means and SEMs; where appropriate p values for ANOVA are shown 
beneath the X axis. All graphs show the variable measured on the Y axis and the fatty acid 
or lipid group on the X axis. Where data for multiple lipid groups or enzymes are shown 
on one graph the group or enzyme is detailed below the graph.
4.3 Results.
4.3.1 Blood Pressure.
Graph 4.3.1 shows the mean systolic blood pressure from the L-NAME-treated and 
control groups at the end of the treatment. The blood pressure of the L-NAME-treated 
group was significantly higher than that of the control group. ^  ^  0 ° ^ ^
L-NAME Control
Graph 4.3.1 Systolic blood pressure (mmHg) for 16 L-NAME treated and 16 control rats 
measured using the tail cuff method.
4.3.2. Total Fattv Acids.
Erythrocytes
Graph 4.3.2a illustrates the differences in the total fatty acids composition between the 
erythrocyte membranes from the L-NAME-treated and control animals. The levels o f the 
following fatty acids were significantly higher in the L-NAM E-treated group compared to 
control, palmitic, palmitoleic, linolenic, linoleic, oleic, stearic, arachidonic, 
docosahexaenoic, behenic and lignoceric acid.
Liver Cell Membranes
In graph 4.3.2b, the composition o f the liver cell membranes from L-NAM E-treated and 
control rats are compared. The concentration o f the following fatty acids were 
significantly lower in the L-NAME-treated group compared to  the control group, 
arachidonic, dihomo-y-linolenic, behenic and lignoceric acid.
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Graph 4.3.2a Total fatty acid composition (ng/mg protein) o f erythrocyte membranes 
from L-NAME treated (n=8) and control (n=8) rats. Results shown as mean and SEM, all 
results shown are statistically significantly different (p<0.05) * indicates p<0.01.
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Graph 4.3 .2b Total fatty acid composition (ng/mg protein) o f  liver cell membranes from L- 
NAME treated (n=8) and control rats (n=8), statistics as described in graph 4.3.2a.
Only results found to be statistically significantly different by t-test are shown in the graph
4.3.3 Neutral Lipids.
Erythrocytes
Graph 4.3.3a illustrates the differences observed in the fatty acids esterified to neutral 
lipids from erythrocyte membranes from the L-NAME-treated animals compared to the 
untreated controls. O f the fatty acids altered in the total lipid fraction (4.3.2), the 
following were significantly altered in the neutral lipids; in CE, there was a higher 
concentration o f palmitoleic, palmitic, and stearic acid in the L-NAM E-treated group 
compared to control. In the FFA fraction, palmitoleic, palmitic, linolenic and stearic acids 
were present at a higher concentration in the L-NAM E-treated group compared to 
control. In the L-NAM E-treated group, the PGS fraction contained more palmitoleic, 
palmitic, stearic, docosahexaenoic and lignoceric acid.
Although not significantly altered in the total lipid fraction by L-NAM E-treatment, a 
reduction in the amount o f nervonic acid present in the FFA fraction o f  the L-NAME-
156
246872
treated group compared to the control was observed. Also the level o f hexacosanoic acid 
in the PGS fraction reduced in the L-NAME-treated group compared to control.
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Graph 4.3 .3a Fatty acid composition o f erythrocyte neutral lipids (ng/mg protein) from L- 
NAME treated and control rats. Statistics as described previously, p values obtained for 
ANOVA are shown below the graph.
Liver Cell Membranes.
Graphs 4.3.3b and 4.3.3c summarise the differences in fatty acids composition of the liver 
membranes between L-NAME-treated and control rats. Arachidonic acid was present at a 
lower concentration in the CE and TRIG fractions but increased in the FFA fraction o f the 
L-NAM E-treated group compared to control. Dihomo-y-linolenic and behenic acid were 
reduced in the TRIG and PGS fractions o f the L-NAM E-treated animals compared to 
control. L-NAM E-treatment reduced the lignoceric acid content o f all the neutral lipids 
studied.
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Although not significantly altered in the total lipid fraction, the levels o f the following fatty 
acids were altered by L-NAME-treatment. Palmitoleic acid was increased in the CE and 
FFA fractions. Palmitic and linoleic acid were increased in CE and FFA and reduced in 
the TRIG fractions. Linolenic was reduced in the TRIG, FFA and PGS fractions. Oleic 
acid was increased in CE and PGS and reduced in the TRIG fraction. Stearic acid was 
increased in the FFA fraction and arachidic acid was reduced in the CE, TRIG and PGS 
fractions.
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Graph 4.3 .3b Fatty acid composition (ng/mg protein) o f CE and TRIG from liver cell 
membranes form L-NAME treated (n=8) and control (n=8) rats. Statistics as described 
previously.
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Graph 4 3.3c Fatty acid composition (ng/mg protein) o f FFA and PGS from liver cell 
membranes from L-NAME treated (n=8) and control (n=8) rats.
4.3.4 Polar Lipids.
Erythrocytes
L-NAME-treatment caused alteration in the levels o f fatty acids in all the polar lipid
groups studied. The results are summarised in graphs 4.3.4a and 4.3.4b.
In the PI fraction, the following fatty acids were increased in the L-NAM E-treated group 
compared to control; palmitoleic, palmitic, linolenic, linoleic, oleic and stearic acid. In the 
PE fraction, the levels o f palmitoleic, palmitic and arachidonic acid were increased in the 
L-NAM E-treated group compared to control.
In the PC fraction from the L-NAME-treated group, the concentrations o f the following 
fatty acids were increased compared to control; palmitoleic, palmitic, linolenic, linoleic, 
oleic, stearic and arachidonic acid. In the same fraction, the levels o f lignoceric acid were 
reduced in the L-NAME-treated group. The same was true for oleic acid in the LPC 
fraction. In the SPG fraction, the concentrations o f the following fatty acids were
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increased compared to control; palmitic stearic, behenic and lignoceric acid. L-NAME- 
treatment increased the amount o f arachidic and dihomo-y-linolenic acid in the polar lipid 
fraction although these were not significantly altered in the total lipid fraction.
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Graph 4.3.4a Fatty acid composition (ng/mg protein) o f PE and PI from erythrocyte 
membranes from L-NAME treated (n=8) and control rats (n=8).
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Graph 4.3.4b Fatty acid composition (ng/mg protein) o f PC, LPC and SPG from 
erythrocyte membrane from L-NAME treated (n=8) and control rats (n=8).
Liver Cell Membranes.
In the liver cell membranes, alterations in fatty acid composition were limited to LPC and 
SPG. In the LPC fraction, the levels o f arachidonic, dihomo-y-linolenic and lignoceric 
acid were reduced in the L-NAME-treated group compared to control. In the SPG 
fraction, the levels o f dihomo-y-linolenic and lignoceric acid were reduced compared to 
control. L-NAM E-treatment increased the levels o f behenic acid in the SPG fraction 
compared to controls.
Although not altered in the total lipid fraction, the concentrations o f the following fatty 
acids were altered by L-NAME-treatment. Palmitic, palmitoleic, linoleic and stearic acid 
were reduced in the LPC fraction. Linolenic and arachidic acid were reduced in both 
fractions and nervonic acid was increased and hexacosanoic acid reduced in the SPG 
fraction.
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Graph 4.3 .4c Fatty acid composition (ng/mg protein) o f LPC and SPG from liver cell 
membranes from L-NAME treated (n=8) and control (n=8) rats.
4.3.5 Desaturase Activities.
The indices o f desaturation were calculated as follows;
A5 desaturase =>
A6 desaturase =>
Total desaturase =>
A9 desaturase =>
arachidonic / dihomo-y-linolenic acid 
linolenic / linoleic acid 
arachidonic / linoleic acid 
oleic / stearic acid
Erythrocytes
Graphs 4.3.5a and 4.3.5b show all the desaturase activities as assessed by erythrocyte 
membrane composition. A5 Desaturase was increased by L-NAME-treatment. This 
change is particularly marked in the PE and PC fraction. A6 Desaturase activity was not 
altered as assessed by the total membrane lipids. However, in the PI fraction o f the L- 
NAM E-treated group A6 desaturase was reduced compared to control; the results 
obtained for LPC was the opposite. Total desaturase activity was reduced in the L-
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NAM E-treated group when FFA and PI were considered but was unaltered in the total 
fatty acid fraction. A9 Desaturase activity was not altered in the total fatty acid fraction by 
L-NAME-treatment. However, a reduction was observed in the TRIG, FFA, PGS, PI and 
PC fractions.
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Graph 4.3 .5a Indices o f essential fatty acid desaturation for erythrocytes from L-NAME 
treated and control rats (n=8).
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Graph 4.3.5b Indices o f A9 desaturation for erythrocyte membranes from L-NAME 
treated and control rats (n=8 for both groups).
Liver Cell Membranes.
Graphs 4.3 .5c and 4.3 .5d shows the indices o f desaturation for the lipids from liver cell 
membranes. A5 Desaturase activity was increased in the total lipid fraction o f the L- 
NAM E-treated group compared to control. This was apparent in the TRIG, FFA, PGS,
PI, PC PE and SPG fractions. No change was observed in the A6 desaturase in the total 
lipid fraction from the two groups. However, a reduction in A6 desaturase activity was 
observed for the CE, TRIG, FFA, PGS and LPC fraction. The same was true for the total 
desaturation o f  the essential fatty acids; reductions in desaturase activity were observed in 
the CE, PGS, PI and LPC fractions. There was no significant change in the activity o f the 
A9 desaturase when total fatty acids were considered. However, there was an increase in 
the index o f  A9 desaturase activity in the CE, PI, PC and LPC fractions in the L-NAME 
treated group. The activity was reduced for the TRIG fraction from the L-NAME-treated 
group compared to control.
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4.3.6 Saturated/Unsaturated Fattv acid Ratio.
Erythrocytes
Graph 4.3.6a compares the saturated/unsaturated fatty acid ratios for the fatty acids in the 
erythrocyte membrane from the L-NAME-treated and control rats. Considering the total 
membrane fatty acids, there was a reduction in the saturated/unsaturated fatty acid ratio in 
the L-NAM E-treated group compared to control. In the individual lipid groups, the 
opposite was observed for the CE, TRIG, FFA and SPG fractions. No significant change 
was seen in other fractions.
^  L-NAME treated 
I  ^ □  Control
H
Graph 4.3 .6a Saturated/unsaturated fatty acid ratio for lipids from erythrocyte membranes 
from L-NAME treated and control rats (n=8).
Liver Cell Membranes.
Graph 4.3 .6b shows a similar comparison o f this ratio in the liver cell membranes form L- 
NAM E-treated and control rats. There was no change in the ratio in the total fatty acid 
fraction but it was increased in the TRIG, PGS, PE and LPC fractions and reduced in the 
CE fraction in the L-NAME-treated group compared to control.
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Graph 4.3.6b Saturated/unsaturated fatty acid ratio for lipids from liver cell membranes 
from L-NAME treated and control rats (n=8 for both groups).
4.3.7 Phospholipids.
Graph 4.3.7 shows the phospholipid composition (derived for the average fatty acid and 
core phospholipid molecular weight) o f the liver and erythrocyte membranes from the L- 
NAME-treated group compared to control animals. In the erythrocyte, the L-NAME- 
treated animals had significantly more PI, PE and PC and less LPC and SPG than the 
controls. In the liver cell membranes, the levels o f LPC and SPG w ere reduced in the L- 
NAME-treated group compared to control.
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Graph 4.3 .7 Derived phospholipid composition (ng/mg protein) for erythrocytes and liver 
cell membranes from L-NAME treated and control rats (n=8 for both groups).
4.3.8 Membrane Cholesterol and Cholesterol/Phospholipid Ratio.
Graph 4.3.8a shows the erythrocyte membrane cholesterol measurements for the L- 
NAM E-treated and control animals. L-NAME-treatment increased the membrane 
cholesterol content. The cholesterol/phospholipid ratio (graph 4.3.8b) was reduced by L- 
N AME-treatment.
4.3.9 Membrane Microviscositv.
Erythrocyte membrane microviscosity was lower in the L-NAM E-treated group than in 
the control group (graph 4.3.9).
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4.4 Discussion.
Inhibition of NO synthesis by L-NAME caused a rapid increase in systolic blood pressure 
to a level similar to that observed in mature SHRSP. L-NAME treatment also caused 
erythrocyte membrane microviscosity to decrease compared to control. Parallel analysis 
of membrane lipid composition showed a complex pattern of changes consequent, directly 
or indirectly, on L-NAME treatment. To what extent can these changes explain the 
physical alteration in the erythrocyte membrane? In which lipid component are these 
changes most significant? Moreover, alteration in the levels of some fatty acids, while 
possibly having little effect in microviscosity, may never-the-less have important 
physiological implications. Finally, it is interesting to compare changes in erythrocyte 
membrane with those of the liver cell membranes.
The fatty acid composition of the membrane affects fluidity. At the most simple level of 
analysis, total fatty acid composition. L-NAME treatment increased the levels of 
endogenously synthesised fatty acids and essential fatty acids and their metabolites. There 
are two possible reasons for these changes. Firstly, there may indeed be more lipid present 
in the membrane from the L-NAME-treated group, or alternatively, because the fatty acid 
concentrations were calculated relative to membrane protein concentration, there may be 
less protein. However, in the later case, changes in fatty acid composition would have 
been the same for all the lipid groups and in the same proportion. This was not the case. 
A combination of saturated (rigidifying) and unsaturated (fluidising) fatty acid were altered 
by L-NAME treatment. Since these have opposite effect, the overall change is difficult to 
estimate. However, as more unsaturated fatty acids were affected than saturated fatty 
acids and the increases in the amounts of arachidonic and docosahexaenoic acid were very 
large, it is possible to suggest that fluidity would be increased.
c- ■
The differences observed in erythrocyte neutral lipid fatty acid composition closely 
mimicked those of the total lipid fraction, with the exception of nervonic acid which was 
higher in the FFA fraction but not in the total lipids. The neutral lipids are present in small 
quantities in the membrane and changes in their composition will probably not have a 
significant effect on membrane physical properties (The combined fatty acids from the 
neutral lipids make up less than 10% of the total fatty acid).
The changes in the fatty acid composition of erythrocyte membrane polar lipids were also 
similar to those observed in the total fatty acid composition. Some of these changes may
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have contributed the increase in membrane fluidity. The arachidonic acid content of the 
PE fraction was increased by L-NAME treatment. PE is the major inner leaflet lipid and 
this increase in an unsaturated fatty acid suggests that this region would have become 
more fluid. In contrast, the changes in the fatty acid composition of the choline-containing 
lipids should predispose to lower fluidity. Thus, increased amounts of long chain fatty 
acids, behenic and lignoceric acid, in the PC and SPG fraction should have increased the 
membrane microviscosity (Lodish et al 1995). PC and SPG are located primarily in the 
outer leaflet, suggesting that this area of the membrane may be less fluid. It would be 
interesting to check these differential effects by using fluorescent probes for the inner and 
outer leaflet of the membrane. Unfortunately, haemoglobin interferes with the 
fluorescence making this impossible. An alternative cell, the platelet, is difficult to obtain 
from rats in large enough quantities to carry out both lipid analysis and membrane 
microviscosity measurement. It is interesting to note that the changes in the LPC fraction 
did not mimic those of the total lipid fraction as well as the other choline-containing lipids; 
only stearic acid was increased by L-NAME treatment. LPC is a minor membrane 
component, (there is roughly 10 times more PE in the membrane than LPC in the treated 
group and 3 times more in the untreated group) and some of these changes may have been 
undetectable.
Another determinant of membrane fluidity is the activity of the desaturases. Increased 
activity leads to the production of more unsaturated fatty acid, thus decreasing 
microviscosity. Erythrocytes have no desaturase activity and their fatty acid composition 
reflects the fatty acid composition of the plasma. This in turn is controlled, in part, by the 
liver which is a major site of fatty acid desaturation. Desaturase activity in the liver 
contributes to the fatty acid composition of erythrocyte membrane. The ratio of fatty acid 
product and substrate for the enzyme in the erythrocyte thus provides an index of 
desaturase activity. A5 Desaturase activity was increased in the total fatty acid fraction by 
L-NAME treatment. This increase was also apparent in the fatty acids esterified to PE and 
PC, the two major membrane lipids, although the amount of arachidonic acid relative to 
dihomo-y-linolenic acid was much greater for the PE fraction than for the PC fraction. 
This increase in desaturation may have contributed to the increased membrane fluidity 
observed here. A6 and A9 Desaturase activity in the total membrane lipid fraction was not 
altered by L-NAME treatment. A6 Desaturase activity was increased in the LPC fraction 
and reduced in the PI fraction. However, the significance of this is questionable as there 
are no reports of desaturases acting on fatty acids esterified to LPC and PI. Neither LPC
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or PI are major membrane lipids and these changes probably do not significantly affect 
membrane fluidity. Changes in the plasma lipid composition were not studied. Whether 
L-NAME prevented the erythrocyte membrane from equilibrating with the plasma or 
whether the plasma composition was altered cannot therefore be determined.
The ratio of saturated/unsaturated fatty acid in the membrane can also determine 
membrane fluidity. This ratio was reduced in the total lipids fraction, suggesting more 
unsaturated fatty acid in the membrane. This should cause the membrane to become more 
fluid (as was the case). In contrast, in CE, TRIG, FFA and SPG, there was an increase in 
the saturated/unsaturated fatty acid. However, apart from SPG, these are minor 
membrane components. SPG contains primarily saturated fatty acid and it is possible that 
a further increase, as seen here, would not further affect membrane fluidity.
Lipid composition, in addition to fatty acid composition affects membrane fluidity. L-NAME treatment 
increased the derived concentrations of PI, PE and PC and reduced the concentration of 
LPC and SPG. SPG is a membrane rigidifying agent and PC is a membrane fluidising 
agent (Shinitzky & Barenholz 1974, Borochov et al 1977). Thus the changes in 
phospholipid composition agree with the direct physical measurements of membrane 
fluidity. Another determinant of fluidity is cholesterol. L-NAME treatment increased the 
levels of erythrocyte membrane cholesterol which should make the membrane more rigid, 
in contradiction to the results of direct measurement. However, the membrane 
cholesterol/phospholipid ratio was lower in the L-NAME treated group, in agreement with 
direct measurement. Thus, increased membrane fatty acid and phospholipid content, 
which reduced the cholesterol/phospholipid ratio in the L-NAME-treated group, appears 
to have more than counteracted the influence of membrane cholesterol. This highlights the 
necessity of analysing both lipid composition and membrane microviscosity when 
considering membrane dynamics.
L-NAME treatment induced changes in liver cell membranes which were different from 
those observed in erythrocytes. These differences may have been due to different effects 
of L-NAME or blood pressure on the two membrane types. Liver cells actively synthesise 
fatty acids and are a major site of essential fatty acid desaturation. Conversely, 
erythrocytes have no desaturase activity and their fatty acid composition is controlled in 
part by the fatty acid composition of the plasma (Donabedian & Karmen 1967). The liver, 
therefore, may be more capable of maintaining cell membrane homeostasis than the
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erythrocyte. Also, the liver cell has a nucleus which allows it to control more precisely 
which proteins are expressed to respond to changes in the environment. It is therefore 
probable that the lipid environment to which the erythrocyte is exposed is more variable 
and subject to short term alteration than that of the liver cell. Thus, it is not unexpected 
that there are differences in the effects of L-NAME in the two membranes, although it has 
been for some time a common misconception that the erythrocyte membrane is an index of 
the fatty acid composition of all other membranes. Obviously, for a study of the changes 
caused by L-NAME and blood pressure, the VSMC would be more relevant. 
Unfortunately, it was not possible to study these cells in the current experiment. 
However, the erythrocyte is probably more similar to VSMC than the hepatocyte as there 
is no evidence to suggest that VSMC have desaturase activity and they are not major sites 
of fatty acid biosynthesis. Thus the levels of at least the PUFA present in this membrane 
are probably determined in a similar fashion. ?
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The alterations in the fatty acid composition of the total lipid fraction were limited to the 
levels of four long chain fatty acids, three (arachidonic, dihomo-y-linolenic and lignoceric 
acid) of which were reduced and the other (behenic acid) increased by L-NAME 
treatment. Again, these were a combination of saturated and unsaturated fatty acids, 
making their contribution to membrane fluidity difficult to compute. However, as two 
unsaturated fatty acids were reduced (arachidonic, dihomo-y-linolenic) and one saturated 
fatty acid greatly increased (behenic acid) by L-NAME treatment a reduction in membrane 
fluidity could be postulated. The reduction in lignoceric acid would increased membrane 
fluidity, but the relative concentrations of the fatty acids would suggest that the other three 
fatty acid would override this effect leading to reduced fluidity. There were no changes in 
the fatty acid composition of the major lipids PE and PC, suggesting that the liver’s 
homeostatic mechanism maintains lipid and fatty acid composition. Changes in fatty acid 
composition were limited to minor lipid groups with the exception of SPG.
The changes observed in the liver cell membrane neutral lipid fraction were more 
widespread and different from those observed for the total lipid fatty acids. Neutral lipids, 
as discussed previously, play a minor role in membrane structure and functioning and the 
fatty acid composition of these lipids will probably not affect membrane fluidity. 
Interestingly, there was a general reduction in the amount of fatty acids present in the 
TRIG and PGS fractions, implying a reduction in the amount of these lipids present in the 
membrane. TRIG and PGS have a similar origins and are precursors of phospholipid
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molecules. TRIGs, although present in the membrane, are primarily fuel storage 
molecules. A reduction in their membrane levels may suggest that L-NAME affects 
storage, perhaps reducing the amount of TRIG produced by the cell. Alternatively, the 
reduction in TRIG may be due to an increased phospholipid synthesis.
The levels of lignoceric acid were reduced in the L-NAME-treated SPG fraction, the 
converse of what occurs in the erythrocyte. Although all the fatty acids which were 
altered in the total lipid fraction were also altered in the SPG fraction, other fatty acid 
were also affected which were unchanged in the total lipids. Many of the fatty acids 
present in the LPC fraction were reduced by L-NAME treatment; calculation of the LPC 
concentration confirmed that there was less LPC present. This could result from an 
increase in acyltransferase activity in the L-NAME-treated animals or a reduction in the 
activity of phospholipase. Further studies are necessary to distinguish between these 
possibilities. The SPG concentration in the membrane was reduced in the L-NAME 
treated group suggesting that, like the erythrocyte, the liver cell membranes will be more 
fluid. Unfortunately, it was not possible to measure membrane microviscosity in these 
cells.
The indices of desaturation measured in the liver cell membranes are more directly relevant 
to enzyme activity. As in the erythrocyte membrane, A5 desaturase activity was increased 
in the total lipid fraction of the L-NAME-treated animals. This effect was observed in all 
membrane lipid groups except CE and LPC. The results of the A6, A9 and total 
desaturase were similar to those in the erythrocyte, in that changes were observed in some 
individual lipid groups but not in the total lipid fraction. The increase in the activity of the 
A5 desaturase in both in the liver and the erythrocyte suggests that the erythrocyte may in 
fact provide a good measure of this enzyme.
The mechanisms by which L-NAME treatment alters the membrane remain unclear. It is 
possible that the increase in blood pressure may have affected the cell membrane directly. 
However, the change in membrane fluidity observed here is opposite to that observed in 
genetic hypertension (Montenay-Garesterier et al 1981, Dominiczak et al 1991, McLaren 
et al 1993). The absence of NO production may also have affected cell membrane 
composition. It is interesting to note that SHRSP have less tissue NO than WKY controls 
despite higher NOS activity (McIntyre et al 1996). SHRSP have higher membrane 
microviscosity. Also, in the L-NAME-treated rats, there is effectively no NO production
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and membrane microviscosity was reduced. Thus, changes in microviscosity found in the 
current experiment may relate to the severely reduced amount of NO produced. Others 
have reported that intravenous infusion of the NO donor, nitroglycerine, into dogs causes 
an increase in platelet membrane microviscosity (Bassenge & Fink 1996). It is also 
possible that L-NAME may itself have had a direct effect on the membrane.
Some previous studies have considered the effect of lipids on NOS activity and the ability 
of NO to permeate the membrane. In bovine aortic endothelial cells, PC, LPC and PE 
increased the activity of NOS in a dose-dependant manner by increasing Vmax (Hirata et 
al 1995). In the current study, the levels of PE and PC were increased and may have had 
the same effect. It is possible that this represents an attempt by the cell to increase the 
amount of NO produced and overcome the inhibition caused by L-NAME. The levels of 
LPC in the membrane were reduced in this study; this would not increase NO production. 
Conversely, arachidonic acid may inhibit NOS in aortic endothelial cells (Hirata et al 
1995). The same is true for oleic acid which is thought to act through a protein-kinase C- 
independent mechanism (Davda et al 1995). In the current study, the levels of erythrocyte 
arachidonic and oleic acid were increased by L-NAME treatment which would further 
exacerbate the inhibition of NOS by L-NAME.
Interestingly, NO has been reported to increase arachidonic acid release from membrane 
lipids by stimulating the activity of a Ca2+-independant phospholipase A in a macrophage­
like cell line (RAW-264.7) (Gross et al 1995). If the same is true for erythrocytes, then L- 
NAME may reduce the activity of this phospholipase which may explain the high levels of 
arachidonic acid remaining in the membrane. Such a mechanism would not involve 
changes in desaturase activity. A reduction in the activity of the phospholipase would 
explain the reduction in the amount of LPC present in both liver and erythrocyte 
membranes. Direct measurement of the enzyme activity would be required to confirm the 
mechanism.
The rise in erythrocyte membrane cholesterol may be a response to the reduction in the 
available NO. It has previously been shown that, by increasing the membrane cholesterol 
artificially, the amount of NO transported into the inside of the bilayer increases 
(Subczynski et al 1996). However, these experiments were carried out in artificial PC 
membranes and their physiological relevance is not clear. If the changes which occur in 
the cholesterol composition of the erythrocyte membrane also occur in VSMC, then this
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might increase the proportion of vasodilator entering from adjacent endothelial cells, thus 
increasing vasodilation and reducing blood pressure. Others have observed that 
cholesterol is capable of modulating the activity of NOS. In fact, cholesterol appears to 
have a biphasic effect on NOS activity. Liposomes containing high and low 
concentrations of cholesterol were incubated with endothelial cells; high cholesterol 
concentration reduced the activity of NOS and low concentrations increased the activity 
(Deliconstantinos e ta l 1995). However, because the actual membrane cholesterol content 
was not measured, it is impossible to say how these results relate to those obtained here.
Inhibition of NOS by L-NAME has been shown to produce a renin-dependent form of 
hypertension (Morton et al 1993), which has the advantage over the two-kidney one-clip 
Goldblatt model that it is non-invasive. To the best of my knowledge, this is the first 
study which shows changes in membrane physical properties in hypertension of this type.
Thus biochemical analysis and physical measurement of the changes in membrane 
properties are in broad agreement. More detailed information is produced by biochemical 
analysis, some of which has functional as opposed to structural significance.
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Chapter 5 Genetic Hypertension in the Stroke-Prone-Spontaneouslv 
Hypertensive R at
5.1 Introduction.
Cell membrane microviscosity is probably increased in genetically hypertensive rats 
(Montenay-Garestier et al 1981, Orlov et al 1982a, Devynck et al 1982, McLaren et al 
1993) and in patients with essential hypertension (Orlov & Prostnov 1982, Naftilan et al 
1986, Tsuda et al 1987). Various abnormalities have also been observed in membrane 
transport systems, such as sodium and potassium channels (Jones 1973, Furspan & Bohr 
1985, Furspan et al 1986) and sodium-calcium exchangers (David-Dufilho et al 1986) in 
hypertension. Because so many membrane functions are altered in hypertension, it has 
been suggested that this is due not to changes in the protein composition but to the matrix 
in which this protein is embedded. Altering the composition of the cell membrane alters 
the activity of some proteins. For example, opioid receptor function can be modulated by 
membrane fatty acid composition (Remmers et al 1990). Others studies have shown that 
decreasing membrane microviscosity increases the P-adrenergic receptor affinity for 
adenylate cyclase (Rimon et al 1978) and increases the activity of Na+-K+-ATPase (Yeagle 
1989). Moreover, by altering the composition of the fatty acids present in PC and PE, it is 
possible to alter the activity of Na+-Li+-counter transport (Engelmann et al 1993). The 
increased membrane microviscosity observed in genetic hypertension could be caused in 
several ways, including increased membrane protein concentration, a reduction in the 
unsaturated fatty acid content of the membrane or an increase in the amount of long chain 
saturated fatty acids present.
A variety of differences have been reported in the composition of the cell membrane in 
hypertension. Naftilan et al (1986) observed that the platelet membranes from patients 
with essential hypertension contain less linoleic acid than those from normotensive 
controls. In the same study, there was a small increase in the amount of arachidonic acid 
present in the membranes from patients with essential hypertension. However, because of 
the small sample number, this difference was not significant. Similar changes have been 
observed in erythrocyte membranes from patients with essential hypertension (Ollerenshaw 
et al 1987). Dominiczak et al (1993) reported an increase in the proportion of arachidonic 
acid in cultured vascular smooth muscle cells from SHRSP as compared to WKY. The 
opposite has been observed in the mesenteric arterial bed, although the results did not 
reach statistical significance (Mtabaji et al 1988). In this case, the lipids were extracted
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from the whole mesenteric arterial bed which is surrounded with fat. It is not clear 
whether the fat was completely removed from the mesenteric bed prior to lipid extraction. 
This may have affected the accuracy of the results.
Most previous studies have concentrated on the fatty acid composition of the total 
membrane lipids. No attempt has so far been made to ascertain whether these 
abnormalities occur in particular lipid groups. The aim of the first part of this study was to 
compare the membrane fatty acid composition of both liver cell and erythrocyte 
membranes from young SHRSP(Giasgow) and WKY. The aim of the second part of this study 
was to compare the fatty acid composition of the erythrocyte membrane from 
SHRSP(Heidelberg) and WKY. An F2 segregating population, produced by brother-sister 
back-crossing the Fi population, was then used to study whether any of the traits observed 
in the parental strains segregated with blood pressure.
5.2 Materials and Methods.
5.2.1 Study 1.
SHRSP (Glasgow) and WKY rats were fed normal rat chow and water ad libitum. At nine 
weeks of age, the systolic blood pressure was measured by the tail cuff method as 
described previously (Chapter 2). Liver and blood samples were obtained at 11 weeks of 
age and analysed as previously described (n=8). Data were analysed as described in 
chapter 4 and results are presented in a similar fashion.
5.2.2 Study 2
Blood samples from the parental strains of SHRSP(Heideiberg) and WKY and the F2 
population of this cross were obtained from the laboratory of Prof. D. Ganten and Dr K. 
Lindpaintner (Berlin, Germany). Samples were obtained when the rats were 20 weeks of 
age. The animals were housed under normal laboratory conditions, fed normal rat chow 
and received sodium chloride in their drinking water. The samples were transported from 
Berlin to Glasgow on ice. Erythrocyte membranes were prepared on arrival.
The samples from the parental strain were analysed as for study 1 (n=14). Where 
statistically significant differences were obtained, these traits were then studied in the F2 
population (n=18). Regression analysis was used to assess whether the traits correlated 
with blood pressure.
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5.3. Results.
5.3.1 Blood Pressure.
There was no significant difference between the systolic blood pressures from the 
SHRSP (Glasgow) and the WKY rats (graph 5.3.1) at 9 weeks o f age.
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Graph 5.3 .1 Tail cuff systolic blood pressure measurements (mmHg) for SH R SP(Giasgow) 
and WKY rats at 9 weeks o f age (n=8 for both groups),
5.3.2 Total Fattv Acid Composition.
Erythrocytes
Graph 5.3.2a shows the differences observed in the total fatty acid composition o f the 
erythrocyte membranes from SHRSP(Giasgow) and WKY. Palmitic, linoleic, stearic, 
arachidonic, dihomo-y-linolenic, docosahexaenoic, behenic, lignoceric and hexacosanoic 
acid were all higher in the erythrocyte membranes from SHRSP(Giasgow) compared to the 
WKY
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Graph 5.3.2a Fatty acid composition (ng/mg protein) o f total erythrocyte lipids from 
SHRSP (Glasgow) and W K Y rats. P value for A N O V A  shown beneath the graph, all results 
ate statistically significantly different by T-test (p<0.05), * indicates p<0.01.
Liver Cell Membranes.
There was no difference in the total fatty acid profiles o f liver cell membranes between 
SHRSP (Glasgow) and W KY.
5.3.3 Neutral Lipids
Erythrocytes
Graph 5.3 .3a details the differences observed in the fatty acid composition o f the neutral 
lipids from SH R SP(Giasgow) and W KY. Palmitic and stearic acid were higher in the CE, FFA  
and PGS fractions o f SHRSP(Giasgow) compared to W KY. In the FFA  fraction, linoleic and 
arachidonic acid were also higher in SHRSP(Giasgow)- There was more docosahexaenoic 
acid and less lignoceric acid present in the PG S fraction from SH R SP(Giasgow) compared to 
W KY
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Although not different in the total lipid fraction, palmitoleic acid was higher in the CE and 
FFA fractions from SH R SP(Giasgow) compared to WKY. Linolenic acid was higher in the 
FFA fraction and lower in the PGS fraction o f the SFfRSP(Giasgow).
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Graph 5.3.3a Fatty acid composition o f neutral lipids (ng/mg protein) for erythrocytes 
from SHRSP (Giasgow) and WKY rats. Statistics as described previously (n=8 for both 
groups).
Liver Cell Membranes
Although there were no significant differences in the fatty acid composition o f the total 
lipid fraction between SH R SP(Giasgow) and WKY, there were differences in the composition 
o f the neutral lipids. In the CE fraction, palmitic, linolenic, linoleic, stearic, arachidonic, 
dihomo-y-linolenic and docosahexaenoic acids were higher in the membranes from 
SH RSP(Giasgow) compared to WKY (Graph 5.3.3b). In the same fraction, behenic acid was 
lower in SHRSP(GiasgoW)- In the TRIG fraction, the levels o f the following fatty acids were 
lower in SH R SP(Giasgow) compared to WKY; palmitoleic, palmitic, linolenic, linoleic, oleic, 
stearic, arachidonic, dihomo-y-linolenic, behenic and lignoceric (Graph 5.3.3c).
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In the FFA fraction, the following fatty acid concentrations were higher in the 
SHRSP (Glasgow) compared to WKY; palmitoleic, palmitic, linoleic, oleic, stearic, 
arachidonic, and dihomo-y-linolenic acid (Graph 5.3.3d).
p<0.01
Graph 5.3.3b Fatty acid composition o f liver cholesterol esters (ng/mg protein) from 
SHRSP (Glasgow) and WKY. Statistics as described previously (n=8) for both groups.
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Graph 5.3.3c Fatty acid composition o f liver cell membrane TRIG (ng/mg protein) from 
SHRSP (Glasgow) and WKY. Statistics as described previously (n=8) for both groups.
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Graph 5.3.3d Fatty acid composition o f liver cell membrane FFA (ng/mg protein) from 
SHRSP (Glasgow) and WKY. Statistics as described previously (n=8) for both groups.
5.3.4 Polar Lipids.
Erythrocytes.
The following fatty acids were increased in the PE fraction from SFCRSP(Giasgow) compared 
to W KY; palmitic, linoleic and stearic acid. In the SPG fraction the levels o f stearic, 
behenic and lignoceric acid were increased in the SH R SP(Giasgow) compared to the W KY. 
These results are summarised in graph 5.3.4a.
Graph 5 .3 .4b details the differences in fatty acid composition if the PI fraction. Here the 
levels o f palmitic, linoleic, stearic, arachidonic, and dihomo-y-linolenic acid were increased 
in the SH R SP(GiasgoW) compared to the WKY.
Although not altered in the total lipid fraction, there was an increase in the amount o f 
linolenic acid in the PE fraction and an increase in the amount o f arachidic acid present in 
the SPG fraction from the SHRSP(Giasgow) compared to WKY. In the PI fraction,
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palmitoleic, linolenic, and oleic acid were increased in the SHRSP(Giasgow) compared to the 
WKY. These results are also summarised in graphs 5.3.4a and 5.3.4b.
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Graph 5.3.4a Fatty acid composition o f erythrocyte membrane PE and SPG (ng/mg 
protein) from SHRSP(Giasgow) and WKY. Statistics as described previously (n=8) for both 
groups.
186
^  SHRSP
□  W K Y
20000  -6000 -
5000 -c
o u a,
WD
E
'd3d
^  3000 d
‘G
<
2000  -
4000 -
10000 -
1000 -
o
<6
(N
OO
o
oo o
m
ooo-—' ’—■ -—' -—i -—« -—i r^ i cn
P I
p<0.01
Graph 5.3.4b Fatty acid composition o f erythrocyte membrane PI (ng/mg protein) from 
SHRSP (Glasgow) and WKY. Statistics as described previously (n=8) for both groups.
Liver Cell Membranes.
In the LPC fraction, the following fatty acids were decreases in SH R SP(Giasgo%v) compared 
to WKY, palmitoleic, palmitic, linolenic, linoleic, arachidonic, dihomo-y-linolenic, behenic 
and docosahexaenoic acid. In the SPG fraction the levels o f palmitic, linolenic, linoleic 
and arachidonic acid were decreases in the SHRSP(GiasgoW) compared to WKY. These 
results are detailed in graph 5.3 .4c.
187
^  SHRSP
□  WKY
30001
5000 -
so 4000 -
©uo.
2000  -
ox
£ 3000 -
~o3d c
2000  -
1000 -
1000 -
oo
vb‘
■I-
o oo
fNj r_  rH rH H  (N M  (N —  <N
LPC SPG
p<0.01 p<0.01
Graph 5.3.4c Fatty acid composition o f liver cell membrane LPC and SPG (ng/mg 
protein) from SHRSP(Giasgow) and WKY. Statistics as described previously (n=8) for both 
groups.
5.3.5 Indices of Fattv Acid Desaturation.
Erythrocytes
Graph 5.3.5a summarises the differences in essential fatty acid desaturation between 
S ffR S P (Glasgow) and W KY. The activity o f the A5 desaturase was increased in the total lipid 
fraction o f SH R SP(Giasgow) compared to W KY. This increase was also observed in the FFA  
and PE fractions. The index o f A6 desaturation was reduced in the total lipid fraction of 
the SFTRSP(Giasgow) compared to W KY. This was observed in the PI and SPG fractions but 
in the LPC fraction, the index o f A6 desaturation was increased.
There was no difference in the index o f total desaturation for total fatty acids between 
SHRSP (Glasgow) and WKY. This index was increased in the FFA fraction and PGS and 
reduced in the PI fraction o f SHRSP(Giasgow) compared to WKY.
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Graph 5.3.5a Indices o f essential fatty acid desaturation for erythrocytes from 
SHRSP (Glasgow) and WKY.
The index o f A9 desaturation was not altered in the total fatty acid fraction but was 
reduced in the FFA, PGS and PE fractions o f erythrocytes from SH R SP(GiasgoW) compared 
to WKY. These results are summarised in graph 5.3.5b.
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Graph 5.3.5b Indices o f A9 desaturation for erythrocytes form SHRSP(Giasgow) and WKY. 
Liver Cell Membranes.
In the total lipid fraction, there were no differences in the indices o f desaturation for the 
total lipid fraction. The index o f A5 desaturation was decreased in the PI and LPC 
fractions and increased in the PC fraction o f SHRSP(Giasgow) compared to WKY. The index 
o f A6 desaturation was reduced in both the PE and PC fractions from SHRSP(Giasgow) 
compared to WKY. The index o f total desaturation was increased in the CE and FFA and 
reduced in the PI and LPC fractions from SHRSP(Giasgow) compared to WKY (Graph 
5.3.5c).
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Graph 5.3.5c Indices o f essential fatty acid desaturation for liver cell membranes from 
SHRSP (Glasgow) and WKY.
The index o f A9 desaturation was increased in the PE, PC and LPC fractions and reduced 
in CE and SPG  fractions o f liver cell membranes from SHRSP(Giasgow) compared to WKY. 
These results are summarised in 5.3.5d.
191
SHRSP
0 .5 -
ao
0 .4-
0 .3 -
t*-o
x
■osl-N
0 . 2 -
0.1 -
0.0
PGS LPCPI PE
Graph 5.3.5d Indices o f A9 desaturation o f liver cell membranes from SHRSP(Giasgow) and 
WKY.
5.3.6 Saturated/! Insatnrated Fatty Acid Ratio.
Erythrocytes
The saturated/unsaturated fatty acid ratio was increased in the SPG  fraction o f erythrocyte 
membrane from SH R SP(Giasgow) compared to WKY. These results are summarised in graph
5.3.6a.
Liver Cell Membranes
There was an increase in the saturated/unsaturated fatty acid ratio in the PE, PC and LPC 
fraction and a reduction in the CE and SPG membrane fractions from SHRSP(Giasgow) 
compared to  WKY (graph 5.3.6b).
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Graph 5.3.6a Saturated/unsaturated fatty acid ratio for erythrocytes from SHRSP(Giasgow) 
and WKY.
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Graph 5.3.6b Saturated/unsaturated fatty acid ratio for liver cell membranes from 
SHRSP(Giasg0W) and WKY.
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5.3.7 Derived Phospholipid Composition
The differences in phospholipid composition are shown in graph 5.3.7. In the erythrocyte 
membranes, there was an increase in the amount o f SPG present in the SHRSP(Giasgow) 
compared to WKY In the liver cell membrane the concentrations o f PC, LPC and SPG 
were reduced in SHRSP(Giasgow) compared to WKY.
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Graph 5.3.7 Derived phospholipid composition o f erythrocytes and liver cell membranes 
from SHRSP(Giasgow) and WKY.
Part 2
5.3.8 Total Fattv Acids
Although ANOVA of the total fatty acid profile for the erythrocyte membrane from 
SHRSP(Heideiberg) compared to WKY suggested the presence o f significant differences, no 
single fatty acid could be identified to account for these (Graph 5.3 .8).
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Graph 5.3.8 Fatty acid composition o f total erythrocyte lipids (ng/mg protein) from 
SHRSP (Heidelberg) and WKY rats. Statistics as described previously (n=14) for both groups.
5.3.9 Neutral Lipids
The fatty acid composition o f TRIG fraction was found to be different between 
SHRSP (Heidelberg) and WKY. However, comparison o f the individual fatty acids did not 
provide any statistically significant differences (graph 5.3.9).
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Graph 5.3.9 Fatty acid composition o f erythrocyte TRIG (ng/mg protein) from 
SHRSP (Heidelberg) and WKY. Statistics as described previously (n=14) for both groups.
5.3.10 Polar Lipids
Statistically significant differences were obtained for the fatty acids composition o f PC and 
LPC. In both cases there was a general increase in the amount o f fatty acid present in the 
SHRSP (Heidelberg) compared to WKY although none o f these fatty acids returned a 
statistically significant t-test. See graphs 5.3.10a and 5.3.10b.
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Graph 5.3.10a Fatty acid composition o f erythrocyte PC (ng/mg protein) from 
SHRSP (Heidelberg) and WKY. Statistics as described previously (n=14) for both groups.
197
^  SHRSP
□  W K Y
10000 -
vb b> oo oo oo oo o  o  o  cn <n b>
Fatty Acid
p<0.01
Graph 5.3.10b Fatty acid composition o f erythrocyte LPC (ng/mg protein) from 
SHRSP (Heidelberg) and WKY. Statistics as described previously (n=14) for both groups.
5.3.11 Indices of Fatty Acid Desaturation.
The results for the indices o f fatty acid desaturation are shown in graphs 5 .3 .11a. For the 
total fatty acid fraction the index o f A5 desaturation was reduced in SHRSP(Heideiberg) 
compared to WKY. This difference was also apparent in the FFA fraction. The index of 
A6 desaturation was not altered for any o f the lipid fractions. The index o f total 
desaturation was also reduced in the total fatty acids fraction and in the FFA fraction of 
the SHRSP (Heidelberg) compared to WKY.
These results are summarised in graph 5.3.11b. The index o f A 9 desaturation was not 
altered in the total lipid fraction but was reduced in the PI and PE fractions o f 
SHRSP (Heidelberg) compared to WKY.
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Graph 5.3.1 la  Indices for essential fatty acid desaturation for erythrocyte membranes for 
SHRSP (H eidelberg) and WKY.
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Graph 5.3.11b Indices o f A9 desaturation for erythrocyte membranes from 
SHRSP (Heidelberg) and WKY.
5.3.12 Saturated/Unsaturated Fattv Acid Ratio
These results are summarised in graph 5.3.12. The saturated/unsaturated fatty acid ratio 
was reduced in the SPG fraction o f SHRSP(Heideiberg) compared to WKY.
5.3.13 Derived Phospholipid Composition.
Graph 5.3.13 shows the changes in the phospholipid composition between the two strains. 
The levels o f P C  were increased in the erythrocyte membranes from SH R S P (H eide iberg) 
compared to WKY.
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Graph 5.3.12 Saturated/unsaturated fatty acid ratio o f SPG from erythrocyte membranes 
from SHRSP(Heideiberg) and WKY.
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Graph 5.3.13 Derived phospholipid concentration o f erythrocyte membrane PC from 
SHRSP (H eidelberg) and WKY.
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5.3.14 Analysis of the F, Population.
Table 5.3.1 details the R and R2 values and the p value obtained for regression analysis for 
the systolic blood pressure and the traits observed to be different between the SHRSP 
(Heidelberg) and WKY. None of the traits studied were found to correlate with systolic 
blood pressure.
Trait P R value R2 Value
A5 in total fatty acid 0.189 0.324 0.105
A5 in FFA 0.27 0.274 0.075
total desaturase in total fatty acids 0.671 0.109 0 . 0 1 2
total desaturase in FFA 0.248 0.288 0.083
A9 in PI & PE 0.068 0.440 0.194
Sat/Unsat in SPG 0 . 8 6 0.044 0 . 0 0 2
Derived PC 0.435 0.197 0.039
Table 5.3.14 Values for regression analysis of traits in the F2  population of an 
SHRSP (Heidelberg) and WKY cross.
5.4 Discussion.
Analysis of the cell membrane composition of genetically hypertensive rats showed that 
there were differences in the fatty acid composition of liver and erythrocyte membranes 
between the S H R S P (GiasgoW) and WKY but these were not the same in both tissues. 
Differences were also observed between the erythrocyte membranes from SHRSP(Heideiberg) 
and WKY. Also, different changes from control were observed in the erythrocyte lipid 
composition of the two S H R S P  strains.
Why the SHRSP(Giasgow) and SHRSP(Heideiberg) membranes behaved differently is difficult to 
explain. The SHRSP(Heideiberg) were nine weeks older than the SHRSP(Giasgow) and had 
marked hypertension probably of some duration whereas the blood pressures of the 
SHRSP(Giasgow) and age-matched WKY were not significantly different at nine weeks 
although a difference might be predicted at 11 weeks (Davidson et al 1995). Even so the 
duration of hypertension still remains different for the two groups. Hypertension may itself 
affect membrane lipid composition. Also it is worth noting the S H R S P (Giasgow) were 
maintained on a normal diet while the S H R S P  (Heidelberg) were given sodium chloride in their 
drinking water; this will tend to elevate blood pressure. Changes in lipid metabolism occur
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with increasing age. PelufFo & Brenner (1974) reported that the activity of the desaturases 
decreases due to a reduction in affinity of the enzyme for its substrate (Hrelia et al 1990) 
but others have observed that activity fluctuates with time (Maniongui et al 1993). Either 
way, the differences may relate to the differences in ages of the two samples. It has also 
been shown that the desaturases activities can be different between rats of the same strain 
from different suppliers (de Antueno et al 1994); this was the case here. These differences 
suggest that the fatty acid composition of the membrane is not controlled by the same 
genetic factors which control blood pressure. Although both strains become hypertensive, 
some membrane changes were opposite. For instance, the index of A5 desaturase activity is 
increased in SHRSP(Giasgow) compared to W K Y  but reduced in SHRSP(Heideiberg)- To ascertain 
whether this difference is due to high blood pressure, it would be necessary to analyse lipid 
composition sequentially as hypertension develops. However, it is impossible to carry out 
this type of experiment without activating the renin-angiotensin system The changes in the 
two hypertensive strains will be discussed separately. The two strains were separated over 
2 0  years and it is possible that genetic differences in the two have become fixed in 
subsequent generations.
There was no statistical difference between the systolic blood pressure of the S H R S P (Giasgow) 
and WKY rats as measured at 9 weeks of age. Unfortunately, the blood pressure was not 
measured again at 11 weeks when the tissue was sampled. Hypertension in the S H R S P  rat 
is fully developed by 12 weeks (Davidson et al 1995). It is therefore likely that blood 
pressure was higher in the S H R S P  rats at 11 weeks (Dominiczak et al (1991) found a 
difference as early as 44 days of age). If so the changes in fatty acid composition may be 
secondary to this increase in blood pressure. If not, the differences observed between these 
two groups will not have been secondary to hypertension and may have played a causative 
role in raising the blood pressure. However, it also is possible that the maternal blood 
pressure, high in S H R S P , may exert some effect. It has been observed that 3 week old SH R  
rats have elevated erythrocyte membrane microviscosity in comparison to age-matched 
WKY. This would be prior to the onset of hypertension (Montenay-Garestier et al 1981).
The total lipid composition of the erythrocyte membrane was different in the SHRSP(Giasgow) 
compared to WKY. This applied to both endogenously-produced fatty acids and the 
essential fatty acids and their metabolites. Notably, the amount of long chain P U F A , in 
particular arachidonic and docosahexaenoic acid, present in the membrane was increased.
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This increase in arachidonic acid is in good agreement with previous studies (Naftilan et al 
1986, Ollerenshaw et al 1987 Dominiczak et al 1993) but is in contradiction with 
Horrobins’ (1995) theory that inadequate amounts of arachidonic acid may be a causal 
factor in coronary artery disease. PUFA are believed to increase membrane fluidity. Thus, 
the increase here is the opposite of the previously observed membrane microviscosity data. 
Arachidonic and docosahexaenoic acid are, however, only two of many unsaturated fatty 
acid present in the cell membrane. Although these are polyunsaturated, their effect on 
membrane fluidity is not directly proportional to the number of double bonds present. 
Studies of synthetic membranes have shown that changing a fatty acid from saturated to 
monounsaturated has a far greater effect on membrane fluidity than changing a 
monounsaturated fatty acid to a polyunsaturated fatty acid. By separating the lipids 
fractions and analysing their individual fatty acid composition, it should be possible to 
determine whether these were general changes or specific to one or more fractions.
In terms of exerting a physical effect on the membrane, alterations in the fatty acid 
composition of the lipids which are present in the largest quantities in the membrane will 
have most effect. PC, PE and SPG these constitute 31,15 and 8.5 percent of the membrane 
lipid respectively. However, some other lipid fractions may be of particular physiological 
importance, for example for cell signalling.
The changes in neutral lipid fatty acid composition were similar to those observed in total 
lipid composition. Difference were observed in the fatty acids present in CE, FFA and P G S. 
Although there was a general increase in the amount of fatty acid present in these fraction in 
the S H R S P  (Glasgow) compared to WKY, these fractions are quantitatively small and therefore 
may not have any measurable effect on the membrane’s physical properties. However, an 
increase in the amount of fatty acid present in the CE fraction of SHRSP(Giasgow) suggests 
that there may be more CE present in the membrane, which would be in accordance with an 
increased membrane microviscosity in these rats. In the FFA fraction, the level of 
arachidonic acid was increased in SHRSP(Giasgow) compared to WKY. The possible 
relevance of this will be discussed further later.
The fatty acid composition of the polar lipids was also different between the SHRSP(Giasgow) 
and WKY. These changes were similar to those observed in the total lipids fraction. The 
lipid groups which were affected were PE, SPG and PI. In terms of altering the physical 
properties of the membrane, the lipids present in the largest quantities were PE and SPG. In
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the PE fraction, there was a large (7 fold) increase in the levels of saturated fatty acids (18:0 
and 16:0) in the S H R S P (Giasgow) and WKY. This increase should be reflected in an increase 
in membrane microviscosity. Although there was also an increase in some of the 
polyunsaturated fatty acids present, the magnitude of the increase was much smaller than 
that for the saturated fatty acids. The changes in the fatty acid present in the S P G  fraction 
were limited to saturated fatty acids. The saturated fatty acids ranging form C l8  to C24 
were all increased in the membranes of SHRSP(Giasgow) compared to WKY. This again will 
have tended to increase membrane microviscosity. The derived membrane content of S P G  
was also increased in SHRSP(Giasgow) compared to WKY. S P G  is known to increase 
membrane microviscosity. The same is true for long chain fatty acids. It is not clear from 
the literature whether these two effects are additive but either one or both may be 
responsible for the increase in microviscosity observed by McLaren et al (1993) in the 
erythrocyte in the S H R S P  rat compared to WKY. The saturated/unsaturated fatty acid 
ratio in S P G  was increased in the SHRSP(Giasgow) as compared to WKY, this is in agreement 
with the changes in fatty acid composition.
Of particular physiological interest is the increase in the arachidonic acid content in the PI 
and FFA fraction from SH R SP (Giasgow) Arachidonic acid is increased in the membranes from 
subjects with genetic hypertension (see 5.1). These current results further show that this 
increase appears to be limited to lipid groups, P I and FFA.
This may be important for cellular signalling, particularly if similar changes occur in other 
cell types such as vascular smooth muscle. Phosphatidylinositol 4,5-bisphosphate (PIP2) is 
produced by phosphorylation of PI. In response to an external stimuli, cells hydrolyse PIP2 
to produce inositol 1,4,5-triphosphate (IP3), diacylglycerol and arachidonic acid, all of 
which are important cell signalling agents (Sperelakis 1995). Arachidonic acid can be 
converted into eicosanoids, a group of vasoactive compounds, consisting of prostaglandins, 
thromboxanes and leukotrienes (Rang & Dale 1991). Without a full scale analysis of the 
cycloxygenase pathway, it is impossible to ascertain whether the compounds produced will 
promote vasoconstriction or relaxation. It is possible that increased vasoconstrictor 
compounds could lead to elevated blood pressure in the SHRSP(Giasgow). However, an 
increase in the amount of vasodilator present could be an ‘effort’ to compensate for 
elevated blood pressure.
Moreover, arachidonic acid and other polyunsaturated fatty acids have been shown to 
inhibit gene transcription. PUFA, but not saturated or monounsaturated fatty acids, inhibit
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hepatic lipogenesis (Armstrong et al 1991, Blake & Clarke 1990), possibly at the level of 
enzyme synthesis (Clarke & Jump 1994), since high PUFA diets reduce the transcription of 
the fatty acid synthase gene (Armstrong et al 1991, Blake & Clarke 1990, Jump et al 1993, 
Limatta et al 1994j^cetylcarboxyla^(Katsurada et al 1990), malic enzyme and glucose X  
6 -phosphate dehydrogenasefSchWartz & Abraham 1983, Tomlinson et al 1988) are 
similarly affected. The suppression of transcription has a rapid onset, suggesting that the 
fatty acids exert a direct effect (Jump & Clarke 1994). Although other PUFA are capable 
of inhibiting gene transcription, it appears that they must undergo desaturation to be 
effective. This has been confirmed using the arachidonic acid analogue, eicosa-5,8,11,14- 
tetraynoic acid (Abraham et al 1977, Clarke & Clarke 1982, Tomlinson et al 1988). 
Conversely, PUFA have been found to induce the expression of peroxisomal enzymes, in 
particular acyl Co A oxidase (Flatmark et al 1988). It is now thought that fatty acids 
regulate gene transcription by affecting the activity of transcription factors which target cis- 
linked elements associated with specific genes (Clarke & Jump 1996). Free PUFA have 
also been shown to have other effects, including the activation of potassium channels in 
smooth muscle cells (Ordway et al 1989). As red cells have no nucleus, this affect is only 
important if the same changes occur in other cell types. What is important is that the 
composition of the erythrocyte membrane is thought to reflect that of the plasma, j 
Therefore if arachidonic acid is increased in the plasma or in lipoproteins, then this may 
have implications for many cell types.
The absence of differences in the saturated/unsaturated fatty acid ratio in any lipid group 
other than SPG is in contradiction to the evidence that the membrane microviscosity is 
increased in the SHRSP compared to WKY. Many factors affect cell membrane 
microviscosity including the membrane protein and cholesterol composition. In biological 
membranes, the control of membrane fluidity is complex and a simple comparison of 
saturated/unsaturated fatty acids will only provide the crudest of estimates.
The above changes in the membrane composition may reflect differences in the fatty acid 
desaturases. Direct measurements of the activity of the hepatic A5 and A6  desaturases have 
shown them to be increased in the SHR compared to WKY (Narce et al 1994). This 
analysis was accompanied by an compositional analysis of the cell membrane which showed 
a surprising reduction in the amount of arachidonic acid present. However, a later study by 
the same group suggested the enzyme activities to be reduced (Narce & Poisson 1995).
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Others have shown that physiological stress, which induces hypertension, reduced the 
activity of the desaturases (Mills & Ward 1989).
It was of interest here to evaluate whether the results obtained using the fatty acid data 
were in agreement with published data obtained using the direct enzyme assay. The A5 
desaturase activity was greater in the SHRSP(Giasgow) compared to WKY, agreeing with their 
relative membrane arachidonic acid content. The difficulty in comparing these 
measurements with previously obtained data is that Narce et al used much older animals 
than those used here.. A6 j desaturation was reduced in the total lipid fraction of 
S H R S P  (Glasgow) compared with WKY. The reduction in A6  activity and the increase in A5 
activity resulted in there being no net change in the total desaturase activity.
It was also of interest to evaluate whether the desaturation index for the individual lipid 
groups agreed with that of the total lipid fraction. Changes were not observed in every lipid 
group but only in PE and FFA. The change was most marked in PE. The index of A6  
desaturation was reduced in the PI and SPG fractions and increased in the LPC fraction . 
Alteration in the total desaturase could only be observed in the relatively minor lipid 
fractions. The A6  desaturase is thought to be the rate limiting enzyme in the desaturation, 
elongation pathway (Bemert & Sprecher 1975). Here the activity of this enzyme was 
reduced, yet the activity of the A5 was increased. It is possible that in the SHRSP, rats the 
A6  desaturase is not rate limiting or that the levels of dihomo-y-linolenic acid present in the 
membrane or the diet were such that the activity of the A6  desaturase was not rate limiting.
The index of A9 desaturation was reduced in the FFA, PGS and PE fractions but this affect 
was not seen in the total fatty acid analysis. The index of A9 desaturase activity is a ratio 
of oleic acid/stearic acid. As mentioned previously, changing a saturated fatty acid to a 
monounsaturated fatty acid has a major effect on membrane fluidity. As this occurs in the 
PE fraction, a quantitatively important component, this is in agreement with the increases 
membrane microviscosity in hypertensive rats.
Many of the differences from normal occurred in the PE fraction. This is an inner 
membrane lipid and it would be of interest to examine whither the changes in membrane 
microviscosity only occur in the inner leaflet. However, it is difficult to use fluorescent 
probes specific for different areas of the membrane with erythrocytes because of the
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interference from haemoglobin. Most studies of membrane microviscosity have been 
carried out in membrane preparations or erythrocyte ghosts.
It has previously been noted (chapter 4) that changes in response to L-NAME occurring in 
the fatty acid composition of the erythrocyte membrane appeared to be greater and more 
generalised than those seen in liver cell membranes. Reasons for this were discussed. A 
similar situation existed in the current experiment. One of the major differences from 
erythrocytes is that, in the liver cell membranes, the total fatty acid composition was not 
different between the two strains.
Like the erythrocytes, there was a general increase in the amount of fatty acid present in the 
CE fraction of the membrane in S H R S P (Giasgow) to WKY. Devynck et al (1982) showed that 
hepatocyte membranes from S H R  are less fluid than those from WKY. If the same is true 
for S H R S P ,  then this may be the mechanism responsible. As in the erythrocyte membranes, 
the concentration of arachidonic acid was increased in the FFA fraction from the 
S H R S P  (Glasgow) compared to the WKY. Unlike the erythrocytes, the fatty acid present in 
TRIG appear to be reduced in SHRSP(Giasgow) compared to WKY. How membrane TRIG 
levels relate to cellular fuel storage or phospholipid synthesis is not clear but this difference 
in TRIG content may be important.
The derived LPC concentration in the liver cell membrane was reduced in the SHRSP(Giasg0W) 
compared to WKY. This could be interpreted in two ways; a) as a reduction in the activity 
of the phospholipase enzymes or, b) as an increase in the activity of the acyl transferase 
enzymes. Previously, the activity of phospholipase A2 has been shown to be increased in 
cardiac myocytes from S H R  (Millanvoye-Van Bussel & Devynck 1995) and in renal cells in 
S H R S P  (Okamoto et al 1989). The increased activity of these enzymes in renal membranes 
is corrected by antihypertensive treatments, suggesting that the increase in blood pressure 
caused the increase in enzyme activity. Although the activity of this enzyme was not 
studied directly in the two rat strains, from the results obtained it is possible to suggest that 
the activity of the phospholipase is reduced as less LPC is produced. The absence of an 
increased phospholipase A2 activity may be due to the absence of an increase in blood 
pressure. Care should be taken not to over interpret the results obtained for LPC. In the 
S H R S P  (Glasgow)? the derived levels of PC and S P G  were also reduced compared to WKY. 
Therefore, there is an overall reduction in the amount of choline-containing lipids present in 
the membrane. This alteration was not observed in erythrocyte membranes although there
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was a reduction in the amount of some of the fatty acids present. As the composition of the 
erythrocyte is probably more similar to the vascular smooth muscle cells than liver cell 
membranes, this difference may not be relevant in terms of vascular physiology.
The changes in the fatty acids composition of SPG were different in the liver from the 
erythrocytes. As mentioned previously, the levels of SPG lignoceric acid were increased in 
the erythrocyte membrane of SHRSP(GiasgoW) compared to WKY but not in liver cell 
membranes. Shorter unsaturated fatty acids were increased in the SHRSP(Giasgow) which 
would tend to promote membrane fluidity. This again may suggest that the membrane has 
an ability to maintain homeostasis.
Although the liver is the major site of desaturation, the indices of fatty acid desaturation 
assessed in the total fatty acid were not altered. Direct measurement of hepatic desaturase 
activities SHR and WKY rats gave conflicting results as discussed previously (Narce et al 
1994, 1995, Narce & Poisson 1995). Thus in the current study, changes were only 
observable in the erythrocyte membranes, the composition of which is dependant on the 
plasma lipid composition.
It was again of interest to study whether the results obtained for the total lipids were 
mimicked by all the lipid groups. The changes observed for the individual lipid groups were 
not uniform. For A5 desaturase, the index was reduced in PI and LPC and increased in PC. 
As LPC is derived from PC and vice versa, it is difficult to explain why the index of 
desaturation is increased in one lipid and reduced in the other. PC is a major membrane 
lipid and the increase observed here agrees the situation in erythrocytes. The index of A6 
desaturase activity was reduced in both PE and PC. Again these are major lipids and the 
situation agrees with that observed with the erythrocytes.
There was no change in the index of A9 desaturation between the two strains but there was 
an increase in the index in PE and PC. This would tend to make the membrane more fluid, 
possibly an attempt by the liver cell to maintain membrane fluidity, although fluidity has 
been reported to be lower in hepatocytes form the SHR rats compared to the WKY 
(Devynck et al 1982). There have been no previous studies of the A9 desaturase in 
genetically hypertensive rats. This is surprising since it is the best characterised enzyme and 
the only one yet cloned.
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Although the saturated/unsaturated fatty acid ratio was not different for the total fatty acids 
it was different in P E , P C  and LPC . Here there was an increase in the ratio, suggesting that 
there is relatively more saturated fatty acid present in the membrane in the S H R S P (Giasgow) 
compared to WKY and that these changes occur in both the inner and outer leaflet. This 
would be in agreement with the Devynck et al study (1982) which showed that hepatocyte 
membrane in S H R  rats is less fluid than in control animals. The saturated/unsaturated ratio 
for S P G  fraction from the liver cell membranes also provided interesting results. SP G , as 
mentioned previously, contains primarily saturated fatty acids. However, in SHRSP(Giasgow), 
the levels of unsaturated fatty acid in this lipid group were increased. This is opposite to 
what was observed in the erythrocyte membrane.
5.4.2 Cosegregation Study.
The aim of the second part of this study was to assess whether the gene(s) which control 
blood pressure cosegregate with putative gene(s) which control membrane composition. 
The membrane compositional traits in the F2 population produced by crossing 
SHRSP(Heidelberg) and WKY rats were studied. In this F2 progeny the genes for membrane 
traits and blood pressure traits will have had a chance to recombine. Therefore, if the 
genetic loci which control membrane composition are the same or closely related to the loci 
which control blood pressure a correlation between the two traits will be observed. If the 
phenotypic indices of membrane composition and blood pressure are correlated then the 
genes for the two traits can be said to cosegregate and may be causally related or the 
changes in the membrane may be secondary to hypertension. If they are found not 
cosegregate then it is possible to carry out a total genome search to identify the gene(s) 
responsible for controlling membrane composition.
Difference between the two parental strains were first identified. The index of A5 and total 
desaturation in both the total lipid fraction and the free fatty acid fraction, the index of A9 
desaturation in the P I and P E  fractions and the saturated /unsaturated ratio in the SP G  
fraction were all reduced in the SHRSP(Heideiberg) compared to WKY. The derived 
concentration of PC  in the membrane was increased in the SHRSP(Heideiberg).
None of these membrane traits correlated with blood pressure in the F2 population. 
Therefore, this study provided no evidence that the genes which control blood pressure and 
those which control the fatty acid composition of the membrane cosegregate. This suggests 
that membrane compositional abnormalities are not causally related to hypertension in the
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genetically hypertensive rat. The differences between the two strains of rats may therefore 
be due to chance fixation of the genes during the inbreeding of the SHRSP and the 
unrelated to the occurrence of increase blood pressure. However the sample size used here 
was small and this may have compromised the results.
Most of the enzymes involved in lipid biochemistry in the cell are membrane-bound, either 
all the time or at certain times during the production of lipids. Thus the enzymes may 
themselves be affected by the membrane fluidity and it may be this effect which leads to 
differences in the membrane composition between the two strains. For this to be true, 
membrane fluidity must be altered by something other than the fatty acids and lipids present, 
possibly protein concentration or cholesterol concentration, neither of which were measured 
here. McLaren et al (1993) failed to show a correlation between membrane microviscosity 
and blood pressure in an F2 population also produced by crossing SHRSP(Heideiberg) and WKY 
rats.
Other phenotypes which relate to ion transport and vascular function have undergone 
similar analysis in F2 populations produced from genetically hypertensive and normotensive 
rats. Lymphocyte potassium efflux rate has been shown to correlate with blood pressure 
but lymphocyte sodium influx did not (Furspan et al 1987). The contractile activity to 
noradrenaline has also been studied; the osccillartyory contractile activity in tail arteries 
(Bruner et al 1986) and mesenteric arteries (Mulvaney 1988) correlated with blood 
pressure. It has also been observed that the aortic smooth muscle contractile response to 
cobalt correlates with blood pressure (Rapp 1982). Other phenotypic variables which have 
failed to show a correlation with blood pressure include whole body exchangeable sodium 
and sodium intake (Harrap 1986).
It is of interest that the traits which do correlate with blood pressure appear to be primarily 
dependant on one protein (and therefore one gene) such as the noradenaline receptor. The 
process of maintaining the membrane composition requires many proteins, and therefore 
many genes. Their relationships with the development of hypertension will be 
correspondingly complex.
The analysis of the F2 population may have been compromised by the small numbers of 
samples available. However the membrane samples did cover the full range of blood 
pressures obtained for the F2 generation (i.e. blood pressures ranged from 120 mmHg to
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160 mmHg). A large amount of variability may have resulted form the way the samples 
were handled prior to lipid analysis. During transit from Germany to Glasgow, some 
haemolyisis occurred which made preparation of milky white membrane, as have been used 
in the previous studies, difficult. In my experience, when samples of whole blood are left on 
ice for prolonged periods before membrane preparation, it becomes very difficult to remove 
all the haemoglobin. However, prolonged washing of the membranes reduces the yield of 
membrane obtained. Therefore, a compromise had to be made. The presence of some 
residual haemoglobin may have affected the lipid results or the protein analysis. Finally, the 
membranes were collected and prepared over many months. Thus the samples were stored 
for different lengths of time possibly contributing to the variability in the results.
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Chanter 6 Cell Membrane Composition in Diabetes.
6.1 Introduction.
It has been suggested that changes in erythrocyte structure and function are implicated in 
the pathogenesis of diabetic vascular disease (Isogia et al 1991, Schmid-Schonbein & 
Volger 1976). Cell membrane microviscosity is inversely related to cell deformability and 
has been extensively studied in diabetic patients. Unfortunately the results of these studies 
have frequently been conflicting (See section 1.13).
Thus, erythrocyte membranes diabetic patients have variously been found to be more fluid, 
(Bryszewska & Leyko 1983) unchanged (Freyburger et al 1988, Hill & Court 1983) or 
less fluid (Caimi et al 1992) compared to control patients. As discussed earlier, 
comparison of these results is compromised by the variation in the success of metabolic 
control between the study groups (Candiloros et al 1995, Watala & Winocour 1992, 
Winocour et al 1990). Few reliable studies of membrane lipid composition have been 
published. Kamada & Otsuji (1983) found more SPG and less PE in the membranes of 
diabetic subjects compared to control. This would mediate toward a less fluid membrane. 
Indeed membrane fluidity was negatively correlated with membrane SPG content (Caimi et 
al 1995). Clearly, many other membrane lipids contribute to its physical characteristics 
and a comprehensive analysis may help to establish the nature of these changes.
6.2 M a te r ia ls  a n d  M eth o d s.
Whole blood was obtained from diabetic patients (8 NIDDM, 8 IDDM and 8 IRD {IRD 
are NIDDM patients requiring treatment with insulin}) attending the diabetic clinic at 
Gartnavel General Hospital, Glasgow. Blood was transported the laboratory on ice and 
erythrocyte membranes prepared. Age matched controls were obtained from within the 
laboratory and the staff of the Western Infirmary, Glasgow.
Membrane lipid composition and membrane microviscosity were analysed and presented as 
previously described (n=8 for all study groups and controls). All results are significant 
(p<0.05), * indicates p<0.01.
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6.3 Results.
All patients were treated either with insulin or metformin ± glibenclamide, see appendix 1.
6.3.1 Total Fattv Acid
When the fatty acid composition o f the total lipid fraction was analysed IDDM patients 
membranes contained significantly more palmitic, palmitoleic, dihomo-y-linolenic acid and 
DHA than normal (Graph 6.3.1), but those from NIDDM  and IRD patients did not differ 
from normal.
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Graph 6.3 .1 Fatty acid composition o f erythrocyte membrane lipids (ng/mg protein) from 
IDDM patients and controls. All results are statistically significantly different (p<0.05) * 
indicates p<0.01 (n=8 for both groups).
6.3.2 Neutral Lipids.
Palmitic and palmitoleic acid were also increased in the CE and FFA fractions from IDDM 
patients. In addition, linolenic acid was reduced and stearic and arachidonic acid were 
increased in IDDM patients compared to control (Graph 6.3.2). These differences were 
not detectable in the total lipid analysis. Although ANOVA indicated differences in the 
fatty acid composition o f the TRIG fraction from IDDM patients no individual differences
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could be identified (Graph 6.3.2b). Again NIDDM and IRD membrane did not differ 
significantly from normal.
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Graph 6.3.2a Fatty acid composition o f erythrocyte membrane CE and FFA (ng/mg 
protein) from IDDM and control patients. All results are statistically significantly different 
(p<0.05) * indicates p<0.01 (n=8 for both groups).
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Graph 6.3 .2b Fatty acid composition o f erythrocyte TRIG (ng/mg protein) from IDDM 
patients and control. All results are statistically significantly different (p<0.05) * indicates 
p<0.01 (n=8 for both groups).
6.3.3 Polar Lipids
In the IDDM PE fraction, palmitic and palmitoleic acid were increased and in the SPG 
fraction, palmitic acid was increased. The linolenic, linoleic and oleic acid content o f the 
PE fraction were also increased as was stearic acid in the SPG fraction (Graph 6.3.3a). 
These differences were not identifiable in the total lipid analysis. Although ANOVA 
indicated possible differences between normal and IDDM in the LPC fraction, individual 
differences could not be identified (Graph 6,3.3b).
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Graph 6.3.3a Fatty acid composition o f erythrocyte PE and SPG (ng/mg protein) from 
IDDM patients and controls. All results are statistically significantly different (p<0.05) * 
indicates p<0.01 (n=8 for both groups).
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Graph 6.3.3b Fatty acid composition o f erythrocyte LPC (ng/mg protein) from IDDM 
patients and controls. All results are statistically significantly different (p<0.05) * indicates 
p<0.01 (n=8 for both groups).
Some changes were also identified in the fatty acid content o f the NIDDM PC and LPC 
fractions which were not apparent in the total lipid analysis. In the PC fraction, arachidic 
acid and DHA were reduced in NIDDM patients while in the LPC fraction, linolenic, 
linoleic and arachidonic acid were higher than normal (Graph 6.3.3c). No specific changes 
in the SPG fraction could be identified despite ANOVA indicating the contrary (Graph 
6.3.3d).
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Graph 6.3 .3 c Fatty acid composition o f erythrocyte PC and LPC (ng/mg protein) from 
NIDDM patients and control. All results are statistically significantly different (p<0.05) * 
indicates p<0.01 (n=8 for both groups).
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Graph 6.3 .3d Fatty acid composition o f erythrocyte SPG (ng/mg protein) from NIDDM 
patients and controls. All results are statistically significantly different (p<0.05) * indicates 
p<0 01 (n=8 for both groups)
Finally, a significant increase in the palmitic and palmitoleic acid content o f LPC was 
observed in IRD compared to control. This was not obvious in the total lipid analysis 
(Graph 6.3 .3e).
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Graph 6.3.3e Fatty acid composition o f erythrocyte LPC (ng/mg protein) from IRD 
patients and controls. All results are statistically significantly different (p<0.05) * indicates 
p<0.01 (n=8 for both groups).
6.3.4 Indices of desaturation
Desaturase activity was normal in the IDDM group but there were identifiable changes in 
the other groups. There was evidence o f less total desaturase activity (total lipid fraction) 
but increased A9 desaturase activity (LPC fraction) in the NIDDM  patients compared to 
control (Graphs 6.3.4a & b). Conversely, in IRD patients both A5 desaturation (PGS 
fraction), total desaturation (PGS and LPC fractions) and A9 desaturation (total lipid and 
PC fractions) were reduced compared to control (Graph 6.3 .4c &d).
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Graph 6.3.4a & b . Indices o f total and A9 desaturase activity for erythrocytes from 
NIDDM patients and controls (n=8 for both groups).
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Graph 6.3.4c Indices o f essential fatty acid desaturation for erythrocytes from IRD and 
control patients (n=8 for both groups).
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Graph 6.3 .4d Indices o f A9 desaturase activity for erythrocytes from IRD patients and 
controls (n=8 for both groups)..
6.3.5 Satnrateri/nnsatiirateri fattv acid ratios.
There were no significant differences between the saturated/unsaturated fatty acid ratios o f 
IDDM or IRD patients and control subjects. However, in the CE fraction from NIDDM 
patients, this ratio was higher than normal (graph 6.3.5).
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Graph 6.3 .5 Saturated/unsaturated fatty acid ratio for erythrocyte cholesterol esters form 
NIDDM patients and control (n=8 for both groups).
6.3.6 Derived phospholipid composition.
The levels o f both PE and SPG were increased in IDDM patients compared to control 
(Graph 6.3.6a). In membranes from IRD patients, there was significantly more LPC than 
normal (Graph 6.3.6b). No differences could be detected between NIDDM patients and 
controls.
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Graph 6.3.6a & b Derived phospholipid composition o f erythrocyte membranes from 
IDDM patients and control and IRD patients and controls (n-8 for both groups).
6.3.7 Membrane cholesterol and cholesterol/phospholipid ratios
There was no significant difference in membrane cholesterol from IDDM patients 
(237.35±36.17 pg/mg protein) and controls (158.81±19.68 pg/mg protein) (p=0.080). 
There was also no significant difference between the C/PL ratio from the IDDM 
(0.41±0.10) and control patients (0.29±0.02) (p=0.29). There were no significant 
differences in the membrane cholesterol between NIDDM patients (259.55±41.21pg/mg 
protein) and controls (206.67±23.41 pg/mg protein) (p=0.28) or in the C/PL ratio from 
NIDDM patients (0.46±0.06) and control (0.35±0.03) (p=0.14). There was no significant 
differences in the membrane cholesterol between IRD patients (193.48±19.8pg/mg 
protein) and controls (207.69±23.40pg/mg protein) (p^O.66) or in the C/PL ratio from 
NIDDM  patients (0.52±0.11) and control (0.49±0.06) (p=0.80).
6.3.8 Membrane microviscositv.
There were no significant differences in erythrocyte membrane microviscosity as measured 
using TM A-DPH between any o f the groups and control values. IDDM  patients: 
(0.258±0.002) compared to control (0.256±0.001) (p=0.43), NIDDM  patients:
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(0.258±0.003) and controls (0.257±0.002) (p=0.96), IRD patients: (0.259±0.001) and 
control (0.255±0.002) (p=0.15).
6.4 Discussion.
The groups of diabetic subjects matched the control subjects well for age. However, it is 
important to emphasise that all the patients were undergoing treatment and that the degree 
of metabolic control varied considerably, tending to be less good in the IRD group (see 
appendix 1) None of the patients were seriously hypertensive. As previously discussed, 
this affects the cell membrane properties (Candiloros et al 1995, Watala & Winoccour 
1992, Winocour et al 1990). In agreement with some previous studies (Hill & Court 
1983, Freyburger et al 1988), no evidence of altered membrane microviscosity was 
obtained. However, interesting abnormalities in lipid composition were identified which 
might have had conflicting and therefore compensating effects on membrane 
microviscosity. Many of these differences were not obvious when the total fatty acid 
analysis was carried out and were revealed only by more detailed analysis of the lipid 
groups. The changes were most marked in the IDDM group.
The changes in the fatty acid composition of the EDDM the total lipids included an 
increase in two endogenously produced fatty acids, palmitic and palmitoleic acid. This 
suggests that endogenous fatty acid production is not impaired in IDDM patients. As one 
fatty acid is saturated and the other unsaturated, their increase will have opposing effects 
on membrane fluidity.
The increase observed in the levels of dihomo-y-linoleic acid in IDDM patients suggests 
that there is possibly a reduction in the activity of the A5 desaturase, thereby causing a 
build-up of the enzyme substrate. Bassi et al (1996) suggested that essential fatty acid 
metabolism was impaired in IDDM patients during ketoacidosis and that this could be 
corrected by insulin. The activity of the A5 and A6 desaturases has also been shown to be 
impaired in platelets from IDDM and NIDDM patients (Jones et al 1986). Although the 
levels of dihomo-y-linoleic acid were increased in the EDDM patients, there were no 
alterations in the actual index of desaturase activity. This may have been because the 
IDDM patients were insulin-treated. DHA is a long chain PUFA; an increase in this would 
have been thought to increase membrane fluidity. This was not the case.
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Unlike the IDDM patients, the fatty acid composition of the membrane was not altered by 
diabetes in the IRD or NIDDM patients. These results are in keeping with the direct 
measurements of membrane fluidity which were also not different in the two groups of 
diabetics and their controls.
Analysis of the neutral lipids from IDDM membranes showed that some of the changes 
observed in the total lipid analysis were conserved here. In particular, the levels of palmitic 
and palmitoleic acid were increased in the FFA and CE fraction. Also in keeping with the 
total lipid analysis, no differences were observed in the fatty acid composition of the 
neutral lipids from NIDDM and IRD patients compared to control. The changes which 
were observed in the IDDM fraction were in comparatively minor lipid groups and thus 
will not have had a major effect on the membrane physical properties.
Analysis of the membrane polar lipids revealed more differences in the fatty acid 
composition of the membrane from diabetics and controls. Both the fatty acid 
composition and the derived phospholipid composition of PE and SPG were different in 
IDDM patients compared to control. The levels of both were increased in the erythrocyte 
from the diabetic patients. As SPG causes a reduction in membrane fluidity and PE an 
increase, the effects of these two lipids appear to have cancelled each other out as there 
was no difference in the observed membrane microviscosity between patients and control. 
The fatty acid composition of these lipids reflects their effect on membrane fluidity. In PE 
the only fatty acids which were altered were unsaturated with the exception of palmitic 
acid. This would be effective at increasing membrane fluidity. The fatty acids which were 
increased in the SPG fraction of the IDDM patients were saturated; these would have been 
effect at reducing membrane fluidity. The results for the derived PE concentration were 
in contradiction to previous reports suggesting that the levels of PE in the membrane are 
reduced in diabetic patients (Caimi et al 1995). Others have observed in increase in SPG 
in the membrane and a reduction in PE (Kamada & Otsuji 1983).
Although no differences were observed in the total fatty acid composition of NIDDM and 
IDDM patients, there were differences in the composition of the polar lipid groups. In the 
PC fraction, there was a reduction in the amount of arachidic acid and DHA in the 
NIDDM patients. In the LPC fraction, there was an increase in the amount of linolenic, 
linoleic and arachidonic acid present in the NIDDM subjects. It is interesting that the fatty 
acids which are altered in PC are not the same as those which are altered in LPC. This
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may mean that in the diabetic subjects, there is more de novo synthesis of PC than 
reacylation of LPC. This would be in agreement with others who have suggested that the 
reacylation of lipids is impaired in diabetics (Le Petit-Thevenin et al 1988, Arduni et al 
1995). Others have analysed the fatty acid composition of PC in NIDDM patients and 
found there to be an increase in palmitic, oleic and arachidonic acid and a reduction in 
palmitic and oleic acid (Perrsom et al 1996). This does not agree with the results obtained 
here.
In the IRD patients, there was an increase in the amount of LPC present in the erythrocyte 
membrane compared to control. This increase may suggest an increase in the activity of 
the phospholipase enzymes or a reduction in the reacylation of lipids. A reduction in lipid 
reacylation has previously been suggested (Le Petit-Thevenin et al 1988, Arduni et al 
1995). The only lipid group where an alteration was observed between IRD and control 
was in the LPC fraction where the levels of palmitic and palmitoleic acid were increased. 
These fatty acid have also been seen to be increased in other lipid groups in IDDM 
patients. Also, a similar trend toward more LPC was observed in IDDM patients and in 
NIDDM patients. The fatty acid composition of PC and LPC suggests that reacylation of 
LPC may be impaired. Thus, this may be a generalised defect in diabetes although further 
experiments would be required to confirm this.
The saturated/unsaturated fatty acid ratio for the total lipids was not different between any 
of the diabetic and control groups. This is in agreement with the direct physical 
measurements which showed no difference in membrane microviscosity. Further analysis 
of the membrane lipid composition revealed that in the NIDDM patients, there was an 
increase in the saturated/unsaturated fatty acid ratio in the CE fraction. This is such a 
minor group that it may not be of physiological relevance.
Although there were few observable changes in the degree of fatty acid unsaturation, there 
were some changes in the indices of fatty acid desaturation. The index of total essential 
fatty acid desaturation was reduced in NIDDM patients compared to controls although 
this change in desaturation could not be observed in any of the individual lipid groups. 
Others have observed that essential fatty acid desaturation is reduced and humans (Jones 
et al 1986, Bassi et al 1996). Although the indices of essential fatty acid desaturation 
were not different in the total lipid fraction between the IRD patients and control there 
were alterations in some of the lipid groups. The index of A5 desaturation was seen to be
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reduced in the PGS fraction of the IRD patients. The PGS fraction also had a reduced 
index of total desaturase activity as had the LPC fraction. Both of these are minor 
membrane fractions which may not affect the physical properties of the membrane.
The index of A9 desaturation was seen to be increased in the LPC fraction from NIDDM 
patients compared to control. This, as mentioned previously, is a relatively small 
membrane component and may not be physiologically relevant. In the ERD patients the 
index of A9 desaturation in the total lipid fraction was reduced compared to control This 
was also observed in the PC fraction, a major outer membrane lipid. To the best of my 
knowledge, desaturase enzymes have never been studied in a group of IRD patients. This 
reduction in the production of oleic acid would lead to the membrane being less fluid. 
However, the direct membrane microviscosity measurements made here did not reflect 
this.
None of the diabetic groups studied showed a difference in membrane microviscosity 
compared to control. This may relate to the membrane lipid composition as discussed 
previously, but it is also possible that the treatment the patients were receiving affected the 
membrane fluidity. Insulin is known to increase membrane fluidity directly (Dutta-Roy et 
al 1985, Bryzewska & Leyko 1983, Juhan Vague et al 1986). Therefore, if there were 
changes in fluidity caused by diabetes, these may have been corrected by insulin treatment. 
Fluidity is also known to be influenced by the metabolic control of the patients, with poor 
control reducing membrane fluidity (Candiloros et al 1995, Watala & Winocour 1992, 
Winocour et al 1990). The only group with consistently poor metabolic control were the 
IRD group, but these were also insulin-treated and the two effects may have compensated 
for each other. The absence of a difference in the C/PL and membrane cholesterol content 
for any of the groups is in agreement with other previous studies in erythrocytes (Hill & 
Court 1983) and platelets (Caimi et al 1995).
The published evidence for changes in membrane structure and function in diabetes is 
varied and often conflicting. Although in this study some of the results obtained were in 
agreement with the previously published observations many, like membrane 
microviscosity, were not. In the case of the IRD and IDDM patients, insulin treatment 
may have affected the results obtained. Another confounding factor is that in human 
studies of this nature, it is impossible to control the dietary lipid intake as with laboratory
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animals. Also, the duration of diabetes can be controlled in rat models. The groups 
studied here had been suffering from diabetes for various lengths of time.
The results obtained here are in agreement with some of the studies carried out in rat 
models. For instance, the increase in the concentration of membrane DHA observed in 
IDDM patients is in agreement with studies carried out in STZ-diabetic rats (Dang et al 
1991). Moreover it has previously been suggested that the activity of the A5 desaturase is 
reduced in heart, liver, kidney, aorta (Holman et al 1983) and adrenal gland (Igal et al 
1991) as well as other tissues in STZ-diabetic rats. This is in agreement with some of the 
results observed here. The same is true of the results obtained for the A9 desaturase which 
has also been shown to have reduced activity in alloxan diabetic rats (Clarke & Queener 
1985) and BB spontaneously diabetic rats (Minouini et al 1992). Some of the results 
obtained here are, however, in contradiction to the results seen in diabetic rats. 
Erythrocytes from STZ-diabetics rats incorporate less palmitic acid and that this could not 
be fully corrected for with insulin treatment (Arduini et al 1995).
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Chapter 7 General Discussion
Cell membrane abnormalities occur in a variety of diseases including hypertension and 
diabetes. As discussed in chapter 1, the membrane controls many cell function but whether 
these abnormalities initiate or contribute to the disease process or are merely responses to it 
remains unclear. To study this problem, good analytical methods are obviously necessary. 
The fluidity (microviscosity) of the membrane can be measured using fluorescent probes 
which are able to distinguish physical changes in the inner and outer leaflets. The 
biochemical basis of the changes is much less easily accessible; published data on membrane 
composition in these diseases are sparse and often conflicting (see 1.11.3 & 1.11.4). Never­
theless, it is desirable for several reasons. Without complete analysis of the membrane 
lipids it is impossible to distinguish whether changes in microviscosity are due to a 
generalised defect in the fatty acid metabolism or to an effect on a specific membrane lipid. 
Thorough analysis of fatty acid composition may be a more informative index of 
microviscosity, especially where it is not possible to use specific probes for the inner and 
out leaflet. Furthermore, it might reveal real changes in composition which have no net 
effect an fluidity. Some of these, such as alterations in arachidonic acid content (see chapter 
5), may have obvious implications for cell function. The current study has sought to devise 
such a method and to test its performance in three situations in which membrane changes 
are recognised.
The method has been based on that of Hamilton and Comia (1988). Careful evaluation, 
however, revealed a serious flaw which required major reorganisation. Firstly, the recovery 
of lipids was less efficient than reported. It was also found that acetic acid, recommended 
by Hamilton and Comia (1988) as a component of solvents for eluting lipids from Sep-pak 
cartridges, caused significant hydrolysis of lipid ester bonds. This caused serious distortion 
of the assessment of FFA content (see chapter 3 sections 3 & 4). These problems were 
solved by adjusting the volumes of eluting solvents, by removing the acid from the solvents 
and by separating the components of neutral lipids and polar lipids on different Sep-pak 
cartridges. The performance criteria were determined (see 3.7.1). The complexity of the 
protocol, while it ensured a high level of specificity, meant that precision was variable. This 
has been taken into account when discussing the results of the three studies. It cannot be 
claimed that the method is a simple routine but it provides a comprehensive analysis of 
membrane lipids with their fatty acid content. From this, it has also been possible to assess 
desaturase activity. It is possible that, if major reproducible changes are identified in 
specific situations, the method could be simplified to focus on these.
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Cell membrane microviscosity in SHRSP and SHR is higher than in WKY rats (see 
1.11.4a). In diabetic rats and human patients, the evidence is more conflicting with both 
increased and reduced membrane fluidity reported (see 1.11.3). In rats treated with L- 
NAME, from which they developed hypertension, membrane fluidity was found to be 
increased (Chapter 4). A primary aim of the current study was to ascertain whether these 
changes could be explained by specific changes in lipid composition.
In general terms, the cell membrane composition by-and-large reflected the changes in 
membrane microviscosity. When membrane microviscosity was increased, the amount of 
unsaturated fatty acid present was decreased and vice versa. Also, the index of A5 
desaturation appeared to follow a similar pattern with increased desaturation leading to 
increased membrane fluidity. The concentrations of the phospholipids also appeared to 
agree in most cases with the direct physical measurements. In some cases, however, the 
direct measurement and the compositional measurement disagree, as was the case for 
cholesterol in the L-NAME-treated rats. Membrane cholesterol increased and membrane 
microviscosity decreased, the opposite to what was expected. This highlights the great 
value of carrying out a full compositional analysis of the membrane. As the changes in 
phospholipid composition appear to have compensated for the increased cholesterol, it 
would be interesting to manipulate membrane composition to study the relative effects of 
various lipids on fluidity. Some such studies have been carried out on artificial membranes 
but their physiological relevance is questionable.
Analysis, as carried out here, can reveal changes which, while not altering the physical 
properties of the membrane, might change the function. In the EDDM patients, there was an 
increase in the amount of PE and SPG present in the membrane. As these have opposite 
effects on fluidity, no net change was observed. The increase may reflect a change in the 
activity of enzymes involved in the production or degradation of these lipids and may be a 
contributor or a consequence of the altered intermediary metabolism characteristic of this 
disease.
The membrane exists in a constantly changing sate with the lipids perpetually being shuttled 
into and out of the membrane. The analyses made here are at best a “snap-shot” of this 
process and gives no indication of over what time scale these alterations have occurred. To 
evaluate this, it would be necessary to carry out a time course experiment, sampling at
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various intervals. With the present method sensitivity, however, the amount of blood 
required would certainly activate the renin-angiotensin system, compromising the results. 
Thus ways of markedly increasing the sensitivity must be sought. Many of the results 
obtained here suggest that enzyme activity is altered and it would now be of interest to 
assess these activities directly to confirm the observation. The method could readily be 
adapted for use with radioactive lipids to measure the rate at which they are taken up into 
the membrane. Radioactive fatty acid could be administered to rats to follow the time 
course of their fate in vivo. Finally, although the method was developed specifically for cell 
membranes it is applicable to all other lipid containing tissues, for example atheromatous 
plaques.
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Annenriix 1
Patient data for diabetic study, see chapter 6.
DOB Duration of 
diabetes (years).
Treatment Blood
Pressure
(mmHg)
Weight
(Kg)
HSAlc
11.7.65 8 ins 120/80 82 4.5
9.2.44 5 ins 110/60 66 6.1
12.2.62 5 ins 110/70 76 5.7
6.2.47 5 ins 110/60 63 6.6
17.5.54 2 ins 116/78 76 NA
29.2.64 14 ins 110/70 59 9.0
26.3.65 18 ins 120/80 81 7.7
3.6.72 6 ins 120/70 73 5.2
Table 1. Patient information for the IDDM patients studied in chapter 6. Abbreviations: 
DOB-date of birth, ins-insulin, HSAic,-Haemoglobin Aic
DOB Duration of 
diabetes (years).
Treatment Blood
Pressure
(mmHg)
Weight HSAic
18.4.63 1 met 130/90 81 4.2
7.11.26 3 glic/met 170/110 89 5.4
15.2.42 8 glic/met 110/70 77 9.1
15.6.41 4 glic/met 160/80 102 6.2
8.3.43 7 glic/met 135/85 94 8.6
17.1.34 7 glic/met 150/74 71 5.5
8.6.31 4 glic 110.50 62 6.2
27.1.56 1 glic 130/82 83 8.2
Table 2 Patient information for the NIDDM patients studied in chapter 6. Abbreviations as 
above, met-metformin, glic-glibenclamide
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1DOB Duration of 
diabetes (years).
Treatment Blood
Pressure
(mmHg)
Weight
(Kg)
HSAic
3.7.34 1/9 ins 160/70 72 6.3
12.10.29 20/25 ins 120/90 54 8.9
4/8/22 4/10 ins 170/70 56
5.5.37 10/23 ins 112/70 71 7.3
1.6.37 13/27 ins 135/80 81 10.5
2.3.30 10/22 ins 135/70 88 10.3
31.8.46 3/4 ins 138/90 68 9.1
31.10.20 2/8 ins 150/80 81 5.9
Table 3 Patient information for the IRD patients studied in chapter 6. Abbreviations as 
before. Duration of diabetes shows the number for years that the patient has been requiring 
insulin for and the total number of years since diagnosed as NIDDM.
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